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ABSTRACT 
 
Negative symptoms – reductions in expression, motivation, pleasure and sociability 
– are observed across the spectrum of functional psychoses. They have been 
identified as a significant predictor of poor outcomes following first-episode 
psychosis and are a treatment priority for individuals with lived-experience of 
psychosis. However, the mechanisms underlying negative symptoms remain poorly 
understood. This thesis aims to contribute to our understanding of negative 
symptoms in the early phase of psychosis using a mixed methods approach.  
 
Participants in the EDEN study (n = 1006) were followed up for 12 months 
following acceptance into UK Early Intervention in Psychosis services. Negative 
symptom severity data were modelled using latent class growth analysis, allowing 
latent classes comprising individuals with similar patterns of change in negative 
symptoms severity over time to be identified. Predictors of latent class membership 
were ascertained and the relationship between negative symptom trajectories and 
concurrent social recovery explored. Subsequently, transcripts of qualitative 
interviews conducted with a subsample (n = 24) of the cohort were analysed 
thematically. Comparisons were made between the accounts of members of the 
identified latent classes. Experiences and personal understandings of negative 
symptoms, psychosis, treatment and recovery were explored, providing insights into 
potential mechanisms underlying negative symptoms and their relationship with 
social recovery. 
 
The quantitative and qualitative findings were integrated and interpreted in relation 
to existing research and theory. Together they informed the development of a 
conceptual model of negative symptoms and their relationship with poor social 
recovery following first-episode psychosis. The model suggests that active 
psychological processes may be important to negative symptoms and their 
contribution to poor social recovery. It is proposed that offering tailored 
psychosocial interventions at the earliest stage of disorder – after the onset of non-
specific negative symptoms but before the emergence of attenuated positive 
symptoms – may be warranted to improve outcomes following psychosis onset.  
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Chapter One – Background 
 
1.1. GENERAL OVERVIEW 
 
Negative symptoms are a common and disabling feature of schizophrenia and other 
psychotic disorders which often go untreated (Kirkpatrick, Fenton, Carpenter, & 
Marder, 2006) despite being a treatment priority for service-users (Sterk, Winter van 
Rossum, Muis, & de Haan, 2013). Negative symptoms are characterised by 
reductions in functioning in five key domains: expression, speech, motivation, 
pleasurable emotions and social interest. These deficits are referred to in the 
literature as affective blunting, alogia, avolition, anhedonia and asociality 
respectively.  
 
The research described in this thesis concerns negative symptoms as they manifest 
during the first psychotic episode and its aftermath. Negative symptoms were 
previously considered residual symptoms of chronic schizophrenia (Pfohl & 
Winokur, 1982; J. S. Strauss, Carpenter, & Bartko, 1974) and the majority of early 
negative symptoms research focused on this population (Montague, Tantam, Newby, 
Thomas, & Ring, 1989). However, it is now clear that negative symptoms are not 
specific to those who meet diagnostic criteria for schizophrenia, nor to chronic 
presentations. Negative symptoms are observed across the spectrum of functional 
psychotic disorders (Lyne et al., 2012; Macmillan et al., 2007) and typically emerge 
early in the course of psychosis, often during the prodromal phase (Häfner, Löffler, 
Maurer, Hambrecht, & an der Heiden, 1999; Yung & McGorry, 1996). 
 
This thesis will advocate a biopsychosocial approach to understanding negative 
symptoms. The literature on negative symptoms has tended to prioritise biological 
explanations (Tarrier, 2006), with much research effort dedicated to identifying 
biological correlates of negative symptomatology (Millan, Fone, Steckler, & Horan, 
2014). Correspondingly, treatment research in this field has largely focused on 
identifying pharmacological agents capable of ameliorating negative symptoms 
(Davis, Horan, & Marder, 2014; Marder, Daniel, Alphs, Awad, & Keefe, 2011). 
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Unfortunately, this approach has been slow to yield results; the mechanisms 
underlying negative symptoms remain poorly understood and effective 
pharmacological treatments for negative symptoms have proved elusive (Erhart, 
Marder, & Carpenter, 2006; Foussias, Siddiqui, Fervaha, Agid, & Remington, 2015).  
 
A growing body of evidence suggests a role for psychological and social factors in 
the maintenance of negative symptoms, sparking interest in the use of psychosocial 
interventions to treat negative symptoms (Kern, Glynn, Horan, & Marder, 2009). 
Early research suggested that cognitive behavioural therapy for psychosis may be an 
effective treatment for negative symptoms (Wykes, Steel, Everitt, & Tarrier, 2008). 
However, a recent meta-analysis found that more recent, methodologically rigorous 
research does not support this conclusion (Velthorst et al., 2015). Interventions 
specifically designed to target the psychological underpinnings of negative 
symptoms are likely to be required in order to adequately treat these debilitating 
symptoms. Improved understanding of the psychosocial factors relevant to negative 
symptoms will be important in facilitating the development of interventions capable 
of meeting this aim. This thesis aspires to contribute to such improvements in 
understanding.   
 
This opening chapter aims to situate the research that follows within the wider 
literature. The chapter begins by defining psychosis and schizophrenia. Next, an 
overview of the history of negative symptoms is provided and contemporary 
definitions and measurement of negative symptoms are discussed. Existing 
theoretical models of negative symptoms are then outlined and currently available 
treatment options reviewed. Next, the rationale for early intervention in psychosis is 
set out and an argument for the importance of focusing on negative symptoms within 
the context of early psychosis presented. Finally, the rationale for the current 
research is summarised and the overarching research design and structure of the 
thesis are outlined.   
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1.2. PSYCHOSIS AND SCHIZOPHRENIA 
 
Experiences sometimes thought of as indicative of psychosis include seeing, hearing, 
smelling, tasting or feeling things that other people do not, believing things that 
others find strange, and speaking in ways that others find hard to follow (The British 
Psychological Society, 2014). Many of those who have these kinds of experiences 
are not distressed by them and never come into contact with mental health services 
(Johns et al., 2014; Peters, Day, Mckenna, & Orbach, 1999). However, where these 
experiences are distressing or impact significantly on functioning, those experiencing 
them may seek professional help, or others may seek it on their behalf. When 
individuals come into contact with mental health services, these experiences may 
come to be thought of as symptoms of a disorder and termed ‘hallucinations’, 
‘delusions’ and ‘thought disorder’ respectively. Hallucinations, delusions and 
thought disorder comprise the category of ‘psychotic symptoms’.  
 
Psychotic symptoms are not specific to any one diagnostic category but occur across 
a range of psychiatric disorders (as well as many organic disorders (Cummings, 
1985)). They are characteristic features of the schizophrenia-spectrum diagnoses 
including schizophrenia, schizoaffective, schizotypal and delusional disorders 
(World Health Organisation, 1992), and also feature in the diagnostic criteria for 
non-schizophrenia spectrum disorders including bipolar disorder and unipolar 
depression (ibid.). Schizophrenia is the most common psychotic disorder, estimated 
to effect more than 21 million people worldwide (World Health Organisation, 2016). 
As such, it is often considered prototypical of psychotic disorders (Barnhill et al., 
2014; Freudenreich, 2016).   
 
The most recent fifth edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5; American Psychiatric Association, 2013) lists five symptom 
domains characteristic of schizophrenia: (1) delusions, (2) hallucinations, (3) 
disorganised speech, (4) grossly disorganised or catatonic behaviour, and (5) 
negative symptoms. Negative symptoms are defined within the DSM-5 as 
‘diminished emotional expression’ (understood to incorporate blunted affect and 
alogia) and ‘avolition’ (understood to encompass amotivation, asociality and 
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anhedonia) (Millan et al., 2014). In order to meet criteria for schizophrenia, an 
individual must present with symptoms from at least two of the five domains, at least 
one of which should be (1), (2) or (3). Thus the DSM-5 considers negative 
symptoms to be neither necessary nor sufficient for a diagnosis of schizophrenia. 
However, the emphasis placed on negative symptoms in the diagnosis of 
schizophrenia has varied considerably over time according to prevailing views of the 
nature of the disorder (Tandon et al., 2013).  
 
1.3. NEGATIVE SYMPTOMS: A BRIEF HISTORY 
 
1.3.1. Negative Symptoms and Schizophrenia 
 
Deficits in line with those now classified as negative symptoms have been 
considered important features of schizophrenia since the earliest descriptions of the 
disorder. Kraepelin, in his description of dementia praecox (1971/1919), describes 
weakening of ‘the main springs of volition’ resulting in ‘emotional dullness, failure 
of mental activities, loss of mastery over volition, of endeavour, and of ability for 
independent action’ as the core of the disorder (Zec, 1995). Similarly, Bleuler 
(1950/1911) considered ambivalence, abnormalities of affect, and disturbance of 
volition to be among the fundamental symptoms – those present in every case and 
during every period of illness – of the ‘group of schizophrenias’ (Heckers, 2011). 
This early emphasis on negative symptoms within descriptions of schizophrenia is 
reflected in the first two versions of the DSM which placed substantial emphasis on 
negative symptoms in the diagnosis of schizophrenia (Tandon et al., 2013).  
 
The DSM-I (American Psychiatric Association, 1952) listed nine subtypes of 
schizophrenia, the first of which was described as being characterised by “reduction 
in external attachments and interests and by impoverishment of human relationships 
… usually accompanied by apathy and indifference but rarely by conspicuous 
delusions or hallucinations” (p. 26). This ‘simple’ subtype of schizophrenia, 
characterised predominantly by what would come to be known as negative 
symptoms, was removed in DSM-III, reintroduced in DSM-IV, and removed again 
24 
 
in DSM-5 (Fortea et al., 2016). The diagnosis of ‘simple schizophrenia’ is retained 
in the most recent International Classification of Diseases (ICD-10; World Health 
Organisation, 1992), thus preserving the possibility of making a diagnosis of 
schizophrenia on the basis of negative symptoms alone. However, simple 
schizophrenia is an extremely uncommon diagnosis even where it continues to be 
employed (Fortea et al., 2016; Serra-Mestres et al., 2000); negative symptoms are 
rarely identified clinically in those who have not also presented with psychotic 
symptoms.  
 
The term ‘negative symptoms’ has its origins in neurology (Pearce, 2004). Early 
epilepsy researchers drew a contrast between symptoms involving a loss of normal 
functioning (such as paralysis and loss of sensation), which they termed ‘negative’, 
and symptoms involving an excess of functioning (such as abnormal movements and 
hallucinations), which they termed ‘positive’. Controversial psychiatrist 
Snezhnevsky (1904 –1987) was the first to apply this terminology to the symptoms 
of schizophrenia (Malaspina et al., 2014). Negative symptoms were a decisive 
feature of Snezhnevsky’s ‘sluggish schizophrenia’ diagnosis, since discredited due to 
its role in the wrongful detention of political dissidents during the Soviet era 
(Smulevich, 1989).  
 
Snezhnevsky’s typology of schizophrenia symptoms was developed and refined by 
Strauss et al. (1974) who delineated three symptom classes: ‘positive symptoms’, 
‘negative symptoms’ and ‘disorders of personal relationships’. They defined positive 
symptoms as ‘disorders of content of thought and perception, certain types of form 
of thought (e.g., distractibility) and certain behaviours (e.g., catatonic motor 
disorders)’. Negative symptoms were defined as ‘blunting of affect, apathy, and 
certain kinds of formal thought disorder, such as blocking’. Disorders of personal 
relationships were described by Strauss et al. as akin to Meehl’s (1962) concept of 
‘interpersonal aversiveness’, encompassing social fear, distrust and expectation of 
rejection. 
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Strauss et al. (1974) suggested that these symptom clusters might reflect distinct 
pathological processes within the schizophrenia syndrome. This suggestion was 
enthusiastically embraced by researchers attempting to explain marked heterogeneity 
in the clinical presentation, course and outcome of schizophrenia. Crow (1980; 1985) 
proposed that schizophrenia could be divided into two distinct syndromes: ‘Type I’ 
schizophrenia, characterised by a predominance of positive symptoms and an acute 
course, and ‘Type II’ schizophrenia, characterised by a predominance of negative 
symptoms and a chronic course. He suggested that Type I schizophrenia might have 
a neurochemical origin responsive to antipsychotic medication whereas Type II 
schizophrenia was more likely to be the result of structural brain changes and 
therefore invulnerable to pharmacological interventions.  
 
Also concerned with delineating distinct subtypes of schizophrenia, and noting 
negative symptoms’ lack of specificity, Carpenter & Kirkpatrick (1988) introduced a 
distinction between ‘primary’ and ‘secondary’ negative symptoms. Primary negative 
symptoms are defined as those negative symptoms stemming directly from the 
neurobiological pathology presumed to underlie schizophrenia. Secondary negative 
symptoms are those negative symptoms that can be explained by other aspects of the 
disorder, for instance responses to positive symptoms, depression, medication or 
environmental under-stimulation. Drawing on this distinction, Carpenter et al. (1988) 
suggested a subtype of schizophrenia characterised by the presence of negative 
symptoms that are both primary and enduring (present for at least 12 consecutive 
months) which they designated the ‘deficit syndrome’. They have argued that the 
deficit syndrome may represent a separate ‘disease’ within the schizophrenia 
syndrome (Kirkpatrick, Buchanan, Ross, & Carpenter, 2001).   
 
Following the 1980s ‘renaissance’ of interest in negative symptoms (Andreasen, 
1982), negative symptoms research has grown considerably (Figure 1.1). Much of 
this research has been stimulated by the association between negative symptoms and 
a range of adverse outcomes (Stahl & Buckley, 2007). More recently, recognition of 
the failure of the new generation of atypical antipsychotics to offer appreciable 
benefits for negative symptoms (Murphy, Chung, Park, & McGorry, 2006) has led to 
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a renewed focus on negative symptoms as a therapeutic target (Erhart et al., 2006; 
Kirkpatrick et al., 2006). 
 
 
Figure 1.1. ‘Citations per year using the terms “negative symptoms” and 
“schizophrenia” reproduced from Cohen, Mitchell, & Elvevåg (2014).  
 
 
1.3.2. Negative Symptoms Beyond Schizophrenia 
 
While the negative symptom construct was initially developed in the context of the 
study of schizophrenia, its trans-diagnostic relevance has become increasingly 
recognised (Foussias, Agid, Fervaha, & Remington, 2014). The occurrence of 
negative symptoms in affective psychoses has been less widely studied than in 
schizophrenia-spectrum disorders and some have supposed negative symptoms to be 
specific to non-affective psychoses (Montague et al., 1989; Reddy, Mukherjee, & 
Schnur, 1992). However, more recent evidence suggests that negative symptoms do 
occur in individuals diagnosed with affective psychoses but less commonly than in 
those diagnosed with non-affective psychoses (Lyne et al., 2012). Further, negative 
symptoms have been found to be a feature of clinical depression (Gerbaldo et al., 
1995) as well as neurological disorders such as Parkinson’s disease, Alzheimer’s 
disease, Huntingdon’s disease, frontal-lobe dementia and traumatic brain injury 
(Foussias et al., 2014; Winograd-Gurvich, Fitzgerald, Georgiou-Karistianis, 
Bradshaw, & White, 2006), and are observed in young people at high risk of 
psychosis (Azar et al., 2016; Yung et al., 2005).   
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1.4. DEFINING AND MEASURING NEGATIVE SYMPTOMS 
 
1.4.1. Clinical Rating Scales for Negative Symptom Measurement 
 
The scientific measurement of negative symptoms commenced with the publication 
of the Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962). The BPRS 
includes just two negative symptom items: ‘emotional withdrawal’ and ‘blunted 
affect’. This was followed in the 1980s by the development of a number of 
instruments measuring negative symptoms more broadly. Of these, the Scale for the 
Assessment of Negative Symptoms (SANS; Andreasen, 1982) and the negative 
subscale of the Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & 
Opler, 1987) have proved most popular and enduring (Marder & Kirkpatrick, 2014). 
Both measures require the researcher to rate aspects of the participant’s behaviour on 
a series of anchored severity scales using information obtained via a clinical 
interview and reports of caregivers and/or family.  
 
Whilst there is significant overlap in the content of these older rating scales, there is 
also some divergence. Fenton & McGlashan (1992) compared the content of eight 
published negative symptom rating scales and found that only blunted affect was 
included by all instruments. In an attempt to counter this lack of consistency, 
participants in the National Institute of Mental Health's Consensus Development 
Conference on Negative Symptoms published a consensus statement (Kirkpatrick et 
al., 2006) stating that they considered blunted affect, alogia, avolition, asociality and 
anhedonia to fall within the domain of the negative symptom construct. This 
definition of negative symptoms has been widely embraced.  
 
The authors of the consensus statement recommended the use of the SANS and 
PANSS to measure negative symptoms (ibid.). However, they also recognised the 
limitations of these measures, including the inclusion of items not considered to 
belong to the negative symptom construct (such as those related to cognitive 
impairments and disorganisation) and the reliance on behavioural observations to 
measure ostensibly experiential phenomena such as anhedonia. As such, the 
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consensus statement advocated the development of improved instruments to measure 
negative symptoms. Since this call, three new clinical rating scales have been 
developed: the Clinical Assessment Interview for Negative Symptoms (CAINS; 
Kring, Gur, Blanchard, Horan, & Reise, 2013), the Brief Negative Symptom Scale 
(BNSS; G. P. Strauss et al., 2012), and the Motor-Affective-Social Scale (MASS; 
Trémeau et al., 2008). The content of the SANS, PANSS, CAINS, BNSS and MASS 
are summarised alongside each other for comparison in Table 1.1.  
 
Table 1.1. Content of first- and second-generation clinical rating scales for the 
assessment of negative symptoms. 
SANS PANSS  
(Negative subscale) 
CAINS BNSS MASS 
 
Affective 
flattening 
 
Blunted affect 
 
Expression: 
Facial and 
gestures 
 
Blunted affect 
 
Spontaneous 
smiles  
 
Coverbal hand 
gestures 
 
Alogia 
 
Poor rapport 
 
Lack of spontaneity/ 
flow of conversation  
 
Expression: 
Vocal prosody 
and speech 
 
 
Alogia 
 
Number of 
questions asked 
by interviewer 
 
Reported verbal 
interaction 
 
Avolition-
Apathy 
 
Emotional withdrawal 
 
Motivation/ 
pleasure:  
recreation, 
vocational 
 
Avolition 
 
Grooming/ 
hygiene 
 
Anhedonia-
Asociality 
 
Passive social 
withdrawal 
 
Motivation/ 
pleasure:  
social 
 
Anhedonia 
 
Asociality 
 
Participation in 
groups/ 
activities 
Attentional 
impairment 
 
Difficulty in abstract 
thinking 
 
Stereotyped thinking 
 Distress  
SANS = Scale for the Assessment of Negative Symptoms; PANSS = Positive and Negative 
Syndrome Scale; CAINS = Clinical Assessment Interview for Negative Symptoms; BNSS = Brief 
Negative Symptom Scale; MASS = Motor-Affective-Social Scale    
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The second-generation clinical rating scales improve on older scales by including 
only item content in line with modern conceptions of negative symptoms, omitting 
items measuring attentional impairments, cognitive difficulties or disorganisation. 
Additionally, the CAINS and BNSS seek patient reports of reductions in pleasure, 
sociability and motivation, thus relying less heavily on behavioural observation to 
gauge the degree of experiential deficits. Conversely, the MASS focuses solely on 
observable behaviour, operationalising avolition and asociality as staff reports of 
grooming and hygiene and participation in activities. The MASS’s authors exclude 
anhedonia from the negative symptoms domain on the grounds that, in laboratory 
conditions, individuals diagnosed with schizophrenia have been found to report as 
much pleasure in response to pleasurable stimuli as healthy controls. The CAINS 
and BNSS account for these findings by distinguishing between consummatory and 
anticipatory pleasure (see section 1.5.2 for discussion of this distinction). 
 
The MASS’s reduction of negative symptoms to certain behaviours was motivated 
by the authors’ desire to create an objective rating method uncontaminated by the 
rater’s subjective global impression. The excellent inter-rater reliability achieved 
(item level intra-class correlations (ICCs) ranged from 0.87 to 1 (Trémeau et al., 
2008)) would suggest that the authors’ efforts to limit subjectivity were successful. 
The inter-rater reliability of the MASS compares favourably to other measures of 
negative symptoms, including the PANSS negative subscale (ICC = 0.80; Peralta & 
Cuesta, 1994), SANS (ICC = 0.84; Andreasen, 1982) and CAINS (ICCs = 0.67-0.94; 
Kring et al., 2013). However, the construct validity of the MASS is questionable; 
reduced participation in activity groups could reflect many factors other than 
asociality, and avolition could manifest in a variety of behavioural changes in 
addition to reduced grooming and hygiene. Thus there is a trade-off to be made 
between greater objectivity (and thus reliability) and better construct validity. 
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1.4.2. Other Paradigms for Negative Symptom Measurement 
 
In addition to the new clinical rating instruments for negative symptoms, a number 
of objective laboratory measures are emerging. Objective paradigms offer a number 
of potential benefits over clinical assessments, including limiting the problems of 
inter-rater reliability, rater-drift, and floor and ceiling effects that often affect clinical 
rating scales (Foussias et al., 2015). Laboratory measures of blunted affect and 
alogia include video-based automated analysis of facial expressiveness and 
expressive movements, as well as acoustic analysis of the rate of speech and vocal 
prosody (Cohen & Elvevåg, 2015; Cohen, Alpert, Nienow, Dinzeo, & Docherty, 
2008; Gard, Kring, Gard, Horan, & Green, 2007). Laboratory measures of anhedonia 
and avolition include tests of emotional experience in response to stimuli and 
computer-based measurements of task effort and cost-effort computations (Horan et 
al., 2015). These new paradigms are still in the early stages of development and their 
external validity remains unclear. Nonetheless they represent promising future 
opportunities for more nuanced investigations of the behavioural and motivational 
constituents of negative symptoms. 
 
There have also been recent efforts to develop self-report measures of negative 
symptoms. The Motivation and Pleasure Scale Self-Report (MPS-SR; Llerena et al., 
2013) is a self-report version of the CAINS developed for use as a screening tool 
where circumstances preclude the administration of a clinical interview. The initial 
intention of the MPS-SR’s authors was to assess all those negative symptoms 
covered by the CAINS, however the poor convergent and discriminant validity of the 
items assessing blunted affect and alogia led to their removal from the final version 
of the measure (Park et al., 2012). Another self-report measure, the Self-Evaluation 
of Negative Symptoms (SNS; Dollfus, Mach, & Morello, 2016) provides a more 
complete assessment of negative symptoms, with items assessing affective blunting 
and alogia in addition to avolition, anhedonia and asociality. The item content of the 
SNS was developed from descriptions of the experience of negative symptoms given 
by individuals diagnosed with schizophrenia during focus groups. The aim was not 
to design a measure that could serve as a proxy for observer-rated measures, but to 
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encourage the service-user’s perspective on their negative symptoms to be 
considered a valuable outcome in itself. 
 
Mirroring the poor convergent validity of the items assessing blunted affect and 
alogia removed from the MPS-SR, SNS items assessing emotional range were found 
not to correlate significantly with corresponding clinical rating scale items. The 
authors explain this discrepancy by noting that what is being assessed via observer 
ratings of blunted affect and alogia – limited expressivity – is distinct from the 
emotional experience of the participant. The one SNS item that did correlate with 
observer-rated blunted affect (“It is difficult for people to know how I feel”), 
suggests that individuals with schizophrenia are able to accurately report reductions 
in their emotional expression when these are inquired about explicitly. 
 
1.4.3. Negative Symptoms: Unitary or Multidimensional Construct?   
 
Negative symptoms have most often been treated as a unitary construct by 
researchers, justified by their having consistently emerged as a single factor in 
studies of schizophrenia symptomatology (Blanchard & Cohen, 2006). However, 
there is an emerging consensus that they may be better characterised as a 
multidimensional construct, comprising at least two separable factors (Messinger et 
al., 2011). A review of factor analytic studies of the SANS found the most 
commonly identified factor structure to comprise one factor indicated by blunted 
affect and alogia, and another by apathy, avolition, asociality and anhedonia 
(Blanchard & Cohen, 2006). These two factors have been referred to as ‘diminished 
expression’ and ‘withdrawal’ (or sometimes ‘diminished experience’, ‘diminished 
motivation’, ‘apathy’ or ‘social amotivation’ depending on how this second factor is 
conceptualised). Studies using other negative symptom measures, including the 
PANSS (Liemburg et al., 2013), CAINS (Kring et al., 2013) and BNSS (G. P. 
Strauss et al., 2013a), have also arrived at this two-factor structure (though see 
Garcia-Portilla et al., 2015).  
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Strauss et al. (2013b) studied the clinical presentations of individuals given a 
diagnosis of schizophrenia and identified two subgroups of patients with distinct 
negative symptom profiles. One subgroup presented with symptoms predominantly 
from the diminished expression domain, another with predominantly motivational 
deficits. The two groups differed significantly on measures of functioning, 
premorbid adjustment, clinical course, deficits in social cognition, sex and ethnicity. 
Such findings have led some to suggest that these two subdomains of negative 
symptoms may have distinct aetiologies (Foussias & Remington, 2010) and thus 
may respond to different treatments (Foussias et al., 2015).  
 
1.5. MODELS OF NEGATIVE SYMPTOMS  
 
Researchers have proposed a number of theoretical models of negative symptoms in 
a bid to explain the nature and causes of these phenomena. These models can be 
grouped into three broad categories: neurodevelopmental, neurocognitive and 
cognitive. This section will outline key models of negative symptoms from each of 
these categories and the evidence in support of them.    
 
1.5.1. Neurodevelopmental Models of Negative Symptoms  
 
Neurodevelopmental models of negative symptoms propose that these symptoms are 
a direct manifestation of the neuropathology at the core of schizophrenia. Whilst this 
theory was implicit in the earliest accounts of schizophrenia, it was first clearly 
articulated by Crow in his writings on the distinction between Type I and Type II 
schizophrenia (1980; 1985). Crow hypothesised that negative symptoms are the 
result of irreversible structural brain changes caused by an unknown pathological 
process. This theory was a response to early evidence of an association between 
negative symptoms and increased ventricle size, as well as negative symptoms’ lack 
of response to anti-psychotic medications. Subsequent neuroimaging studies have 
uncovered associations between negative symptoms and abnormalities in grey and 
white matter volumes in several regions including the prefrontal cortex, thalamus, 
precentral cortex and inferior parietal gyrus (Asami et al., 2014). Furthermore, there 
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is some evidence implicating dysfunctional neural circuitry in negative symptom 
maintenance – most consistently frontotemporal and frontocorticostriatal circuits 
(Millan et al., 2014). 
 
Cornblatt et al. (Cornblatt et al., 2003; Lencz, Smith, Auther, Correll, & Cornblatt, 
2004) proposed that negative symptoms are the result of underlying brain 
abnormalities with a significant genetic component, perhaps contributed to by early 
insults such as viral infection or environmental toxins. They suggest that, prior to the 
onset of psychosis, this underlying neuropathology manifests as negative-like 
symptoms and other non-specific behavioural disturbances. In the absence of a 
trigger that causes positive symptoms to emerge, these non-specific disturbances 
might come to be viewed as symptoms of schizotypal, schizoid or avoidant 
personality disorders. In cases where positive symptoms are triggered, schizophrenia 
is fully expressed and the disturbances stemming directly from the underlying 
neuropathology manifest as negative symptoms. Thus, within this model, negative 
symptoms represent a direct manifestation of the biological vulnerability to 
schizophrenia. This biological vulnerability is proposed to be the primary cause of 
the social disability associated with psychosis.   
 
Cornblatt et al.’s model is supported by evidence that negative symptoms often 
emerge before the onset of even attenuated positive symptoms (Manuel Cuesta, 
Peralta, Gil, & Artamendi, 2007; Häfner et al., 1999; Yung & McGorry, 1996), and 
that those diagnosed with schizophrenia often met criteria for schizotypal, schizoid 
and avoidant personality disorder before the onset of the disorder (Solano & De 
Chávez, 2000). Further, structural brain abnormalities are evident early in the course 
of psychosis (Steen, Mull, Mcclure, Hamer, & Lieberman, 2006) and have been 
found to predate the onset of positive psychotic symptoms in longitudinal studies of 
high-risk individuals (Pantelis et al., 2003).  
 
Evidence of structural brain abnormalities at this early stage of disorder, before 
prolonged exposure to psychiatric medications, is clearly better evidence that these 
abnormalities may have a role in symptom expression than similar evidence obtained 
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in those with chronic psychosis. However, it remains unclear whether such brain 
abnormalities cause negative symptoms. Given that negative symptoms typically 
emerge before positive symptoms, it remains possible that these brain changes are a 
consequence of negative symptoms. A further possibility is that both negative 
symptoms and their associated brain abnormalities are epiphenomena of a currently 
unknown process.  
 
The contention that it is an underlying vulnerability to psychosis that is the primary 
cause of the social disability associated with it is supported by evidence that negative 
symptoms predict poor longer-term functional outcomes in those at high risk of 
psychosis, whether or not they go on to develop positive symptoms (Lin et al., 
2011). However, the claim that this vulnerability is neurobiological in nature is in 
need of verification. It is possible that the vulnerability to psychosis giving rise to 
negative symptoms and their associated adverse outcomes is conferred by 
psychosocial factors rather than neurobiology.  
 
1.5.2. Neurocognitive Models of Negative Symptoms  
 
Neurocognitive models suggest that negative symptoms are the result of cognitive 
impairments in specific domains. A number of theorists have suggested that 
impairments in the cognitive mechanisms that underpin goal-directed behaviour may 
be at the core of negative symptomatology. For instance, Frith (Frith, 1987; Frith & 
Done, 1988) proposed that individuals who present with negative symptoms retain 
the capacity for stimulus driven actions performed in response to changes in the 
environment but have reduced capacity for spontaneous, ‘willed’ actions intended to 
bring about particular goals. He hypothesised that while the intention to act is present 
in those with negative symptoms, the translation of this intention into action is 
disrupted due to faulty neural circuitry linking the prefrontal cortex and striatum.  
 
Research investigating the neural substrates of negative symptoms lends some 
support to this theory; the frontotemporal and frontocorticostriatal circuits, the neural 
circuits most consistently linked to negative symptoms, are thought to play important 
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roles in the planning and organisation of goal-directed behaviours (Millan et al., 
2014). Further, research carried out by Velligan et al. (2008, 2009) suggests that 
external cues can be successfully employed to prompt individuals with negative 
symptoms to initiate and complete behaviours that would not otherwise have been 
carried out. This supports the contention that spontaneous but not stimulus-driven 
actions are disrupted in those diagnosed with schizophrenia.  
 
Barch & Dowd (2010) developed Firth’s theory by suggesting that negative 
symptoms are the result of difficulties using internal representations of emotional 
experiences, anticipated rewards and future goals to guide behaviour. Their model 
draws on the affective neuroscience literature regarding the neural basis of the 
processes involved in converting internal representations to behaviour. These 
processes include ‘liking’ (hedonics), ‘wanting’ (reward prediction), cost-benefit 
analysis (the ability to represent the value of the outcome, compute the effort 
involved in achieving the outcome, and weigh the two against each other), and 
generating and executing a plan appropriate to achieve the intended outcome.  
 
Barch & Dowd noted that those with negative symptoms do not seem to have any 
difficulty ‘liking’ since the hedonic responses of those with negative symptoms are 
comparable to those of controls when measured in laboratory conditions (Gard et al., 
2007; Kring & Moran, 2008; Trémeau, Antonius, Nolan, Butler, & Javitt, 2014). 
However, there is evidence that individuals with prominent negative symptoms may 
have impaired reward anticipation, since they predict future life events will be less 
pleasurable in comparison to healthy controls despite finding them just as rewarding 
when they occur (Dowd & Barch, 2012; Gard et al., 2007). This has been 
conceptualised as anhedonia in schizophrenia comprising a deficit in anticipatory 
pleasure (pleasure related to the anticipation of future events) but not consummatory 
pleasure (pleasure when engaged in an enjoyable activity).   
 
Impairment in reward anticipation may confer deficits in ‘wanting’, impacting the 
outcome of cost-benefit analyses. If an individual does not believe that performing 
an action will be rewarding then they are unlikely to deem even limited effort to be 
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worthwhile in achieving it. However, there is also emerging evidence that negative 
symptoms may be associated with abnormalities in the assessment of the cost of 
engaging in the actions necessary to obtain a rewarding outcome. Gold et al. (2013) 
found that whilst those with elevated negative symptoms were willing to make more 
effort for a higher value monetary reward, they were less likely than healthy controls 
to exert more effort when offered a 100% chance of reward than when offered a 50% 
chance of receiving the same reward. The authors hypothesise that this unexpected 
finding might be explained by a higher chance of reward increasing the salience of 
the effort required to achieve it in those with high levels of negative symptoms. As a 
result of this increased salience, the perceived effort required might neutralise the 
value attributed to an increased chance of reward.  
 
Whilst Bard & Doward limit their model to the withdrawal subdomain of negative 
symptoms, Foussias & Remington (2010) suggest that impairment in the translation 
of internal representations into action may also be at the core of affective blunting 
and alogia. Foussias & Remington propose that all negative symptoms, including 
those within the diminished expression domain, are phenotypic manifestations of a 
pervasive reduction in appetitive drive. However, Hartmann et al. (2015) found that 
greater propensity to choose not to engage in rewarding but effortful behaviour was 
associated with the withdrawal subdomain of negative symptoms, but not with 
diminished expression. This suggests that the neurocognitive underpinnings of 
diminished expression may not be identical to those of withdrawal. 
 
Indications of the possible neurocognitive underpinnings of diminished expression 
are provided by research demonstrating that individuals given a diagnosis of 
schizophrenia show deficits in the affective and cognitive capacities involved in 
empathy. Derntl et al. (2009) found that, relative to healthy controls, individuals 
meeting diagnostic criteria for schizophrenia show deficits in emotion recognition, 
emotional perspective taking and affective responsiveness. Contrary to the authors’ 
expectations, those presenting with predominant negative symptoms were less 
impaired in these domains than those with predominant positive symptoms. This 
finding might prompt the hypothesis that negative symptoms function as a 
mechanism for coping with intense affective states in those experiencing 
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schizophrenia accompanied by intact affective responsiveness. However, the very 
small numbers in the subgroups compared (n = 5 for the subgroup with predominant 
negative symptoms) prevent firm conclusions from being drawn. In a subsequent 
study exploring the neural correlates of empathy deficits in schizophrenia (Derntl et 
al., 2012), decreased amygdala activation was found to correlate with negative 
symptom severity. Thus, it remains possible that deficits in emotion processing may 
be relevant to understanding affective blunting and/or alogia.     
 
1.5.3. Cognitive Models of Negative Symptoms 
 
Cognitive models of psychopathology posit that, whilst biological and social factors 
may create vulnerability to psychopathology, it is dysfunctional beliefs and 
appraisals that are its most proximal causes. Cognitive models of positive symptoms 
have received a good deal of research attention and are now supported by a 
substantial evidence-base (Garety & Freeman, 2013; Mawson, Cohen, & Berry, 
2010). Cognitive models of negative symptoms on the other hand, have been 
developed only relatively recently and are thus supported by a less comprehensive 
(though growing) evidence-base.  
 
Whilst formal cognitive models of negative symptoms are a relatively recent 
development, the idea that beliefs and appraisals may be relevant to understanding 
negative symptoms is not new. Bleuler (1950/1911) was the first to suggest that 
presentations that might today be described as negative symptoms may represent the 
individual’s attempts to defend themselves against unbearable levels of stress 
(Kingdon & Turkington, 2005). This idea was developed by Strauss et al. (1989) 
who proposed that negative symptoms often reflect active coping in difficult 
psychological and social circumstances, the premise at the core of all subsequent 
cognitive models. Strauss et al. suggest that negative symptoms can helpfully be 
seen as understandable, and in some circumstances perhaps even adaptive, responses 
to the experience of psychosis (Table 1.2). 
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Table 1.2. Psychological factors proposed by Strauss et al. (1989) to contribute to 
negative symptoms. 
Psychological Contributor Description   
Fear of relapse 
 
An individual whose positive symptoms are exacerbated in 
stimulating environments may stop participating in valued 
activities to protect themselves from the pain of relapse. 
Loss of hope and self 
esteem 
A person who suffers from repeated psychotic episodes and 
experiences social and occupational decline may simply give 
up on life due to loss of hope and positive self-image.  
Possibility of 
impulsive/bizarre 
behaviour 
Apathy and withdrawal may serve to protect against public 
displays of bizarre or impulsive behaviour that might prove 
socially or personally destructive. 
Problems finding a new 
identity 
A person for whom being unwell has become central to their 
identity may withdraw due to difficulty establishing an 
identity distinct from their psychosis. 
Guilt for past dysfunction 
 
An individual who has experienced psychosis might feel guilt 
for their behaviour whilst unwell. This guilt may lead to 
withdrawal and demotivation. 
Threat of 
complex/stressful social 
situations 
Social and occupational situations are extremely stressful for 
some who have experienced psychosis. Negative symptoms 
might serve to reduce the threat of entering such stressful 
situations. 
Helplessness due to 
overwhelming barriers to 
success 
For some, barriers to improvement may seem 
insurmountable. Giving up in such circumstance might be 
adaptive in so far as it allows the individual to recruit help 
from others. 
 
 
1.5.3.1. Kingdon & Turkington’s Cognitive Model of Negative Symptoms (Kingdon 
& Turkington, 1994, 2005) 
 
Drawing on the ideas of Strauss et al. (1989), Kingdon & Turkington developed an 
early cognitive model of negative symptoms. The model suggests that active 
attempts to cope with the stress imposed by altered perceptions, cognitive deficits, 
impaired identity and the expectations of others may be at the core of negative 
symptomatology. It is proposed that reductions in expressivity might reflect 
demoralisation and hopelessness, that avolition might reflect a reaction to 
overwhelming pressure and repeated failure, and that social withdrawal might be a 
mechanism for decreasing stress by reducing overstimulation. Kingdon & 
Turkington emphasise the protective nature of negative symptoms, stressing the 
importance of convalescence in the psychological healing process. They note that 
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healthy individuals often respond to unpleasant feelings, concentration difficulties, 
etc. by taking a break or switching to another activity. In contrast, those with 
schizophrenia are often encouraged to stubbornly persevere with tasks despite 
frustration and setbacks. They suggest that not allowing sufficient time for 
recuperation following a psychotic episode may prolong negative symptoms by 
increasing the perception of failure.  
 
On the basis of this model, they encourage clinicians working with people with 
negative symptoms to sanction avoidance and set goals well below an individual’s 
capability. While the model has not been the subject of direct empirical verification, 
trials of cognitive behavioural therapy based on treatment manuals incorporating 
Kingdon & Turkington’s cognitive model of negative symptoms have been 
completed. These found significant effects on negative symptoms at both one year 
(Turkington et al., 2006; Turkington, Kingdon, & Turner, 2002) and five year 
follow-ups (Sensky et al., 2000; Turkington et al., 2008). However, since these trials 
were not accompanied by process evaluation, it is not possible to establish which 
components of these complex interventions led to the reductions in negative 
symptoms observed. As such, caution must be exercised in interpreting these results 
as providing support for Kingdon & Turkington’s model of negative symptoms.  
  
1.5.3.2. Beck et al.’s Cognitive Model of Negative Symptoms (Beck, Rector, Stolar, 
& Grant, 2008; Beck & Rector, 2005; Rector, Beck, & Stolar, 2005) 
 
Beck et al.’s cognitive model takes its start from evidence of an association between 
negative symptoms and cognitive deficits. However, unlike neurocognitive models 
which propose that specific cognitive deficits account for negative symptoms 
directly, Beck et al.’s model asserts that neurocognitive impairments are indirectly 
associated with negative symptoms via their impact on an individual’s beliefs and 
expectancies. According to the model, suffering neurocognitive impairments 
increases the likelihood of discouraging life experiences such as academic and social 
difficulties. These experiences of ‘failure’ result in a cognitive set characterised by 
dysfunctional beliefs and negative expectancies. These beliefs and expectancies lead 
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the person to disengage from other people and activities in an attempt to avoid 
further painful experiences. Thus, in common with other cognitive models of 
negative symptoms, Beck et al.’s model conceptualises negative symptoms as 
understandable but maladaptive attempts to cope with adverse circumstances. The 
model is depicted graphically in Figure 1.2.  
 
 
Figure 1.2.  Diagrammatic representation of Beck et al.’s cognitive model of 
negative symptoms. 
 
 
The dysfunctional beliefs and negative expectancies thought to be particularly 
relevant to the manifestation of negative symptoms include: defeatist performance 
beliefs (over-generalised negative conclusions about the significance of imperfect 
performance), social distancing beliefs (negative attitudes towards social 
affiliations), low expectancies for pleasure, acceptance and success, and perception 
of limited cognitive resources. The model suggests that the relationship between 
these beliefs and negative symptoms is bidirectional, with negative symptoms 
serving to reinforce the negative expectancies proposed to underlie them.    
 
Empirical evidence for the relevance of dysfunctional cognitions to negative 
symptoms is beginning to accumulate, with defeatist performance beliefs having so 
far received most research attention. The relationship between defeatist performance 
beliefs and negative symptoms first received empirical support over a decade ago 
and was found to be independent of depression or positive symptoms (Rector, 2004). 
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At the time of writing, eleven further studies had been conducted investigating the 
association between defeatist performance beliefs and negative symptom severity. 
Ten of these were included in a recent meta-analysis (Campellone, Sanchez, & 
Kring, 2016) assessing the strength of the relationship between negative symptoms 
and defeatist performance beliefs; the meta-analysis revealed a small but significant 
effect. Further, Grant & Beck (2009) demonstrated that defeatist performance beliefs 
partially mediate the relationship between cognitive impairment and negative 
symptoms, as predicted by the model.  
 
However, Campellone et al.’s meta-analysis found that only 5% of variance in 
negative symptoms could be explained by variance in defeatist performance beliefs. 
This would suggest that these beliefs play no more than a small role in the 
manifestation of negative symptoms. Since defeatist performance beliefs are only 
one type of dysfunctional cognition hypothesised to be relevant to negative 
symptoms, this finding does not present a major challenge to Beck et al.’s model. 
Nonetheless, it does caution against seeking to oversimplify the mechanisms 
underlying negative symptoms.  
 
Social distancing beliefs are another dysfunctional cognition whose relevance to 
negative symptoms has received empirical support. Social distancing beliefs 
encompass negative attitudes towards social affiliations and a preference for solitary 
occupations. These beliefs have been found to be more common among those with 
schizophrenia than non-psychiatric controls (Blanchard, Mueser, & Bellack, 1998). 
Further, a longitudinal study by Grant & Beck (2010) demonstrated that baseline 
asocial beliefs, but not neurocognitive difficulties or poor emotion perception, 
predicted later social disengagement. The magnitude of this effect was greater than 
that of the prediction of future attitudes to social engagement from previous social 
functioning, suggesting that asocial beliefs might play a greater role in fostering 
asocial behaviour than vice versa.  
 
Paralleling findings of decreased expectations of pleasure but intact hedonic 
capacity, an experience sampling study by Oorschot et al. (2013) found evidence for 
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greater asocial beliefs despite unaffected social experience in those with psychosis 
compared to healthy controls. Participants were asked to report their emotional 
experience and behaviour at unpredictable time points across six consecutive days. 
All participants displayed comparable emotional responses to the company of others, 
but those with psychosis (particularly those with higher levels of negative 
symptoms) were more likely to express that they would prefer to be alone when in 
company, and to choose to spend time alone. This finding would suggest that 
asociality in psychosis is not driven by reduced capacity for enjoying the company of 
others, but by asocial attitudes despite intact capacity for enjoyment.  
 
Findings regarding hedonic capacity incorporated into neurocognitive models can 
also be interpreted as supporting Beck et al.’s model. Arguably, the deficit in 
anticipatory pleasure in schizophrenia discussed by neurocognitive researchers is 
better understood in terms of dysfunctional beliefs than reduced cognitive capacity. 
Strauss & Gold (2012) call attention to the fact that it is not just measures of 
anticipatory pleasure but all measures of non-current feeling, including retrospective, 
hypothetical, and trait measures, that suggest reduced pleasure in individuals given a 
diagnosis of schizophrenia. On the basis of these findings, they argue that apparent 
anhedonia in those with psychosis should be attributed to dysfunctional beliefs about 
the likelihood of obtaining pleasure and a consequent reduction in pleasure-seeking 
behaviour. Thus anhedonia in schizophrenia might be better understood as a 
consequence of low expectations for pleasure than a deficit in the capacity for 
pleasure, anticipatory or otherwise.   
 
1.5.3.3. Staring et al.’s Cognitive Model of Negative Symptoms (Staring, ter 
Huurne, & van der Gaag, 2013) 
 
Staring et al. developed an extension of the cognitive model proposed by Beck et al. 
within their cognitive behavioural therapy for negative symptoms treatment manual. 
The model as depicted in Staring et al. (2013) is reproduced in Figure 1.3.  
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Figure 1.3. Staring et al.’s cognitive model of negative symptoms reproduced from 
Staring, ter Huurne, & van der Gaag (2013). 
 
 
The model preserves a central role for negative expectations but also grants an 
important role for internalised stigma. Staring et al. suggest that individuals with 
experience of psychosis might be especially vulnerable to internalising stigmatising 
beliefs about mental ill-health as a result of the setbacks and losses that often 
accompany the disorder. They argue that this self-stigma might contribute to 
expectations of discrimination and social exclusion, leading to demoralisation and 
thus to the manifestation of negative symptoms. Evidence cited for the inclusion of 
stigma in the cognitive model of negative symptoms includes research demonstrating 
that high levels of self-stigmatising beliefs in conjunction with good insight predict 
demoralisation, hopelessness, low self-esteem and low quality of life (Cavelti, 
Kvrgic, Beck, Rüsch, & Vauth, 2012; Lysaker, Roe, & Yanos, 2007; Staring, Van 
der Gaag, Van den Berge, Duivenvoorden, & Mulder, 2009). Further support for the 
inclusion of self-stigma in the model is provided by a path analysis demonstrating 
that internalised stigma increases avoidant coping and active social avoidance via 
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decreased hope and self-esteem in those diagnosed with schizophrenia-spectrum 
disorders (Yanos, Roe, Markus, & Lysaker, 2008).  
  
In addition, the range of discouraging experiences hypothesised to give rise to 
dysfunctional cognitions is extended within Staring et al.’s model. Whilst Beck et al. 
focus on the potential for social and occupational failures to negatively impact an 
individual’s cognitive set, Staring et al. suggest that loss of identity and lessening of 
previous capabilities might also be relevant. Further, the factors proposed to 
contribute to discouraging experiences are expanded beyond neurocognitive 
impairments to include impairments in behavioural and emotional functioning. These 
extensions of Beck et al.’s model, whilst intuitively sound, remain in need of 
empirical verification.  
 
1.6. TREATING NEGATIVE SYMPTOMS 
 
1.6.1. Pharmacological Treatments  
 
Antipsychotic medications remain the central pillar of the treatment of psychosis and 
schizophrenia (National Institute for Health and Care Excellence [NICE], 2014). 
However, whilst antipsychotic medications are effective in reducing positive 
symptoms, they have proved relatively ineffective in reducing negative symptoms 
(Tandon, Nasrallah, & Keshavan, 2010). The introduction of the second-generation 
antipsychotics was accompanied by much anticipation of a breakthrough in negative 
symptom treatment (Fleischhacker, 1995). However, whilst those marketing second-
generation drugs often claim that they bring about “better negative symptom control 
than conventional antipsychotics” (Sernyak & Rosenheck, 2007), they have not been 
found to be consistently superior to first-generation antipsychotics in this regard 
(Leucht et al., 2009).  
 
The modest improvements in negative symptoms sometimes observed in those 
treated with antipsychotics are likely conferred largely indirectly via their effect on 
positive symptoms. Improvements in negative symptoms during antipsychotic 
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treatment tend to coincide with improvements in positive symptoms (Tandon, 
Ribeiro, DeQuardo, & Goldman, 1993), and studies that have attempted to establish 
a direct effect of antipsychotics on primary negative symptoms have produced 
inclusive results (Murphy et al., 2006). Furthermore, extrapyramidal side-effects of 
antipsychotic medication are acknowledged to contribute to secondary negative 
symptoms (Carpenter et al., 1988). Thus, for an antipsychotic medication to have a 
net benefit on negative symptoms, decreases in negative symptoms must offset 
increases in negative symptoms due to extrapyramidal side-effects (Tandon et al., 
2010).  
 
The limited efficacy of antipsychotics in treating negative symptoms has led 
researchers to investigate a range of potential pharmacological adjuncts to 
antipsychotic medications. There is some evidence that adding antidepressants to 
antipsychotics may result in improvements in negative symptoms (Rummel-Kluge, 
Kissling, & Leucht, 2006). There is also preliminary evidence of a beneficial effect 
of a number of other agents, including dehydroepiandrosterone, deprenyl, 
galantamine, Ginkgo, methylene blue, naltrexone, selegiline, pergolide and essential 
fatty acids (Murphy et al., 2006). However, currently there is no conclusive evidence 
supporting the use of any adjunct agent in the treatment of negative symptoms. This 
is reflected in the absence of recommendations for the use of adjunct 
pharmacological agents for the treatment of negative symptoms from NICE 
guidelines (2014).   
 
1.6.2. Non-Pharmacological treatments  
 
The inadequacy of currently available pharmacological treatments for negative 
symptoms makes the development and implementation of effective psychosocial 
interventions all the more important. Non-pharmacological treatments whose 
effectiveness in reducing negative symptoms has been investigated include art 
therapies, social skills training, cognitive remediation therapy, cognitive behavioural 
therapy and exercise. The evidence in support of each of these intervention types will 
be reviewed in turn.      
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1.6.2.1. Art therapies 
 
Art therapies involve working with a trained therapist to use artistic media, including 
visual arts, music, dance and drama, as a form of expression and communication to 
address emotional confusion or distress (Darton, 2013; The British Association of 
Art Therapists, n.d.). NICE first included a tentative recommendation to consider 
offering art therapies to individuals presenting with negative symptoms in the 2009 
update of their guidelines for the treatment of psychosis and schizophrenia (NICE, 
2014). This recommendation was based on the findings of six small-scale trials 
(Priebe et al., 2013) and was accompanied by a call for further research.  
 
Since the 2009 NICE guidelines were published, two large trials of art therapies in 
schizophrenia have been completed. Crawford et al. (2012) randomised 417 
outpatients to receive 12 months of either weekly group art therapy plus standard 
care, weekly group activity sessions plus standard care, or standard care alone. At 
follow-up, the three arms did not differ significantly on any of the primary outcomes, 
including negative symptom severity. Attendance at both the art therapy and activity 
groups were low. The study’s authors concluded that, whilst art therapy may benefit 
‘a few highly motivated’ people, offering art therapy to individuals diagnosed with 
schizophrenia in community settings does not lead to improved outcomes. Similarly, 
Priebe et al. (2016) randomised 275 participants to receive either Pilates (active 
control) or body psychotherapy, a form of art therapy facilitated by a qualified dance 
movement psychotherapist. The study found that body psychotherapy was no more 
beneficial for negative symptoms than was the control intervention. Despite these 
findings, the recommendation to consider offering art therapies to individuals 
presenting with negative symptoms was retained in the 2014 version of the NICE 
guidelines.  
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1.6.2.2. Social skills training 
 
Social skills training consists of teaching designed to develop a range of skills 
important in interacting successfully with others (Kopelowicz, Liberman, & Zarate, 
2006). These skills include assertiveness, conversation skills, medication control, 
job-hunting, recreational skills, family communication and conflict resolution 
(Morales Vigil, Orellana, García, & Correa, 2015). The techniques used to teach 
these skills include goal setting, modelling, behavioural rehearsal with corrective 
feedback, positive reinforcement, and homework to encourage generalisation of 
skills learnt (Kurtz & Mueser, 2008).   
 
Although the primary goal of social skills training is improvement in psychosocial 
functioning, it has also been found to be effective in reducing negative symptoms. A 
meta-analysis of randomised controlled trials of social skills training for individuals 
diagnosed with schizophrenia-spectrum disorders carried out by Kurtz & Mueser 
(ibid.) found a medium average effect on negative symptoms. However, most of the 
evidence for the effectiveness of social skills training in alleviating negative 
symptoms is from non-UK trials (Elis, Caponigro, & Kring, 2013) and NICE 
currently recommend that social skills training should not be routinely offered to 
those experiencing psychosis (NICE, 2014). Given the relatively large evidence-base 
for social skills training as practiced in other countries, further UK-based research 
investigating the effectiveness of social skills training as a treatment for negative 
symptoms is warranted.  
 
1.6.2.3. Cognitive Remediation Therapy  
 
Cognitive remediation therapy (CRT) aims to enhance cognitive processes with the 
goal that improved cognition will lead to improvements in daily functioning (Wykes, 
Huddy, Cellard, McGurk, & Czobor, 2011). While the primary target of CRT is 
improved cognition, some studies have found evidence of an effect on negative 
symptoms (Bellucci, Glaberman, & Haslam, 2003; Gharaeipour & Scott, 2012). A 
meta-analysis of trials of CRT in schizophrenia suggested that the average effect on 
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negative symptoms is minimal (Wykes et al., 2011), however the results of a recent 
analysis suggest that this finding may be an artefact of inadequate measurement of 
negative symptoms (Cella, Reeder, & Wykes, 2014). Interestingly, it has been 
suggested that the effect of CRT on daily functioning may be mediated by reductions 
in negative symptoms, not by improvements in cognition (Farreny, Aguado, Ochoa, 
Haro, & Usall, 2013). This suggests that the mechanisms by which CRT leads to 
improvements in negative symptoms may be distinct from those that bring about 
improvements in cognitive functions.  
 
1.6.2.4. Cognitive Behavioural Therapy 
 
Cognitive behavioural therapy for psychosis (CBTp) developed from similar 
approaches used to treat common mental health problems such as depression. Like 
other forms of cognitive behavioural therapy, CBTp is built on the principle that it is 
not the events we experience that determine how we feel, but the way we interpret 
and respond to these events. According to cognitive models of positive symptoms, 
misattribution of unusual experiences triggered by stressful life events can account 
for psychotic symptoms themselves, and understandable but unhelpful reactions to 
these experiences for the distress and dysfunction associated with them (Freeman, 
Garety, Kuipers, Fowler, & Bebbington, 2002; Garety, Kuipers, Fowler, Freeman, & 
Bebbington, 2001; Morrison, 2001). Thus, intervening to change how an individual 
interprets and responds to unusual experiences might reduce symptoms, lessen 
distress and improve functioning.  
 
The primary focus of CBTp is typically reducing distress associated with positive 
symptoms and most trials have investigated its impact on negative symptoms only as 
a secondary outcome (Wykes et al., 2008). Wykes et al.’s frequently cited meta-
analysis (ibid.) investigated the impact of CBTp on a range of outcomes and found 
evidence of a moderate beneficial effect on negative symptoms when measured as a 
secondary outcome. However, a more recent meta-analysis looking specifically at 
the effect of CBTp on negative symptoms found the pooled effect of CBTp on 
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negative symptoms to be small (Velthorst et al., 2015). Larger effects were found to 
be associated with earlier year of publication and lower study quality.  
 
Early trials of cognitive therapies specifically designed to target negative symptoms 
(CBTn) have shown promising results however. Grant, Huh, Perivoliotis, Stolar & 
Beck (2012) carried out a randomised controlled trial (RCT) of a cognitive therapy 
designed to target negative symptoms and poor psychosocial functioning in 
chronically low-functioning individuals given a diagnosis of schizophrenia. The 
therapy was based on Beck et al.’s cognitive model of negative symptoms and aimed 
to challenge dysfunctional beliefs about pleasure, cognitive abilities, performance 
and social functioning. Participants who received the trial intervention showed 
significantly greater reductions in avolition-apathy than the control group, as well as 
clinically significant improvements in functioning.  
 
A non-controlled pilot trial of CBTn based on Staring et al.’s cognitive model of 
negative symptoms also produced encouraging results. Clinically important changes 
in negative symptoms were observed and there was a large within-group effect size 
on the PANSS negative subscale (Staring et al., 2013). Further, reductions in 
dysfunctional beliefs were found to partially mediate change in negative symptoms, 
lending support to the cognitive model underlying the intervention. However, a 
significant proportion of variation in negative symptom change was unexplained by 
the mediating variables considered, highlighting the gaps that remain in our 
understanding of the mechanisms underlying negative symptom change.  
 
The MOVE programme (Velligan, Maples, Roberts, & Medellin, 2014) is a further 
promising intervention for negative symptoms. MOVE is a multicomponent 
psychological intervention for persistent negative symptoms based on a model that 
combines neurocognitive and cognitive explanations of negative symptoms. Key 
components of the intervention include antecedent control (using external cues to 
prompt specific behaviours), identifying and addressing deficits in anticipatory 
pleasure, enhancing emotional processing, skills building to address social and other 
skills deficits, and cognitive and behavioural techniques designed to target 
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dysfunctional beliefs. A recent pilot RCT of MOVE in individuals with persistent 
negative symptoms found a medium effect of the intervention immediately post 
treatment (Velligan et al., 2015). It remains to be seen whether these encouraging 
findings will be supported by larger trials, and whether any effects are maintained 
post-treatment.  
 
1.6.2.4. Exercise 
 
Exercise is defined within health research as physical activity that is planned, 
structured and repetitive, performed with the objective of improving physical fitness 
(Caspersen, Powell, & Christenson, 1985). Exercise has been observed to be an 
effective add-on treatment for individuals with psychosis, leading to improvements 
in a variety of domains including negative symptoms. Two independent meta-
analyses of the effects of exercise interventions in non-affective psychosis have been 
recently published. Firth et al. (2015) examined the effects of exercise in individuals 
diagnosed with a non-affective psychotic disorder or experiencing a first episode of 
psychosis. They found a medium effect on negative symptoms of interventions 
incorporating exercise of moderate-to-vigorous intensity. Dauwan et al. (2016) 
examined studies of exercise interventions (including yoga) in individuals diagnosed 
with schizophrenia-spectrum disorders and also found a medium effect of exercise 
on negative symptoms. Yoga and aerobic exercise were found to be comparably 
effective in reducing negative symptoms. 
 
These results suggest that exercise interventions are among the most effective 
currently available for negative symptoms. Moreover, qualitative evidence suggests 
that exercise interventions can be popular with young people experiencing a first-
episode of psychosis provided they are tailored to the individual and incorporate 
adequate social support (Firth et al., 2016). However, the mechanisms through which 
exercise interventions influence negative symptoms remain unclear.  
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1.7. FIRST-EPISODE PSYCHOSIS AND EARLY INTERVENTION 
 
Psychosis usually emerges during adolescence or early adulthood with 80% of first 
psychotic episodes occurring before age 30 (Shiers & Lester, 2004; van Os & Kapur, 
2009). However, for many years community services often neglected early 
psychosis, focusing instead on treatment-resistant psychosis and the rehabilitation of 
individuals who had developed severe and chronic disability (Birchwood, McGorry, 
& Jackson, 1997; Marshall & Rathbone, 2011). As such, chronic presentations 
tended to dominate the attention of both clinicians and researchers. Over the past two 
decades there has been a shift towards a greater proportion of therapeutic resources 
being allocated to individuals in the early phases of psychosis, in particular the first 
psychotic episode and its aftermath. This has been accompanied by a corresponding 
shift in research focus towards the identification, understanding and treatment of 
first-episode psychosis (FEP).  
 
Increased interest in the early phase of psychosis was largely a response to research 
indicating that the first few years following psychosis onset may represent a ‘critical 
period’ during which ‘biological, psychological and psychosocial influences are 
developing and show maximum plasticity’ (Birchwood, Todd, & Jackson, 1998). 
Contemporary orthodoxy held that treatments for psychosis were merely palliative 
and could not influence the ‘natural history’ of the disorder (McGlashan & 
Johannessen, 1996). However, research demonstrated that much of the symptomatic 
and psychosocial deterioration that follows the onset of psychosis occurs relatively 
early on – within the first few years – and then plateaus (Birchwood et al., 1997, 
1998). Further, it was observed that the early phase of psychotic disorders are highly 
responsive to treatment relative to more chronic presentations (Lieberman et al., 
1993). Thus it was hoped that providing prompt treatment of the first episode might 
favourably influence the trajectory of the disorder by preventing or reducing early 
symptomatic and functional decline (Birchwood et al., 1997, 1998). 
  
The critical period hypothesis inspired a sizeable body of research on the relationship 
between psychosis outcomes and duration of untreated psychosis (the time between 
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the first threshold psychotic symptom and commencement of appropriate treatment). 
Studies consistently found shorter duration of untreated psychosis to be associated 
with better outcomes, both symptomatic and functional (Marshall et al., 2005). This 
research provided the empirical justification for establishing specialist Early 
Intervention in Psychosis (EIP) services offering intensive, time-limited support to 
young people with FEP. Whilst there is a lack of consistent operationalised criteria to 
define the FEP population (Breitborde, Srihari, & Woods, 2009), in the context of 
EIP services (and the research reported in this thesis) it is used to refer to those 
presenting to mental health services with psychotic symptoms for the first time. 
Unlike the narrower concept of ‘first-episode schizophrenia’, an established 
diagnosis is not necessary to classify an individual as experiencing FEP, allowing for 
early diagnostic uncertainty (Department of Health, 2001). 
 
In 2000, the UK government made the commitment that ‘all young people who 
experience a first episode of psychosis, such as schizophrenia, will receive the early 
and intensive support they need’ (Department of Health, 2000, p. 119). This 
commitment led to the implementation of the EIP service model throughout England 
in the ensuing years. EIP services are now widespread in Europe and Australia, and 
increasing in the United States (Birchwood et al., 2014). EIP services aim to provide 
age and phase appropriate care, incorporating pharmacological, psychological, social 
and occupational interventions (Department of Health, 2001; NICE, 2014). 
Treatment is provided in community settings or the service-user’s own home, 
employing a modified version of the assertive outreach approach to maximise 
engagement (ibid.). EIP teams seek to normalise unusual experiences and offer hope 
for recovery, aiming to promote social recovery in addition to achieving symptom 
control (Birchwood et al., 2014). Services are founded on a core set of values 
including respect for the strengths of those experiencing psychosis, promotion of 
social inclusion, provision of responsive, person-centred care, and involvement of 
family and friends wherever possible (Bertolote & McGorry, 2005).  
 
Whilst the theoretical rationale for early intervention is compelling, empirical 
support for EIP remains somewhat limited (Marshall & Rathbone, 2011). Qualitative 
research suggests that the service provided by EIP teams is valued by both service-
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users and their families (Lavis et al., 2015; Lester et al., 2011). Further, a systematic 
review and meta-analysis of RCTs of EIP treatment indicated that EIP results in 
reduced hospital admissions, reduced symptom severity and improved relapse rates, 
as well as improving access to and engagement with services (Bird et al., 2010). The 
most recent Cochrane review of EIP services (Marshall & Rathbone, 2011) agreed 
that there is some evidence for the effectiveness of specialised EIP services. 
However, these reviews were limited by a paucity of available trials and by the 
methodological quality of the trials included; for instance the OPUS trial (Petersen et 
al., 2005), recognised by the Cochrane reviewers as the largest and highest quality 
trial of EIP, did not blind assessors to treatment allocation, introducing a substantial 
possibility of bias.  
 
Improving functional outcomes following FEP is an important ambition of EIP 
services. Studies that have considered the impact of EIP on functional outcomes 
provide some support for a beneficial impact of EIP (Fowler et al., 2009a; Major et 
al., 2010; Singh et al., 2007). Nonetheless, rates of social recovery among those who 
receive treatment from EIP services remain stubbornly low (Hodgekins et al., 2015a; 
Morgan et al., 2014). Further, it is questionable whether any gains made whilst under 
the care of EIP services are sustained; follow-up studies suggest that positive effects 
observed immediately after EIP treatment are not maintained post discharge (Csillag 
et al., 2015; Marshall & Rathbone, 2011). For instance, in the OPUS trial the 
beneficial impact of EIP on both symptoms and global functioning observed at the 
end of 2 years of treatment (Petersen et al., 2005) was no longer evident 3 years later 
(Bertelsen et al., 2008). At 10 year follow-up, only 14% of the OPUS cohort met 
criteria for full recovery (both symptomatic and functional), and only 20% were 
engaged in either full- or part-time employment or education (Austin et al., 2013).   
 
Thus whilst the EIP model offers benefits over conventional approaches to treating 
psychosis, scope for improving outcomes following FEP remains considerable. The 
factors that influence recovery from FEP are not fully understood but it has been 
suggested that negative symptoms may play a central role (ibid.). Elevated negative 
symptoms have been found to be a significant predictor of poor functional outcomes 
following FEP in both short and longer-term follow-up studies (Austin et al., 2013; 
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Hodgekins et al., 2015a; Milev, Ho, Arndt, & Andreasen, 2005). Conversely, low 
levels of negative symptoms early in the course of psychosis have been found to be a 
significant predictor of good symptomatic and functional recovery at five years 
(Albert et al., 2011). As such, targeting early negative symptoms as part of EIP 
treatment might be an important means of improving outcomes following FEP.  
 
Unfortunately, negative symptoms in FEP remain under-researched and poorly 
understood, creating a significant barrier to the development of interventions to 
effectively target early negative symptoms. Most negative symptoms research 
carried out to date has focused on negative symptoms in individuals who have been 
unwell for many years and who meet diagnostic criteria for schizophrenia. It cannot 
be assumed that the findings of research conducted with participants with chronic 
schizophrenia can be applied to the population of EIP service-users. Current 
evidence suggests that negative symptoms are generally less persistent in FEP than 
in more chronic psychosis but, when they do show signs of persistence at this early 
stage, may be of particular prognostic significance (Galderisi et al., 2013; Malla & 
Payne, 2005). Further research is needed to build our understanding of negative 
symptoms as they occur in FEP in order to facilitate improved early intervention 
strategies.  
 
1.8. SUMMARY AND RATIONALE FOR FURTHER RESEARCH 
 
This chapter has introduced concepts that will be central to the thesis and sought to 
situate the research carried out within the wider clinical and academic context. 
Initially conceived as a core feature of schizophrenia, negative symptoms are now 
recognised to occur across diagnostic categories. The association between negative 
symptoms and poor outcomes following psychosis has prompted considerable 
growth in negative symptoms research since their 1980s ‘renaissance’. This growth 
has been accelerated by the development of a consensus regarding the parameters of 
the negative symptom construct and the creation of new tools for negative symptom 
measurement. A number of theoretical models of negative symptoms have been 
proposed, supported by a growing (but incomplete) evidence-base. The search for 
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effective treatment strategies is ongoing but there are a number of promising non-
pharmacological approaches, including social skills training, cognitive therapy and 
exercise. The mechanisms through which such treatments might bring about 
improvements in negative symptoms are not fully understood. 
 
The varying designs of the recently developed tools for negative symptom 
measurement reveal some remaining disagreement about the conceptualisation of 
negative symptoms. In particular, it is unclear whether experiential deficits should be 
viewed as essential to negative symptoms, or whether negative symptoms can be 
reduced to behavioural deficits and thus adequately measured via objective 
observations of behaviour. Evidence that individuals with psychosis have intact 
hedonic responses and social experience suggests that conceptualising negative 
symptoms as involving deficits in experiential capacity would be a mistake. This 
conclusion is supported by the limited correspondence between self-reported 
emotional range and observed negative symptom severity. Research investigating the 
experiential dimension of negative symptoms will be important in clarifying the 
phenomenology of negative symptoms, and thus how these symptoms are best 
conceptualised and measured. 
 
It is becoming increasingly clear that dysfunctional attitudes and negative 
expectancies have a role in the manifestation of negative symptoms, and may 
account for the apparent experiential deficits observed in those with psychosis. The 
acceptance of a central role for dysfunctional cognitions in the manifestation of 
negative symptomatology entails that a cognitive model of negative symptoms be 
embraced. However, this is not to say that alternative models of negative symptoms 
should be dismissed. Human behaviour is complex and requires multiple levels of 
explanation. As in other domains of psychosis psychopathology, multi-modal 
intervention (incorporating both psychosocial and medical components) is likely to 
be necessary if negative symptoms are to be adequately treated. It is only by taking a 
biopsychosocial approach to understanding negative symptoms that such treatment 
strategies can be successfully developed. 
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Most of the currently available evidence regarding negative symptoms concerns 
individuals in the chronic phase of schizophrenia, with relatively little research effort 
having been directed towards understanding negative symptoms as they occur early 
in the course of psychosis. Given the association between elevated negative 
symptoms during FEP and poor functional outcomes, the incorporation of targeted 
interventions for those with elevated negative symptoms into the EIP treatment 
model has the potential to boost stubbornly low rates of social recovery. However, 
this will only be achieved if we more fully understand the early course of negative 
symptoms, the factors associated with early negative symptom persistence, and their 
relationship to poor social recovery during the early phases of treatment.    
 
1.9. THESIS OVERVIEW 
 
1.9.1. Research Design 
 
This thesis aims to provide insights into the early course of negative symptoms in 
individuals under the care of EIP services. In order to facilitate a rich, multifaceted 
understanding of negative symptoms in FEP, and in line with the metatheoretical 
underpinnings of the research, the thesis takes a mixed methods approach. 
Quantitative and qualitative methods are combined in a variation on a sequential 
explanatory design, in which quantitative and then qualitative data are analysed in 
separate but contingent phases (QUAN → QUAL; Cresswell, Plano-Clark, 
Gutmann, & Hanson, 2003). 
 
In the first phase, quantitative data from a large FEP cohort (n = 1006) obtained 
using standardised assessment instruments are analysed statistically. In the second 
phase, qualitative data in the form of transcripts of in-depth interviews conducted 
with a subsample of members of the same cohort (n = 24) are analysed thematically. 
The results of the longitudinal modelling carried out during the first phase are 
important prerequisites of the second, informing the purposive sample of cohort 
members whose interview transcripts are analysed, and defining groups of 
participants with differing negative symptom trajectories whose experiences are 
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compared. The results of the quantitative and qualitative analyses are then integrated 
and interpreted in the light of existing research and theory. The overarching design 
of the research is depicted in Figure 1.4. 
 
 
Note. An arrow between two studies denotes the study at the base of the arrow being 
a prerequisite of the study it points towards.  
Figure 1.4. Diagrammatic representation of overall research design.  
 
 
1.9.2. Structure of the Thesis 
 
The thesis is divided into four parts. Part One comprises the current chapter and one 
further chapter addressing methodological issues. Part Two details the quantitative 
research conducted. The three studies reported in Part Two sought to facilitate the 
selection of PANSS items to measure the negative symptom construct (Chapter 
Three), identify distinct trajectories of early negative symptom progression and 
ascertain predictors of the trajectories identified (Chapter Four), and examine the 
relationship between these early negative symptom trajectories and early social 
recovery (Chapter Five). Part Three of the thesis reports the qualitative research 
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conducted. The two studies described in Part Three explore the lived-experience of 
those whose negative symptoms followed the distinct courses identified in Part Two. 
The studies address experiences and understandings of negative symptoms 
themselves (Chapter Six), and the way in which individuals with differing early 
negative symptoms trajectories make sense of their psychosis, describe the treatment 
they received and the process of recovery (Chapter Seven). Parts Two and Three are 
intersected by a short bridging section (Interlude) which presents the rationale for the 
use of qualitative methods to complement the quantitative work conducted. Part Four 
comprises a single closing chapter (Chapter Eight) which focuses on integrating the 
quantitative and qualitative findings, relating them to the wider literature, evaluating 
their significance and discussing their potential theoretical and clinical implications. 
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Chapter Two – Methodological Considerations 
 
2.1. OVERVIEW 
 
This chapter addresses a number of important issues pertaining to the methodology 
of the research described in the ensuing five chapters. After first outlining the 
ontological and epistemological stance underpinning the research, the context in 
which the data were collected is described and ethical issues concerning secondary 
data analysis discussed. Finally, reflexivity is addressed through reflection on the 
impact of my own personal background and beliefs, and those of others, on the 
research process and findings.   
 
2.2. METATHEORETICAL FOUNDATIONS 
 
All scientific research is underpinned by ontological and epistemological 
assumptions: assumptions about the nature of the reality being investigated and the 
means of acquiring knowledge of this reality. Mixed methods research combines 
research paradigms whose proponents traditionally take contrasting ontological and 
epistemological positions. As such, whereas the metatheoretical position of the 
researcher is often taken for granted in quantitative investigations, the adoption of a 
mixed methods approach requires that the researcher’s ontological and 
epistemological positions are explicitly acknowledged. 
 
The ontological and epistemological foundations of the research described in this 
thesis are provided by critical realism. Proponents of critical realism acknowledge 
the existence of an objective reality but assert that our knowledge of this reality is 
conceptually mediated, that is, our understanding of the world is always filtered 
through language and concepts that are relative and changeable across time, cultures 
and individuals (Danermark, Ekstrӧm, Jakobsen, & Karlsson, 2002). The critical 
realist approach is motivated by a desire to acknowledge the untenability of the naïve 
realist’s acceptance of the existence of neutral empirical ‘facts’, whilst preserving the 
possibility of scientific explanation of human phenomena (ibid).      
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The critical realist is an ontological realist, that is he or she accepts the existence of a 
reality independent of the observer, but rejects the empiricist’s reduction of reality to 
the observable (Collier, 1989). Critical realism emerged from the philosophy of 
science of  Bhaskar (1975, 1979) who asserted that it is possible to distinguish three 
ontological domains: the empirical (what we experience), the actual (events that 
happen whether we experience them or not), and the real (generative mechanisms 
with the potential to bring about events in the world). Bhaskar emphasised the 
importance of this third ontological domain to scientific endeavour; he argued that 
only by acknowledging the reality of unobservable generative mechanisms is causal 
explanation of observed phenomena made possible (Danermark et al., 2002). For the 
critical realists, to have knowledge entails understanding the unobservable 
mechanisms that produce empirical events, not just the events themselves.  
 
Since generative mechanisms – the central object of scientific inquiry according to 
the critical realist – are not directly observable, we can only understand them through 
proposing theoretical models. However, this does not preclude the possibility of 
acquiring scientific knowledge through observation; empirical testing plays a central 
role in the epistemology of critical realism. Whilst the critical realist accepts that all 
such theories are fallible and subject to revision, they assert that theories should be 
evaluated according to their ability to explain observed regularities. Thus knowledge 
can be acquired through the process of proposing theoretical explanations and 
rejecting those that do not adequately account for one’s observations in favour of 
theories that prove less fallible. 
 
The choice of critical realism as the metatheoretical grounding of this thesis is partly 
informed by its subject matter. Psychotic phenomena offer a rare insight into the gap 
between subjective experience and external reality; that it is possible to have 
hallucinatory experiences demonstrates that our perceptions of the world are not 
direct representations of it, making a position of naïve realism impossible to 
maintain. However, the possibility of distinguishing delusional from veridical 
understandings of the world demonstrates our collective capacity to use empirical 
evidence to reveal the fallibility of particular ways of understanding the world 
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around us. Furthermore, the nature of psychiatric concepts provides strong support 
for the metatheoretical claims of critical realism. Psychiatric concepts (symptoms, 
diagnoses, treatment models, etc.) are not empirical facts, but nor are they abstract 
theories with no grounding in reality. Instead they provide a conceptual scaffolding 
intended to help users make sense of biological, psychological and social phenomena 
observed in connection to mental distress and dysfunction.  
 
It would be inappropriate to approach research concerning such phenomena from a 
perspective which assumes direct, unmediated access to the object of study. Equally, 
for research to remain a worthwhile endeavour it is important not to preclude the 
possibility of judging any theory to be more or less true than another. Critical realism 
allows that we can judge the merits of a psychiatric conceptualisation or theory 
according to how far it concurs with our observations of reality, without considering 
the knowledge so acquired indubitable.   
 
The adoption of a critical realist stance was also motivated by the need to provide 
firm philosophical groundings for a mixed methods approach. Much early unease 
about mixed methods research concerned the differing philosophical foundations of 
quantitative and qualitative approaches. It was argued that since quantitative and 
qualitative methods emerged from paradigms with incompatible ontological and 
epistemological assumptions, mixing these methods is neither sensible nor possible 
(Greene, Caracelli, & Graham, 1989). Mixed methods research has often been based 
on a pragmatic approach in which practicality and usefulness take precedence over 
ontological and epistemological considerations (Tashakkori & Teddlie, 1998). 
However, critics of this approach warn that attempting to divorce method from 
metatheory is futile: all research makes assumptions about the nature of the object of 
study and the means by which knowledge of it can be obtained, whether they are 
explicitly acknowledged or not (Danermark et al., 2002).  
 
Critical realism provides solid metatheoretical foundations for mixed methods 
research since it holds that generative mechanisms are not just constant conjunctions 
of observed events but a domain of reality. As such, understanding the world as it is 
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requires not just ‘extensive’ inquiry, aimed at describing empirical regularities, but 
also ‘intensive’ inquiry, aimed at generating theories regarding the processes 
underlying the regularities observed (ibid.). As such, a critical realist perspective 
suggests the tandem utilisation of qualitative and quantitative methods as the 
approach most likely to facilitate deep understanding of reality.  
 
2.3. DATA COLLECTION: THE EDEN RESEARCH PROGRAMME  
 
This thesis makes use of data collected as part of the EDEN research programme 
(Birchwood et al., 2014). EDEN was a multisite, multi-phase, mixed-methods 
research programme funded by the Department of Health (2005-2010 and extended 
2011-2016). The programme was designed to evaluate the implementation, impact 
and cost-effectiveness of EIP services in the UK, and to develop an explanatory 
model of variance in patient outcomes (ibid.). Participants were recruited from EIP 
services in five purposively selected sites: Birmingham, Cambridgeshire, Cornwall, 
Lancashire and Norfolk. Sites were selected to reflect national diversity in urbanicity 
and service configuration. All individuals recruited into participating EIP services 
between August 2005 and April 2009 were invited to take part. Since the programme 
was designed to assess outcomes of EIP services, no special inclusion criteria were 
set beyond the individual having been accepted by one of the participating services 
(although those who had not experienced an episode of psychosis and had been 
accepted into services on account of being at high-risk of psychosis were excluded). 
Of those service-users eligible for participation, 49% (1027 individuals) consented to 
take part. Participants did not differ significantly from non-participants in terms of 
age, gender, ethnicity or marital status (ibid.).  
 
In the first phase of the programme – National EDEN – participants were assessed 
using a battery of quantitative assessment measurements within 3 months of entry 
into EIP services (baseline), and again six and twelve months later. National EDEN 
also included a qualitative component designed to assess the acceptability of 
services. A purposive sample of service-users and family carers were interviewed 
within six months of entry to EIS and twelve months later. Further, annual focus 
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groups with EIP staff were conducted, concentrating on their views on barriers and 
facilitators to service implementation.  
 
The second phase of the research programme – Super EDEN – began in 2011. 
During this phase, the cohort were followed-up annually for a further two year 
period in order to assess outcomes at the end of, and post discharge from, EIP. In 
addition to re-administering the quantitative assessment battery used during National 
EDEN at a further three to four time points, Super EDEN involved a substantial 
qualitative component involving a series of in-depth interviews with both 
participants and family carers. A total of 518 service-users consented to participate 
in Super EDEN, with 207 of them choosing to take part in its qualitative component, 
along with 98 of their family carers. The quantitative studies in this thesis use data 
from the first phase of the programme (National EDEN), and the qualitative studies 
data from the second phase (Super EDEN).  
 
2.4. ETHICAL CONSIDERATIONS 
 
Ethical approval for the EDEN programme was granted by Suffolk Research Ethics 
Committee (reference number: 05/Q0102/44) and by the local research governance 
department at each of the participating research sites. Individuals invited to 
participate were provided with a written information sheet (Appendix B) detailing 
the purpose of the research programme, what participation would involve, the 
possible risks and benefits of taking part, and information about how confidentiality 
would be safeguarded. The information sheet also emphasised the right to decline 
participation or withdraw from the study at any time, and explained that a decision 
not to take part or to withdraw would not adversely affect the clinical care received. 
Potential participants were also provided with a verbal explanation of the research 
and had the opportunity to have their questions answered.  
 
Individuals who wished to participate were asked to complete a consent form to 
provide a written record of their informed consent. In the case of participants under 
the age of 16, the informed consent of the young person was supplemented by the 
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informed assent of a parent or legal guardian. Renewed informed consent was sought 
and recorded prior to the second phase of the programme. Participants received £20 
per quantitative assessment and £10 per in-depth interview to compensate them for 
their time and were reimbursed for any travel expenses.  
 
To protect participants’ confidentiality, each individual was allocated an identifier 
code. Identifiable participant information was removed from study data and replaced 
with the identifier code such that data from a single participant could be matched 
without the participant’s identity being revealed. Raw data is stored in locked filing 
cabinets in secure locations at participating sites. Consent and assent forms and all 
other documents containing participant identifiable information are stored separately 
from anonymised data. All electronic data is stored in password protected locations 
to prevent unauthorised access and data transferred between sites using a secure file 
transfer system.              
 
Since participants were not required to undertake any additional procedures for the 
purposes of the current research, there was minimal additional risk to, and no 
additional burden on, participants. Nonetheless, the secondary analysis of existing 
data is not ethically unproblematic and should not be undertaken without careful 
consideration of the relevant ethical issues. 
 
Secondary analysis can be defined as ‘the utilisation of existing data, collected for 
the purposes of a prior study, in order to pursue a research interest which is distinct 
from that of the original work’ (Heaton, 1998). Codes of ethical research practice 
suggest that consent should not be considered a ‘once-and–for-all’ event prior to data 
collection, but an ongoing process (Grinyer, 2009). The British Psychological 
Society’s guidelines on informed consent (The British Psychological Society, 2009) 
recommend that psychologists should, after obtaining initial informed consent to the 
full extent allowed by the capacity of the individual concerned, ‘obtain supplemental 
informed consent as circumstances indicate, when professional services or research 
occur over an extended period of time, or when there is significant change in the 
nature or focus of such activities’ (p. 13). Such guidelines suggest that it may be 
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necessary to obtain supplementary informed consent prior to secondary analysis of a 
participant’s data. As such, the decision not to seek additional consent prior to 
carrying out the research described in this thesis is in need of justification.  
  
Decisions about whether secondary analyses of data require additional consent 
largely hinge on whether the intended use of the data is sufficiently distinct from that 
initially intended to invalidate the original contract between participant and study 
team. The British Psychological Society guidelines suggest that supplementary 
consent should be sought when ‘there is significant change in the nature or focus of’ 
the research, however the definition of ‘significant change’ in this context is unclear. 
Determining whether a change in focus is significant is particularly difficult when, as 
in the EDEN research programme, the initial aims of a project were broad. Whilst 
the primary remit of the EDEN programme was the evaluation of EIP services, the 
development of an explanatory model of variance in patient outcomes was also a 
stated aim of the programme. Given the close relationship between negative 
symptoms and outcomes, investigating negative symptoms is of clear relevance to 
this aim. As such, an argument can be made that the studies described in this thesis 
fall within the scope of the original aims of the programme and so do not represent a 
significant change in the focus of the research. 
 
Whilst it is clearly ethically important that participants are adequately informed 
about the use that will be made of their data, this must be balanced against the 
demands made of them. Participants are not usually required to have a detailed 
understanding of the analysis plan of a study before agreeing to participate since this 
requirement would impose undue burden. As such, requesting supplementary 
consent to conduct additional analyses in line with the initial aims of the project 
would be rather odd given that few participants would have been aware of the 
original analysis plan. Further, repeated requests for additional consent would place 
increased demands on participants’ time and might be perceived as a nuisance by 
some. Arguably, researchers have a duty to respect the time and efforts of their 
participants by using their data to the full. For some participants, greater volume of 
research outputs might make their participation more worthwhile (Grinyer, 2009).  
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Additionally, since much research (the EDEN programme included) is funded by 
public money, researchers have a responsibility to the wider public to ensure that the 
data they generate is fully utilised. Using public money to carry out a primary study 
with research questions that could be adequately addressed through analysis of pre-
existing data would not be easy to justify (Research Councils UK, 2015). Requiring 
additional consent to be provided for all secondary analyses would be a significant 
barrier to the efficient use of public resources. 
 
2.5. REFLEXIVITY: THE ROLE OF THE RESEARCHER IN THE 
RESEARCH  
 
Reflexivity is the process of engaging in explicit, self-aware reflection on one’s 
personal impact on the process and outcomes of research (Finlay, 2002). Critical 
realism entails an epistemological relativism in which the possibility of attaining 
objective knowledge is rejected. Thus the products of research are acknowledged to 
be subjective interpretations of reality, not objective representations (Wikgren, 
2005). Whilst there might be empirical grounds for judging some interpretations 
superior to others, researchers taking a critical realist perspective must avoid falling 
into the trap of believing that the products of their research are neutral facts. We each 
occupy a unique vantage point, influenced by our past experiences and social, 
cultural and historical context, and it is only from this vantage point that we can 
experience and interpret the world. Through acknowledging the role of the 
researcher in the research process and the subjectivity of its outputs, the transparency 
of the research process and the integrity of its findings can be maximised. Further, by 
making one’s ‘conceptual baggage’ explicit, another dimension of the research is 
revealed, one that is always present but often unacknowledged (Kirby & McKenna, 
1989).  
 
My interest in early psychosis began when, as a recent graduate, I was lucky to 
secure a position as an Assistant Psychologist within Central Norfolk Early 
Intervention Team (CNEIT). During my time with CNEIT, I had the privilege of 
meeting many young people experiencing FEP. I was moved by their courage and 
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resilience, and fascinated by the ways they sought to come to terms with, and make 
sense of, their experiences. Many of CNEIT’s clients were a similar age to me but 
were faced with circumstances that, not having experienced psychosis personally, I 
could scarcely imagine. I was also inspired by the dedication, compassion and 
insight of my CNEIT colleagues, many of whom had been integral in establishing 
the service. In common with other EIP services, CNEIT adopts a normalising, non-
pathologising approach to psychosis. The service the team provides is holistic, 
encompassing physical and social as well as psychological needs, and is tailored to 
the priorities of the client (Social Care Institute for Excellence, 2011).  
 
The non-pathologising, person-centred ethos of the team shaped my understanding 
of psychosis and its treatment. I came to believe that psychotic symptoms are often 
understandable reactions to extreme circumstances, can be understood in terms of 
ordinary psychological processes, and are usually meaningful to those experiencing 
them. I learnt that whilst reducing or eliminating psychotic symptoms is often 
important to young people and their families, other aspects of life, including work, 
education, housing, family and peer relationships are frequently just as, if not more, 
important.  
 
My motivation to study negative symptoms was founded on the realisation that it is 
often negative and not positive symptoms that prove most enduringly disruptive to 
the lives of individuals who experience psychosis. I found it surprising that, whilst 
positive symptoms are now widely understood to lie on a continuum with 
experiences that are common across the population, the same is not true of negative 
symptoms. Nearly everyone, whether they have experienced mental health problems 
or not, will encounter periods during which they don’t feel much like talking, lack 
motivation or prefer not to be around others. As such, it struck me as odd that when 
individuals with psychosis present with similar phenomena, these are taken to be 
fundamentally different from these ‘ordinary’ negative symptom-like experiences.   
 
At the time I joined CNEIT, the second phase of the EDEN programme was just 
getting underway. I was tasked with re-contacting members of the cohort from the 
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Norfolk site and inviting them to participate in the next phase of the study. Over the 
next 18 months I conducted both quantitative assessments and qualitative interviews 
with EDEN participants alongside my role within the clinical team. As such, I did 
not approach the EDEN data as an impartial outsider; I had formed impressions of 
the participants I met during data collection and had already begun to develop ideas 
about the nature of negative symptoms in this cohort. My experiences working with 
young people with non-psychotic mental health problems after leaving CNEIT also 
served to reinforce my impression that negative symptoms in those with psychosis 
may not be fundamentally different from similar phenomena in those without 
experience of psychosis. 
 
The impact of my own personal experiences and beliefs on the research is most 
apparent when considering the studies employing qualitative methods. My choice of 
research questions was certainly influenced by the interests I developed and the 
questions that arouse during my time with CNEIT. Furthermore, although I made 
efforts to ensure that my analysis was firmly grounded in the data throughout, my 
approach to analysis, interpretation of the data and selection of themes will have 
been influenced by my ‘conceptual baggage’.  
 
The role of the researcher in shaping quantitative research is less often 
acknowledged but no less pertinent (Ryan & Golden, 2006). In the case of the 
quantitative research described in this thesis, there was perhaps more room for my 
own personal background and beliefs to influence the conclusions reached than in 
most quantitative studies due to the statistical methods employed. Since selection of 
the optimal model of negative symptom trajectory classes involved weighing 
statistical considerations against subjective judgements of parsimony and 
interpretability, it is possible that a different researcher would have selected an 
alternative model as optimal and thus reached different conclusions. 
 
Given that the research described in this thesis involved analysis of data collected, in 
the most part, by others, a complete consideration of reflexivity in this case requires 
reflection on the role in shaping the research of all those involved in data collection 
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in addition to myself. Collecting data on the lives of individual people, whether 
quantitative or qualitative in nature, is a complex, dynamic process influenced by 
multi-layered power dynamics (ibid.). The Research Assistants working on the 
EDEN programme were from diverse backgrounds, both professionally and 
personally, each bringing with them a unique set of experiences, values and beliefs. 
Given the complexity of the social interactions involved in producing the data, it is 
impossible to establish the impact of the individual attributes of the many researchers 
involved on the conclusions reached. This impossibility supports the critical realist 
insistence on avoiding regarding the products of research as objective representations 
of reality.    
 
2.6. SUMMARY 
 
This chapter has described the critical realist underpinnings of the research, 
described the EDEN research programme through which the data were collected, and 
argued for the ethical justification of secondary analysis of this data in the absence of 
additional informed consent. The final section of the chapter aimed to address the 
reflexivity inherent in psychological research through explicitly addressing my own 
and other researchers’ impact on the process and products of the research. The five 
chapters that follow report the empirical research conducted.  
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PART TWO 
 
A Quantitative Investigation of 
Negative Symptoms in First-Episode 
Psychosis 
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Chapter Three – Exploring the Factor Structure of the Positive and Negative 
Syndrome Scale in a First-Episode Psychosis Sample 
 
3.1. BACKGROUND AND RATIONALE 
 
The PANSS (Kay, Fiszbein, & Opler, 1987) is one of the most widely used measures 
of psychopathology in psychosis research, and was the only measure of negative 
symptom severity included in the EDEN battery. The PANSS is a 30-item 
instrument designed to measure a wide range of symptoms associated with 
schizophrenia. Symptom severity over the previous seven days is assessed by a 
trained rater on the basis of a semi-structured interview with the participant and the 
reports of professional carers or family members. Each symptom is rated on a 7-
point scale from 1 (absent) to 7 (extreme) according to a set of symptom-specific 
anchoring criteria. 
 
The PANSS items were originally grouped into three subscales: positive symptoms, 
negative symptoms and general psychopathology. However, it is now accepted that 
these a priori subscales are not an accurate reflection of the scales underlying factor 
structure (Kay, Opler, & Fiszbein, 2000). Numerous principle component analyses of 
the PANSS have been conducted, typically yielding four to seven factors, of which 
one corresponds to the negative symptoms construct (Fitzgerald et al., 2003). The 
negative symptoms factors identified by these analyses vary (Emsley, Rabinowitz, & 
Torreman, 2003; Wallwork, Fortgang, Hashimoto, Weinberger, & Dickinson, 2012), 
but none align with the original negative subscale. Indeed, it is now widely accepted 
that the PANSS negative subscale contains several items measuring symptoms that 
do not fall within the domain of negative symptoms (Kirkpatrick et al., 2006). As 
such, the negative subscale of the PANSS is an unsatisfactory tool for the assessment 
of negative symptom severity.     
 
Due to the limitations of the original PANSS subscales, it is becoming increasingly 
common for studies using the PANSS to utilise a bespoke subscale structure based 
on a published factor model (Nicotra, Casu, Piras, & Marchese, 2015). However, 
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there remains much controversy surrounding the factor structure of the PANSS 
(Malaspina et al., 2014), making the choice of factor model to employ in using this 
strategy less than straightforward. Studies investigating the factor structure of the 
PANSS in schizophrenia have most commonly identified models with five factors, 
and the five-factor ‘pentagonal model’ (White, Harvey, Opler, & Lindenmayer, 
1997) developed by the PANSS study group was included in the most recent PANSS 
manual (Kay et al., 2000). However, a subsequent independent study found that this 
model was an inadequate fit for data from a sample of 347 individuals diagnosed 
with schizophrenia (Fitzgerald et al., 2003). A recent attempt has been made to 
construct a ‘consensus’ five-factor model through identifying the most common 
item-factor assignments among 29 independent five-factor models (Wallwork et al., 
2012). The resulting factor structure was found to be a good fit to data obtained from 
two independent samples from differing cultural backgrounds.  
 
Such a consensus factor structure might be considered a suitable basis for the 
formation of a negative symptoms subscale for use in this thesis. However, 
Wallwork et al.’s samples included only individuals with an established diagnosis of 
either schizophrenia or schizoaffective disorder and who were, on average, more 
than a decade older than the EDEN cohort. It cannot be assumed that a factor model 
confirmed in an older, diagnostically homogeneous sample can necessarily be 
successfully applied to an FEP cohort. Substantiating this assertion, Langeveld et al. 
(2013) examined the fit of five widely used PANSS factor models (including 
Wallwork et al.’s consensus model) in a large FEP sample (n = 588) and found that 
none of the models tested met criteria for satisfactory model fit.  
 
Use of PANSS symptom subscales based on an inadequate factor model may result 
in suboptimal sensitivity to change. As such, it is important to determine the best-
fitting factor model for the population of interest when determining symptom 
subscales. Given a lack of a consensus regarding the optimum factor model of the 
PANSS in an FEP sample, the decision was taken to carry out a study to determine 
the factor structure of the PANSS in the EDEN cohort itself rather than choosing a 
published factor model. The factor model identified could then be used to determine 
the most suitable PANSS items to measure negative symptom severity for the 
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purposes of this thesis. This approach has been recognised as a valid means of 
ascertaining an appropriate subscale structure for the PANSS for the particular 
sample under investigation (Nicotra et al., 2015). 
 
It should be noted that while none of the PANSS factor structures developed in 
schizophrenia samples were an adequate fit for Langeveld et al.’s FEP data, neither 
was the one factor structure developed in a sample with recent-onset psychosis. Thus 
their failure to confirm the published factor structures considered may represent a 
wider problem of lack of stability of PANSS factor structures across samples. A 
study that examined the goodness-of-fit of all previously published five-factor 
models of the PANSS in a sample of 5769 individuals diagnosed with schizophrenia 
failed to confirm the appropriateness of any of the models considered (van der Gaag 
et al., 2006a). 
 
An important limitation of much work exploring the factor structure of the PANSS 
to date is the use of restrictive models that do not allow for the free estimation of 
cross-loadings, thereby restricting each item to load on only one factor. Some 
authors suggest that allowing free estimation of cross-loadings is necessary to 
adequately reflect clinical reality and thus obtain satisfactory model fit (van der Gaag 
et al., 2006b; van den Oord et al., 2006). Following their failure to confirm any of 
the published five-factor models identified in the literature, van der Gaag et al. 
(2006b) used ten-fold cross-validation to develop a revised five-factor model. Ten-
fold cross-validation involves randomly assigning participants to one of ten equally 
sized subsamples. Nine of these subsamples serve as training sets and the remaining 
subsample is used to test the validity of the resulting model. This process is then 
repeated with each of the subsamples in turn serving as the validation set.  
 
Using this method, van der Gaag et al. demonstrated that a five-factor model can 
achieve good fit when items are permitted to load on more than one factor. Perhaps 
more importantly, they demonstrated the stability and clinical face-validity of such 
cross-loadings, indicating that they may be necessary due to some symptoms having 
multiple causes rather than certain PANSS items simply being ill-defined. The 
74 
 
negative symptom factor they identified was particularly stable; eight PANSS items 
– ‘blunted affect’ (N1)1, ‘emotional withdrawal’ (N2), ‘poor rapport’ (N3), 
‘apathetic social withdrawal’ (N4), ‘lack of spontaneity and flow of conversation’ 
(N6), ‘motor retardation’ (G7), ‘uncooperativeness’ (G8) and ‘active social 
avoidance’ (G16) – loaded on the negative factor in all 10 cross-validations. 
 
Van den Oord et al. (2006) also recognised the disadvantages of modelling the 
structure of the PANSS using restrictive models and thus used a combination of 
exploratory and confirmatory factor analysis to develop and assess the fit of a model 
that allowed items to load on multiple factors. The ‘Negative’ factor in the six-factor 
model they obtained was indicated by the items ‘blunted affect’ (N1), ‘poor rapport’ 
(N3), ‘motor retardation’ (G7) and ‘disturbance of volition’ (G13). However, the 
factor labelled ‘Withdrawn’ by the authors, indicated by ‘active social avoidance’ 
(G16), ‘emotional withdrawal’ (N2) and ‘apathetic social withdrawal’ (N4), could 
also be argued to reflect the negative symptoms construct. 
 
For ease of comparison, the negative symptoms factors in van der Gaag et al. and 
van den Oord et al.’s models are presented alongside the negative factors from White 
et al.’s pentagonal model and Wallwork et al.’s consensus model in Table 3.1.  
  
                                                 
1Each PANSS items was labelled by the scale’s authors with a combination of a letter and a number. 
The letter denotes which of the original subscales it formed part of (‘P’ for the positive subscale, ‘N’ 
for the negative subscale, and ‘G’ for the general psychopathology subscale).     
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Table 3.1. Summary of PANSS items assigned to the factor corresponding to the 
negative symptoms construct in four competing factor models.  
PANSS Item White Wallwork Van der Gaag Van den Oord 
 
N1 Blunted affect    N 
N2 Emotional withdrawal    W 
N3 Poor rapport    N 
N4 Passive withdrawal    W 
N6 Lack of spontaneity      
G5 Mannerisms and 
posturing 
    
G7 Motor retardation 
 
   N 
G8 Uncooperativeness 
 
    
G13 Disturbance of 
volition 
   N 
G14 Poor impulse control  
 
    
G16 Active social 
avoidance  
   W 
‘’ = included in a single negative symptoms factor 
‘N’ = included in van den Oord et al.’s ‘Negative’ factor 
‘W’ = included in van den Oord et al.’s ‘Withdrawal’ factor 
Note. Complete citations for the factor models compared are White et al. (1997), 
Wallwork et al. (2012), van der Gaag et al. (2006b) and van den Oord et al. (2006).  
 
 
Several factor models were fitted to the data in the current study. Initially, 
exploratory factor analysis (EFA) was used to generate a factor model and 
confirmatory factor analysis (CFA) used to test how well this model fitted the data. 
The advantage of this approach is that if it were possible to identify a factor model 
with adequate fit to the data using CFA then a single structural equation model 
incorporating both the measurement model for negative symptoms and longitudinal 
growth analyses would be able to be specified in the subsequent study. However, if 
(as was anticipated on the basis of the work by van der Gaag et al. and van den Oord 
et al. discussed above) it proved impossible to confirm the fit of the model suggested 
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by EFA using CFA, it was planned that exploratory structural equation modelling 
would be employed to determine the factor structure instead.   
 
Exploratory structural equation modelling (ESEM) is a relatively new modelling 
technique (Asparouhov & Muthén, 2009) which combines advantages of both 
confirmatory and exploratory factor analysis (Marsh, Morin, Parker, & Kaur, 2014). 
Like EFA, ESEM does not require cross-loadings to be fixed at zero, allowing for 
the sort of complex factor models that van der Gaag et al. and van den Oord et al. 
argue are necessary to adequately reflect clinical reality and thus obtain satisfactory 
model fit. However, unlike EFA and in common with CFA, model fit indices can be 
obtained using ESEM, enabling the adequacy of the fit of the model to the data to be 
verified. 
 
3.2. RESEARCH QUESTION  
 
What is the optimum factor model of the PANSS in a sample of EIP service-users 
and which items indicate the factor (or factors) in this model corresponding to the 
negative symptoms construct? 
 
3.3. METHODS 
 
3.3.1. Design 
 
PANSS data from a large sample of individuals with FEP were explored using factor 
analytic techniques. Participants were assessed using the PANSS within 3 months of 
entry into participating EIP services. This study employed a cross-sectional design: 
whilst participants went on to be assessed longitudinally, only PANSS data collected 
at baseline were used in this study.  
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3.3.2. Participants 
 
All individuals included in the current study were participants in the National EDEN 
study (see section 2.3 for further details). All National EDEN participants with 
complete baseline PANSS data (n = 967) were included in the current study. 
 
3.3.3. Sample size 
 
There are varying opinions as to the sample size required to successfully conduct 
factor analysis. A number of rules of thumb, typically stated in terms of minimum 
sample size or ratio of the sample size to the number of variables analysed, have 
been proposed. The minimum sample sizes suggested vary considerably but several 
authors recommend n = 100 as the minimum adequate sample size required 
(MacCallum, Widaman, Zhang, & Hong, 1999). Comrey & Lee (1992, cited by 
MacCallum et al., 1999) offered the following guidelines for assessing the adequacy 
of a sample size for factor analysis: 100 = poor, 200 = fair, 300 = good, 500 = very 
good, and 1000 or more = excellent. Suggestions as to the necessary ratio of 
participants to measured variables range from 20:1 at the most conservative to 3:1 at 
the least. Comprising 967 participants – 32.23 (967/30) participants per measured 
variable – this study’s sample is large enough for successful factor analysis 
according to even the more conservative guidelines.  
 
3.3.4. Procedure  
 
Individuals who consented to take part in National EDEN met with a study Research 
Assistant to complete an assessment as soon as possible following acceptance into a 
participating EIP Service. Research Assistants were graduates in psychology or 
another relevant discipline working alongside participating EIP services. 
Assessments were conducted at a venue convenient for the participant, for instance 
the participant’s home, their GP surgery or mental health service base. A large 
battery of assessment measures was administered in order to address the wide-
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ranging research objectives of National EDEN. The PANSS was one of 18 measures 
administered at baseline.  
 
Steps were taken to ensure adequate inter-rater reliability and guard against rater 
‘drift’ over time (for further details see Birchwood et al., 2014). All Research 
Assistants were trained in rating the PANSS by experienced members of the study 
team and were required to demonstrate adequate inter-rater reliability (kappa or 
intra-class correlation r > 0.75) using standardised training videos before being 
permitted to begin providing ratings for the study. Throughout the study, a 
proportion of PANSS interviews conducted at each site were rated independently by 
multiple trained assessors and good inter-rater reliability was observed.     
 
3.3.5. Analysis Plan 
 
All analyses were conducted using Mplus for Windows, Version 7.1 (Muthén & 
Muthén, 1998 - 2012).  
 
First, score distributions for each PANSS item were examined to check whether 
assumptions of normality could be justified. Next, EFA with geomin rotation (an 
oblique rotation which allows for correlation between factors) was conducted. EFA 
aims to identify the smallest number of unobserved latent factors that can explain the 
shared variability in a set of observed data. It is a data-driven technique used when 
the researcher has no a priori theory about the factor structure of a scale. Factor 
solutions with between three and seven factors were compared on the basis that 
published factor solutions for the PANSS have retained a minimum of three and 
maximum of seven factors.  
 
Application of the Kaiser criterion, inspection of a scree plot of the eigenvalues, and 
parallel analysis were used in conjunction with consideration of the theoretical 
interpretability of the factors retained in deciding how many factors to retain. 
Kaiser’s criterion (H. Kaiser, 1960) states that only factors with an eigenvalue 
greater than one should be retained. The eigenvalue of a factor indicates the amount 
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of variance accounted for by that factor; the lower the eigenvalue the less variance is 
explained. Since the average eigenvalue for a set of factors will always be one, 
Kaiser’s criterion has the effect of classing all factors that account for greater than 
average variance as worthy of retention. Whilst this is the most common method of 
determining the number of factors to retain following EFA (Gaskin & Happell, 
2014), reliance on this criterion is now widely discouraged (Courtney, 2013). As 
discussed by Fabrigar, Wegener, MacCallum, & Strahan (1999), not only is this rule 
rather arbitrary, several simulation studies have demonstrated that this criterion tends 
to overestimate the optimal number of factors to retain.  
 
The scree test (Cattell, 1966) involves plotting the eigenvalues of each factor in order 
of magnitude (from largest to smallest) and visually inspecting the graph to identify 
the ‘elbow’: the point at which the last substantial drop in eigenvalues occurs. This 
method enables the researcher to identify and discard those factors that describe 
relatively minimal variance relative to other more major factors. However, since 
there is no clear definition of what constitutes a substantial drop in eigenvalues, the 
procedure suffers from a high degree of subjectivity when there is not a clear 
discontinuity in the plot (Courtney, 2013). 
 
Parallel analysis (Horn, 1965) involves plotting the eigenvalues of the sample data 
alongside the average eigenvalues of a number of random datasets with the same 
sample size and number of variables. Sample eigenvalues which are greater than the 
eigenvalues of the random datasets are retained and those which are equal to or 
smaller than the values for the random data are assumed to be the result of sampling 
error. Parallel analysis has been argued to be one of the most accurate factor 
retention methods (Hayton, Allen, & Scarpello, 2004). 
 
CFA was then carried out to determine how well the model created on the basis of 
the EFA fitted to the observed data. As its name would suggest, CFA is a technique 
used to confirm the adequacy of a pre-determined factor model; the fit of the model 
to the data is observed and quantified using fit indices. A wide range of fit indices 
can be computed and, since each index has advantages and disadvantages, it is 
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recommended that a range of indices are utilised when making decisions regarding 
fit adequacy (Hu & Bentler, 1998). The fit indices considered in this study were the 
Root Mean Square Error of Approximation (RMSEA), Comparative Fit Index (CFI) 
and Tucker-Lewis Index (TLI). In line with common ‘rules of thumb’, cut-offs for 
these indices for adequacy of model fit were set a priori at > 0.90 for the CFI and 
TLI, and < 0.06 for the RMSEA (Marsh, Hau, & Wen, 2004).  
 
Finally, ESEM was conducted. ESEM (Asparouhov & Muthén, 2009) is a method of 
evaluating the underlying factor structure of a measure which integrates exploratory 
and confirmatory factor analysis. Unlike CFA, which allows each item to load on 
only one factor and constrains all other loadings to zero, ESEM allows items to act 
as indicators of more than one factor. ESEM requires the number of factors to be 
specified a priori but does not require the researcher to make any decisions about 
which items indicate which factors. Both the correlation and variance/covariance 
matrices are analysed in obtaining the solution and the structure obtained with factor 
rotation. In this study, the choice of the number of factors to specify was guided by 
the results of the EFA and geomin rotation used to obtain the factor structure. The fit 
indices considered were those described above. Items with a factor loading of at least 
0.3 were used to create a custom negative symptoms subscale.  
 
3.4. RESULTS 
 
Score distributions for all PANSS items were positively skewed. For this reason, an 
estimator robust to violations of the assumption of normality (maximum likelihood 
with robust means and variances) was employed in all analyses. 
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3.4.1. Exploratory and Confirmatory Factor Analysis 
 
EFA with geomin rotation was used to obtain factor solutions with between three 
and seven factors. Items were allocated to factors according to their highest loading. 
Six factors had eigenvalues greater than one, suggesting that the six-factor solution 
should be selected according to the Kaiser criterion. A scree test did not yield a clear 
result as the plot of eigenvalues (Figure 3.1) was difficult to interpret due to lack of a 
clear ‘elbow’; however, it would appear to suggest retaining between three and five 
factors. Parallel analysis conducted with 50 randomly generated datasets indicated 
that five factors should be retained (also Figure 3.1).  
 
 
Figure 3.1. Scree plot of sample eigenvalues and parallel eigenvalues for 50 random 
datasets.   
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Given the limitations of the Kaiser criterion and good performance of parallel 
analysis in studies using data with known factor structure (Ruscio & Roche, 2012), 
the five-factor solution favoured by parallel analysis and in the range suggested by 
the scree plot was selected over the six-factor solution favoured by the Kaiser 
criteria. The factors were labelled ‘Negative Symptoms’, ‘Aggression/Hostility’, 
‘Disorganisation’, ‘Positive Symptoms’ and ‘Affective Symptoms’. The items which 
indicate each factor and corresponding factor loadings are presented in Table 3.2. 
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Table 3.2. Factors and standardised item loadings for EFA with geomin rotation: 
five-factor solution. 
PANSS Items 
 
Factor Loading 
 
Factor 1 – Negative Symptoms  
N1 Blunted affect 
N6 Lack of spontaneity and flow of conversation 
N2 Emotional withdrawal 
N4 Passive social withdrawal 
N3 Poor rapport 
G7 Motor retardation 
 
Factor 2 – Aggression/Hostility 
P7 Hostility 
G8 Uncooperativeness 
G14 Poor impulse control  
 
Factor 3 – Disorganisation 
P2 Conceptual disorganisation 
G11 Poor Attention  
G13 Disturbance of volition 
G15 Preoccupation 
P4 Excitement 
N7 Stereotyped thinking 
N5 Abstract thinking 
G5 Mannerisms and posturing 
G10 Disorientation 
 
Factor 4 – Positive Symptoms 
P1 Delusions  
G9 Unusual thought content 
P6 Suspiciousness/persecution 
P5 Grandiosity 
P3 Hallucinations 
 
Factor 5 – Affective Symptoms 
G2 Anxiety 
G6 Depression  
G4 Tension 
G3 Guilt feelings 
G16 Active social avoidance  
G12 Lack of judgement and insight 
G1 Somatic concern 
 
 
 
0.800 
0.732 
0.729 
0.707 
0.646 
0.627 
 
 
0.809 
0.623 
0.537 
 
 
0.761 
0.702 
0.608 
0.559 
0.531 
0.437 
0.359 
0.363 
0.297 
 
 
0.800 
0.690 
0.459 
0.363 
0.356 
 
 
0.765 
0.683 
0.583 
0.411 
0.391 
0.319 
0.249 
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Next, CFA was conducted to determine whether the five-factor model suggested by 
the EFA fit the data adequately. The CFA suggested unacceptably poor model fit 
according to all three fit indices calculated (RMSEA = 0.079; CFI = 0.752; TLI = 
0.727). Inspection of the factor loadings revealed that several items loaded strongly 
on more than one factor.  
 
3.4.2. Exploratory Structural Equation Modelling 
 
Since the CFA did not confirm the adequacy of a five-factor model in which all 
cross-loadings are constrained to zero, ESEM was carried out to determine whether 
it would be possible to obtain a five-factor model that fit the data adequately by 
allowing items to load on more than one factor. This approach yielded acceptable 
model fit according to the majority of indices (RMSEA = 0.054; CFI = 0.914; TLI = 
0.874). The factors that resulted and the factor loadings associated with each item are 
presented in Table 3.3. The factor structure obtained using ESEM corresponded 
closely with that obtained using EFA and factors were labelled accordingly. Two 
items – ‘tension’ (G4) and ‘active social avoidance’ (G16) loaded strongly on more 
than one factor.       
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Table 3.3. Factors and standardised item loadings for ESEM with geomin rotation 
(loadings greater than 0.3 retained). 
Items Grouped by Factors  
 
Factor Loading 
 
Factor 1 – Negative Symptoms 
N1 Blunted affect 
N6 Lack of spontaneity and flow of conversation 
N2 Emotional withdrawal 
N4 Passive social withdrawal 
N3 Poor rapport 
G7 Motor retardation 
G16 Active social avoidance 
 
Factor 2 – Aggression/Hostility 
P7 Hostility 
G8 Uncooperativeness  
G14 Poor impulse control  
 
Factor 3 – Disorganisation   
P2 Conceptual disorganisation 
G11 Poor Attention 
G13 Disturbance of volition 
G15 Preoccupation 
P4 Excitement 
N7 Stereotyped thinking 
G5 Mannerisms and posturing 
N5 Abstract thinking 
G4 Tension 
 
Factor 4 – Positive Symptoms 
P1 Delusions  
G9 Unusual thought content 
P6 Suspiciousness/persecution 
P5 Grandiosity 
P3 Hallucinations 
G12 Lack of judgement and insight  
 
Factor 5 – Affective Symptoms 
G2 Anxiety 
G6 Depression  
G4 Tension 
G3 Guilt feelings 
G16 Active social avoidance 
 
 
0.800 
0.732 
0.729 
0.707 
0.646 
0.627 
0.369 
 
 
0.809 
0.623 
0.537 
 
 
0.761 
0.702 
0.608 
0.559 
0.531 
0.437 
0.363 
0.359 
0.324 
 
 
0.800 
0.690 
0.459 
0.363 
0.356 
0.305 
 
 
0.765 
0.683 
0.583 
0.411 
0.391 
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3.5. DISCUSSION  
 
3.5.1. Summary of Findings  
 
Using EFA to explore PANSS data from an FEP sample resulted in a five-factor 
model. However, this model was found to be an inadequate fit to the data when CFA 
was employed. By using ESEM a five-factor model was arrived at that fitted the FEP 
data adequately according to the majority of fit indices. The five factors in this 
model were labelled ‘Negative Symptoms’, ‘Aggression/Hostility’, 
‘Disorganisation’, ‘Positive Symptoms’ and ‘Affective Symptoms’, in line with 
labels given to PANSS factors with similar indicating items in the literature. Two 
items loaded strongly on more than one factor, including ‘active social avoidance’ 
(G16) which loaded on both the Negative Symptoms and Affective Symptoms 
factors. The factor corresponding to the negative symptoms construct included five 
items from the negative subscale of the PANSS (‘blunted affect’ (N1), ‘emotional 
withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive social withdrawal’ (N4), and ‘lack of 
spontaneity and flow of conversation’ (N6)) and two items from the general subscale 
(‘motor retardation’ (G7) and ‘active social avoidance’ (G16)). 
 
3.5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
 
In common with previous studies (Fitzgerald et al., 2003; van der Gaag et al., 2006a) 
the CFA in the present study failed to confirm the adequacy of a five-factor model of 
the PANSS identified using EFA. As noted by Marsh et al. (2009), failure to confirm 
a factor structure using CFA is not a problem peculiar to the PANSS but a difficulty 
encountered by researchers investigating the factor structures of many psychological 
measurement tools. 
 
Many psychological instruments have an apparently well-defined EFA 
structure, but cannot be represented adequately within a CFA approach. 
Typically this is the result of their factor structures not being consistent with 
the highly restrictive independent clusters model typically used in CFA 
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studies in which each item is allowed to load on one factor and all non-target 
loadings are constrained to be zero.  
(Marsh et al., 2009; p. 440) 
 
Van den Oord et al. (2006) observe that it is those PANSS items that display 
substantial cross-loadings that do not consistently appear in the same scale across the 
literature, and which are often omitted altogether. It might be argued that omitting 
items with substantial cross-loadings increases discriminant validity, and so should 
be preferred to employing techniques that allow for cross-loadings. However, this 
assumes that the cross-loadings observed are the result of items being poorly defined 
rather than symptoms having multiple possible causes. As van der Gaag et al. 
(2006b) argue, this is unlikely to be a valid assumption in the case of the PANSS 
since many of the symptoms it measures have more than one possible cause.  
 
For instance, ‘active social avoidance’ (G16), rated on the basis of diminished social 
involvement judged to be due to fear, hostility or distrust, might be the result of 
asociality, social anxiety, paranoid beliefs, or a combination of all three. Thus, that 
the current study found this item to load on both the Negative Symptoms and 
Affective Symptoms factors can be seen to reflect the complex clinical reality of 
psychosis presentations. To remove this item would be to ignore this complexity, 
and result in inadequate measurement of the asociality dimension of the negative 
symptoms construct.    
 
Despite the unconventional method employed, the five factors identified by the 
current study were in line with those commonly identified in factor analytic studies 
of the PANSS (Fitzgerald et al., 2003; Wallwork et al., 2012). The factors identified 
correspond closely to those of other five-factor models including the pentagonal 
model (White et al., 1997), the consensus model identified by Wallwork et al. 
(2012), the model identified by Emsley et al. (2003) in an FEP sample, and to the 
model suggested by van der Gaag et al.’s (2006b) cross-validation study. The five 
factors are also conceptually similar to those identified by a recently published study 
that used ESEM to confirm the factor structure of the PANSS in a small sample of 
Chinese schizophrenia patients (Fong, Ho, Wan, Siu, & Au-Yeung, 2015).  
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Turning to the Negative Symptoms factor specifically, Liemburg et al. (2013) 
retrieved all previous factor analytic studies of the PANSS that reported a negative 
symptom factor (n = 33) and listed the items that had been identified as measuring 
negative symptoms by each of these studies. Of the 30 PANSS items, half were 
deemed to measure negative symptoms by at least one study. Those items found to 
indicate the negative factor in the current study were the seven items most 
commonly identified as negative symptoms: ‘blunted affect’ (N1), ‘emotional 
withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive social withdrawal’ (N4), and ‘lack of 
spontaneity and flow of conversation’ (N6) were all included as part of the negative 
symptom factor by at least 31/33 studies, ‘motor retardation’ (G7) was included by 
23/33 and ‘active social avoidance’ (G16) by 20/33. The next most commonly 
included item was ‘disturbance of volition’ (G13); all other items were rarely 
identified as indicating the negative symptom construct (≤ 5 studies).  
 
A five-factor model was specified in the ESEM for this study based on the results of 
the EFA. However, had a six-factor model been specified, two negative symptoms 
factors would have emerged, one indicated by the items ‘blunted affect’ (N1), ‘poor 
rapport’ (N3), ‘lack of spontaneity and flow of conversation’ (N6) and ‘motor 
retardation’ (G7), the other by ‘emotional withdrawal’ (N2), ‘passive social 
withdrawal’ (N4) and ‘active social avoidance’ (G16) (see Appendix A). The item-
assignments of these two factors are identical to those of the ‘Negative’ and 
‘Withdrawn’ factors in van den Oord et al.’s six-factor model. They also mirror the 
two factors that emerged when Liemburg et al. (2013) subjected PANSS items 
related to the negative symptom construct to EFA (in all respects other than the 
inclusion of ‘disturbance of volition’ (G13) and ‘mannerisms and posturing’ (G5) as 
negative symptoms in Liemburg et al.’s analysis). Whilst negative symptoms are, for 
the most part, treated as a unitary concept in this thesis, this suggests the potential 
value of treating negative symptoms as comprising two distinct symptom domains in 
future FEP research.  
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3.5.3. Limitations  
 
When interpreting the results of factor analyses, it is important to keep in mind that 
statistical techniques can only provide information about the mathematical 
relationship between variables. The results of a factor analysis leave unanswered 
questions about why there is a relationship between variables. Whilst it is hoped that 
items that load on the same factor do so due to their shared measurement of a latent 
variable, this cannot be guaranteed. There are a number of other possible 
explanations for items loading on a shared factor. For instance, in the case of the 
PANSS, shared methodological variance might be introduced by the fact that certain 
items are rated on the basis of observations of behaviour whereas other ratings are 
grounded primarily in the content of responses given to specific questions in the 
semi-structured interview. This shared methodological variance may result in the 
greater coherence of items with a similar basis for rating. It is also possible that there 
may be higher order factor structures (related to systematic differences between 
raters or study sites for instance) not included in the model. Such higher-order factor 
structures may also account for the coherence of certain items and for the cross-
loadings of items. 
 
If factor analytic techniques are unable to provide firm assurance that items that load 
on a single factor do so as a result of their measuring a common latent variable, they 
are still less able to attest the nature of this latent variable. While inferences can be 
drawn about the latent variable from the items found to indicate it (assuming it is the 
reason for their shared variance), these inferences must be informed by sound 
theoretical understanding of the constructs in question. However, in the current study 
the interpretation of factors was informed by a substantial literature on the structure 
of psychotic symptomatology and is unlikely to be controversial.  
 
When interpreting the results of this study, it should be kept in mind that it is 
possible that the EDEN cohort is not representative of the wider FEP population. Of 
the individuals eligible for inclusion in EDEN during the study period, 51% were 
unable to be recruited. Whilst participants were demographically similar to non-
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participants (Birchwood et al., 2014), it is possible that participants may have 
differed from non-participants on one or more dimensions not captured by the 
limited data available on non-participants. For instance it is possible that 
participants’ symptom profiles differed from those of non-participants, which may 
have influenced the factor structure observed. Since it is possible that a model might 
fit the data from a non-representative sample well but be a poor fit for a sample 
drawn randomly from the population, caution must be exercised in generalising the 
findings beyond this particular sample.  
 
While this study sought to overcome a major limitation of using the PANSS to 
measure negative symptoms, i.e. the inclusion of items not reflecting negative 
symptom severity in the negative subscale, the construction of a bespoke negative 
symptom subscale reflecting the scale’s factor structure cannot overcome the 
limitations of the PANSS altogether. For instance, including the item ‘active social 
avoidance’ (G16) in the negative symptom subscale will result in more accurate 
measurement of negative symptom severity in individuals whose diminished social 
involvement reflects asociality. However, where an individual presents with 
diminished social involvement as a result of social anxiety, the inclusion of this item 
will lead to an artificial inflation of their negative symptoms score. Thus the 
measurement of negative symptoms in this thesis remains limited. 
 
3.6. CONCLUSION 
 
This study suggests that a five-factor model fits PANSS data from an FEP sample 
adequately if some items are permitted to load on more than one factor. The five-
factor model that emerged incorporated a single negative symptom factor indicated 
by five items from the negative subscale of the PANSS (‘blunted affect’ (N1), 
‘emotional withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive social withdrawal’ (N4), 
and ‘lack of spontaneity and flow of conversation’ (N6)) and two items from the 
general subscale (‘motor retardation’ (G7) and ‘active social avoidance’ (G16)). The 
mean score of these seven items was thus used to measure negative symptom 
severity for the purposes of this thesis.   
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Chapter Four – The Course of Negative Symptoms in First-Episode Psychosis 
 
4.1. BACKGROUND AND RATIONALE 
 
4.1.1. The Heterogeneous Course of Negative Symptoms 
 
Negative symptoms are not a stable trait, as was once thought, but can fluctuate 
significantly over time, particularly in the early course of psychosis (Edwards, 
Mcgorry, Waddell, & Harrigan, 1999; Ventura et al., 2004). However, individuals 
vary in the stability of their negative symptoms (Kelley, Haas, & van Kammen, 
2008) and there is a subgroup of individuals who present with stably elevated 
negative symptoms through the early course of psychosis (Chang et al., 2011; 
Norman, Manchanda, Harricharan, & Northcott, 2015). This subgroup is at elevated 
risk of poor outcomes (Hovington, Bodnar, Joober, Malla, & Lepage, 2012; 
Mäkinen, Miettunen, Isohanni, & Koponen, 2008) making early identification of this 
group an important goal in the quest to improve outcomes following FEP.    
 
Estimates of the prevalence of stably elevated negative symptoms in FEP vary 
considerably across studies. For example, Galderisi et al. (2013) reported that only 
6.7% of their sample presented with negative symptoms that persisted for at least 12 
months, whereas 51% of Malla et al.’s (2004) sample were reported to exhibit 
elevated negative symptoms for 12 months or more. These discrepancies are likely 
caused, at least in part, by the lack of consensus among researchers and clinicians as 
to how enduring negative symptoms should be defined. Edwards et al. (1999) and 
Hovington et al. (2012) compared criteria for defining enduring negative symptoms 
and both found that the proportion of their FEP samples classed as having enduring 
negative symptoms varied dramatically depending on the criteria employed.  
 
The ‘deficit syndrome’ criteria (Carpenter, Heinrichs, & Alphs, 1985; Kirkpatrick, 
Buchanan, Alphs, Carpenter, & Mckenney, 1989) are perhaps the most influential 
criteria for categorising individuals according to the persistence of their negative 
symptoms. An individual is categorised as a deficit syndrome patient if he or she: (1) 
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has been given a diagnosis of schizophrenia, (2) has presented with at least two 
negative symptoms continuously during all periods of clinical stability over the 
previous 12 months, and (3) these symptoms were not secondary to other factors. 
Individuals who meet these criteria have been found to differ from non-deficit 
patients in their course of illness, biological correlates and treatment response, and 
these difference have been used to justify the assertion that the deficit syndrome 
reflects a distinct disease within the schizophrenia syndrome (Kirkpatrick, 
Buchanan, Ross, & Carpenter, 2001). However, it is unclear that these differences 
are indicative of a distinct subtype of schizophrenia rather than simply the extreme 
end of a continuum of negative symptom severity (S. Kaiser, Heekeren, & Simon, 
2011).     
 
Evidence in support of a categorical approach to negative symptoms was provided 
by Blanchard et al. (2005) who used taxonomic statistical techniques to assess 
whether those with elevated negative symptoms form a distinct latent class. The 
study supported the existence of a discrete taxon of individuals with elevated 
negative symptoms within a schizophrenia sample. Individuals in this class were 
more likely to be males than those not in the class, and demonstrated poorer social 
functioning. The authors interpreted their findings as providing empirical evidence 
for the existence of a discrete class of deficit syndrome patients. However, the study 
did not examine the degree of overlap between membership of the elevated negative 
symptoms taxon and deficit syndrome classification. As such, Blanchard et al.’s 
study can only serve as evidence for the validity of a categorical approach to 
negative symptoms in general, not for the validity of the deficit syndrome approach 
specifically.   
 
Although the deficit syndrome criteria have been applied to FEP samples, there is 
evidence that deficit syndrome status assessed soon after psychosis onset is not an 
accurate predictor of subsequent negative symptom persistence. Subotnik et al. 
(1998) assessed the stability of deficit symptoms in early psychosis over a 12 month 
period. Although deficit status at baseline was found to be associated with 
persistence of negative symptoms over the subsequent 12 months, this association 
was accounted for primarily by stability of negative symptom absence; participants 
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classified as non-deficit rarely went on to develop negative symptoms. However, 
only 40% of those classified as deficit patients at baseline went on to present with 
stably elevated negative symptoms over the next 12 months. This finding calls into 
question the validity of the deficit syndrome criteria when applied to FEP.   
 
An alternative means of identifying a distinct subgroup of psychosis patients with 
enduring negative symptoms is offered by the criteria for ‘persistent negative 
symptoms’ (Buchanan, 2007). Persistent negative symptoms are defined as those 
that: (1) persist for a minimum of 6 months despite usual treatment, (2) interfere with 
the ability of the patient to perform normal role functions, (3) persist during periods 
of clinical stability, and (4) represent an unmet clinical need. Unlike the deficit 
syndrome however, there is no requirement for the negative symptoms to be primary 
and the severity of symptoms is defined in relation to their impact on functioning. 
Unfortunately, as these criteria have not been operationalised in a consistent manner, 
the determination of whether an individual fits into the persistent negative symptoms 
category is largely dependent on the cut-off points chosen by the classifier. Further, 
since these criteria require the severity of symptoms to be defined in relation to their 
impact on functioning, any study looking at the relative functioning of this group in 
relation to those without persistent negative symptoms would encounter problems of 
tautology.   
 
Given the lack of consensus regarding how enduring negative symptoms should be 
defined in FEP, a preferable approach might be to identify clusters of individuals 
with distinct patterns of longitudinal change in negative symptom severity via an 
empirically driven approach. Chen et al. (2013) employed such a data-driven 
approach – Growth Mixture Modelling (GMM; Muthén & Muthén, 2000) – to 
cluster a sample of individuals with non-affective psychosis according to their 
pattern of negative symptom change over a 49 week period. Whereas conventional 
growth modelling techniques assume all individuals change in the same way over 
time, GMM allows that individuals within a sample might vary in their starting 
point, rate and direction of change (Jung & Wickrama, 2008). This inter-individual 
variation is captured by the inclusion of multiple growth curves within the model. 
The number of growth curves is not specified a priori but is determined using 
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measures of statistical fit in combination with considerations such as parsimony and 
theoretical justification.            
 
Chen et al. identified four distinct negative symptom trajectories within their sample: 
(1) reduction in negative symptoms over the first few weeks followed by a sustained 
low level of negative symptoms, (2) relatively low negative symptom severity 
throughout the study period, (3) initially high levels of negative symptoms followed 
by gradual reduction in severity throughout the study period, and (4) sustained high 
levels of negative symptoms throughout the study period. The most common 
trajectory was stably low negative symptoms (accounting for 71% of the sample); 
the least common trajectory (followed by only 2% of the sample) was gradual 
reduction in negative symptoms. A trajectory of persistently elevated negative 
symptoms was characteristic of 16% of the sample.   
 
Chen et al.’s sample consisted of participants in a RCT of antipsychotic medication, 
a group unlikely to be representative of the wider population of individuals 
experiencing psychosis. Further, their sample had, on average, experienced 6.4 
psychiatric hospitalisations and been ill for more than 17 years. As such, their 
findings cannot be generalised to individuals early in the course of a psychotic 
disorder. It is not yet known whether multiple distinct negative symptom trajectories 
are similarly evident in FEP. If latent classes of individuals with similar negative 
symptom courses could be identified in an FEP sample, examining predictors of 
membership of these latent classes may help inform models of negative symptom 
maintenance in FEP and perhaps facilitate targeted monitoring and intervention.     
 
The current study used Latent Class Growth Analysis (LCGA; Nagin, 1999; 2005) to 
identify distinct trajectories of change in negative symptom severity in a cohort of 
individuals with FEP. LCGA is a statistical technique used to identify homogenous 
sub-groups (latent classes) of individuals with distinct patterns of change over time 
(Andruff, Carraro, Thompson, & Gaudreau, 2009). LCGA is a subtype of GMM 
which fixes within-class variation to zero on the assumption that all individuals 
within a latent class can be modelled by a single trajectory. It is therefore well suited 
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to investigating whether distinct trajectories of negative symptoms are evident during 
the early course of psychosis. 
 
4.1.2. Predictors of Negative Symptom Course   
 
Despite variability in their definition, there has been some agreement as to the 
variables associated with enduring negative symptoms in FEP. The variables 
explored as possible predictors of negative symptom trajectories in the current study 
were guided by this literature, but ultimately constrained by the data available within 
the National EDEN dataset. As such, this section does not seek to provide a 
comprehensive overview of those factors associated with negative symptom course, 
but to justify the inclusion of the variables considered as predictors.  
 
Poor premorbid adjustment has been linked with persistence of negative symptoms 
by several research groups. Bailer et al. (1996) reported an association between 
premorbid adjustment and the three year course of negative symptoms following a 
first admission to hospital for non-affective psychosis. They found that those with 
the poorest premorbid adjustment had persistently higher levels of negative 
symptoms across all follow-up points than those with better premorbid adjustment. 
Malla et al. (2004) found that FEP patients whose negative symptoms persisted over 
the course of 12 months had worse premorbid adjustment during early and late 
adolescence than did those patients whose negative symptoms had remitted within 
12 months. Similarly, Chang et al. (2011) found poor premorbid academic 
functioning to be the best predictor of persistent negative symptom status three years 
after it was first assessed in a sample of FEP participants. Evensen et al. (2012) 
found that stability of blunted affect over a 10 year period following onset of 
psychosis was best predicted by poor premorbid social functioning.        
 
There is good evidence of a relationship between duration of untreated psychosis 
(DUP) (the time between the emergence of psychotic symptoms and commencement 
of antipsychotic medication) and cross-sectional negative symptom severity 
(Boonstra et al., 2012). The relationship between DUP and negative symptom 
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persistence over time has been less frequently studied. However, Galderisi et al. 
(2013) found that longer DUP predicted which of the FEP patients in their sample 
who presented with at least one negative symptom at baseline would continue to do 
so one year later. Likewise, Chang et al. (2011) studied persistence of primary 
negative symptoms over a three year period and found prolonged DUP to predict 
negative symptom persistence.  
 
Family history of non-affective psychosis, but not other psychiatric disorders, has 
been found to be associated with persistent negative symptoms in established 
schizophrenia (Dollfus, Ribeyre, & Petit, 1996; Kirkpatrick, Castle, Murray, & 
Carpenter, 2000). Male gender has been associated with persistent negative 
symptoms both in schizophrenia patients (Bottlender, Jäger, Groll, Strauss, & 
Möller, 2001; Roy, Maziade, Labbé, & Mérette, 2001), FEP patients (Chang et al., 
2011), and also in a non-clinical sample (Maric, Krabbendam, Vollebergh, de Graaf, 
& van Os, 2003). Additionally, Galderisi et al. (2013) found that FEP patients given 
a diagnosis of schizophrenia were more likely to experience persistent negative 
symptoms than those given other diagnoses.     
 
Whilst a positive association has been observed between negative symptoms severity 
and depression in individuals given a diagnosis of schizophrenia (Kulhara et al., 
1989; Sax et al., 1996), Oosthuizen et al. (2002) found an inverse correlation 
between baseline depression and negative symptom severity in those with FEP. A 
meta-analysis has confirmed the association between not using substances and cross-
sectional negative symptom severity (Potvin, Sepehry, & Stip, 2006). Further, the 
association between deficit syndrome classification and less severe lifetime use of 
alcohol, cannabis and other drugs (Kirkpatrick et al., 1996) suggests there may be a 
relationship between not using substances and negative symptom persistence.  
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4.2. RESEARCH QUESTIONS 
 
1. Are distinct trajectories of negative symptoms evident during the first 12 
months of treatment for FEP? 
2. What factors predict the trajectory an individual’s negative symptoms will 
take during the first 12 months of treatment for FEP?  
 
4.3. METHOD 
 
4.3.1. Design 
 
This study has a longitudinal design with participants having been assessed at three 
time points: on entry into the study (baseline), and six and twelve months later. 
Negative symptoms were assessed at all three time points using the PANSS. 
Premorbid adjustment, DUP, past and current substance use, and depression were 
assessed at baseline. Family history of non-affective psychosis, age at onset, 
demographic information and baseline clinical diagnosis were ascertained at baseline 
via participant report and/or case note review.     
 
4.3.2. Participants 
 
The participants were recruited as part of the National EDEN study as described in 
the previous chapter (section 3.3.2). All those participants who were assessed using 
the PANSS at one time point or more (n = 1006) were included in the current study.            
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4.3.3. Sample Size  
 
4.3.3.1. Latent Growth Modelling and Latent Class Growth Analysis  
 
Accurately determining an adequate sample size for Latent Growth Modelling 
(LGM) is difficult due to the relevance of factors such as the amount of variance 
explained by the model, however sample sizes of at least 100 are often preferred 
(Curran, Obeidat, & Losardo, 2010). Similarly, although it is believed that small 
sample sizes limit analysis power and reduce the number of trajectories that can be 
identified (Andruff et al., 2009), determining adequate sample sizes for LCGA 
requires a Monte Carlo simulation study (L. K. Muthén & Muthén, 2002). Nagin 
(2005), who developed LCGA, suggested that a minimum of 300-500 participants 
are required to successfully conduct LCGA. Given that this study’s sample size (n = 
1006) comfortably exceeds the higher limit of this estimate, it is likely to be 
adequate for successful use of this analytic technique.               
 
4.3.3.2. One-Way Analysis of Variance (ANOVA) 
 
A power calculation carried out using G*Power Version 3.1.9.2 (Faul, Erdfelder, 
Lang, & Buchner, 2007) found that to achieve 90% power with a significance level 
of 0.05, an estimated medium effect size and four comparison groups a minimum 
sample size of 232 would be required. As such, the one-way ANOVAs conducted 
were adequately powered.  
 
4.3.3.2. Multinomial Regression 
 
There is not a clear consensus regarding the sample size requirements for 
multinomial regression. Heuristics for determining an adequate sample size for 
multinomial logistic regression suggest a minimum of 10 cases per independent 
variable (Starkweather & Moske, 2011). Since there were twelve candidate 
explanatory variables, if the maximum number of explanatory variables had been 
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entered into the multinomial regression model this heuristic would suggest a 
minimum sample size of 120 participants. However, a simulation study by Taylor et 
al. (2006) investigating the minimum sample size needed to achieve 80% power in 
logistic regression models with different numbers of categories suggests that this 
may be an underestimate. They found that where the underlying distribution is 
skewed (to take the most conservative estimate), a model with three categories 
would require 461 cases and a model with five categories 377. These findings 
provide reasonable confidence that the multinomial regression conducted in this 
study was adequately powered.  
 
4.3.4. Procedure  
 
The procedures were as described in the previous chapter (section 3.3.4). In addition 
to the eighteen measures administered at baseline, nine were measured at 6 months, 
and thirteen at 12 months; a mixture of self-reports, interviewer rated instruments, 
and clinician completed measures. Data was also extracted from clinical notes. The 
subset of National EDEN measures included in the current study is described in the 
next section. 
 
4.3.5. Measures 
 
4.3.5.1. Positive and Negative Syndrome Scale (Kay, Fiszbein, & Opler, 1987) 
 
The PANSS was used to provide a measure of negative symptom severity. The 
PANSS is a 30-item instrument designed to assess the severity of symptoms 
associated with schizophrenia. The mean score of seven PANSS items – ‘blunted 
affect’ (N1), ‘emotional withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive social 
withdrawal’ (N4), and ‘lack of spontaneity and flow of conversation’ (N6), ‘motor 
retardation’ (G7) and ‘active social avoidance’ (G16) – was used as the measure of 
negative symptoms in this study. A detailed explanation of the rationale for the use 
of these PANSS items to measure negative symptoms was provided in the previous 
chapter.   
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4.3.5.2. Duration of Untreated Psychosis (Larsen, McGlashan, & Moe, 1996) 
 
In line with the method described by Larsen et al. (1996), DUP was defined as the 
interval between onset of frank psychosis and commencement of criterion treatment. 
Psychosis onset was defined as the first point at which the participant meets criteria 
for a rating of 4 (moderate severity) on one or more of the items from the PANSS 
Positive subscale; this rating must be sustained for a period 2 weeks or more (unless 
remission of symptoms is attributed to commencement of medication). Criterion 
treatment was defined as adherence to antipsychotic medication prescribed at a dose 
deemed to be therapeutic for psychosis. Information required to assess the length of 
this interval was acquired using the PANSS interview, the ‘Pathways to Care’ 
interview which systematically questioned the participant about services accessed, 
presenting problems, treatments offered and duration of treatment received, and by 
accessing information recorded in clinical notes. Continuous data were dichotomised 
for the purposes of this study: participants with a DUP of nine months or longer were 
coded as having a long DUP; participants with a DUP shorter than nine months were 
coded as having a short DUP. This decision was made because of the non-linear 
relationship between DUP and negative symptoms such that there is a clear 
association between DUP and negative symptoms where DUP is less than 9 months 
but not where it exceeds 9 months (Boonstra et al., 2012).     
 
4.3.5.3. Premorbid Adjustment Scale (PAS; Cannon-Spoor, Potkin, & Wyatt, 
1982) 
 
Adjustment prior to the onset of psychosis was assessed using the PAS. The PAS is a 
retrospective measure of the extent of achievement of key developmental goals 
during childhood (up to 11 years), early adolescence (11-15 years), late adolescence 
(16-18 years), and adulthood (19 years and above). Four domains are assessed: 
sociability and withdrawal, peer relationships, scholastic ability and adaption, and 
capacity to form intimate sexual relationships (capacity to form sexual relationships 
is not assessed for the childhood period and scholastic ability and adaption is not 
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assessed for the adulthood period). Age appropriate functioning in each domain is 
rated by the researcher on a 7-point scale with 0 denoting optimal adjustment in that 
domain (no problems with functioning) and 6 denoting the worst adjustment (major 
problems functioning).   
 
Ratings were based on information obtained during an interview with the participant 
and corroborated by information from family members where appropriate. Scores for 
each of the four subscales were calculated by dividing the total score obtained by the 
participant on that subscale by the total possible score. Since around a third of the 
national EDEN sample experienced onset of their psychosis before the age of 19, 
only adjustment in childhood and early adolescence was considered in this study to 
reduce the risk of confounding with early psychosis onset.                      
 
4.3.5.4. DrugCheck (Kavanagh et al., 1999)  
 
The DrugCheck is an interviewer-administered instrument designed to screen for 
substance misuse disorders in people with psychosis. The interviewer asks the 
participant about the frequency of their drug use over the previous 3 months and, if 
relevant, gains an estimate of the quantity used. The instrument also includes a 13-
item problem list that assessed the functional impact of the most problematic 
substance. In addition, participants in National EDEN were asked about their past 
use of substances. For the purposes of the current study, baseline substance misuse 
was coded as present if the participant reported lifetime use of any illicit substance.  
 
4.3.5.5. Calgary Depression Scale for Schizophrenia (CDSS; Addington, 
Addington, Matickatyndale, & Maticka-Tyndale, 1994)  
 
The CDSS was used to measure severity of depression. The CDSS is a 9-item scale 
rated by a trained interviewer on the basis of observation and a semi-structured 
interview with the participant. Each item is rated according to operational criteria on 
a 4-point scale. The CDSS depression score is calculated by summing each of the 9 
item scores; higher scores represent more severe depression. An important advantage 
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of the CDSS over other measures of depression severity is that, because it was 
developed specifically to assess depression in individuals experiencing psychosis, it 
is designed to minimise overlap with negative symptoms. The specificity of the 
CDSS has been confirmed empirically (Addington et al., 1994).   
  
4.3.6. Analysis Plan 
 
Analyses were conducted using SPSS for Windows, Version 22 (IBM, 2013) and 
Mplus for Windows, Version 7.1 (Muthén & Muthén, 1998 – 2012).         
 
4.3.6.1. Preliminary Analysis and Treatment of Missing Data 
 
First, descriptive statistics were calculated for all measures and the distributions of 
each variable were examined to check whether assumptions of normality are 
justified. Patterns of missing data were examined to determine whether the 
assumption that data is missing at random is justified.  
 
Missing data were estimated using full information maximum likelihood (FIML) 
under the assumption that missing data were missing at random. FIML is a technique 
for modelling missing data which takes into account all available information by 
identifying and utilising patterns of missingness. All data, including from 
participants with incomplete data, are used in estimating parameters. These 
parameters, together with information on the number of complete data points for 
each participant, and the observed data at complete time points, are used in the 
computation of likelihood functions which are maximised across the sample. FIML 
is considered preferable to alternative procedures for dealing with missing data 
(Enders & Bandalos, 2001): unlike deletion techniques, FIML makes use of all 
available data in creating the model but unlike imputation techniques (e.g. mean 
imputation, similar response pattern imputation) it avoids analysing estimated values 
as if they were observed. 
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4.3.6.2. Research Question 1: Are distinct trajectories of negative symptoms 
evident during the 12 months following initiation of treatment for FEP? 
 
In order to examine the pattern of negative symptom change in the sample as a 
whole and the degree of inter-individual variability in negative symptom course, 
LGM was carried out prior to beginning LCGA. LGM involves fitting a single 
trajectory with random effects (representing individual differences) to the data. The 
mean intercept and slope describe the pattern of change across the whole cohort. 
Next, LCGA (see section 4.1.1 for discussion of the suitability of this technique) was 
employed to determine whether variability in individual trajectories is better 
modelled by multiple, homogenous latent classes with distinct trajectories, than by a 
single trajectory. Models with increasing numbers of latent classes were fitted to the 
data and the best model selected according to a number of considerations including 
goodness of fit to the data, entropy, specificity of posterior probabilities, parsimony 
and interpretability (Jung & Wickrama, 2008).  
 
Since there is no consensus on the best criteria for determining the relative fit of 
models with different numbers of classes (Nylund, Asparouhov, & Muthén, 2007), 
four indices were used in tandem to assess statistical fit. The fit indices considered 
were Akaike’s Information Criterion (AIC), Bayesian Information Criterion (BIC), 
Bootstrap Likelihood Ratio Test (BLRT) and Lo–Mendell–Rubin Likelihood Ratio 
Test (LMR-LRT). These fit indices give an indication of relative, but not absolute, 
model fit. Lower AIC and BIC values indicate superior fit: given any two models, 
the model with the lower IC value should be preferred. A significant BLRT or LMR-
LRT value is indicative of the model being a better fit than the model with one fewer 
latent classes. Entropy is a measure of how distinct each of the latent classes is from 
the other classes in the model. Entropy values range from 0 to 1, with values close to 
1 indicating a high degree of distinctness. The mean posterior probabilities of an 
individual belonging to a latent class indicate the probability of a model allocating an 
individual to the ‘true’ class. Good models should have classes with mean posterior 
probabilities close to 1 (probabilities greater than 0.7 can be considered adequate; 
Andruff et al., 2009), indicating a high probability of belonging to just one class.  
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4.3.6.3. Research Question 2: What factors predict the trajectory an individual’s 
negative symptoms will take during the 12 months following initiation of treatment 
for FEP?  
 
To address the second research question, the latent classes resulting from the 
selected model were compared on demographic and baseline variables hypothesised 
to be associated with negative symptom course. There were twelve candidate 
exploratory variables: age at psychosis onset; gender; ethnicity; family history of 
non-affective psychosis; schizophrenia diagnosis; DUP; premorbid social adjustment 
in childhood; premorbid social adjustment in adolescence; premorbid academic 
adjustment in childhood; premorbid academic adjustment in adolescence; baseline 
depression; and history of substance use. A two-step process was employed to 
reduce the risk of overfitting the regression model. First, a series of univariate 
between class comparisons were conducted and only those variables that differed 
significantly were entered into the multinomial regression examining predictors of 
negative symptom course. 
 
In the case of continuous variables, differences between classes were examined using 
one-way ANOVAs. Due to the use of multiple comparisons, the Bonferroni 
correction was used to adjust the critical p-value (0.05/7 = 0.007) to minimise the 
risk of Type I errors. Where an ANOVA identified a significant main effect, post-
hoc Turkey’s HSD tests were used to examine which classes differ significantly. In 
the case of categorical variables, Person’s Chi-Squared tests were used to assess 
associations with negative symptom class. Fisher’s Exact Test was used to calculate 
the p value where expected values were small (< 5) in the case of 20% or more of the 
cells. Where a significant association was found, the adjusted standardised residuals 
of the Chi-squared test were examined to establish which of the latent classes were 
over- or under-represented. Variables that differed significantly between latent 
classes were entered into a multinomial regression model with latent class as the 
dependent variable. 
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4.4. RESULTS 
 
4.4.1. Sample Characteristics and Descriptive Data 
 
Information on the demographic and baseline clinical characteristics of the 
participants included in the present study (n = 1006) are presented in Table 4.1. 
There were significantly more men than women (χ2 (1) = 146.58, p = <0.001) and 
significantly more participants identified their ethnicity as White British than any 
other ethnicity (χ2 (14) = 6656.67, p = <0.001). The majority of participants (72%) 
received a clinical diagnosis of ‘Unspecified Psychosis’ at baseline. This is in line 
with the underlying philosophy of EIP services which encourages embracing early 
diagnostic uncertainty and allowing sufficient time for symptoms to stabilise before 
a diagnosis is made (Department of Health, 2001). Descriptive statistics for 
continuous baseline variables included in the analysis are given in Table 4.2. 
 
Table 4.1.  Characteristics of participants included in the current study (n = 1006).   
 Sample Characteristics 
 
 
Age at Onset – Mean (SD) 
 
 
20.07 (7.78) 
Gender (% Male) 69.1 
 
Ethnicity (%) 
     White British 
     Asian 
     Black  
     Mixed 
     Other 
 
 
70.3 
15.5 
6.8 
4.2 
3.3 
 
Family History of Non-Affective Psychosis (%) 
 
8.9 
 
Initial Clinical Diagnosis (%) 
     Unspecified Psychosis 
     Schizophrenia 
     Bipolar 
     Drug Induced Psychosis 
     Paranoid Psychosis       
     Schizoaffective Disorder 
 
72.0 
10.6 
5.2 
6.7 
3.7 
1.7 
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Table 4.2. Descriptive statistics for continuous baseline variables included in the 
current study. 
 
 
Mean (SD) 
 
Skewness 
PANSS Negative Symptoms Mean 
 
PAS Social – Childhood 
PAS Social – Adolescence 
 
PAS Academic – Childhood 
PAS Academic – Adolescence 
 
Calgary Depression 
 
2.16 (1.00) 
 
0.20 (0.21) 
0.23 (0.19) 
 
0.26 (0.21) 
0.36 (0.24) 
 
6.30 (5.38) 
0.86* 
 
0.87* 
0.89* 
 
0.66* 
0.32* 
 
0.77* 
 
Notes. ‘PANSS Negative Symptoms’ refer to the items used to measure negative 
symptom severity in the current study as opposed to the original negative subscale.  
* = The distribution of the variable deviates significantly from normality 
(Komolgorov-Smirnov test for normality yielded a p-value ≤ 0.05)  
 
 
The distribution of all continuous baseline variables were explored using visual 
inspection of histograms and P-P plots in conjunction with Komolgorov-Smirnov 
tests. All variables were found to be positively skewed. Non-normality was 
accounted for in the latent growth modelling and latent class growth analysis by use 
of an estimator robust to violations of the assumption of normality (maximum 
likelihood with robust means and variances). Simulation studies have demonstrated 
the ANOVA to be robust to minor violations of normality in large samples (Harwell, 
Rubinstein, Hayes, & Olds, 1992). Whilst moderately skewed distributions can lead 
to reductions in statistical power, given the current study’s relatively large sample 
size this was judged to be unlikely to pose significant problems.  
 
4.4.2. Missing Data 
 
Of the participants in National EDEN, 98.0% (1006) had complete PANSS data for 
at least one time point and were therefore included in the current study. There was no 
difference between those who did and did not have PANSS data at one time point or 
more in terms of gender (χ2 (1) = 0.056, p = 0.812), age at onset of psychosis (t (981) 
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= -0.109, p = 0.913), ethnicity (Fisher’s Exact Test, p = 0.426), or family history of 
non-affective psychosis (Fisher’s Exact Test, p = 1.000). This suggests that the 
participants included in this study are likely to be representative of the National 
EDEN cohort as a whole.     
 
Of the 1006 participants included in the current study, 63.4% had complete PANSS 
data at all three time points and 85.7% had complete PANSS data at two time points 
or more. There was a significant main effect of number of time points with complete 
PANSS data on baseline average negative symptom score (F (2) = 4.885, p = 0.008). 
Post-hoc comparisons using Tukey’s HSD test indicated that those with complete 
PANSS data at all three time points had significantly higher levels of negative 
symptoms at baseline than those with data at only two time points. There were no 
significant differences in the baseline negative symptoms of those with complete 
data at three versus one, or two versus one time point. The ramifications of the 
relationship between missingness and negative symptom severity will be considered 
in the limitations section at the end of this chapter (section 4.5.3). 
 
4.4.3. Latent Growth Modelling and Latent Class Growth Analysis 
 
Prior to examining models with multiple latent classes, a single-class latent growth 
model was specified. The unstandardised mean intercept was 2.08 (p = <0.001) and 
the unstandardised mean slope was –0.21 (p = <0.001), indicating that negative 
symptoms tended to decrease over time in the sample as a whole. However, this 
model fitted the data poorly (RMSEA = 0.193, CFI = 0.887, TLI = 0.661). Notably, 
there was significant variance in both the slope (estimated variance = 0.085, p = 
0.001) and intercept (estimated variance = 0.450, p = <0.001) of the estimated 
growth curve, suggesting that the negative symptom trajectories followed by the 
sample are not homogeneous.       
 
LCGA was then applied to examine models of negative symptom change 
incorporating multiple trajectories. Beginning with a model with two latent classes, 
models with increasing numbers of latent classes were specified. Fit indices, entropy, 
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accuracy of posterior classifications, and the size of each class were compared for 
each of the alternative models, as presented in Table 4.3. The model with four latent 
classes was selected from the models considered. This model fit the data 
significantly better than the models with one, two and three latent classes according 
to all fit indices (ICs for single-class latent growth model: AIC = 6007.67, BIC = 
6046.98). Further, each of the four latent classes represented a distinct symptom 
trajectory with significant theoretical relevance. Mean posterior probabilities for all 
four latent classes are adequately high (> 0.70), indicating high probability of 
classification to the correct latent class. Further, no latent class is made up of less 
than 5% of the sample, indicating that each trajectory characterises a substantial 
subgroup of the sample.   
 
Whilst models with five classes fit the data significantly better than the four-class 
model according to all fit indices other than the LMR-LRT, this model was not 
preferred for reasons of parsimony and interpretability. As the number of latent 
classes increased, the two Information Criteria continued to decrease: no stagnation 
or reverse in the direction of change was observed. However, models with more than 
four latent classes increasingly included classes comprising less than 5% of the 
sample and which did not represent a sufficiently unique and distinct trajectory to be 
easily interpretable.         
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Table 4.3. Comparison of LCGA models with two to six latent classes. 
 2 3 4 5 6 
AIC 5893.21 5740.96 5639.24 5564.28 5464.70 
BIC 5932.52 5795.01 5708.03 5647.81 5562.98 
BLRT 0.00 0.00 0.00 0.00 0.00 
LMR-LRT 0.00 0.06 0.03 0.13 0.06 
Entropy 0.83 0.81 0.79 0.79 0.79 
Classification 
Probabilities 
0.96, 0.90 0.84, 
0.94, 
0.89 
0.84, 0.92, 
0.91, 0.79 
0.89, 0.77, 
0.91, 0.83, 
0.80 
0.83, 0.76, 
0.91, 0.84, 
0.88, 0.87 
Class Size 
(%) 
81, 19 21, 74, 5  14, 64, 5, 
17 
3, 17, 64, 11, 
5 
15, 14, 3, 7, 
57, 3 
Note. AIC = Akaike’s Information Criterion, BIC = Bayesian Information Criterion, 
BLRT = Bootstrap Likelihood Ratio Test, LMR-LRT = Lo–Mendell–Rubin 
Likelihood Ratio Test. Classification Probabilities = mean posterior probabilities for 
each class, Class Size = proportion of the sample making up the membership of each 
class.  
 
 
4.4.4. Description of Latent Classes 
 
Modal assignment was used to allocate participants to latent classes, that is, 
estimates of the posterior probabilities of each participant belonging to each of the 
latent classes were calculated and the participant assigned to the class with the 
highest posterior probability. The characteristics of each latent class were as follows. 
The model is presented graphically in Figure 4.1. 
 
Class 1 – ‘Mild Stable’ Negative Symptoms   The first class contained 13.5% of 
the sample (n = 108). It was characterised by an intercept corresponding to elevated 
negative symptoms (unstandardised mean intercept = 2.185) and a non-significant 
slope (unstandardised mean slope = 0.237, p = 0.080) indicating stable mild negative 
symptoms. 
 
Class 2 – ‘Minimal Decreasing’ Negative Symptoms   The second class comprised 
the majority of the sample (63.9%, n = 674). This class was characterised by a low 
intercept (unstandardised mean intercept = 1.620), indicating minimal levels of 
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negative symptoms at baseline. These negative symptoms decreased slightly but 
significantly over time (unstandardised mean slope = -0.166, p = <0.001).   
 
Class 3 – ‘High Stable’ Negative Symptoms   The third class contained the fewest 
participants (5.4%, n = 50). This class had the highest mean intercept 
(unstandardised mean intercept = 3.581) and a non-significant slope (unstandardised 
mean slope = 0.053, p = 0.696), indicating persistently high levels of negative 
symptoms.   
 
Class 4 – ‘High Decreasing’ Negative Symptoms   The final class contained 17.1% 
of the sample (n = 174). The class are characterised by an intercept comparable to 
the High Stable class (unstandardised mean intercept = 3.351) indicating high levels 
of negative symptoms at baseline. However, this class’ symptoms decreased 
significantly over time (unstandardised mean slope = -0.890, p = <0.001), realising a 
level similar to the ‘Minimal Decreasing’ class by 12 months.    
 
 
Figure 4.1. LCGA with four latent classes: average negative symptom score 
estimated means.  
 
 
  
1
1.5
2
2.5
3
3.5
4
Baseline 6 Months 12 Months
A
ve
ra
g
e
 n
e
g
a
ti
ve
 s
y
m
p
to
m
 s
co
re
 m
e
a
n
s
High Stable, 5.4% High Decreasing, 17.1%
Mild Stable, 13.5% Minimal Decreasing, 63.9%
111 
 
4.4.5. Between Class Differences 
 
The four negative symptom trajectory classes were compared on demographic and 
baseline variables. Descriptive statistics for each class are presented in Table 4.4. 
Class differences were found in gender (χ2 (3) = 9.253, p = 0.026), baseline clinical 
diagnosis (Fisher’s Exact Test, p = 0.019), family history of non-affective psychosis 
(Fisher’s Exact Test, p = 0.001), premorbid social adjustment in childhood (F (3, 
904) = 5.116, p = 0.002) and early adolescence (F (3, 864) = 7.240, p = <0.001), 
premorbid academic adjustment in childhood (F (3, 904) = 7.270, p = <0.001) and 
early adolescence (F (3, 899) = 10.236, p = <0.001), and baseline depression (3, 943) 
= 11.285, p = <0.001). No significant class differences were found in age at onset (F 
(3, 1002) = 1.094, p = 0.351), ethnicity (Fisher’s Exact Test, p = 0.096), DUP (χ2 (3) 
= 0.837, p = 0.841) or illicit substance use (χ2 (3) = 3.388, p = 0.336).   
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Table 4.4. Descriptive statistics (mean (SD) unless otherwise indicated) for each 
negative symptom trajectory class.  
 Minimal 
Decreasing 
(n = 674) 
Mild  
Stable 
 (n = 108) 
High 
Decreasing 
(n = 174) 
High Stable 
(n = 50) 
Age at Onset 
 
19.99 
(8.45) 
20.65 
(5.27) 
20.48 
(6.54) 
18.46 
(6.78) 
Male Gender 
 
66.9% 77.8% 68.4% 82.0% 
White British Ethnicity 
 
70.9% 68.5% 72.4% 58.0% 
Family History 
 
6.9% 9.4% 11.5% 25.5% 
Schizophrenia 
Diagnosis 
 
9.8% 10.8% 9.6% 23.4% 
DUP ≥ 9 months 
 
27.8% 31.8% 28.3% 26.0% 
PAS Social - Childhood 
PAS Social - Adolescence 
          
0.19 (0.20) 
0.21 (0.18) 
 
0.25 (0.25) 
0.26 (0.23) 
 
0.17 (0.19) 
0.26 (0.21) 
 
0.27 (0.21) 
0.31 (0.17) 
 
PAS Acad. - Childhood 
PAS Acad. - Adolescence 
         
0.24 (0.21) 
0.33 (0.24) 
 
0.34 (0.21) 
0.45 (0.24) 
 
0.26 (0.19) 
0.41 (0.25) 
 
0.31 (0.21) 
0.41 (0.21) 
 
Calgary Depression 
 
5.61 (5.03) 
 
7.36 (5.62) 8.04 (5.66) 6.86 (6.60) 
 Substance Use 
 
66.3% 63.2% 68.5% 55.1% 
Note. Family History = Family History of Non-Affective Psychosis; DUP = 
Duration of Untreated Psychosis; PAS = Premorbid Adjustment Scale; Acad. = 
Academic 
 
 
The Minimal Decreasing class were less likely to have a family history of non-
affective psychosis and more likely to have a diagnosis of bipolar or schizoaffective 
disorder. This class had better premorbid adjustment than members of other classes 
and were significantly less depressed. The High Decreasing class were less likely to 
be diagnosed with bipolar disorder and had better premorbid social adjustment 
during childhood than the High Stable class, but worse social adjustment than the 
Minimal Decreasing class during adolescence. Members of the Mild Stable class 
were more likely to be male, had poorer premorbid adjustment, and were more 
depressed relative to the Minimal Decreasing class. The High Stable class were also 
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more likely to be male and had poorer premorbid adjustment, as well as a family 
history of non-affective psychosis and diagnosis of schizophrenia.  
 
An additional post hoc analysis was conducted to investigate whether trajectory 
classes differed in the profile of negative symptoms exhibited: specifically, if classes 
differed in the relative prevalence of expressive deficit symptoms (as indicated by 
the items ‘blunted affect’, ‘poor rapport’, ‘lack of spontaneity and flow of 
conversation’ and ‘motor retardation’) versus withdrawal symptoms (indicated by 
the items ‘emotional withdrawal’, ‘passive social withdrawal’, and ‘active social 
avoidance’). The choice of these items to measure expressive deficit and withdrawal 
domains of negative symptoms was discussed in section 3.5.2. Mean average 
expressive deficit and withdrawal symptoms scores by negative symptom trajectory 
group at each time point are presented in Table 4.5. A one-way ANOVA revealed no 
significant differences between trajectory groups in the proportion of expressive 
deficit versus withdrawal symptoms at baseline (F = 2.22, p = 0.085), suggesting that 
the distinct trajectories observed are not explained by differing baseline negative 
symptom profiles. 
 
Table 4.5. Mean average expressive deficits and withdrawal scores by negative 
symptom trajectory group. 
 Baseline 6 Months 12 Months 
 Exp. 
Deficits 
Withdrawal Exp. 
Deficits 
Withdrawal Exp. 
Deficits 
Withdrawal 
Minimal 
Decreasing 
 
1.41 2.00 1.25 1.57 1.18 1.50 
Mild 
Stable  
 
1.92 2.64 2.04 2.79 2.40 3.22 
High 
Decreasing 
 
3.15 4.10 
 
1.91 2.82 1.42 1.92 
High 
Stable 
 
3.57 3.91 3.22 3.80 3.60 3.96 
Note. Expressive deficits = Blunted affect (N1), Poor rapport (N3), Lack of 
spontaneity (N6) and Motor retardation (G7). Withdrawal symptoms = Emotional 
withdrawal (N2), Passive social withdrawal (N4) and Active social avoidance (G16). 
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4.4.6. Predictors of Negative Symptom Course 
 
Baseline variables with significant between class differences were entered into a 
multinomial regression with negative symptom trajectory class as the dependent 
variable. The Minimal Decreasing trajectory class served as the reference category. 
Full results of the multinomial regression are presented in Table 4.6. 
 
Table 4.6. Results of multinomial regression investigating predictors of negative 
symptom trajectory class. 
 B (SE) Odds Ratio  
(95% CI) 
 
P Value 
Mild Stable vs. Minimal 
Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis 
vs. Schizophrenia Diagnosis 
 
No Family History vs. Family 
History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
High Stable vs. Minimal 
Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis 
vs. Schizophrenia Diagnosis 
 
No Family History vs. Family 
History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
 
 
-0.36 (0.30) 
 
0.04 (0.44) 
 
 
0.24 (0.48) 
 
 
-0.03 (0.84) 
0.63 (0.84) 
 
1.70 (0.90) 
0.52 (0.76) 
 
0.02 (0.02) 
 
 
 
 
-1.04 (0.48) 
 
-0.86 (0.44) 
 
 
-1.18 (0.44) 
 
 
-0.12 (1.18) 
2.17 (1.12) 
 
 
 
0.70 (0.39 – 1.25) 
 
1.04 (0.44 – 2.45) 
 
 
1.27 (0.50 – 3.21) 
 
 
0.98 (0.19 – 5.02) 
1.87 (0.36 – 9.65) 
 
5.50 (0.94 – 32.14) 
1.68 (0.38 – 7.48) 
 
1.02 (0.98 – 1.07) 
 
 
 
 
0.35 (0.14 – 0.90) 
 
0.42 (0.18 – 1.00) 
 
 
0.31 (0.13 – 0.72) 
 
 
0.89 (0.09 – 8.95) 
8.79 (0.99 – 78.11) 
 
 
 
0.23 
 
0.94 
 
 
0.62 
 
 
0.98 
0.46 
 
0.06 
0.49 
 
0.35 
 
 
 
 
0.03 
 
0.05 
 
 
0.01 
 
 
0.92 
0.05 
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Continuation of Table 4.6.  
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
High Decreasing vs. Minimal 
Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis 
vs. Schizophrenia Diagnosis 
 
No Family History vs. Family 
History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
 
 
0.79 (1.25) 
-0.07 (1.08) 
 
0.05 (0.03) 
 
 
 
 
-0.06 (0.24) 
 
0.37 (0.40) 
 
 
-0.68 (0.34) 
 
 
-2.21 (0.76) 
2.11 (0.71) 
 
-0.26 (0.77) 
1.01 (0.62) 
 
0.09 (0.02) 
 
 
2.21 (0.19 – 25.74) 
0.93 (0.11 – 7.66) 
 
1.06 (0.99 – 1.12) 
 
 
 
 
0.94 (0.60 – 1.50) 
 
1.45 (0.66 – 3.19) 
 
 
0.51 (0.30 – 0.99) 
 
 
0.11 (0.03 – 0.49) 
8.26 (2.07 – 33.01) 
 
0.77 (0.16 – 3.67) 
2.75 (0.82 – 9.29) 
 
1.09 (1.05 – 1.14) 
 
 
0.53 
0.95 
 
0.09 
 
 
 
 
0.81 
 
0.35 
 
 
0.046 
 
 
0.004 
0.003 
 
0.74 
0.10 
 
<0.001 
 
Note. Model: χ2 (24) = 92.50, p <0.001. Family History = family history of non-
affective psychosis; PAS = Premorbid Adjustment Scale  
 
 
Compared to individuals in the Minimal Decreasing class, those in the High Stable 
class were significantly more likely to be male (Β = -1.04, p = 0.03) and to have a 
family history of non-affective psychosis (Β = -1.18, p = 0.01). Whilst those in the 
High Stable Class were more likely to have been given an initial diagnosis of 
schizophrenia and to have experienced poorer adolescent social adjustment than 
members of the Minimal Decreasing class, these findings just failed to reach 
significance (both p = 0.05). Compared to the Minimal Decreasing class, those in the 
High Decreasing class were more likely have a family history of non-affective 
psychosis (Β = -0.68, p = 0.046) and had higher levels of depression (Β = 0.09, p = 
<0.001). Members of the High Decreasing class had better premorbid social 
adjustment during childhood than the Minimal Decreasing class (Β = -2.21, p = 
0.004) but poorer premorbid social adjustment in adolescence (Β = 2.11, p = 0.003). 
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4.5. DISCUSSION 
 
4.5.1. Summary of Findings  
 
There was significant variability in the early negative symptom trajectories of 
members of the EDEN cohort. LGM suggested that negative symptoms tended to be 
mild at baseline and decrease over time in the sample as a whole. However, there 
was significant variance in both the intercept and slope of the estimated individual 
growth trajectories. This suggests that neither levels of baseline negative symptoms 
nor change in individuals’ negative symptoms over time are homogeneous across the 
sample. The single-class model fit the data poorly, suggesting that patterns of change 
in negative symptoms during the first 12 months of treatment cannot be satisfactorily 
modelled by a single trajectory. A model with four negative symptom trajectory 
classes was selected as the optimal model of the data. The four-class model fit the 
data significantly better than models with one, two or three trajectories and identified 
latent classes with distinct and theoretically relevant patterns of negative symptom 
change over the 12 month study period.     
 
The majority of the sample (63.9%) presented with consistently minimal negative 
symptoms throughout the study period. This suggests that most EIP service-users do 
not present with notable negative symptoms at any point during the first year of 
treatment. Only a small proportion of the sample (5.4%) followed a trajectory of 
persistently high levels of negative symptoms. A further 13.5% of the sample 
presented with consistently elevated negative symptoms of lesser severity. 
Membership of the class with the highest levels of persistent negative symptoms was 
predicted by male gender and family history of non-affective psychosis. A trajectory 
of initially high but decreasing negative symptoms was followed by 17.1% of the 
sample. This suggests that negative symptoms observed early in the course of EIP 
service-use often remit within the first 12 months of treatment. Those with remitting 
negative symptoms were distinguished from those with consistently minimal 
negative symptoms by poorer premorbid social adjustment during adolescence 
despite better social adjustment during childhood. They were also more likely than 
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those with consistently minimal negative symptoms to have a family history of non-
affective psychosis and had higher baseline depression scores. 
 
4.5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
 
4.5.2.1. The Course of Negative Symptoms in FEP 
 
Most previous negative symptoms research has emphasised just two categories of 
patients: those with persistent negative symptoms and those without. However, the 
results of the current study suggest that such an approach does not capture the 
complexity of patterns in negative symptom change following FEP. Whilst most 
previous studies have considered those with persistent negative symptoms to be a 
homogeneous group, the current study identified two distinct elevated negative 
symptom trajectories. The mean intercept of both these trajectories was sufficiently 
high to indicate multiple clinically significant negative symptoms. A rating of ‘4’ on 
the PANSS indicates that the symptom ‘represents a serious problem’ and is 
commonly interpreted as the threshold for clinical significance. A participant with an 
average negative symptom score of 3.58, the unstandardised mean intercept of the 
High Stable trajectory class, might have rated ‘4’ for six out of seven negative 
symptom items. A participant with an average negative symptom score of 2.19, the 
unstandardised mean intercept of the Mild Stable group, might have rated ‘4’ for two 
of the seven negative symptom items. Since a priori cut-offs typically require only 
one or two negative symptoms to be present, it is likely that members of both 
trajectory classes would be classified as having persistent negative symptoms on the 
basis of such criteria. Thus research employing a categorical approach based on a 
priori criteria for negative symptom persistence might mask considerable intra-
category variation in symptom severity.  
 
The large proportion of the sample found to have presented with consistently 
minimal negative symptoms throughout is surprising given that estimates of the 
cross-sectional prevalence of negative symptoms in FEP have been as high as 90% 
(Mäkinen et al., 2008). The high proportion of individuals with consistently low 
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levels of negative symptoms in the current study might be accounted for by 
characteristics of the EDEN cohort. Since the EIP services used by the study’s 
participants follow a policy of tolerating initial diagnostic uncertainty (Department 
of Health, 2001), the sample is likely to be more heterogeneous than those of studies 
that limit participation to those with a confirmed schizophrenia-spectrum diagnosis. 
Further, the majority of EIP service-users are identified and treated in the 
community, and this may account for the high prevalence of consistently minimal 
negative symptoms relative to studies in which participation is limited to individuals 
who were inpatients at baseline (e.g. Gerbaldo, Georgi, & Pieschl, 1997; Subotnik et 
al., 1998).  
 
The considerable proportion of those participants presenting with high levels of 
negative symptoms at baseline who experienced a remission of these symptoms 
within 12 months is a cause for optimism. Contrary to often pessimistic assumptions 
about the course of negative symptoms, a recent systematic review and meta-analysis 
of longitudinal studies of negative symptoms found that negative symptoms tend to 
decrease over time in outpatient schizophrenia samples (Savill, Banks, Khanom, & 
Priebe, 2015). The current study suggests the same overall trend may be evident in 
FEP, accounted for primarily by marked reductions in the negative symptom severity 
of a small subgroup. It is unclear whether such reductions in negative symptom 
severity should be attributed to successful treatment of secondary negative 
symptoms, natural recovery, or something else. This study was not designed to 
answer the question why do negative symptoms remit in some people but not others, 
however differences in the baseline characteristics of the High Decreasing and High 
Stable trajectory classes may provide some clues and are of particular theoretical 
interest.          
 
A recently published study that used latent class analysis to investigate negative 
symptom trajectories over a 10 year period post-FEP (Austin et al., 2015) indicates 
that those who do not experience decreases in their negative symptom severity 
within the first 12 months of treatment may do so subsequently. A latent class 
comprising 19% of Austin et al.’s sample presented with an initial increase in 
negative symptoms during the first two years of treatment followed by a gradual 
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decrease to minimal levels during the remaining eight years. However, a larger latent 
class (26% of the sample) experienced an initial reduction in negative symptom 
severity followed by steadily increasing negative symptoms during the remainder of 
the study period. This tempers the optimism engendered by the current study, 
suggesting that early negative symptom remission might be followed by relapse in 
subsequent years. However, Austin et al.’s sample had been participants in the 
OPUS trial (Petersen et al., 2005) and, as such, only half had received specialist EIP 
treatment during the first two years. Austin et al. observed striking differences in the 
negative symptom trajectories followed by those who received specialist EIP 
treatment relative to those who did not. Thus it is plausible that the negative 
symptom trajectories of the EIP service-users who were the focus of the current 
study may differ from those of other FEP patients.  
 
Two subdomains of negative symptoms – diminished expression and withdrawal 
(avolition/asociality) – have now been established (see section 1.4.3). Therefore, a 
question arose whether the negative symptom trajectory classes identified differed in 
the relative prominence of these two negative symptom subdomains. It seemed 
plausible that those whose negative symptoms remitted might have been those who 
presented with a higher proportion of symptoms from one or the other subdomains 
compared to those whose symptoms remained elevated. However, we found no 
significant differences between trajectory groups in the proportion of expressive 
deficit versus withdrawal symptoms at baseline. This suggests that the differing 
negative symptom trajectories observed were not accounted for by differences in 
baseline negative symptom type. Nonetheless, it is certainly true that the findings of 
the current study would have been different had trajectories of diminished expression 
and withdrawal symptoms been modelled separately. A recent study of negative 
symptom course during the first five years of treatment for FEP found diminished 
expression symptoms to be both less prevalent and less persistent than symptoms 
from the avolition/asociality domain (Norman et al., 2015). 
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4.5.2.2. Predictors of Negative Symptom Course 
 
In line with previous research indicating an association between male gender and 
negative symptom severity, male gender was found to predict a trajectory of stably 
high negative symptoms. Whilst it is tempting to look to a biological explanation for 
this difference, and there may well be a role for biology in explaining differing 
symptom profiles, there are also plausible psychosocial explanations of such 
differences. For instance, Read & Beavan (2013) argue that the higher incidence of 
prominent negative symptoms in men might reflect the adoption of an extreme 
masculine role involving restriction of emotional expression. According to cognitive 
models, negative symptoms can be viewed as active attempts to cope with stress 
through withdrawing and restricting expression. Since avoidant coping strategies are 
more often adopted by men than by women in the general population (Eschenbeck, 
Kohlmann, & Lohaus, 2007; Matud, 2004), it may be that the relationship between 
male gender and less favourable negative symptom course following FEP is 
symptomatic of more men than women employing strategies of avoidance to cope 
with the stress associated with psychosis.   
 
Poor premorbid social adjustment during adolescence was identified as a predictor of 
initially high but decreasing negative symptoms and approached significance as a 
predictor of stably high negative symptoms. It has been argued that poor premorbid 
adjustment may reflect early symptomology during the prodromal phase of the 
disorder (Häfner, Nowotny, Löffler, an der Heiden, & Maurer, 1995). The prodromal 
phase of psychosis is more often characterised by negative symptoms than by 
attenuated psychotic symptoms (Häfner et al., 1999). As such, it may be that the poor 
premorbid social adjustment of those with high levels of negative symptoms at 
baseline may reflect negative symptoms having been present during the prodromal 
phase of psychosis. That those with initially high but remitting negative symptoms 
were functioning significantly better during childhood than those who presented with 
consistently minimal negative symptoms aligns with this hypothesis. 
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An alternative theory in line with cognitive models of negative symptoms is that 
social failure in adolescence engenders negative beliefs about the self, and primes 
expectations of failure and lack of pleasure in demanding situations. These 
expectations create a predisposition to adopt a strategy of withdrawal and avoidance 
when faced with stressful situations, which manifests as negative symptoms in the 
context of psychosis. This theory places poor premorbid adjustment as a precursor of 
negative symptoms rather than their consequence. Of course, it may be that a circular 
relationship exists whereby poor premorbid functioning creates a dysfunctional 
cognitive set, which leads to the emergence of prodromal negative symptoms, which 
serves to reinforce the dysfunctional beliefs, which worsens the prodromal negative 
symptoms. Prospective studies examining the relationship between poor premorbid 
functioning, dysfunctional beliefs and negative symptoms will be required to 
disentangle the relationship between these factors during early psychosis.  
 
Previous research has suggested that premorbid social adjustment is of most 
relevance for negative symptoms, whilst premorbid academic adjustment is linked to 
cognitive outcome (Chang et al., 2013). The current study supported this suggestion; 
social but not academic adjustment during adolescence distinguished the High 
Decreasing class from the Minimal Decreasing class and the same trend in the same 
direction was observed between the High Stable class and Minimal Decreasing class. 
This might be because negative symptoms reflect primarily social deficits; blunted 
affect, alogia and asociality all reflect a reluctance or inability to engage with others. 
Therefore, if it is assumed that poor premorbid functioning results from the 
emergence of negative symptomology during the prodrome, it makes sense that 
social functioning would be impacted to a greater extent than academic functioning. 
Likewise, adverse social experiences might be more likely than academic failure to 
prime the avoidant coping strategies that have been proposed to underlie negative 
symptoms.    
 
Family history of non-affective psychosis was a further factor whose hypothesised 
relationship with negative symptom trajectories was supported by the current study. 
Having a family history of non-affective psychosis predicted membership of both the 
High Stable class and High decreasing class. This might suggest a genetic 
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predisposition to elevated negative symptoms. It has been proposed that enduring 
negative symptoms might be the result of neurodevelopmental impairment resulting 
from genetic defects (Carpenter, Buchanan, Kirkpatrick, Tamminga, & Wood, 1993; 
Murray, 1994). However, this would not explain the relationship between family 
history and negative symptoms that swiftly remitted. Another possible explanation is 
that young people with a parent or sibling with non-affective psychosis might be 
more likely to experience adverse life-events (e.g. bullying, poverty, being a young 
carer) and that this might contribute to the development of negative symptoms. A 
third possible explanation of the relationship between negative symptom course and 
family history is that a care giver with non-affective psychosis may be less able to 
model adaptive coping strategies. An individual who has not learnt how to cope with 
stress effectively might be more likely to manifest negative symptoms. 
 
The association between higher baseline depression scores and membership of the 
trajectory class with initially high but remitting negative symptoms might suggest 
that members of this class were presenting with negative symptoms secondary to 
depression. The remission of this group’s negative symptoms might then be 
attributed to successful treatment of their depression. However, since only baseline 
depression was considered in the current study, it is not known whether the High 
Decreasing class did indeed experienced reductions in depression that might account 
for the remission of their negative symptoms. Further research is required to 
establish what role depression might play in the course of negative symptoms 
following FEP. 
 
That DUP was not associated with negative symptom class in the current study was 
surprising given that a meta-analysis of 16 studies involving 3339 FEP participants 
concluded that DUP of less than nine months is associated with less severe negative 
symptoms at both short and long-term follow up (Boonstra et al., 2012). It is possible 
that this discrepancy is a result of differing methods; the studies Boonstra et al. 
synthesised examined group level correlations between DUP and negative symptom 
severity as opposed to the association between DUP and specific negative symptom 
trajectories. Austin et al. (2015), who employed similar methods to the current study, 
did not find DUP to be a significant predictor of negative symptom course, though 
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they did find an association between longer DUP and negative symptom course in 
their univariate analyses.  
 
Also contrary to expectations, no association between illicit substance use and less 
persistent negative symptoms was observed in the current study. However, there 
were significant limitations in the measurement of substance use in this study which 
may have impacted the results. Participants who reported lifetime use of any illicit 
substance were treated as a single group for the purposes of the analysis. It is 
possible that there may be a different relationship between negative symptom course 
and infrequent use of recreational drugs, and negative symptom course and habitual 
substance abuse that were obscured by the methods employed in this study.  
 
4.5.3. Limitations  
 
As previously discussed, missing data were estimated using FIML under the 
assumption that data were missing at random (MAR). However, unfortunately there 
was evidence of an association between missingness and negative symptom severity 
– those with less severe negative symptoms at baseline were more likely to be lost to 
follow up than those with more severe negative symptoms – which suggests that the 
MAR assumption is not justified. Arguably, in a study of negative symptoms, it is 
preferable that participants with less severe negative symptoms be lost to follow-up 
rather than those with more severe symptoms. Nonetheless, the results of a study will 
inevitably be biased by the loss of participants with a particular negative symptom 
profile, however this is dealt with.   
 
As a check on the impact of the decision to use all available data as opposed to 
excluding those participants deemed to have insufficient PANSS data, the LCGA 
was repeated including only participants with complete PANSS data at baseline and 
at least one subsequent time point (n = 848). The analysis yielded classes that 
followed trajectories with intercepts and slopes extremely similar to those of the 
original model (see Appendix A). Only four individuals (less than 0.5% of the 
sample subset) were allocated to a different class in this repeat analysis to that they 
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were allocated to in the original model. This suggests that the estimation of missing 
data points using FIML, rather than excluding participants deemed to have 
insufficient data for the estimation of a trajectory, had minimal impact on the 
conclusions reached. 
 
Since participants were assessed at only three time points, the model forms that 
could be fitted to the data were limited. Further, the follow-up period of the current 
study was relatively short. Whilst the first 12 months of treatment are an important 
period for research given EIP services’ focus on providing intensive support soon 
after psychosis onset, it is possible that further trajectories would emerge if 
participants were followed over a longer period. For instance, Evensen et al. (2012), 
in their study of the course of blunted affect over a 10 year period, found that 16% of 
participants developed blunted affect over the course of the follow-up period. Thus, 
it is possible that a trajectory of increasing negative symptoms would have emerged 
had negative symptoms been assessed over a longer time period. A longer term 
follow-up incorporating more frequent assessment would provide a more nuanced 
picture of variation in negative symptom course. 
 
The retrospective nature of several baseline measurements might have impacted the 
findings. Participants were required to recall their premorbid functioning, pathway to 
care, family history of mental illness, and previous substance use after the onset of 
psychosis and commencement of treatment with EIP. Since current symptomatology 
and treatment might conceivably have an impact on participant recollection or 
reporting, there is a risk of recall bias having influenced the findings. This limitation 
could only be fully overcome by recruiting participants prior to the onset of their 
psychosis and following them prospectively, for instance as part of a birth cohort 
study.   
 
Since the current study made use of data collected as part of the EDEN programme, 
the potential predictors of negative symptom course available for exploration were 
limited to those variables present in the dataset. Factors that may have been relevant 
to understanding variability in early negative symptom course were not included in 
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the analysis for this reason. For instance, the neurocognitive functioning of members 
of the EDEN cohort was not measured and thus neurocognitive variables were not 
included as potential predictors in the current analysis. However, neurocognitive 
deficits, including verbal memory impairments, have been found to be associated 
with persistent negative symptoms in FEP (Hovington, Bodnar, Joober, Malla, & 
Lepage, 2013). The relationship between neurocognitive functioning and other 
negative symptom trajectories is worthy of further investigation. 
 
4.6. CONCLUSION 
 
Negative symptom course following FEP is characterised by distinct trajectories. 
Persistent negative symptoms are observed in only a small proportion of those 
experiencing FEP and are associated with male gender and a family history of non-
affective psychosis. Decreasing negative symptoms are observed in a sizeable sub-
group of those with elevated negative symptoms on entry to EIP. Membership of the 
trajectory class characterised by initially elevated but decreasing negative symptoms 
is predicted by relatively good social adjustment during childhood but relatively poor 
social adjustment during early adolescence, high depression at baseline, and a family 
history of non-affective psychosis.  
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Chapter Five – The Relationship Between Negative Symptom Course and Social 
Recovery in First-Episode Psychosis 
 
5.1. BACKGROUND AND RATIONALE 
 
5.1.1. Social Disability and Psychosis 
 
Many individuals who experience psychosis have difficulties in a range of social 
domains including work, study, social relationships and independent living. Such 
social disability is already evident by the time individuals present with their first 
psychotic episode: compared to matched controls, individuals with FEP are less 
likely to be employed, less likely to be in a romantic relationship, and have fewer 
friends (Macdonald, Hayes, & Baglioni, 2000; Morgan et al., 2008). Indeed, 
difficulties with social functioning often predate the emergence of positive psychotic 
symptoms (Häfner et al., 1995), and thus functional decline is acknowledged to be an 
important indicator of psychosis risk (Yung et al., 2005). Moreover, there is evidence 
that early social disability is sustained in the longer-term. A study of the 10 year 
outcomes of individuals recruited during their first psychotic episode identified 
persistently high levels of social disability (Morgan et al., 2014). Only 12% of the 
sample had been employed for more than 75% of the follow-up period and 72% had 
been employed for less than 25% of the follow-up period. Furthermore, 71% of the 
sample were not in a romantic relationship during most of the follow-up period.  
 
Morgan et al. contrasted the poor social outcomes of participants with their relatively 
good symptomatic outcomes; only a minority of participants experienced continuous 
psychotic symptoms during the follow-up period and almost half had been 
completely free of positive psychotic symptoms for the two years prior to follow up. 
It has long been known that functional recovery is largely independent of recovery 
from positive symptoms (Carpenter & Strauss, 1977). Social disability has been 
found to persist in the absence of ongoing positive symptoms (Henry et al., 2010). 
Equally, some individuals make a good social recovery despite ongoing psychotic 
symptoms (Amminger et al., 2011; The British Psychological Society, 2014).  
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5.1.2. The Relationship between Negative Symptoms and Functional Outcome 
 
Whilst social functioning and positive psychotic symptoms are largely independent 
of one another, this is not true of social functioning and negative symptoms. The 
association between negative symptom severity and poor functional outcomes is well 
established (Álvarez-Jiménez et al., 2012). Studies have found negative symptoms to 
be of greater prognostic importance for later functioning than not only positive 
symptoms (Ho, Nopoulos, Flaum, Arndt, & Andreasen, 1998; Hoffmann, Kupper, 
Zbinden, & Hirsbrunner, 2003; Lysaker & Davis, 2004; Rabinowitz et al., 2012), but 
also cognitive impairment (Guaiana, Tyson, Roberts, & Mortimer, 2007; Leifker, 
Bowie, & Harvey, 2009). Negative symptoms that persist despite antipsychotic 
treatment are of particular prognostic importance; such negative symptoms predict 
poorer functional outcome than negative symptoms that prove more transient (Chang 
et al., 2011; Galderisi et al., 2013; Husted, Beiser, & Iaconoc, 1992). The poor social 
functioning of those who present with elevated negative symptoms is a key 
motivator of the drive to develop effective treatment strategies for negative 
symptoms (Elis et al., 2013; Kirkpatrick et al., 2006).  
 
Whilst the relationship between persistent negative symptoms and poor functional 
outcome is well established, few studies have looked at longitudinal change in 
negative symptoms and improvement in functioning concurrently. Fluctuations in 
negative symptoms have been shown to coincide with fluctuations in functioning 
over time in a sample of individuals with chronic schizophrenia taking part in a 
supported employment programme (Erickson, Jaafari, & Lysaker, 2011). However, it 
is not known whether improvements in negative symptom severity are accompanied 
by concurrent improvements in social functioning early in the course of psychosis. 
The current study investigated the relationship between the trajectory of an 
individual’s negative symptoms during the first 12 months of treatment for FEP and 
their social recovery trajectory during the same period.  
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Better understanding the relationship between the early course of negative symptoms 
and concurrent change in functioning might provide clues as to the nature of the 
relationship between negative symptom severity and poor functioning. Erickson et 
al. (2011) accounted for the close temporal relationship they observed between 
increases in negative symptom severity and deteriorations in functioning by noting 
the importance of communication and motivation to successful occupational 
functioning. That negative symptoms have a detrimental impact on the ability to 
function successfully, i.e. there is a direct causal relationship between negative 
symptoms and poor functioning, is implicit in many authors’ discussions of the 
relationship between negative symptoms and poor functional outcome. However, 
there is evidence to suggest that the relationship between negative symptoms and 
functioning may be bi-directional with negative symptom severity predicting later 
functional outcome, as well as early functional outcome predicating later chronicity 
of negative symptoms (Álvarez-Jiménez et al., 2012). Further, it is possible that the 
relationship between negative symptoms and functioning is not direct, but mediated 
by other variables.  
 
5.1.3. Measuring Social Recovery: The Time Use Survey 
 
Good social and occupational functioning have been deemed to be among the most 
important markers of recovery, both by experts by professional experience (Kane, 
Leucht, Carpenter, & Docherty, 2003), and by experts by lived experience (Pitt, 
Kilbride, Nothard, Welford, & Morrison, 2007). However, there is no consistent way 
of measuring social and occupational functioning in psychosis (Mausbach, Moore, 
Bowie, Cardenas, & Patterson, 2008), and no consensus criteria for a good functional 
outcome (Menezes, Arenovich, & Zipursky, 2006).  
 
The current study uses time spent in ‘structured activity’ as measured by the Time 
Use Survey (TUS) as a measure of social recovery, conceptualised as the process of 
getting one’s life “back on track” after an episode of psychosis. The original version 
of the TUS, consisting of detailed daily diaries supplemented by a structured 
interview, was designed by the Office for National Statistics for use in a nationwide 
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study of how individuals in the UK spend their time (Short, 2003). The TUS was 
modified for use with psychiatric populations by Fowler and colleagues. The key 
modifications to the original measure included: (1) limiting the types of activities 
enquired about to those relevant to the assessment of time spent in constructive 
economic and structured leisure activities, and (2) omitting the requirement for 
participants to complete daily diaries, instead collecting all information required via 
a semi-structured interview. These modifications were intended to minimise the 
burden placed on participants and thus increase the likelihood of obtaining complete 
data. The modified version of the TUS has been successfully used both with 
individuals with early psychosis and those at risk of psychosis (Fowler et al., 2009b; 
Hodgekins et al., 2015b).  
 
During the interview the participant is asked detailed questions about how they spent 
their time during the previous month. Lists of activities are provided by the 
interviewer and where the participant reports having engaged in a listed activity, 
further questions are asked to assess frequency and duration. Activities inquired 
about include employment, education, voluntary work, childcare, housework, leisure 
activities, hobbies, socialising, rest, and sleeping. Information obtained from this 
interview is used to provide an estimate of the average number of hours per week the 
participant has spent engaging in structured activity over the previous month. 
Structured activity is defined as time spent engaging in work (paid and voluntary), 
education, childcare, housework, sport and structured leisure activities (e.g. going to 
the cinema, on a shopping trip, eating out, attending a sporting or cultural event, or 
participating in a community group).  
 
The main strength of the use of the TUS in the context of this study is that it 
provides a measure of functional outcome with limited conceptual overlap with 
negative symptoms, reducing the risk of confounding. Many of the measures used to 
quantify functional outcome, including those that have been employed in studies 
investigating the association between negative symptoms and functioning, contain 
content that overlaps significantly with that of negative symptom measures. For 
instance, a frequently employed measure of functional impairment is the Quality of 
Life Scale (QLS; Heinrichs, Hanlon, & Carpenter, 1984). The QLS is a 21-item 
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interviewer-rated instrument designed to measure deficit symptoms (i.e. enduring 
negative symptoms) during the preceding four weeks. Items included in the QLS 
include social initiative and withdrawal, degree of motivation, emotional interaction, 
and anhedonia, all of which clearly intersect with the negative symptoms construct. 
Other commonly used measures of social functioning in psychosis contain items 
which similarly overlap with negative symptoms. For instance, the Social 
Functioning Scale (Birchwood, Smith, Cochrane, Wetton, & Copestake, 1990) 
contains items which assess the quality of a participant’s communication and ability 
to initiate conversations, both likely to overlap with ratings of alogia, and an item 
measuring social avoidance, almost certainly a confound with asociality. 
 
A more general strength of the TUS as a measure of social functioning is its relative 
objectivity. The interviewer is not required to make any judgements about a 
participant’s quality of life, degree of social competence, or independent living 
skills; instead the score derived is a direct reflection of the amount of time the 
participant reports having spent engaged in the activities of interest. As such, very 
high levels of inter-rater reliability have been observed (Hodgekins et al., 2015b). A 
further strength of the measure is its emphasis on activities beyond paid 
employment. Definitions of social recovery have often emphasised competitive 
employment to the exclusion of other economically valuable and personally 
meaningful activities. For instance, Warner (2004) defines social recovery as: 
“economic and residential independence and low social disruption. This means 
working adequately to provide for oneself and not being dependent on others for 
basic needs or housing” (p.56).  
 
In line with this definition, many studies have used paid employment as a marker of 
social recovery, yet this approach is problematic for a number of reasons. First, it 
devalues non-paid work including voluntary work, housework and childcare. The 
economic value of unpaid work is increasingly being recognised: the annual 
economic contrition of volunteers to the UK economy has recently been estimated at 
£41.5 billion (Volunteering England, 2009). Moreover, unpaid work can provide a 
meaningful and valued life role (Pitt et al., 2007). Second, economic independence is 
arguably a developmentally inappropriate expectation for many individuals with FEP 
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in their teens or early twenties, whose peers will often still be engaged in education 
or training. Further, employment status is unlikely to provide a sufficiently sensitive 
measure to capture the subtle changes in social functioning which may be significant 
indicators of recovery following FEP. The TUS overcomes these limitations by 
measuring a range of economically and personally beneficial activities in addition to 
time spent in paid employment.  
 
The current study builds upon a prior analysis of the National EDEN dataset 
conducted by Hodgekins et al. (2015a). Hodgekins et al. investigated longitudinal 
change in social functioning following FEP by using LCGA to model hours spent in 
structured activity (as measured by the TUS). Three social recovery trajectories were 
identified: (1) low levels of social functioning sustained over the course of the study 
(‘Low Stable’), (2) moderate social functioning which improved slightly over the 
course of the study (‘Moderate Increasing’), and (3) initially high social functioning 
which decreased slightly over the course of the study but remained high (‘High 
Decreasing’). The trajectories are represented graphically in Figure 5.1.  
 
Figure 5.1. LCGA model with three social recovery trajectories reproduced from 
Hodgekins et al. (2015a). 
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The Low Stable trajectory class comprised the majority (66%) of the cohort. The 
Moderate Increasing class had the second largest membership, accounting for 27% 
of the sample. The High Decreasing trajectory was the least common: only 7% of the 
sample were members of this class. The availability of data on time use from both a 
general population sample and from individuals with psychosis has enabled 
empirically grounded clinical cut-offs to be calculated (Hodgekins et al., 2015b). UK 
residents aged 16-35 years spend an average of 63.5 hours per week engaged in 
structured activity (Short, 2006). Participants engaging in less than 45 hours per 
week of structured activity can be defined as at risk of social disability, those 
engaged in less than 30 hours per week can be defined as experiencing social 
disability, and those engaging in less than 15 hours per week can be defined as 
experiencing severe social disability.  
 
As both the Moderate Increasing and High Decreasing trajectories were engaged in 
amounts of activity within the non-clinical range by the end of the study period, 
members of both these classes might be deemed to have made a ‘good social 
recovery’. In the case of the High Decreasing group, whose hours per week in 
structured activity decreased during the follow-up period, it might seem rather 
counterintuitive to talk of them having made a ‘good social recovery’. However, 
since this group were engaging in very high levels of structured activity at baseline – 
over 90 hours per week on average – the decrease in their activity to levels more in 
line with those of their peers might equally be seen as indicative of recovery. Since 
the Stable Low trajectory class were consistently engaged in levels of structured 
activity indicative of social disability, this class might be deemed to have made a 
‘poor social recovery’.  
 
The current study aims to increase understanding of the relationship between 
negative symptom severity and functioning during FEP through investigating the 
social recovery trajectories followed by members of the negative symptoms 
trajectory classes described in the previous chapter. The proportion of individuals 
from each of the negative symptom trajectory classes who make a ‘good’ social 
recovery versus those who make a ‘poor’ social recovery will also be examined.    
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5.2. RESEARCH QUESTION 
 
What is the relationship between the trajectory of an individual’s negative symptoms 
during the first 12 months of treatment for FEP and their social recovery trajectory 
over the same period?  
 
5.3. METHODS 
 
5.3.1. Design 
 
This study has a longitudinal design with participants having been assessed at three 
time points: baseline, six and twelve months. Negative symptoms were assessed at 
all three time points using the PANSS. Social functioning was assessed at all three 
time points using the TUS.  
 
5.3.2. Participants 
 
Only those participants who completed the TUS at at least two time points (n = 764) 
were included in the analysis of social recovery trajectories. The total number of 
participants included in the analysis of the association between negative symptom 
trajectories and social recovery trajectories is 759 individuals (those National EDEN 
participants eligible for inclusion in the current study who were also included in the 
analysis of social recovery trajectories).   
 
5.3.3. Sample Size 
 
A power calculation carried out using G*Power Version 3.1.9.2 (Faul et al., 2007) 
found that to achieve 90% power with a significance level of 0.05, an estimated 
medium effect size and six degrees of freedom a minimum sample size of 194 would 
be required. Thus the study was adequately powered.    
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4.3.4. Procedure  
 
The procedures were as described in the Chapter Three (section 3.3.4). The National 
EDEN measures included in the current study are described in the following section. 
 
5.3.5. Measures 
 
5.3.5.1. Positive and Negative Syndrome Scale (Kay, Fiszbein, & Opler, 1987) 
 
As previously described (section 4.3.5.1), the mean score of seven PANSS items – 
‘blunted affect’ (N1), ‘emotional withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive 
social withdrawal’ (N4), and ‘lack of spontaneity and flow of conversation’ (N6), 
‘motor retardation’ (G7) and ‘active social avoidance’ (G16) – was used as the 
measure of negative symptoms. A detailed explanation of the rationale for the use of 
these seven PANSS items, as opposed to the negative subscale of the PANSS, to 
measure negative symptom severity is provided in Chapter Three.   
 
5.3.5.2. Time Use Survey (Short, 2003) 
 
Social functioning was measured using the TUS. As previously outlined, the TUS is 
a semi-structured interview designed to provide an objective assessment of the 
amount of time the participant has spent engaged in structured activity over the 
previous month. Information obtained from this interview is used to estimate of the 
total time spent in structured activity each week on average over the previous month. 
For further information about the TUS and the rationale for its use as a measure of 
social functioning see section 5.1.3 above. 
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5.3.6. Analysis Plan  
 
Statistical analyses were carried out using SPSS for Windows, Version 22 (IBM, 
2013).  
 
The social recovery trajectory class of the members of each of the negative symptom 
trajectory classes outlined in the previous chapter were identified by matching the 
participants included in Hodgekins et al.’s LCGA with those included in the negative 
symptoms LCGA described in the previous chapter using participants’ identifier 
codes. A matrix of all the possible combinations or negative symptom and social 
recovery trajectories was constructed and individuals assigned to cells of the matrix 
according to their trajectory permutation. The independence of negative symptom 
and social recovery trajectory class membership was then tested statistically using 
Pearson’s Chi-Squared test. Examination of the adjusted standardised residuals of 
this Chi-squared test was used to determine which combinations of the two trajectory 
classes were over/under-represented in the sample relative to what would be 
expected were the two sets of latent classes independent of one another.  
 
The proportion of each negative symptom trajectory class that made a ‘good social 
recovery’ during the study period – defined as membership of the Moderate 
Increasing or High Decreasing trajectory class – was calculated and represented 
graphically.    
 
5.4. RESULTS 
 
As previously outlined, Hodgekins et al. (2015a) identified three trajectories of 
social functioning: (1) low levels of social functioning sustained over the course of 
the study (Low Stable); (2) moderate social functioning which improved slightly 
over the course of the study (Moderate Increasing); and (3) initially high social 
functioning which decreased slightly over the course of the study but remained high 
(High Decreasing). In order to explore the relationship between these three social 
functioning trajectories and the four negative symptom trajectories identified, a 
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matrix of negative symptom trajectory class against social recovery trajectory class 
was constructed (Table 5.1).  
 
Table 5.1. Matrix of intersections between negative symptom trajectory classes and 
social functioning trajectory classes.   
 
 
 High Decreasing 
 
Moderate 
Increasing 
Low Stable 
Minimal 
Decreasing 
 
n = 44 (9.0%) 
Significantly 
over-represented 
n = 166 (34.1%) 
Significantly 
over-represented 
n = 277 (56.9%) 
Significantly 
under-
represented 
Mild Stable 
 
 
n = 4 (4.2%) 
Within expected 
range 
n = 12 (12.5%) 
Significantly 
under-represented 
n = 80 (83.3%) 
Significantly 
over-represented 
High 
Decreasing 
 
 
n = 4 (3.1%) 
Within expected 
range 
n = 23 (17.6%) 
Significantly 
under-represented 
n = 104 (79.4%) 
Significantly 
over-represented 
High Stable 
 
 
n = 1 (2.2%) 
Within expected 
range 
n = 2 (4.4%) 
Significantly 
under-represented 
n = 42 (93.3%) 
Significantly 
over-represented 
 
Note. The text in each cell refers to whether the class is over- or under-represented 
according to the adjusted standardised residual of the relevant Chi-Squared test.   
 
 
Negative symptom trajectories and social recovery trajectories were not independent 
of one another (χ2 = 57.06, p = <0.001). Examination of the adjusted standardised 
residuals (ASR) of the Chi-squared test was used to determine which cells were 
over- and under-represented in the matrix. Trajectory permutations that were over-
represented in the sample were: Minimal Decreasing negative symptoms and High 
Decreasing social functioning (ASR = 3.0); Minimal Decreasing negative symptoms 
and Moderate Increasing social functioning (ASR = 6.1); Mild Stable negative 
symptoms and Low Stable social functioning (ASR = 3.8); High Decreasing 
negative symptoms and Low Stable social functioning (ASR = 3.5); and High Stable 
negative symptoms and Low Stable social functioning (ASR = 4.0). Trajectory 
combinations under-represented in the sample were: Minimal Decreasing negative 
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symptoms and Low Stable social functioning (ASR = -7.3); Mild Stable negative 
symptoms and Moderate Increasing social functioning (ASR = -3.4); High 
Decreasing negative symptoms and Moderate Increasing social functioning (ASR = -
2.6); and High Stable negative symptoms and Moderate Increasing social 
functioning (ASR = -3.5).  
 
Since both the Moderate Increasing and High Decreasing trajectories were 
characterised by non-clinical levels of structured activity at 12 months, membership 
of either class was taken to indicate a participant having made a ‘good social 
recovery’. Using this definition, 43.1% of Minimal Decreasing negative symptom 
participants made a good social recovery versus 6.6% of High Stable negative 
symptoms participants. The proportion of each negative symptoms trajectory class 
that made a good social recovery within the study period relative to those that did not 
is presented graphically in Figure 5.2. 
 
 
Figure 5.2. Proportion of each negative symptoms trajectory class that followed a 
social functioning trajectory characterised by non-clinical levels of structured 
activity by 12 months (‘Good Social Recovery’) versus those with stably low levels of 
structured activity (‘Poor Social Recovery’).  
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As Figure 5.2 makes evident, members of the Mild Stable, High Decreasing and 
High Stable were less likely to have made a good social recovery after 12 months of 
EIP treatment than were members of the Minimal Decreasing class. However, the 
figure also shows that the majority of those in all negative symptom trajectory 
classes, including members of the Minimal Decreasing class, did not make a good 
social recovery within the study period. Indeed, Minimal Decreasing/Low Stable was 
the most common negative symptom trajectory/social recovery trajectory 
permutation, accounting for 36.5% of the sample, indicating that elevated negative 
symptoms at baseline are not a prerequisite for poor social recovery.      
 
5.5. DISCUSSION 
 
5.5.1. Summary of Findings  
 
Examination of the social recovery trajectories followed by members of each 
negative symptom trajectory class revealed an association between the two 
trajectories. Those who followed a negative symptom trajectory characterised by 
elevated symptoms at baseline, whether or not those negative symptoms decreased 
over time, were significantly less likely to make a good social recovery during their 
first 12 months of EIP service receipt. Those who presented with consistently 
minimal negative symptoms were significantly more likely to make a good social 
recovery than would be expected were social recovery independent of negative 
symptom trajectory. Nonetheless, a significant proportion of the sample failed to 
make a good social recovery during their first 12 months of EIP despite minimal 
negative symptoms throughout this period, indicating that a pattern of elevated 
negative symptoms does not fully account for poor social recovery. 
 
5.5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
  
The results of the current study suggest that those who have elevated negative 
symptoms at baseline, even those whose negative symptoms remit early in the course 
of their psychosis, are less likely to achieve a good social recovery within 12 months 
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of treatment onset than those with consistently low levels of negative symptoms. 
This finding was partially unexpected: while it was predicted that persistent negative 
symptoms would be associated with stably low social functioning, it was anticipated 
that individuals who experienced a reduction in their negative symptoms would be 
likely to experience a corresponding increase in functioning. This prediction was 
based on the assumption that there is a direct relationship between negative symptom 
severity and functioning; that this was not borne out suggests that their relationship 
may be less straightforward than often assumed. 
 
Given that those with initially high but decreasing negative symptoms were 
functioning relatively poorly prior to the emergence of their psychosis, the worse 
than anticipated social recovery of this class could be hypothesised to be a legacy of 
premorbid social disability. An individual who has failed to achieve key functional 
milestones prior to the onset of psychosis is likely to find it much more challenging 
to achieve a good level of functioning after its onset. Given that negative symptoms 
emerge before positive symptoms (Häfner et al., 1999, 1995), it is possible that the 
premorbid social disability experienced by the High Decreasing class was the result 
of prodromal negative symptoms. This would provide an explanation for the 
relatively poor social functioning of the High Decreasing group during adolescence 
despite having been relatively well adjusted during adolescence. However, it is also 
possible that early social disability might have a role in the initial development of 
negative symptoms.  
 
There is evidence that early social disability may play a role in maintaining negative 
symptoms once they have emerged: Alvarez-Jiminez at al. (2012) found that failure 
to make a functional recovery early in the course of psychosis was a significant 
predictor of greater negative symptom severity six years later, independent of earlier 
persistence of negative symptoms. However, research also suggests that negative 
symptoms have a role in maintaining social disability: Brill et al. (2009) used path 
analysis to show that negative symptoms mediate the relationship between 
premorbid functioning and later functional outcomes. Taken together, these findings 
suggest that negative symptoms and social disability may maintain one another in a 
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vicious cycle, with poor social functioning leading to negative symptoms, which 
further entrench social disability.  
 
That social functioning does not tend to improve as negative symptoms decrease 
would suggest that there is no corresponding ‘virtuous cycle’. It might be that the 
experience of negative symptoms early in the course of psychosis creates enduring 
barriers to successful functioning. Psychosis typically emerges during adolescence or 
early adulthood, an important development period characterised by important social 
and occupational transitions, such as taking examinations, finding work or moving 
into higher education, establishing romantic relationships, and moving to living 
independently. Failure to reach such milestones during adolescence as a result of 
negative symptoms might have far reaching effects on a person’s social recovery. 
For instance, poor examination results might have implications for future career 
prospects. This possibility suggests that intervening at the earliest stage of disorder – 
at the first signs of non-specific negative symptoms and social disability, rather than 
waiting for attenuated positive symptoms to emerge – may be necessary in order to 
prevent long term disability (Fowler et al., 2010). 
  
More optimistically, it is plausible that decreased negative symptom severity does 
tend to be followed by improvements in functioning but that these improvements 
take some time to become evident. Processes such as securing employment, finding a 
voluntary opportunity, enrolling on a course and rebuilding a social network take 
time. As such, it may be that an individual whose social functioning has been 
disrupted by negative symptoms will experience a delay in returning to optimal 
levels of structured activity following the remission of these symptoms. Longer term 
follow-up studies will be necessary to establish the stability of social disability after 
early negative symptoms have remitted.  
 
As anticipated, those who presented with consistently minimal negative symptoms 
were significantly more likely to make a good social recovery. However, it is also 
clear that a large number of FEP patients do not make a good social recovery within 
12 months even in the absence of significant negative symptoms. This is a clear 
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indication that negative symptom severity is far from the only factor at play in poor 
social recovery following FEP. Poor social recovery is likely to be the result of a 
wide range of interacting factors, including symptoms and neurocognition but also 
social and economic factors (Warner, 2004). As such, improved rates of social 
recovery following FEP will not be achieved by focusing on any one factor in 
isolation.   
 
5.5.3. Limitations  
 
The amount and pattern of missing social recovery data is an important limitation of 
the study. Of the 1006 participants included in the previous study, 247 were not 
included in the current study as their social recovery trajectory was not modelled due 
to insufficient TUS data. The participants for whom social recovery trajectories were 
not available did not differ from participants for whom it was available in terms of 
age of psychosis onset, baseline diagnosis, DUP, gender, ethnicity, or employment 
status (Hodgekins et al., 2015a). However, there was an association between the 
negative symptom trajectory class of participants and whether or not sufficient TUS 
data was available for a social recovery trajectory class to be modelled. Those with 
more severe and persistent negative symptoms were more likely to have sufficient 
data: 90% of High Stable class members had a social recovery trajectory class versus 
only 72.3% of the Minimal Decreasing class.   
 
The impact of the relative lack of social functioning data for those with less severe 
negative symptoms is not possible to access with precision. However, even if all 
those Minimal Decreasing negative symptom class participants for whom social 
functioning trajectory data was missing had been in the Stably Low social 
functioning class, there would still have been an association between negative 
symptom trajectory and social recovery trajectory (χ2 = 24.07, p = 0.001), with the 
Minimal Decreasing negative symptoms and Stably Low social functioning 
permutation still significantly under-represented (ASR = -4.5). As such, the pattern 
of missing social recovery trajectories is unlikely to have impacted the conclusions 
reached.     
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The methods used in this study were only able to paint a broad-brush picture of the 
relationship between negative symptom course and concurrent social recovery. 
Further insights into their relationship could have been generated through the use of 
alternative methods. For example, if sufficient data had been available the social 
functioning trajectories of each negative symptom trajectory class could have been 
modelled individually. This may have revealed greater nuances in the relationship 
between negative symptoms and social functioning. However, introducing greater 
complexity to the analysis may also have decreased the interpretability of the data; 
since each round of modelling would have yielded a unique set of trajectories it 
would not have been possible to directly compare the occurrence of trajectories 
across groups, limiting the conclusions that could be drawn.  
 
While the amount of time spent in structured activity is a useful marker of recovery, 
there are clear limitations of prescribing whether or not an individual has made a 
‘good’ social recovery on the basis of this alone. First, it does not necessarily capture 
everything that is important to an individual’s social recovery, for instance it does 
not measure the quality of engagement in activities, whether individuals are able to 
connect with those around them, or feel that they have a valued role in society. 
Second, multiple domains of functioning, including vocational, residential and 
interpersonal functioning, are conflated within the category of structured activity. 
However, there is evidence that some domains of functioning might be more closely 
associated with negative symptom severity than others, for instance, one study found 
that there may be a closer relationship between negative symptoms and interpersonal 
functioning than residential functioning (Leifker et al., 2009).  
 
What is more, the TUS does not take into account the personal meaning attributed to 
the activities it enquires about, leading to a rather prescriptive definition of what 
constitutes a ‘good’ recovery. The relationship between negative symptom course 
and subjective conceptions of recovery should be considered alongside normative 
definitions of recovery. The personal understandings of recovery of those with 
differing negative symptom trajectories are explored in Chapter Seven of this thesis.  
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5.6. CONCLUSION 
 
Those with elevated negative symptoms at baseline are disproportionately likely to 
experience a lack of improvement in their social functioning over the first 12 months 
of their engagement with EIP services. Unexpectedly, this is the case even when 
those negative symptoms remit within 12 months. Further research is needed to 
ascertain whether social disability is sustained in this group or if improvements in 
social functioning are merely delayed relative to reductions in negative symptoms. 
Those with consistently low levels of negative symptoms are more likely to make a 
good social recovery than other FEP patients. Nonetheless, given that the majority of 
such patients will not have reached a level of social functioning comparable to their 
peers within 12 months, the social recovery needs of this group should not be 
overlooked.  
  
144 
 
INTERLUDE 
From Quantitative to Qualitative Investigation: The Merits of Mixing Methods 
 
The strength of qualitative research is its ability to provide complex textual 
descriptions of how people experience a given research issue. It provides 
information about the “human” side of an issue – that is, the often 
contradictory behaviours, beliefs, opinions, emotions, and relationships of 
individuals … When used along with quantitative methods, qualitative 
research can help us to interpret and better understand the complex reality of 
a given situation and the implications of quantitative data.  
(Mack, Woodsong, MacQueen, Guest, & Namey, 2005, pp. 1–2) 
 
The studies described in Part Two used quantitative methods to investigate the factor 
structure of the PANSS in FEP, the course of negative symptoms during FEP, and 
the relationship between negative symptom course and social recovery. The findings 
demonstrate that there is a high degree of heterogeneity in negative symptom course 
following FEP but that it is possible to distinguish latent classes with similar 
negative symptom trajectories within this heterogeneous group. Further, the results 
suggest that the trajectory of an individual’s negative symptoms can, at least in part, 
be accounted for by demographic and baseline clinical characteristics. Following a 
trajectory characterised by elevated negative symptoms on entry to EIP services 
appears to have worrying implications for the likelihood of making a good social 
recovery within 12 months. 
 
Quantitative methods are extremely valuable in that they are capable of generating 
findings that can be generalised to a wider population. However, reducing the 
complex behaviours, beliefs, emotions and relationships of human beings to a set of 
numbers inevitably leaves much uncaptured. Whilst statistical findings are 
informative at the level of the population of EIP service-users, they tell us little about 
the experiences of the individuals who make up this population. Further, they 
provide only limited information about the underlying processes that generate the 
statistical regularities observed. The use of qualitative methods alongside 
quantitative methods in the research conducted for this thesis was intended to 
minimise these limitations.   
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Whereas the quantitative research carried out aimed to produce findings 
generalisable to the population of EIP service-users, the qualitative research aimed to 
provide rich insights into the experiences of individual members of this population. 
To meet this aim, transcripts of in-depth interviews with a subsample of participants 
from each of the identified trajectory classes were analysed thematically in order to 
learn about the individual experiences of members of each class. Exploring the 
experiences of individual participants was considered important because of the 
potential for such exploration to provide insights into the complex psychosocial 
processes underlying differing negative symptom trajectories. These insights might 
aid in the interpretation of the quantitative findings, exposing the mechanisms 
underlying persistent negative symptoms following FEP and offering possible 
explanations of the relationship between elevated negative symptoms on entry to EIP 
and delayed social recovery.  
 
Further, exploring the experiences of individual service-users presents the 
opportunity to gain a more complete understanding of the phenomena at hand. 
Psychiatric symptoms, including negative symptoms, are conceptualised as 
experiential as well as behavioural phenomena. As such, neglecting to consider what 
it is like to be a person presenting with negative symptoms is to leave a fundamental 
aspect of negative symptoms unexamined. It is only by seeking to take the 
perspective of individuals with lived-experience that this experiential dimension of 
negative symptoms is revealed.  
 
Greene et al. (1989) identified five distinct rationales for the integration of 
quantitative and qualitative methods. The use of mixed methods in the current 
research spans three of these rationales: complementarity, development and 
expansion. Complementarity denotes the potential for findings obtained using one 
method to elaborate, illustrate or clarify the findings of another. In the current 
research, the qualitative work was designed to illustrate and aid interpretation of the 
quantitative findings through the focus on individual lived-experiences. 
Development refers to using one method to extend work conducted using the other. 
Most commonly the quantitative aspect of a study builds upon earlier exploratory 
work using qualitative methods. Conversely, in the current research, the qualitative 
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work was a development of the quantitative research; the findings of the quantitative 
work informed sampling decisions and guided the choice of research questions in the 
qualitative phase.  
 
Expansion describes the potential for mixed methods research to address a wider 
breadth of questions than could be answered using a single method. Research 
questions regarding the lived-experiences of individual service-users could not have 
been satisfactorily addressed through the use of quantitative methods alone, likewise 
questions about the course of negative symptoms and relationship with social 
recovery in the population of EIP service-users could not have been effectively 
answered through the use of qualitative methods alone. Therefore, the scope of the 
thesis was expanded through the adoption of a mixed methods approach. 
 
Part Three of the thesis reports the qualitative phase of the research before the 
quantitative and qualitative findings are brought together in Part Four.  
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PART THREE 
 
A Qualitative Investigation of Negative 
Symptoms in First-Episode Psychosis 
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Chapter Six – Lived-Experiences and Personal Understandings of Negative 
Symptoms in First-Episode Psychosis 
 
6.1. BACKGROUND AND RATIONALE 
 
6.1.1. Qualitative Research and Psychosis 
 
The perspectives of those with severe mental health problems have, historically, 
been largely overlooked by researchers (Larsen, 2004). People with lived-experience 
of psychosis were rarely considered capable of actively contributing to 
understanding the disorder. Most psychosis research continues to be centred on the 
judgements of external observers who make ratings based on their assessment of 
participants’ behaviour and responses to set questions. In such research, the 
investigator determines what is important about participants’ experiences, largely 
ignoring how they themselves understand their experiences and what they consider 
to be important about them. In contrast, qualitative investigations of psychosis 
attempt to give precedence to participants’ understandings and interpretations of 
their experiences. Such investigations – though still far outnumbered by quantitative 
studies – have become increasingly common over the past decade (McCarthy-Jones, 
Marriott, Knowles, Rowse, & Thompson, 2013). Together they provide a rich insight 
into the lived-experience of psychosis.  
 
Aspects of psychosis that have received attention from qualitative researchers 
include the phenomenology of psychotic symptoms (Engqvist & Nilsson, 2013; Le 
Lievre, Schweitzer, & Barnard, 2011; Luhrmann, Padmavati, Tharoor, & Osei, 
2015), the meanings attributed to psychotic symptoms (Hirschfeld, Smith, Trower, & 
Griffin, 2005; J. A. Larsen, 2004; Werbart & Levander, 2005), opinions of treatment 
received (Berry & Hayward, 2011; Lester et al., 2011; O’Toole et al., 2004; Tranulis, 
Goff, Henderson, & Freudenreich, 2011), barriers to accessing treatment (Anderson, 
Fuhrer, & Malla, 2013; Bay, Bjørnestad, Johannessen, Larsen, & Joa, 2016), the 
experience of stigma (Jenkins & Carpenter-Song, 2008; Knight, Wykes, & Hayward, 
2003; Pyle & Morrison, 2013), and the impact of psychosis on identity (Dinos, 
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Lyons, & Finlay, 2005), relationships (Lloyd, Sullivan, & Williams, 2005; 
MacDonald, Sauer, Howie, & Albiston, 2005; Mackrell & Lavender, 2004) and 
occupational functioning (Krupa, Woodside, & Pocock, 2010; Lal et al., 2013; 
Nithsdale, Davies, & Croucher, 2008; Pondé, Peireira, Leal, & Oliveira, 2009).   
 
McCarthy-Jones et al. (2013) synthesised the findings of 97 studies that used 
inductive qualitative methods to analyse the accounts of individuals with lived-
experience of psychosis. Four superordinate ‘meta-themes’ were identified. The first 
meta-theme, ‘Losing’, encompassed losses encountered as a result of psychosis, 
including loss of a shared reality, loss of self, loss of relationships, and loss of hope 
and motivation. The second meta-theme, ‘Identifying a need for, and seeking, help’ 
centred on the process of accepting a need for help and seeking out that help: a 
process that can be hindered by reluctance to attribute experiences to illness and 
negative perceptions of mental health services. The third meta-theme identified, 
‘Rebuilding and reforging’, concerned recovery from psychosis and identified 
rebuilding and reforging reality, self, hope, security and relationships as important 
elements of this process. The final meta-theme ‘Better than new: gifts from 
psychosis’ integrated themes of psychosis having a positive impact on the lives of 
participants. Such positive impacts included enhanced creativity and compassion, 
and improved family relationships.  
 
The majority of the qualitative studies identified by McCarthy-Jones et al. involved 
participants given a diagnosis of schizophrenia who had been unwell for many years; 
studies of FEP were much less numerous. However, FEP is becoming an 
increasingly popular focus of qualitative enquiry. A systematic review carried out by 
Boydell et al. (2010) identified no studies based on first-person accounts of 
individuals experiencing FEP published before 2000, but 17 such studies published 
during the following decade. The findings of the review highlight the complex 
meanings individuals attribute to various aspects of the experience of FEP, including 
passivity and withdrawal, and the role of the social contexts in which young people 
live in shaping these meanings. Many studies of the lived-experience of FEP have 
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been published since Boydell et al.’s review concluded2, suggesting that recognition 
of the value of qualitative research in understanding FEP continues to grow. 
 
6.1.2. Qualitative Research and Negative Symptoms  
 
Despite the recent growth in the qualitative literature on psychosis, negative 
symptoms have largely escaped the attention of qualitative researchers. None of the 
studies reviewed by McCarthy-Jones et al. (2013) or Boydell et al. (2010) focused 
specifically on the experience of negative symptoms. However, several studies have 
addressed topics and identified themes of relevance to understanding the lived-
experience of negative symptoms. Le Lievre et al.’s (2011) investigation of the 
changing experience of emotional expression in individuals given a diagnosis of 
schizophrenia was one such study. The theme ‘experience of not being expressive’ is 
of particular relevance to understanding the experience of blunted affect and alogia. 
Reasons participants gave for staying silent included fears of being ignored or 
provoking negative reactions, and the belief that they would be unable to contribute 
to conversations due to perceived cognitive difficulties. Other participants explained 
that they chose not to speak because they felt slowed down as a side-effect of their 
medication, making conversations more difficult and less rewarding.  
 
Another theme identified in Le Lievre et al.’s study, ‘experience of detachment’, is 
relevant to understanding asociality. This theme was evident in participants’ 
accounts of isolating themselves from others and an associated loss of emotional 
connection. Le Lievre et al.’s participants explained that making themselves 
emotionally or physically distant from others served to minimise their anxiety and 
protect their sense of self. Similarly, Krupa et al.’s (2010) study of activity and social 
participation following FEP found that young people described a lack of emotional 
connection, including a ‘deadening of emotions’, lack of pleasure, and loss of 
purpose, following their episode of psychosis. A mental health professional 
interviewed as part of the study suggested that participants’ professed loss of interest 
                                                 
2My literature search identified 34 qualitative studies of the lived-experience of FEP published 
between January 2010 and May 2015.     
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in previously valued activities may function as a coping mechanism, protecting them 
from the possibility of failure. 
 
Boydell et al. (2003) conducted a qualitative study of diminished motivation in 
schizophrenia. While they chose not to frame the investigation as a study of negative 
symptoms, aiming to move beyond a narrow view of amotivation as a biologically 
determined symptom of schizophrenia, their findings are of relevance to 
understanding avolition. The study found that participants saw their motivation 
difficulties as a consequence of psychotic symptoms, concentration problems, 
depressed mood, medication side-effects, or others’ low expectations of them. 
Participants discussed the stigma associated with low motivation, which is often 
perceived as laziness by others. Participants struggling with motivation, and 
consequently feeling excluded from society, often reported choosing to further 
isolate themselves in an effort to cope. However, participants also identified a 
number of more adaptive coping strategies, including having someone or something 
to care for, having someone to talk to, and building routine into their lives.       
 
A further study that identified themes of potential relevance to understanding 
negative symptoms is Sandhu et al.’s (2013) exploration of depression following 
FEP. Participants expressed that emerging from acute psychosis and beginning to 
reflect on their experiences precipitated a downward spiral. Loss of established life 
roles and the break-down of relationships led to a ‘crisis of identity’, which 
manifested as low energy, pessimism and lack of motivation. Participants said that 
they became increasingly socially withdrawn due to a perceived lack of empathy, 
fear of further embarrassment in the event of relapse, or just not being in the mood to 
communicate with others. For some, struggling to keep up with college or work led 
them to stop these activities, which exacerbated their social isolation. Other 
qualitative researchers have found similar meanings to be attached to withdrawal 
following psychosis (Judge, Estroff, Perkins, & Penn, 2008; MacDonald et al., 2005; 
Mauritz & van Meijel, 2009). 
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These studies indicate the potential for qualitative research to offer insights into the 
lived-experience of negative symptoms and the personal meanings attributed to these 
experiences. However, these topics remain under-explored. Better understanding the 
lived-experiences of negative symptoms has the potential to offer insights into the 
complex psychosocial processes underlying these presentations, facilitating 
improved intervention. Thus the current study used qualitative methods to explicitly 
address how negative symptoms are experienced and understood by individuals with 
lived-experience of FEP.  
 
6.1.3. Qualitative Secondary Data Analysis 
 
Both the current study and the study described in Chapter Seven involved the 
secondary analysis of qualitative data. Qualitative secondary data analysis (QSA) is  
defined as the use of previously collected qualitative data to answer new or 
additional research questions, or to verify the findings of previous studies (Heaton, 
2004). Whilst secondary analysis of quantitative data is a well-established research 
method, QSA has only relatively recently emerged as an acknowledged branch of 
qualitative research (Boydell, Gladstone, & Volpe, 2006). However, there is now a 
drive to encourage greater re-use of qualitative data (Irwin & Winterton, 2011). The 
Economic and Social Research Council (ESRC) strongly advocate the re-use of 
qualitative data, as evidenced by their policy of encouraging the researchers whose 
work they fund to make their qualitative data available for secondary analysis via 
their ‘UK Data Service’ archive (ESRC, 2015).  
 
Qualitative data collection is resource intensive. As such, making maximum use of 
the resulting data has the potential to improve the efficiency of qualitative research. 
Since qualitative data are often extremely rich, it is almost inevitable that a single 
analysis will leave much of the data generated under-explored. Irwin & Winterton 
(2011) note several ways in which new insights can be generated from previously 
collected data. These include ‘prioritising a concept or issue that was present in the 
original data but was not the analytical focus at that time’ and selecting ‘purposively 
from the sample used in the original study’. These strategies were used in tandem in 
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the current analysis: the analytic focus shifted from the evaluation of EIP services to 
the lived-experience of negative symptoms and a purposive subsample was selected 
to facilitate this change of focus.  
 
6.2. RESEARCH QUESTIONS 
 
1. To what extent do negative symptoms feature within participants’ accounts of 
the experience of psychosis? How do participants describe the experience of 
negative symptoms?  
2. How do participants understand and make sense of any negative symptoms 
they experienced? 
3. Are there differences in the extent to which negative symptoms feature 
within the accounts given by those who followed differing negative symptom 
trajectories or the way in which the experience of negative symptoms is 
described?  
 
6.3. METHOD 
 
6.3.1. Design 
 
The study employed QSA of the transcripts of interviews conducted with members 
of the EDEN cohort. Participants were interviewed up to three times about their 
experiences during their time with EIP services. The first interview was carried out 
towards the end of the participant’s time with EIP or following discharge and 
subsequent interviews were conducted at yearly intervals. Interviews were semi-
structured and focused on topics relevant to their experience of EIP, including 
psychosis, identity, relationships, recovery, and physical health. A purposive sample 
of negative symptom trajectory class members who took part in these interviews was 
selected for inclusion in the current study. Verbatim transcripts of the interviews 
were analysed thematically and comparisons made between the themes of interviews 
with those who followed differing negative symptom trajectories.  
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6.3.2. Setting 
 
The individuals included in the current study were participants in the second phase 
of the EDEN programme: Super EDEN (see section 2.3 for further details). As part 
of the Super EDEN study, all participants were invited to take part in a qualitative 
sub-study exploring personal experiences of psychosis and EIP care. Participants 
who chose to take part in this sub-study were interviewed at yearly intervals during 
the two year follow-up period.   
 
6.3.3. Data Collection 
 
Topic guides for the interviews (Appendix C) were devised by the Super EDEN 
research team, led by medical anthropologist Dr Anna Lavis, in collaboration with 
the Super EDEN Lived Experience Advisory Panel: a panel of young people with 
first-hand experience of psychosis. Topic guide development was an iterative 
process in that later topic guides were updated to reflect themes participants guided 
interviews towards in earlier interviews. The initial topic guide was relatively 
structured. Later topic guides were less structured, offering participants a choice of 
possible topics to focus on during the interview. Topic guides were not intended to 
be prescriptive and interviewers were encouraged to follow the course set by the 
participant where possible in order to facilitate a free-flowing narrative. This 
approach was motivated by a desire to prioritise those issues deemed important by 
participants rather than imposing the interests of the researchers. 
 
Interviews were conducted by study Research Assistants3 (graduates in psychology 
or another relevant discipline) working alongside the participating EIP services. All 
interviewers were trained in qualitative interviewing by experienced qualitative 
researchers. Interviews were conducted in the participant’s home or an alternative 
venue convenient for the participant (e.g. their GP practice or mental health service 
                                                 
3
 I personally conducted 28 interviews as part of the Super EDEN qualitative study. 
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base). Interviews were designed to take approximately one hour but varied in length 
depending on the level of detail participants chose to provide. Interviews were audio-
recorded and transcribed verbatim by a professional transcription company4. These 
interview transcripts were the data for the secondary analysis.   
 
6.3.4. Sampling Strategy 
 
The sampling frame comprised 162 participants, each of whom participated in at 
least one Super EDEN qualitative interview. Further, these participants were 
included in the study described in Chapter Four and their trajectory class was 
calculated on the basis of complete PANSS data at two time points or more. 
 
From within the sampling frame, a purposive sample was selected for inclusion in 
the current study. The sample was selected to maximise variation in key 
demographic variables including gender, ethnicity and study site. The proportion of 
participants selected from each of the negative symptom trajectory classes mirrored 
the relative size of the trajectory classes within the EDEN cohort as a whole. Since 
the majority followed the Minimal Decreasing trajectory, not all of those from this 
trajectory class selected during the initial sampling were included in the final 
analysis: the analysis was concluded once no new themes were identified through the 
analysis of an additional participant’s transcripts (i.e. once saturation was reached).  
 
This sampling strategy was intended to produce a dataset of a manageable size for 
qualitative analysis. Clearly it would not have been feasible to include transcripts 
from all 162 participants in the analysis while achieving the depth of analysis 
necessary to successful qualitative research. However, it was also considered 
important to include a sufficiently diverse range of participants from each negative 
symptom trajectory class; only by capturing a broad range of experiences would 
comparing the experiences of members of different classes be meaningful. The final 
sample included 24 participants who took part in a total of 57 interviews. Seven 
                                                 
4
 A very small number of participants expressed that they would prefer their interviews not to be 
audio-recorded and in such cases the interview was transcribed in situ by a second Research Assistant. 
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participants were members of the High Stable or Mild Stable negative symptoms 
trajectory class, six were members of the High Decreasing class, and eleven were 
members of the Minimal Decreasing class.   
 
6.3.5. Analysis Plan 
 
The analysis took an inductive thematic approach (Braun & Clarke, 2006, 2013; 
Notley, Green, & Marsland, 2014). Thematic analysis is a method of identifying and 
recording patterns of meaning, or ‘themes’, in qualitative data in order to organise 
and describe the data in a way that answers the research questions posed. This 
method is appropriate for relatively large datasets and allows for categories to be 
data-driven rather than imposed on the basis of theoretical assumptions. The 
transcripts were grouped by negative symptom trajectory class and each group 
analysed independently before comparisons between groups were made.  
 
Due to the small number of potential participants from the High Stable negative 
symptom trajectory class, the High Stable and Mild Stable classes were treated as a 
single group in the analysis. Thus the experiences of three groups were compared: 
the ‘Elevated’ negative symptoms group (members of the High Stable or Mild Stable 
latent classes), the ‘Decreasing’ negative symptoms group (members of the High 
Decreasing latent class), and the ‘Minimal’ negative symptoms group (members of 
the Minimal Decreasing latent class).  
 
The thematic analysis followed the five phase procedure described by Braun & 
Clarke (2006): (1) familiarisation; (2) initial code generation; (3) searching for 
themes; (4) reviewing themes; and (5) defining and naming themes. The first phase – 
familiarisation – involved reading each of the transcripts carefully and noting initial 
impressions. The second phase – initial code generation – involved re-reading each 
transcript and dividing the text into small meaningful segments. Each segment was 
labelled in a way that attempted to capture the semantic meaning of the unit, using 
the participants own words if possible. The third phase – searching for themes – 
involved organising the codes generated in the second phase into themes 
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representing patterns within the data. This process was aided by the creation of a 
documents summarising the thematic content of each participant’s transcripts.  
 
Once a set of possible themes had been devised, the fourth phase – reviewing themes 
– began. This phase was an iterative process involving revisiting the data supporting 
each theme, adding, removing, subdividing or collapsing themes where necessary, 
before returning again to the data. The aim during this phase was to ensure themes 
were sufficiently coherent to form a meaningful unit whilst being sufficiently 
different from one another to be clearly distinct. At this stage, differences and 
similarities between the themes developed for each of the negative symptoms groups 
were explored and common themes amalgamated into one overarching theme where 
appropriate. In the final phase, themes were named to communicate the essence of 
each theme and, taken together, the overarching story of the analysis. Verbatim 
quotes to be included in the presentation of the study’s findings were selected on the 
basis of their suitability as illustrations of the analytic themes developed.    
 
The qualitative data analysis software package NVivo (Version 10; QSR 
International, 2012) was used to assist the analysis process. Initial coding was 
completed by hand using hard copies of the transcripts. NVivo was then used to 
organise the codes generated into possible themes, and to review and refine these 
themes. It was also used to organise the documents summarising participants’ 
transcripts and memorandums documenting the analytic process.    
 
To enhance the credibility of the analysis, a small number of transcripts were 
selected at random5 to be subjected to independent analysis by a second researcher. 
The researcher was kept blind to the negative symptom trajectory of the participant 
who gave the interview. This process was intend to substantiate that the study’s 
findings were rooted in the data analysed, and not unduly influenced by knowledge 
of the participant’s negative symptom trajectory class membership. The researcher 
who carried out the independent analysis is a clinical academic and a qualified 
                                                 
5
 The online random number generation service provided by www.random.org (operated by 
Randomness and Integrity Services Ltd.) was used to facilitate random selection of transcripts.  
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clinical psychologist, with expertise in early psychosis. The independent analysis 
converged with the emerging themes of the primary analysis, lending credibility to 
the claim that the themes generated were firmly grounded in the accounts of the 
study’s participants. 
 
Nearly all included participants took part in more than one interview, and thus there 
was the opportunity to observe longitudinal developments in participants’ views and 
interpretation of events. While changes in participants’ accounts over time were 
considered during the analysis, their limited relevance to the study’s research 
questions led to a decision to present the findings as if the data were cross-sectional. 
Given the already relatively complex comparative analysis, it was felt that including 
discussion of longitudinal developments in individual narratives would over-
complicate the presentation of the results, obscuring the central findings. 
 
6.4. RESULTS 
 
6.4.1. Participant Characteristics 
 
Demographic characteristics and negative symptom severity scores of the 24 
participants included in the current analysis are presented in Table 6.1. Participants 
are referred to using pseudonyms throughout to maintain their anonymity.  
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Table 6.1. Sample characteristics by negative symptom trajectory group.  
 Pseudonym Study Site Ethnicity Age at 
Initial 
Interview  
Mean Negative 
Symptom Score 
BL 6M 12M 
Elevated 
Negative 
Symptoms 
 
Daniel 
Max 
Nathan 
Yasmin 
Tom 
Hayley 
John 
 
Norfolk 
Cheshire 
Birmingham 
Lancashire 
Cambs. 
Cornwall 
Birmingham 
 
White British 
White British 
White British 
Asian Pakistani 
White British 
White British 
White British 
 
20 
27 
26 
28 
20 
28 
31 
4.00       4.43        4.00 
4.00       3.43        2.71 
3.43       3.29        2.57         
1.57       3.29        2.57 
1.71       2.29        2.14 
3.00       2.86        2.86 
2.57       3.00        2.57 
 
Decreasing 
Negative 
Symptoms 
 
Jacob 
Aisha 
Oliver 
Stacey 
Aidan 
Steve 
 
Birmingham 
Birmingham 
Cornwall 
Cornwall 
Norfolk 
Lancashire 
Black Caribbean 
Asian Pakistani 
White British 
White British 
White British 
White British 
 
28 
28 
30 
27 
25 
27 
3.43        3.43        1.00 
3.29        2.00        1.43 
3.14        1.29        2.00 
4.29        2.29        1.29 
3.00        3.43        2.14 
2.86        3.71        2.14 
Minimal 
Negative 
Symptoms 
 
Philip 
Nazir 
Alexander 
Shelly 
Isabella 
Jennifer 
Ben 
Kelly 
Clara 
Jack 
Callum 
Norfolk 
Lancashire 
Devon 
Birmingham 
Cambs. 
Lancashire 
Birmingham 
Norfolk 
Cornwall 
Cambs. 
Cheshire 
White British 
Other Asian 
Other White 
Black Caribbean 
White/Asian 
White British 
White/Caribbean 
White British 
White/African 
White Irish 
White British 
37 
21 
32 
28 
35 
30 
27 
22 
30 
29 
27 
 
1.00        1.29        1.29 
2.29        2.29        1.86 
1.00        2.57        1.00 
1.29        1.57        1.29 
1.57        1.14        1.14 
2.14        1.57        1.00 
2.43        1.57        1.14 
1.43        1.57        1.71 
2.14        1.00        1.00 
1.71        1.00        1.00 
1.14        1.00        1.00 
 
 
6.4.2. Thematic Analysis 
 
The term ‘negative symptoms’ was used on just one occasion during the interviews 
analysed. During an interview with Jennifer – a member of the Minimal negative 
symptoms group – she remarked that she didn’t experience ‘them negative symptoms 
that you get with schizophrenia’. This remark was made in the context of explaining 
that she considered herself to be less in need of support than individuals with ‘really 
really bad schizophrenia’ who she believed to be at risk of self-neglect, depression, 
and misuse of alcohol or drugs as a result of not having ‘enough anxiety’. For 
Jennifer, negative symptoms were a marker of severity and stating that she did not 
experience them offered a means of distancing herself from those she perceived to be 
more unwell than herself.   
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Whilst the term ‘negative symptoms’ featured in the transcripts only once, 
descriptions of experiences corresponding to the negative symptom construct 
featured in the accounts of the majority of participants from all negative symptom 
trajectory groups. Descriptions of lack of motivation and withdrawal were very 
common features of the analysed accounts, appearing in the transcripts of 20 out of 
24 participants’ interviews. References to diminished expression were less common, 
featuring in nine participants’ interview transcripts.  
 
There were no notable differences in the extent to which accounts of difficulties with 
expression, social withdrawal or lack of motivation featured in the interviews given 
by individuals with differing negative symptom trajectories. Reports of lack of 
motivation and social withdrawal symptoms were most common in the transcripts of 
interviews with members of the Elevated negative symptoms group, but accounts of 
expressive deficits were more common in the transcripts of interviews with members 
of the Minimal negative symptoms group. There were also no group differences in 
themes related to the experience or understanding of negative symptoms identified. 
However, the analysis revealed a number of commonalities across all groups in the 
way negative symptom-like experiences were described and understood. 
 
‘Like a zombie’ 
 
Several participants recounted difficulties interacting with others during their 
episode of psychosis. Participants often mentioned that they did not talk as much as 
was usual for them and some described being unable to express appropriate 
emotions. The simile ‘like a zombie’ was used by several participants when 
describing these experiences.  
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 I wasn't moving, I was sitting down … I wasn't talking. I was just like, you 
know, like a zombie, just sitting there … I'd just sit down and not interact 
with anyone.6 
 Aisha, Birmingham – Decreasing Negative Symptoms 
  
 Before I was just sitting all day and not speaking at all and not showing any 
reaction when people were talking to me and stuff like that … I didn’t even 
like say anything when my sister had a baby. I wasn’t even interested. I was 
just like a zombie and everything 
 Jennifer, Lancashire – Minimal Negative Symptoms 
 
Through the use of this simile, the participants powerfully evoke the sense of 
otherness they experienced as a result of their difficulties interacting; it seems that 
participants felt remote not only from other people, but also from themselves. This 
self-alienation is exemplified by Callum’s statement that he was not himself whilst 
he was in this zombie-like state.  
 
I’m a zombie. Like when I’m walking around. People ask me questions and 
I’m like ‘err’ … I’m not me.  
Callum, Cheshire – Minimal Negative Symptoms  
 
Thus for some participants, disruption in the ability to interact as usual appears to 
have led to a discontinuity in their identity. This is perhaps unsurprising given the 
importance of social performance to the construction and maintenance of identity. 
 
Diminished internal experience 
 
In a small number of cases, participants expressed that their diminished expression 
reflected reduced internal experience, that is, they reported that they were unable to 
talk due to a decrease in their ability to think, or failed to express the emotions 
expected of them because of decreased emotional intensity. For instance one 
                                                 
6To improve ease of reading, nonverbal utterances by the researcher (e.g. hmm, uh-huh, yeah) are 
omitted from quotations. Nonverbal utterances by participants are presented as transcribed. Where 
other material has been omitted, this is indicated by an ellipsis.   
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participant, Clara, explained that she was unable to communicate because she felt 
‘numb’ and like her head was ‘blocked’.  
 
P7: I couldn't really communicate with anybody. Erm it's difficult to 
describe myself. 
R: Did you feel locked in? Or? 
P: I didn't feel like detached. And I, I didn't feel like anything. 
R: Sort of empty? Or? 
P: Yeah. Erm numb. Blocked. My head was sort of blocked. I couldn't 
think, therefore couldn't speak, because I didn't know what to say.  
Clara, Cornwall – Minimal Negative Symptoms 
 
For Jennifer, a lack of emotional expression was symptomatic of a long-standing 
inability to experience any strong emotion other than anxiety. Jennifer illustrated her 
account of the experience of diminished emotion by describing her indifference 
towards the events of September 11th.  
 
I’d been not been able to have any feelings or anything and just like except to 
have feelings of anxiety but I didn’t have feelings like that. Do you know that 
twin towers, when it crashed, I didn’t care. I sat watching it, I was like, oh 
yeah boring. But now, when I watch programmes on it, I was nearly crying 
because I was like oh it’s so dramatic and emotional and everything. But I 
remember distinctly when it happened, I just sat there staring and I was just 
like, I’m just not interested in that … I didn’t have any feelings for any of it. 
It was horrible. It was like I’d been possessed by a demon or something, it 
was really weird. It was like I wasn’t even in my own body.  
Jennifer, Lancashire – Minimal Negative Symptoms 
 
Similarly, some participants explained decreased motivation as a consequence of a 
reduction in their drive and enthusiasm. Isabella gave a particularly moving account 
of such reduced drive. 
 
  
                                                 
7
‘P’ is used to indicate words spoken by a participant, and ‘R’ to indicate words spoken by a study 
Research Assistant. 
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Before this happened to me I was always right let’s do this, let’s do that, right 
we’ll get this plan and we’ll do this, now I’m more kind of … I’ll get the Play 
Doh out and sit with my son even if I don’t want to and I’ll enjoy it but … it’s 
harder for me to enjoy those kinds of things because you do feel like you’ve 
had so much sucked out of you that, it’s like that inner child it’s a bit like 
someone’s taken it by the neck, strangled it, it’s just survived and then shaken 
it again and then said, right your life’s never going to be the same again … we 
go to the park, we go out for lunch, we go into town and go to groups or 
whatever and I do do that but just not with as much gusto as I did before. 
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
Such accounts align with traditional psychiatric definitions of blunted affect, alogia, 
avolition and anhedonia, which take reductions in expression and activity to be 
indicative of limited emotional range, reduced capacity for thought, lack of drive and 
reduced hedonic capacity. However, diminished internal experience was described 
by only a minority of participants who reported reductions in expression, motivation 
and sociability. More often, participants indicated that their capacity for thought and 
emotions remained intact and explained reductions in expression and activity in 
other ways. 
 
Medication side-effects 
 
The explanation for diminished expression, motivation and sociability most 
frequently given by participants was that these experiences were – or indirectly 
resulted from – side-effects of prescribed medication. Participants often commented 
that the sedative effect of antipsychotic medication decreased their drive to engage in 
activities requiring relatively more effort and energy. For instance, Isabella spoke 
about being less motivated to go to the gym due to the sedative effect of her 
medication.     
 
You don't feel as motivated to get up and do things as perhaps I think I did 
before, more likely to go to the gym before I got ill than I am now because all 
I want to do, all the medicine really makes me want to do sometimes is just 
kind of, even though it's low dose, is just sort of curl up and be quite sedate 
really which obviously is the idea of it really.  
Isabella, Cambridgeshire – Minimal Negative Symptoms 
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Another participant, Hayley, discussed the trade-off between the positive effects of 
sedation on her positive symptoms and the negative impact of sedation on the ability 
to socialise and participate in activities outside the home.   
 
And because my thoughts were racing in really weird directions, they thought 
that a more sedative tablet would be better for me. But, of course, then that 
meant that I wasn’t going out very much. I wasn’t socialising. I wasn’t really 
doing the things that may have helped me, you know, in the other part, the 
not medication part.  
Hayley, Cornwall – Elevated Negative Symptoms  
 
Although the medication Hayley was prescribed helped control her unusual thoughts, 
its sedative effect decreased her ability to socialise and participate in activities that 
might have aided psychosocial aspects of her recovery. 
 
The experience of feeling ‘like a zombie’ was often, but not always, linked to 
medication side-effects. For Aisha, a change in her medication led to a dramatic 
increase in her ability to express herself, allowing her to reassert her identity as 
someone who likes to talk. 
 
Actually I'm really happy with that because like even my mum says, 'You 
talk too much,' [laughs] but I feel like I've gone from not talking. I like to 
talk.  
Aisha, Birmingham – Decreasing Negative Symptoms 
 
For some participants, lack of motivation was not seen as a direct side-effect of 
medication, but the result of medication-induced weight-gain. This is illustrated by 
Aisha’s description of the impact of her rapid weight-gain triggered by use of 
antipsychotic medication.  
 
I feel like the heavier I am, the more harder for me to move around. And 
when I was lighter I was more active and doing loads of things and I had 
motivation and everything. And now like - my motivation - like before I had 
loads of motivation. Now that my motivation isn't really there. It's like 
someone has to push me to do things. Give me that extra support.  
Aisha, Birmingham – Decreasing Negative Symptoms 
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Similarly, Hayley described a vicious cycle sparked by medication: the medication 
led to weight-gain, which lead to her feeling down, which lead to low energy, which 
lead to inactivity, which lead to further weight gain. 
 
P: I didn’t have one item of clothing that would fit me, well, other than my 
socks. Everything else didn’t fit. Erm, even shoes were too tight, erm, 
everything, from pants to t-shirts, jumpers, coats, nothing fitted me. Erm, 
that was just, it was awful. 
R: So then that contributed to you feeling more low and… 
P: Yeah, and therefore not going out as much, and that, then, lack of 
energy, lack of doing anything [inaudible]. 
R: Was just a vicious circle, really?  
P: Yeah, yeah. 
Hayley, Cornwall – Elevated Negative Symptoms  
 
 
‘A confidence thing’  
 
Lack of confidence in their abilities was another explanation participants gave for 
difficulties expressing themselves, socialising and maintaining motivation. One 
participant, Yasmin, describes how her experience of psychosis undermined her 
confidence in her ability to interact with others.     
 
Yeah, and it’s funny, oh, I mean I don’t talk to anybody that much and I 
haven’t got confidence left in me, because I think, ‘Oh, my God.’ I’m not 
sure about things which I’m doing. Like, am I not, am I doing right or not, 
because, you know, like, when you’re unwell, you don’t realise, do you? So 
it made me think, like, I’ve got no confidence, like, I don’t know if what I’m 
doing is right or wrong.  
Yasmin, Lancashire – Elevated Negative Symptoms 
 
Yasmin talked at some length about her experience of behaving in ways that she now 
regards as inappropriate having undermined her confidence in her abilities. She 
described crippling doubt about whether her actions are right or wrong. Later in the 
interview, when discussing her hopes for the future, Yasmin spoke about not making 
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plans for the future because she felt she wouldn’t be capable of carrying them out 
successfully.  
 
At the moment I can't plan much because I know I've got not that much 
capability to do things.  
Yasmin, Lancashire – Elevated Negative Symptoms 
 
An account given by John illustrates how lack of confidence can manifest as not 
‘feeling up to’ participating in recreational activities. John’s reluctance to participate 
in activities outside the home seems to have stemmed from him underestimating his 
capabilities. This lack of confidence manifested as a lack of energy and drive: as not 
feeling up to going out. 
 
In the early days I wasn’t going out the house at all basically and there was a 
group, a group of people that got you out doing activities, which I didn’t 
really want to do them 'cos I didn’t feel up to them but it was, because they 
were they, give me these things to do I kind of forced myself and I think that 
helped quite a lot. It gave me the confidence that I knew I could actually go 
and do these things, like go out to a coffee shop or go to a garden centre and, 
or go for a walk or something, like simple things. 
John, Birmingham – Elevated Negative Symptoms 
 
As John’s confidence in his ability to successfully engage in simple activities 
increased, he became more motivated to leave the house and begin doing things he 
enjoyed. As John began to recover his confidence, his parents’ confidence in how far 
they could push him also increased. John explained that his parents moved from 
‘tread[ing] on egg shells’ to nagging him to ‘get up and go and do something’.  
 
Both Yasmin and John described a general lack of confidence in their ability to 
successfully engage in even simple everyday activities. For other participants, their 
lack of confidence was specific to a certain domain. For instance Clara discussed her 
reluctance to engage in ‘intellectual’ conversations as a result of reduced confidence 
in her intellectual abilities. 
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I feel like I've lost a load of my knowledge. Erm and also I found it very 
difficult to learn again when I started to get back into things. I couldn't 
process information. So I feel like I've lost out on like ten years of learning.  
So now I'm with other 30 year olds and 40 year olds, even mid-20s, 20 year 
olds, and they know more than I do, and I can't - erm so I kind of - rather than 
sit down and have an intellectual conversation with someone, that scares me 
because I feel like I don't know. And perhaps that's a confidence thing. I 
know things that they don't know perhaps, but it just seems like I don't have 
that, that way of being able to process information or to capture the - to have 
that information that I had before.  
Clara, Cornwall – Minimal Negative Symptoms 
 
Although Clara was able to concede the possibility she might have knowledge that 
others do not, the belief that she no longer has the ability to process information in 
the way she once did prevented her from engaging with others she perceived as more 
intellectual. She noted that her place of work – a university – made this problem 
particularly acute.   
 
Active avoidance 
 
Participants often presented social withdrawal as a deliberate strategy, intended to 
protect them from rejection or ridicule. Several participants spoke about deliberately 
cutting contact with friends or making fewer efforts to form new friendships than 
they would have done before experiencing psychosis. 
 
P: Do you feel that having gone through psychosis that’s had an 
influence on your relationships with your family or friends in any 
way? 
R: Erm yeah it’s had an influence on my friends because when I had 
the psychosis and the problems I cut myself off from a lot of people, 
I withdrew and I lost a lot of friends through that.  
John, Birmingham – Elevated Negative Symptoms 
 
Isabella expressed that getting to know new people following her psychotic episode 
was a risk where before it had been an opportunity.  
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P: Perhaps not so, perhaps not so likely to take the risk to get to know a 
lot more people I think. I tend to sort of see what happens and go 
with that rather than sort of try and make more, try and widen my 
social circle by talking to more people, probably just let it happen 
now rather than make more effort.  
R: And what's the worst that could happen then if you were to make 
more of an effort? 
P: When you get instances where, you know, you'll talk to people and 
you just, you'll chat and you just sort of get the idea that they're, you 
know, they perhaps don't want to be as friendly as you'd like to be 
perhaps so it's all about sort of being a bit more, with relationships 
just being a little bit more…generally just letting things develop on 
their own really and not worry too much about it really. Whereas 
before I think perhaps I'd be a bit more keen to sort of get to know 
people better and perhaps be a little bit more intent on making 
friends I suppose in that way.   
Isabella, Cambridgeshire – Minimal Negative Symptoms  
 
Isabella went on to talk about putting ‘the boundaries up’ in order to protect herself 
from perceived social threat.  
 
Since what’s happened I don’t really want too many people around, I suppose 
I yeah I’ve put the boundaries up and now I don’t let so many people in and 
I’m happy with being, keeping things very narrow and not so broad … That 
goes for family as well I don’t, I mean my brother … I don’t let him get close 
enough to cause any trouble. 
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
Isabella was aware that this strategy had resulted in a narrower social circle and had 
distanced her from extended family but saw this as a price worth paying in return for 
avoiding ‘trouble’.  
 
While Isabella was not explicit about why she perceived social situations to be more 
risky since her episode of psychosis, others linked their withdrawal to the stigma of 
having experienced mental health problems. For instance Ben explained that he 
withdrew from friendships due to the shame he felt. 
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My relationship with, erm, quite a few of my friends has changed in a 
negative way, and it’s not been because of prejudice or lack of understanding 
on their part, it’s because at first I felt very ashamed, and I deliberately cut 
them out of my life.  
Ben, Birmingham – Minimal Negative Symptoms 
 
Although Ben was clear that he was not subject to direct stigma regarding his mental 
health status, internalised stigma resulted in an intense feeling of shame which 
caused him to cease contact with friends. Participants were often acutely aware of 
negative media portrayals of psychosis and schizophrenia, which fed into their fears 
about how others would perceive them. Jennifer stated that the few ‘vague friends’ 
she had ‘wouldn’t have been [her] friend no more if they knew [she] had a mental 
illness’. Another participant, Aidan, who had lost contact with all of his former 
friends since experiencing psychosis expressed that he felt others would find him 
‘disgusting’ if he were to disclose his symptoms.  
 
Shame and stigma were also key to some participants’ decisions to avoid romantic 
relationships. Several participants shared the dilemma set out by Jennifer. 
 
It’d be really really hard to establish a relationship because you wouldn’t 
know when to say to them, ‘I’ve got schizophrenia’ because if you leave it 
too late, they’ll say, ‘Oh why didn’t you tell me, you’ve led me on.’ And if 
you say it too soon, they’d never even speak to you because they’ll just 
assume you’re mad and it’s very very, that’s very difficult.  
Jennifer, Lancashire – Minimal Negative Symptoms 
 
In common with several other participants, Jennifer felt she was trapped in a Catch-
22 situation; whatever stage of a new relationship she chose to disclose her diagnosis 
of schizophrenia would be the wrong one: either too early or too late, both 
preventing the relationship from progressing any further. She had therefore ruled out 
the possibility of forming an intimate relationship and didn’t believe she would ever 
be in a position to marry or have children. Definitions of negative symptoms 
frequently consider lack of intimate relationships in individuals with psychosis to be 
symptomatic of the loss of capacity for emotional closeness. Jennifer’s account 
offers the alternative explanation that people with psychosis may have given up hope 
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of fulfilling their desire for an intimate relationship due to the perceived 
impossibility of establishing one. 
 
Some participants employed an active strategy of avoidance in order to escape 
negative evaluation of their changed appearance following medication induced 
weight-gain. For instance, Clara explained that after her dress size increased from a 
size 12 to a size 22 following rapid weight-gain as a side-effect of antipsychotic 
medication she avoided social situations in order to protect herself from the critical 
gaze of others. 
 
P: I think that [rapid weight-gain] gave me a lot of the anxiety I had 
from err not going out, not wanting to see anybody that I knew, 
because I had my episode and was in the ward in London, then came 
back down. No one knew what had happened to me, but I was huge 
and I wasn't talking to anyone. 
R: Okay. So it made you more socially isolated? 
P: Oh yeah. I didn't want anyone to see me like that. I know it's sad, but 
I really didn't. 
Clara, Cornwall – Minimal Negative Symptoms 
 
Stigma seems to have played an important role in Clara’s decision to withdraw 
socially: she feared her sudden weight-gain would alert people to the fact that she 
had experienced mental health problems. In discussing the impact of her weight-gain 
she commented: 
 
I think it is a quite big pressure on somebody that's already vulnerable to then 
give them the stigma … because you then become, you don't really, you don't 
really fit anywhere any more.  
Clara, Cornwall – Minimal Negative Symptoms 
 
Given the context of this extract, Clara’s use of the word ‘fit’ here suggests a double 
meaning: as she gained weight, not only did Clara no longer fit into her old clothes, 
but also into society.  
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Ongoing alogia?  
 
While there were not notable differences in the extent to which negative symptoms 
featured in the transcripts of the groups compared, there were conspicuous 
differences in the fullness of the descriptions of negative symptoms provided. The 
descriptions of negative symptoms given by members of the Minimal group tended 
to be fuller than those given by the Decreasing group, which were in turn fuller than 
those given by the Elevated group. These differences were in line with striking 
differences between the interviews given by members of the three groups in terms of 
their length and the configuration of interactions between the participant and 
interviewee more generally. Interviews given by members of the Elevated negative 
symptoms group were notably brief and were characterised by participants taking 
short conversational turns and rarely taking the conversational initiative in 
comparison to members of the other groups. They were also less likely to introduce 
new topics or otherwise take the conversational lead than were other participants. 
 
For example, compare the response given by Daniel, a member of the Elevated 
group, to the question ‘can you describe what things are most important to you at the 
moment?’ to the response given by Callum, a member of the Minimal group, to an 
almost identical question about the things that are most important to him. Although 
both participants answer that their family is the most important thing in their life, 
there answers are very different.  
 
R: Can you, sort of, describe to me a bit about what things are most 
important to you at the moment. 
P: Family and stuff like that, really. 
R: Family and stuff like that, yeah. 
P: Yeah. 
Daniel, Norfolk – Elevated Negative Symptoms 
 
  
172 
 
R: Can you describe the things that are most important to you at the 
moment in life? 
P: In life? Me dad, obviously, because he’s got Motor Neurone’s and 
me girlfriend, me brother [Name], because it’s, like, we got brought 
up together; my other brothers, we didn’t, you know what I mean. 
So he, if something happened to one of my other brothers I would be 
upset, you know what I mean, but if something was to happen to 
him, I would be, like, really upset, like, because the other brothers, I 
care because they’re me brother, but at the end of the day it, they 
wouldn’t really affect me, because I haven’t lost someone that hasn’t 
been there, because I lost them anyway, already [participants talking 
over one another].  
Callum, Cheshire – Minimal Negative Symptoms 
 
Whereas Daniel answers with just a few words, Callum is comparatively verbose and 
volunteers a great deal of detail. This example is representative of the way in which 
Daniel and Callum respond to questions throughout the interviews, and each are 
typical of their respective negative symptom trajectory groups in this respect.  
 
The brief conversational turns and lack of conversational initiative displayed in 
interviews with members of the Elevated negative symptoms group might be 
interpreted as evidence of alogia. It is plausible, given that these participants 
followed a trajectory of stably elevated negative symptoms during their first 12 
months with EIP, that this group were continuing to experience negative symptoms 
and were thus less able to express themselves during the interview. This possibility 
is discussed further in section 6.5.2.  
 
6.5. DISCUSSION 
 
6.5.1. Review of Findings in Relation to Research Questions 
 
To what extent do negative symptoms feature within participants’ accounts of the 
experience of psychosis? How do participants describe the experience of negative 
symptoms?  
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The term ‘negative symptoms’ featured in only one participant’s account of her 
psychosis, in the context of stating that she did not experience negative symptoms. 
However, descriptions of negative symptoms – including diminished expression, 
social withdrawal and lack of motivation – were given by members of all three 
negative symptom trajectory groups. The experience of negative symptoms was 
described by some participants as feeling ‘like a zombie’: some described being 
unable to react to events and other people as they usually would and so feeling 
disconnected from themselves and the world around them. A minority of participants 
described decreased internal experience – decreased emotion, thought or drive – 
during their psychosis.  
 
How do participants understand and make sense of any negative symptoms they 
experienced? 
 
Participants’ accounted for the diminished expression, social withdrawal and lack of 
motivation they experienced in a variety of ways, attributing divergent meanings to 
these symptoms. Whilst some participants put their negative symptoms down to 
decreased emotional range, capacity for thought or diminished drive, this explanation 
was not prevalent. Most participants’ personal understandings of the negative 
symptoms they experienced related to side-effects of psychiatric medication, lack of 
self-confidence and/or active avoidance in the face of difficult circumstances.   
 
Are there differences in the extent to which negative symptoms feature within the 
accounts given by those who followed differing negative symptom trajectories or the 
way in which the experience of negative symptoms is described?  
 
The descriptions of negative symptoms given by members of the Minimal group 
tended to be fuller (in keeping with the more expansive style of this group’s 
interviews more generally) but there were not marked differences between groups in 
terms of the extent to which descriptions of negative symptoms were a feature of 
participants’ accounts, or in the content of these descriptions.  
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6.5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
 
It might be suggested that the absence of the term ‘negative symptoms’ within 
participants’ accounts indicates that these symptoms are not acknowledged or 
deemed important by participants. Selten et al. (1998; 2000) found that inpatients 
diagnosed with schizophrenia gave lower ratings of the frequency and severity of 
their negative symptoms than did psychiatrists. They concluded from this that 
patients often underestimate the severity of their negative symptoms due to lack of 
insight. The absence of explicit mentions of negative symptoms within participants’ 
transcripts could be taken as evidence in support of Selten et al.’s findings. However, 
given that participants frequently described diminished expression, social withdrawal 
and lack of motivation, it seems likely that participants’ not having used the term 
‘negative symptoms’ is indicative of a preference for natural, non-technical language 
rather than limited insight. In support of this interpretation, note that the term 
‘positive symptoms’ did not feature in participants’ accounts at all. While 
participants did sometimes refer to having experienced ‘hallucinations’ or 
‘delusions’, they were more likely to talk about seeing things, hearing voices and 
having had strange or paranoid thoughts. 
 
That descriptions of negative symptoms occurred in the transcripts of interviews 
with participants from each of the negative symptom trajectory groups to a similar 
extent was unexpected. It was anticipated that experiences of negative symptoms 
would be most likely to feature in the accounts given by members of the Elevated 
negative symptom group, and would rarely feature in the transcripts of interviews 
with Minimal negative symptom group members. There are a number of potential 
explanations for this unforeseen finding. Given that the correspondence between 
self-reported experiential deficits and observed negative symptoms has been found to 
be limited (see section 1.4.2), it is possible that the subjective experiences of 
diminished expression, social withdrawal and lack of motivation reported by 
members of the Minimal negative symptoms group do not correspond to observable 
negative symptoms. Alternatively, it may be that the these experiences did 
correspond to observable negative symptoms but that these occurred outside of the 
period during which participants’ negative symptom severity was measured. Under-
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reporting of negative symptoms by the Elevated group might also be relevant in 
explaining this finding.  
 
It was observed that the Elevated negative symptoms group’s interviews were 
markedly shorter than those given by members of other groups and were 
characterised by short conversational turns by participants and a comparatively 
passive conversational style. A possible explanation of this finding is that 
participants from this group, who had previously presented with persistently elevated 
negative symptoms, were manifesting ongoing expressive deficits. Given that the 
interviews were, in most cases, conducted several years after the data used to 
determine the participants’ negative symptom trajectory were collected, if this 
interpretation is accurate it would imply the longer-term stability of the trajectory of 
stably elevated negative symptoms observed during the first 12 months of EIP. 
Analysis of longer term follow-up data would serve to verify whether participants 
from the Elevated group did indeed continue to follow a trajectory of stably elevated 
negative symptoms, and thus whether this explanation is plausible.   
 
Several participants in this study used the simile ‘like a zombie’ to describe 
experiences of having difficulties interacting with the world around them. In doing 
so they evoked a sense of otherness and alienation. Consistent with theories of the 
importance of social performance to the construction and maintenance of one’s 
identity (Goffman, 1959), some described a discontinuity in their identity as a result 
of changes in their ability to interact with others. The participants’ narratives 
highlight the challenge of maintaining one’s sense of identity while experiencing 
symptoms that undermine the performance of this identity.    
 
Participants’ descriptions of their experiences of difficulties with communication and 
motivation suggests that European phenomenological approaches to psychosis may 
be of relevance to understanding the subjective experience of negative symptoms. 
The European literature on the phenomenology of schizophrenia provides perhaps 
the richest explorations of the experiential facet of negative symptoms (Bürgy, 
2008). This literature suggests that negative symptoms are not straightforward deficit 
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states but are instead characterised by positive experiential disturbances stemming 
from core disturbances in the sense of self (Sass & Parnas, 2003). The findings of the 
current study support the contention that subjective experiences of negative 
symptoms are not always simple absences of something normally present. Instead, 
they can encompass positive experiential states that are not necessarily ‘direct 
analogues of what is observed at the behavioural level’ (ibid., p. 433). The role of 
disturbances in the sense of self in negative symptom presentations was explored in a 
subsequent study (Appendix D). 
 
Participants offered varying explanations of the negative symptom-like experiences 
they described. Consistent with research carried out with individuals with more 
chronic psychosis (Boydell et al., 2003; Le Lievre et al., 2011), participants often 
believed that reductions in expression and motivation could be accounted for by the 
side-effects of psychiatric medications. Some participants described decreased 
emotional experience, capacity for thought or drive as lying behind changes in their 
behaviour. This finding echoes a theme identified by Krupa et al. (2010) who 
reported that individuals recovering from FEP described a deadening of emotions, 
apathy and reduced pleasure, turning participation in previously valued activities and 
social interactions into experiences to be endured. Participants also identified lack of 
confidence as a reason for negative symptom-like behaviour. Previous psychotic 
symptoms and the perception of decreased cognitive capacities undermined 
participants’ confidence in their abilities, leading to decreased activity and 
interaction. This finding supports quantitative evidence that pessimistic assessments 
of cognitive and social capabilities may be implicated in negative symptom 
maintenance (Beck & Rector, 2005; Horan et al., 2010; Oorschot et al., 2013).  
 
The theme ‘active avoidance’ corresponds closely with themes identified by studies 
that have explored social withdrawal following psychosis. A number of studies have 
described narrowing of social circles and increased isolation as deliberate strategies 
for minimising the risk of embarrassment, exposure to negative judgments, or lack of 
understanding (Boydell et al., 2003; Judge et al., 2008; Le Lievre et al., 2011; 
MacDonald et al., 2005; Mauritz & van Meijel, 2009; Sandhu et al., 2013). The 
difficulties engaging in new romantic relationships following psychosis highlighted 
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in the current study have previously been discussed by Redmond et al. (2010). In a 
study of the personal meaning of romantic relationships for young people with 
psychosis, the authors identified the theme ‘illness as incompatible with 
relationships’ encompassing dilemmas regarding disclosure of past psychotic 
episodes.  
 
Participants’ personal understandings of their experiences of withdrawal fit within 
the explanatory framework provided by the cognitive models of negative symptoms 
(see section 1.5.3). Facets of the lack of self-confidence described by participants 
can be aligned to the negative expectancies thought to be particularly relevant to the 
manifestation of negative symptoms by Beck et al. (Figure 6.1).  
 
Figure 6.1. Cognitive expectancies proposed to contribute to negative symptoms 
illustrated by extracts from interviews with Aisha, John, Clara and Isabella (clock-
wise from top left). Adapted from Rector et al. (2005).  
 
 
 
That many participants in the current study described negative symptom-like 
behaviour as an active coping strategy further supports a cognitive approach to 
understanding negative symptoms. Participants described avoiding social 
interactions and limiting their involvement in potentially challenging activities in 
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order to stave off failure, rejection or ridicule. This supports the contention that 
apparent emotional and motivational deficits are often underpinned by psychological 
processes that reflect active coping in difficult psychological and social 
circumstances. There were striking correspondences between the psychological 
factors proposed by Strauss et al. (1989) to contribute to negative symptoms and the 
narratives of some participants. For instance, Yasmin’s account of limiting her 
interactions with others in order to minimise the possibility of doing or saying 
something inappropriate, as she felt she had during her episode of psychosis, closely 
resembles Strauss et al.’s depiction of withdrawal as a means of protecting oneself 
against public displays of bizarre or impulsive behaviour. 
 
The relevance of perceived stigma to some participant’s active avoidance supports 
the inclusion of negative self-perceptions, self-stigmatisation and expectation of 
social exclusion in Staring et al.’s (2013) cognitive model of negative symptoms. In 
line with Staring et al.’s model, shame and expectations of discrimination 
contributed to some participants choice to withdraw from former friendships and to 
limit attempts to establish new relationships. Awareness of negative portrayals of 
psychosis and schizophrenia were sometimes implicated in such withdrawal. This 
finding points to the importance of considering societal as well as individual factors 
when seeking to understand negative symptoms.  
 
Taken together, participants’ narratives suggest a role for agency in negative 
symptom presentations, countering the framing of negative symptoms as passive 
manifestations of diminished capacity. This alternative interpretation of negative 
symptoms as, at least in some instances, reflecting personal agency recalls the 
findings of an anthropological study conducted by Corin (1990). Corin compared 
individuals given a diagnosis of schizophrenia who were frequently re-hospitalised 
with those who were not re-hospitalised. She found that individuals who remained 
out of hospital were characterised by maintenance of a position apart from the social 
world, associated with an attitude of detachment. Corin characterised this detached 
position as ‘positive withdrawal’, a recovery strategy characterised by the deliberate 
maintenance of distance from normative social roles and relationships (Corin & 
Lauzon, 1992; Corin, 1990). On the basis of her study, she concluded that negative 
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symptoms ‘include behaviours or reactions that share some external features but that 
are associated with profoundly diverging meanings’ (Corin, 1990, p. 171), a 
conclusion substantiated by the findings of the current study. 
 
6.5.3. Limitations 
 
Since the study employed QSA, the data were collected without a focus on this 
study’s research questions; participants were not specifically asked about their 
experience of negative symptoms and this could be considered a major limitation of 
the study. Had the data been collected using an interview schedule designed to elicit 
material of relevance to the research questions, it might have been possible to gain 
further insights into the subjective experience of specific negative symptoms and 
participants views on their genesis. Given that participants were not specifically 
asked about negative symptoms during the interview, that they were not mentioned 
during some participant’s interviews cannot be taken as evidence that they did not 
experience these symptoms. It is plausible that those that did not mention these 
symptoms spontaneously may have attached different meanings to these experiences 
than did those who did, and that these divergent views were not captured by this 
study.  
 
However, there are perhaps also advantages of the interview questions not having 
been focused on negative symptoms specifically. Allowing participants to speak 
about the aspects of their psychosis they considered to be most important made it 
possible to observe the extent to which participants chose to prioritise negative 
symptoms within their narratives. It also allowed the explanatory frameworks 
participants employed to talk about negative symptoms to be observed. An interview 
schedule centred on negative symptoms would likely have primed participants to 
focus on specific aspects of negative symptomatology and encouraged them to talk 
about them using explanatory frameworks specified by the researcher.  
 
It was not the initial intention to consider interactional patterns within the interviews 
as part of the analysis. However, striking differences in the interactional styles of 
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members of the Elevated group relative to other participants became apparent during 
the familiarisation phase of the analysis. Given the inductive nature of the analysis, it 
was considered appropriate to include this finding as a result of the study. However, 
the methods used were not well suited to exploring the differences that emerged in 
the interactional styles of members of different negative symptom trajectory groups; 
thematic analysis is intended to identify and record patterns in the content of 
qualitative data, not patterns in interactional style. These could have been more fully 
explored through conversation analysis which allows for the detailed study of oral 
interaction (Ten Have, 1999). Such an analysis would require the re-transcription of 
the interviews in line with the conventions of conversation analysis in order to 
facilitate the consideration of the structure of utterances and characteristics of speech 
delivery.  
 
The timing of data collection might also be considered a limitation of the study. 
Participants were interviewed for the first time towards the end of their time with 
EIP or following discharge, in some cases several years on from their initial episode 
of psychosis. It is possible that the period of time that had elapsed between their 
episode of psychosis and the interviews might have limited participants’ ability to 
accurately recall what went on during that period of their life. However, the timing 
of the interviews also had some advantages. A period of time having passed since the 
onset of their psychosis might also have afforded participants more time to reflect on 
their experiences. Further, the timing of the interviews might also have meant fewer 
participants were prevented from participating by ongoing symptoms. For instance, 
one participant from the Elevated negative symptoms group commented that, had the 
interviewer met him at the beginning of his period of recovery, he would not have 
felt able to participate in a conversation.   
 
An additional limitation of the study is that there was a relatively small pool of 
participants with high levels of negative symptoms from which to draw the 
subsample for this study. This was both because the proportion of the National 
EDEN cohort who were members of the High Stable and Mild Stable classes was 
comparatively small, but also because members of these classes, particularly 
members of the High Stable class, were less likely than members of other classes to 
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consent to take part in a qualitative interview. It is not surprising that those who had 
presented as withdrawn, amotivated or inexpressive often declined the opportunity to 
take part in an in-depth interview about their experiences. However, as a result it is 
likely that the experiences of some of those with the greatest negative symptom 
severity were missed.  
 
Failure to capture the views of those with the most severe negative symptoms is a 
problem likely to confront any interview-based qualitative study of negative 
symptoms. This difficulty has perhaps contributed to the lack of qualitative negative 
symptom research to date. The design of the current study did at least allow for the 
views of some individuals who experienced the most severe and persistent negative 
symptoms to be captured. Future qualitative research might benefit from employing 
methods less dependent on potential participants’ ability and willingness to engage 
in in-depth interviews, such as participant observation or analysis of written 
communication.   
 
6.6. CONCLUSION 
 
In a purposive sample of EIP service-users who presented with varied early negative 
symptom trajectories, phenomena corresponding to the negative symptom construct 
were found to be a common feature of participants’ accounts of the experience of 
psychosis. Several participants used the simile ‘like a zombie’ to describe their 
experience of having difficulties interacting with and responding appropriately to the 
world around them. Participants often attributed negative symptom-like experiences 
to the side-effects of psychiatric medication, lack of confidence, and active 
avoidance as a means of self-protection. Participants’ narratives challenge the 
widespread framing of negative symptoms as passive manifestations of diminished 
capacity.   
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Chapter Seven – Exploring the Lived-Experience of First-Episode Psychosis in 
Individuals with Differing Negative Symptom Trajectories 
 
7.1. BACKGROUND AND RATIONALE 
 
7.1.1. Overview 
 
This study used qualitative methods to investigate the lived-experiences of those 
who followed differing negative symptom trajectories during their first 12 months of 
EIP treatment. The study described in Chapter Four identified a number of baseline 
predictors of negative symptom trajectories. However, it is likely that experiences a 
participant has during their time with EIP are also relevant to the course of their 
negative symptoms. Understanding differences in the individual lived-experiences of 
those who presented with differing negative symptom severity and persistence might 
provide clues to the factors that contribute to negative symptom development and 
persistence. Exploring such differences might also help explain why there is an 
association between an individual’s early negative symptom course and their social 
recovery during the first 12 months of EIP treatment. 
 
The study focused on four key aspects of participants’ experiences: their 
understanding of psychosis, their accounts of the treatment they received, their 
understanding and experience of recovery following FEP, and the impact of the 
experience of psychosis on participants’ identities. These topics of inquiry were 
chosen on the basis of their having been found to be important aspects of the lived-
experience of FEP in previous qualitative research and because it was felt they may 
be of relevance to understanding differences in the experience of those with differing 
negative symptom trajectories. The topics were selected from amongst those that 
featured in the Super EDEN topic guides, and, as such, were aspects of psychosis 
considered important by individuals with first-hand experience of psychosis (see 
section 6.3.3). Since the aspect of the study focused on identity developed into a 
somewhat distinct investigation, and in the interest of brevity, this part of the study is 
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reported in a separate chapter which is included as an appendix to the thesis 
(Appendix D).  
 
The remainder of this section summarises what qualitative research has already 
revealed about first-person understandings of psychosis, experience of EIP treatment 
and the process of recovery following FEP. 
 
7.1.2. Understandings of Psychosis 
 
Several researchers have investigated the way in which individuals make sense of 
what they have experienced in the wake of FEP. An ethnographic study conducted 
by Larsen (2004), found that EIP service-users actively engage in finding meaning in 
their experiences of psychosis, making use of explanatory systems made available to 
them through psychoeducation and wider ‘cultural repertoire’. Biomedical and 
psychological systems of explanation often featured alongside one another in 
participants’ narratives. Spiritual explanations were also important to some 
participants and were often held in parallel to biomedical explanations despite the 
apparent incompatibility of these explanatory systems.  
 
Larsen found two strategies for making sense of the experience of psychosis to be 
evident among his participants. He related these contrasting strategies to McGlashan 
et al.’s (1975) distinction between two recovery styles: ‘integration’ and ‘sealing 
over’. ‘Integration’ refers to endeavouring to place one’s experiences within one’s 
wider life-history, and thus to accept the experience of psychosis as part of one’s 
identity. ‘Sealing over’ refers to attempting to forget about their experiences and 
separate them off from their wider life in an attempt to protect their pre-psychosis 
identity. He found that, while some participants embraced a single strategy 
throughout the study period, the majority moved between the two, influenced by 
their current social and therapeutic context, and stage of recovery.  
 
Werbart & Levander (2005) followed a small group of people who had been 
admitted to a specialist centre for FEP over an 18 month period in order to track the 
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development of their ‘private theories’ related to their psychotic symptoms. They 
found that the basic elements of participants’ theories remained remarkably stable 
over time but that more subtle elements of the theory tended to evolve and become 
more ‘coherent’. Several participants pointed to difficult circumstances during early 
childhood as important to the development of their psychosis but none relied on a 
single event in explaining their experiences. Like Larsen, Werbart & Levander 
related their findings to McGlashan et al.’s (1975) recovery styles; they observed 
that while some participants attempted to integrate their unusual experiences into the 
narrative of their life, others saw their psychosis as a ‘gulf’ in this narrative. 
However, in contrast to Larsen’s study, none of Werbart & Levander’s participants 
articulated theories of their psychosis centred on a biomedical explanatory 
framework. This might reflect the psychoanalytic treatment context and the 
researcher’s focus on idiosyncratic personal theories as opposed to broader 
explanatory frameworks.   
 
7.1.3. Experiences of Treatment  
 
Studies focusing on experiences of the treatment provided by EIP services, the 
majority of which have been conducted in the UK, have identified a number of 
common themes. All identified studies (Harris, Collinson, & das Nair, 2012; Islam, 
Rabiee, & Singh, 2015; J. A. Larsen, 2007; Lester et al., 2011; O’Toole et al., 2004; 
van Schalkwyk, Davidson, & Srihari, 2015) found service users’ relationships with 
their key worker to be central to the experience of EIP. Participants described close, 
supportive and trusting relationships with their key workers, which were highly 
valued. All studies found participants’ views of the treatment provided by EIP to be 
largely positive. Several studies found that participants saw EIP as a ‘Gold Standard’ 
service, set apart from, and superior to, other mental health services (Harris et al., 
2012; Lester et al., 2012; O’Toole et al., 2004). A theme identified by a number of 
studies was that participants felt involved in decisions regarding their treatment and 
experienced a sense of agency in their recovery (Harris et al., 2012; Lester et al., 
2012; O’Toole et al., 2004).  
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Most studies reported few negative experiences of EIP: the only negative theme 
reported by more than one study was that high staff turnover sometimes led to 
discontinuities of care (Islam et al., 2015; Lester et al., 2011). Due to the strong 
relationship between EIP service users and their key workers, staff changes were 
experienced as particularly unsettling. Other negative themes related to some 
participants perceiving the support provided by EIP as over intensive (Lester et al., 
2011), and some black and ethnic minority service users perceiving a disconnect 
between the support they received from EIP and the spiritual aspects of their lives 
(Islam et al., 2015).  
 
7.1.4. The Process of Recovery 
 
Within the medical field, recovery is usually defined as returning towards a normal 
or healthy state, demarcated by the absence of symptoms and return to premorbid 
levels of functioning. However, since the symptoms of psychosis are often persistent 
and those who experience psychosis usually do not have the opportunity to reach 
their full functional potential before the onset of the disorder, the applicability of this 
definition of recovery to this field has been questioned. Led by service-user 
movements, an alternative conceptualisation of recovery, sometimes referred to as 
personal recovery, has been developed. There have been many definitions of 
personal recovery since the concept first began attracting interest in the mid-1980s 
but the definition proposed by Anthony (1993) is perhaps the most frequently cited:  
 
… a deeply personal, unique process of changing one’s attitudes, values, 
feelings, goals, skills, and/or roles. It is a way of living a satisfying, hopeful, 
and contributing life even with limitations caused by illness. Recovery 
involves the development of new meaning and purpose in one’s life as one 
grows beyond the catastrophic effects of mental illness. (Anthony, 1993, p. 
527) 
 
Within this conceptualisation, recovery is a process of moving towards living in line 
with individually determined values and achieving personally meaningful goals. 
Importantly, this process is not viewed as being contingent on the absence of 
symptoms.  
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Leamy et al. (2011) conducted a systematic review and narrative synthesis of 
descriptions of personal recovery from mental health problems. The aim was to 
develop a conceptual framework of personal recovery for use in recovery orientated 
research and services. The framework developed included five key recovery 
processes: connectedness, hope, identity, meaning and empowerment. 
Connectedness refers to the importance of feeling supported by others, having 
relationships and being part of a community. Hope includes belief in the possibility 
of recovery, motivation to change and participation in hope inspiring relationships. 
Identity comprises rebuilding a positive sense of identity and overcoming stigma. 
Meaning encompasses both finding meaning in the experience of mental ill-health 
itself and in building a meaningful life outside of this. Finally, empowerment 
involves taking control over one’s own life and focusing on personal strengths.  
 
Recovery has been a popular focus for qualitative investigations of FEP. Echoing the 
first-person recovery literature, qualitative studies have found that individuals 
experiencing psychosis often hold a far broader view of recovery than the mental 
health professionals caring for them (Lam et al., 2010). Key elements of the process 
of recovery from FEP identified by qualitative studies echo several of the recovery 
processes included in Leamy et al.’s (2011) model. They include finding meaning in 
the experience of psychosis (Connell, Schweitzer, & King, 2015; Lam et al., 2010; 
Subandi, 2015; Tan, Gould, Combes, & Lehmann, 2014; Windell, Norman, Lal, & 
Malla, 2015), rebuilding relationships (Connell et al., 2015; de Wet, Swartz, & 
Chiliza, 2015; Eisenstadt, Monteiro, Diniz, & Chaves, 2012; Subandi, 2015), 
reforging a strong sense of identity (Connell et al., 2015; Tan et al., 2014), and 
regaining control and agency (de Wet et al., 2015; Eisenstadt et al., 2012; Henderson 
& Cock, 2015; Subandi, 2015; Tan et al., 2014; Windell et al., 2015). Both personal 
striving and external support – including both professional interventions and the 
support of family and friends – are seen by participants as necessary to recovery 
from FEP (Henderson & Cock, 2015).      
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7.2. RESEARCH QUESTIONS 
 
1. Are there differences in the way those who followed differing negative 
symptom trajectories understood their experience of psychosis? 
2. Do individuals who followed differing negative symptom trajectories give 
divergent accounts of the treatment they received from EIP services?  
3. Are their differences in the way those who followed differing negative 
symptom trajectories understood and experienced the process of recovery? 
 
7.3. METHOD 
 
The method for this study was the same as for the study described in Chapter Six 
(see section 6.3). An identical set of transcripts formed the dataset and analysis 
proceeded alongside analysis for the previous study, following the same procedure.  
 
7.4. RESULTS 
 
The themes identified are presented under three subheadings corresponding to the 
study’s three research questions: (1) understandings of psychosis; (2) experiences of 
treatment; and (3) the process of recovery.  
 
7.4.1. Understandings of Psychosis 
 
‘Just chemical imbalances in your head’ 
 
Participants were asked how they made sense of what had happened to them: what 
they believed caused their psychosis and what the experience meant to them. Some 
participants articulated a primarily biomedical explanation of their experiences. A 
number of participants, for instance John, viewed psychosis as an illness caused by 
imbalances in the brain’s chemistry. 
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R: we've obviously talked quite a bit about psychosis, can you describe 
what psychosis means to you? 
P: Err psychosis is a problem that occurs in the brain erm I'm not quite 
sure why, chemical imbalances or whatever 
John, Birmingham – Elevated Negative Symptoms 
 
Those who held biomedical beliefs about the origin of their psychosis often appeared 
to derive benefits from employing this explanatory framework. These benefits 
included minimisation of self-blame, expectation of parity of esteem with physical 
illness, and hope that symptoms might be successfully treated with medication. For 
instance, John expressed that adopting a biomedical explanation of his psychosis as 
‘just an illness’ helped him accept that his mental health problems were not his fault 
 
I guess the health professionals that I saw from Early Intervention they kind 
of made me realised that it’s just an illness, it’s, it’s something that happens, 
it’s just like getting a cold or like it’s just an illness, it’s not who you are 
really, it’s, it’s not your fault, it just happens to some people and I don't 
know, yeah.  
John, Birmingham – Elevated Negative Symptoms 
 
John’s use of the phrase ‘it’s just an illness, it’s not who you are really’ suggests that 
adopting a biomedical understanding of his experiences also served to protect his 
pre-psychosis identity by distancing his true, ‘real’ self from the self who emerged as 
a result of the illness. Another participant, Nathan, described how coming to 
understand psychosis as a neurobiological illness helped him accept the possibility of 
a cure, giving him hope for recovery.  
 
I guess when I first suffered from my mental illness, I thought it was 
incurable. You sort of thought there’s nothing that can make you better and 
my understanding now is that’s totally wrong, you know, it’s literally just 
finding the right medication and getting people well again. I guess my 
understanding of mental illness is that it’s a curable illness which is just 
literally down to the chemicals in your head, that’s it. 
Nathan, Birmingham – Elevated Negative Symptoms 
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Wholly or mainly biomedical understandings of psychosis were most often 
articulated by members of the Elevated negative symptoms group, as well as by 
several members of the Decreasing group. Although the explanations given by some 
members of the Minimal negative symptoms group included biomedical elements, 
these tended to form part of multi-level explanations incorporating psychosocial as 
well as biological precipitating factors.  
 
‘It starts with stress that’s in your life’  
 
Other participants expressed understandings of their psychosis rooted in the 
damaging effects of stress and adverse life-events. This was the explanatory 
framework favoured by most members of the Minimal negative symptoms group. 
For instance, Jennifer’s personal theory of the origin of her psychosis centred on her 
having experienced a number of traumatic events.  
 
I’d had a lot of traumas. I’d kept getting sacked from jobs over and over 
again. Erm, like, not sacked, but they’d say, ‘Laid off,’ and it meant sacked 
really, but you didn’t get into trouble for it, so you just went back on the dole, 
and it was really stressful. So I’ve had a massive amount of stress in my life, 
all these things going wrong, and that had caused the depression. I’m pretty 
sure, if I’d just had a job and I’d been fine, and nothing had gone wrong for 
me, I’d never have got the schizophrenia.  
Jennifer, Lancashire – Minimal Negative Symptoms 
 
For Jennifer, difficult life experiences – including the absence of her father, bullying 
by peers and a series of redundancies – led to anxiety and depression, which 
escalated into paranoia and episodes of derealisation on account of her not receiving 
timely support. Similarly, Nazir attributed his psychosis to having been bullied at 
school and becoming depressed as a result.  
 
P: Yeah I reckon that stress can cause mental health problems as well, 
stress, that’s how I got my problems, mental health problems 
because other people, that’s why I was saying I’ve not got 
schizophrenia because type of people that get schizophrenia 
normally, people who have done drugs, I’ve never done drugs in my 
life because obviously it’s against my religion …  
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R: So you feel as though stress caused your mental health difficulties? 
P: Stress caused my mental health, yeah. Because I was going through 
a bit of bullying in school and I was getting stressed and depressed 
and that’s when my problem came. 
Nazir, Lancashire – Minimal Negative Symptoms 
 
While Jennifer accepted her diagnosis of schizophrenia despite not viewing her 
problems as biologically driven, Nazir believed a diagnosis of schizophrenia to be 
incompatible with his understanding of the nature of his problems. Nazir distanced 
himself from the ‘type of people that get schizophrenia’, perhaps as a means of 
protecting his identity from the stigma associated with schizophrenia.  
 
Isabella was another participant who attributed her mental health problems to 
stressful circumstances. She described how the stress caused by problem neighbours, 
in combination with a lack of social support, led to the development of her 
psychosis.  
 
Stress, yes I feel that was definitely a trigger because obviously I had a 
stressful time with my neighbours and that is possibly what really started it 
all off so I'd say stress was definitely a major, major factor, um, and probably 
social isolation as well probably doesn't help. You know I didn't have a very 
good support group, I did, I have lots of friends but I always felt very 
tokenistic.  
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
As well as viewing social isolation as a contributor to her psychosis, Isabella spoke 
about withdrawing socially as a result of her psychosis (section 6.4.2; p.167). This 
suggests the possibility of a vicious cycle whereby the social isolation which follows 
psychosis might contribute to the genesis of future psychotic episodes.  
 
While most participants drew links between the non-specific stress of adverse life-
events and deterioration in their mental health, others made connections between the 
nature of particular adverse events they had experienced and the specific symptoms 
they later developed. For instance, Clara, whose symptoms included extreme self-
consciousness and a belief she was being watched, felt these symptoms might be 
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connected to her experience of being looked at as a child. She explained that, as a 
child with Nigerian heritage growing up in rural Cornwall, she stood out from those 
around her and often attracted the attention of strangers. 
 
Ever since I was a little girl, I remember people just to look at me. Like a lot 
of people in the small village I lived in were like, 'Oh, isn't she cute?' And I 
remember lots and lots of that. I also remember just like grown men just 
looking out, driving past and just staring at me. There wasn't necessarily a 
sort of like weird or negative, but always, always being looked at. And now 
I'm, I'm really paranoid. Really paranoid, self-conscious person.  
Clara, Cornwall – Minimal Negative Symptoms 
 
Jennifer also made links between her childhood experiences and the content of her 
psychotic symptoms. One of the unusual beliefs Jennifer held when she was unwell 
was that she was a reincarnation of Marilyn Monroe; she believed she was about to 
undergo a spontaneous transformation whereby she would take on the physical 
characteristics of the film star. In explaining why she developed this belief she 
referred to a traumatic incident during her teenage years.  
 
The reason I got the obsession with her, is at, erm, school, it started at 14; I 
wasn’t depressed until I was 14. And this lad who I fancied, er, pretended 
that he fancied me, for a joke, because everyone called me a geek. And they 
told me to go and meet him in this place, and they were all waiting, erm, to 
make fun of me when I went to meet him, and he wasn’t really fancying 
[inaudible]. And then he came and said, ‘Oh, I’d never fancy you, ugly, 
ugly.’ And he fancied Marilyn Monroe. He had a picture of her on his little 
science book, and so I became obsessed with her, because that was. For some 
reason I still liked him, even though he’d done that to me [laughs], so I don’t 
know why I still liked him. So I got obsessed with her. I thought, ‘He likes 
her, she must be really good’.  
Jennifer, Lancashire – Minimal Negative Symptoms 
 
Jennifer also linked her experience of being rejected and humiliated by her 
classmates to unusual beliefs she held about romantic and familial relationships to 
high status individuals. She explained that she developed these beliefs as a way of 
transferring some of the ‘status, authority, and power’ held by these high profile 
individuals onto herself. 
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Some such narratives linking experiences and beliefs to psychotic symptoms are 
reminiscent of longitudinal formulations. It is plausible that experiences of 
psychological therapy might have played a role in the development of such 
explanations. Whilst participants did not explicitly attribute their explanatory 
accounts to understandings developed during therapy, many members who presented 
such accounts talked extensively about their experiences of psychological therapy. 
Among the most unequivocal indications of a link between a participant’s 
understanding of their psychosis and their experiences of psychological therapy 
comes in the following section of an interview with Jack (emphasis added). 
 
P: Would you maybe want me to explain why I get psychosis or?  
R: Yeah, what do you think it’s about, why do you think? 
P: You get; well it starts, it starts really with like, stress that’s in your 
life you know, like there’s all different types of stresses like money 
stress or family or relationship you know … and when you factor in 
my low self-esteem as well, you know, when it all kind of goes 
together and then, from family history as well, my family history 
you know, it just all kind of, goes together and I start to get paranoid 
thoughts you know, and they kind of escalate, they can be about like 
people and work, you know, oh they’re leaving me to do all the 
work or my boss thinks I’m not doing a good enough job you know, 
and I would get, I would spend time going over and it would go 
round and round in my head and get more and more paranoid and 
then I think you just take it that, your own mind just takes it to the 
next level you know and think you’re; with me I kind of think, I’m 
not sure, I’m going to have to check with [Name of therapist], but I 
think kind of, I was having so many paranoid thoughts and so many 
different feelings and I almost needed to create something, to 
rationalise it, you know, like a big conspiracy theory you know, just 
explain the feelings that were going on, how bad I felt, you know, 
and I think that’s basically my psychosis, you know. 
Jack, Cambridgeshire – Minimal Negative Symptoms 
 
Jack interrupts his account of the factors involved in the development of his 
psychosis to remark that he would like to seek corroboration of a particular element 
of his explanation from his psychological therapist. This suggests a shared 
development of the explanation. Indeed, Jack referred several times in his interviews 
to his psychological therapist’s role in helping him to understand himself and his 
psychosis.    
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The relatively complex, formulation-like explanations provided by members of the 
Minimal negative symptoms group contrast with the less-complex explanations 
preferred by most members of the Elevated negative symptoms group. Members of 
the Elevated negative symptoms group were less likely to invoke psychosocial 
factors in explaining the development of their psychosis and where they did, these 
explanations were less fully developed. They rarely elaborated on the way in which 
the life events they described could have contributed to their psychosis, despite 
sometimes being prompted to do so by the interviewer.  
 
7.4.2. Experiences of Treatment 
 
‘You’ve got to learn to swim or you drown … the early intervention team was a 
nice set of armbands’ 
 
Participants were asked for their views of the support they received from the EIP 
service responsible for their care. The majority of participants from all three negative 
symptom groups were extremely positive about the service. Many participants 
appreciated the flexibility of support offered by the multidisciplinary team. 
Participants valued the holistic nature of the support they were offered: for instance, 
assistance with practical difficulties not directly related to their mental health 
problem and facilitation of social activities. Staff were described as professional, 
friendly and caring. The following extract presents a view typical of the majority of 
participants.    
 
R: And when you first started, what was your expectation or idea about 
Early Intervention? 
P: I had no idea at all. It was literally, to me they were a piece of 
driftwood, just something to latch onto. I needed something. 
R: Yeah. And did they explain to you who they are and what they do? 
P: Yes, they fully explained what they offered and the other services 
they, you know, provided.  
R: Yeah. And what was your impression of the service as, you know, as 
time went on, whilst you were with them? 
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P: Very impressive, very considerate, and very tailored to the user’s 
needs. 
R: Yeah. And how did you find the staff? 
P: Friendly, polite and professional.  
Ben, Birmingham – Minimal Negative Symptoms 
 
Many participants considered the support they received from EIP to have been 
integral to their recovery. Aisha credited the support she received from Early 
Intervention with moving her from feeling life wasn’t worth living to feeling she 
‘can do everything’. 
 
R: Okay, um, say for example you were talking to another person now 
and they were just about to start with Early Intervention, and they 
asked you your opinion about it, what would you tell them? 
P: I'd say it's really good, it's great. It's one of the best things that can 
help people move on. 
R: It's good in what way? 
P: It helps you to like be yourself again, like it helps you to get back to 
normal, like even though like you feel that like um, that you can't do 
anything and you’re not like worth living anymore and things like 
that it helps in a way that like you feel that you can do everything, 
that you’ve gone back to normal. 
Aisha, Birmingham – Decreasing Negative Symptoms 
 
Although the majority of views expressed were positive, not all participants were 
satisfied by the care they had received from their EIP service. Negative views 
centred on services taking control away from participants, the over-emphasis of 
medication at the expense of psychological treatment options, and experiences of 
inpatient care, each of which link to themes that distinguished the three negative 
symptom groups. 
 
  
195 
 
‘I would like to be able to make the choices which led to my recovery’ 
 
The extent to which participants expressed that they felt able to make choices and 
exercise control over the treatment they received varied across negative symptom 
groups. Most participants from the Minimal and Decreasing groups articulated that 
they felt very much in control of the treatment they received. These participants 
described being provided with a range of treatment options and being supported to 
choose the best options for their symptoms, social circumstances and personal 
preferences.   
 
I liked the flexibility, and I liked the fact that once I’d come to a certain stage 
with the service, that they allowed me to trust my own instincts to a degree, 
as well, and, you know, there wasn’t a case of, it was never a case of, ‘Oh, 
you should do this. You should do that. You must do this to get better.’ It was 
a case of, ‘Well, let’s sit down. What do you think would help?’  
Ben, Birmingham – Minimal Negative Symptoms 
 
It was kind of like the same with [EIP], they give you a lot of err, like kind of 
you’re in charge you know it’s, they put a lot of emphasis on what you want 
to actually do you know. 
Jack, Cambridgeshire – Minimal Negative Symptoms  
 
That’s why I was actually quite happy ‘cause I didn’t feel like they were 
forcing the pills down my neck as in ‘You’ve got to have them’ like that. 
They were like ‘Well, if you don’t wanna take them’, you, you know, what I 
mean, like there, there’s other avenues to explore so yeah. 
Callum, Cheshire – Minimal Negative Symptoms 
 
Callum made clear that the EIP service’s willingness to support him in reducing, and 
eventually discontinuing, his medication was crucial in maintaining his engagement 
with the service. He explained that, had the EIP service insisted he continue to take 
medication, he would simply have stopped taking it against their advice. 
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They didn’t just, like I say, just, like, ‘Do it,’ you know what I mean, and 
then not give you a choice and stuff like that. Because at the end of the day, I 
didn’t have to take it, I could have just turned round and went, ‘Fine, I won’t 
take it at all,’ but they were, like, ‘Okay, we understand. We’ll lower your 
dose … And then they was, like, and slowly they weaned me down and got 
me off it, rather than me in the end just turning round and going, ‘Well, fine. 
If you’re saying that…well, I just won’t take it at all, because you can’t force 
me, like that, so they had the right attitude.  
Callum, Cheshire – Minimal Negative Symptoms 
 
The service’s support for his decision to stop taking medication resulted in a gradual 
titration of his dose under medical supervision. This experience contrasts with that of 
Hayley, a member of the Elevated negative symptoms group, who was not offered 
the same degree of control over the treatment she received. 
 
P: I used to try and be off medication for at least a couple of months a 
year.  
R: Okay, okay. And was that done in conjunction with your CPN 
[Community Psychiatric Nurse] and psychiatrist, or? 
P: That was done, generally, on my own [laughs] … 
R: So, would you reduce your meds on your own or just stopped? 
P: Just stopped. 
R: Right, okay. 
P: I know that’s really unadvisable, but, erm, but, yeah, I just wanted to 
be back in control, and, erm, back in control of my life. 
Hayley, Cornwall – Elevated Negative Symptoms 
 
Hayley’s desire to feel ‘back in control’ of her life took precedence over her 
understanding of the potential risks of sudden discontinuation of antipsychotic 
medication. As a result, she chose to stop taking her medication without the 
knowledge of the professionals involved in her care. The contrast between the 
experience of Callum and Hayley, highlights the advantage of service-users feeling 
supported to make decisions about their treatment, even when these decisions go 
against the advice of the professionals involved in their care.   
 
Hayley was not alone amongst Elevated negative symptom group members in 
feeling that she had limited control over her treatment. Whilst most members of the 
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Minimal and Decreasing groups felt they could exercise choice over the treatment 
they received, members of the Elevated negative symptoms group often described 
choices being made for them, resulting in a sense of powerlessness.  
 
R: Is there anything about service that you maybe don't like, about the 
early intervention team, maybe about the way they do things?  
P: Sometimes it's controlling on you. Control. You have to obey their, 
and listen to them, what they have to say or what they have to do … 
I've got a life but the thing is I haven't got a full control over it. Do 
you understand? And that sort of thing. My life is going and I'm just 
controlled under the team. It's horrible sometimes when you think 
about it. You want to do some other things and you don't want to be 
on medication, you want to live a free life but you can't. 
Yasmin, Lancashire – Elevated Negative Symptoms  
 
The frustration Yasmin felt at having to ‘obey’ mental health professionals is 
powerfully conveyed. Yasmin did not feel the professionals working with her shared 
her priorities: to have enough energy to do the things that were important to her and 
to retain sovereignty over her own life. Instead the EIP team’s priority was to ensure 
she continued to take her medication as prescribed in order to prevent her psychotic 
symptoms re-emerging. Whilst Yasmin’s frustration is initially directed externally 
this later transmutes into frustration at herself. She commented that she was ‘letting 
them’ interfere in her life due to her lack of self-confidence.  
 
R: Do you feel, like, that people are interfering in your life now? 
P: But I’m letting them, that’s the thing, because, because of how I’ve 
got no confidence in myself, and I, and I, so… 
Yasmin, Lancashire – Elevated Negative Symptoms 
 
Where Yasmin clearly resented the lack of control she was able to exercise over her 
treatment, other participants appeared resigned to their lack of influence. For 
instance Daniel, having not had any choice in his medication during his time in 
hospital, felt he should just continue the status quo when responsibility for his care 
was transferred to EIP.  
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R: And do you feel like you had a choice over your medication or do 
you feel like you kind of have to go along?  
P: I’d go along with it yeah, when I was in hospital I had no choice but 
to take the medication. 
R: Yeah. And when you came out of hospital do you feel like you could 
have had a voice and an opinion in to your medication? 
P: I could of but it’s probably just best to take it. 
Daniel, Norfolk – Elevated Negative Symptoms  
 
It is unclear whether this resignation should be interpreted as stemming from relief at 
someone else taking responsibility for difficult decisions, or from powerlessness in 
the face of a system perceived as overwhelmingly powerful.  
 
Whilst most participants saw being offered control over their treatment as a positive, 
Shelly – a member of the Minimal group who was encouraged to make choices about 
her treatment once under the care of EIP – expressed ambivalence at being expected 
to make decisions about her care.    
 
P: When I was with home treatment team it was different, there was 
always someone saying let's do this [Shelly], let's do that, let's do 
this [Shelly], let's do that and then when I was with … Early 
Intervention, it was different. It was - I was more in control of 
everything.  
R: Okay, so. 
P: So because I was more in control of everything, I was the one that 
had to say where this needs to be done or that needs to be done, and 
that’s it really. 
R: Do you think that was better, that you were more in control?  
P: Well, yes and no.  
Shelly, Birmingham – Minimal Negative Symptoms 
 
She went on to explain that she would have preferred the EIP service to take some 
decisions on her behalf, in accordance with her best interests. This highlights the 
potential for some participants to perceive responsibility for decisions about their 
treatment as a burden.  
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Psychological therapy 
 
An interesting difference between the negative symptom groups was the extent to 
which psychological therapy featured in the accounts of the treatment they received. 
Participants from the Elevated and Decreasing negative symptom groups rarely 
mentioned having received psychological therapy. When explicitly asked whether 
they received psychological therapy during their time with EIP, most said no. In 
contrast, most members of the Minimal negative symptoms group spontaneously 
brought up their experience of psychological therapy.  
 
Participants who mentioned having received therapy usually expressed that the 
experience had been beneficial. Key benefits of psychological therapy described by 
participants included improved coping strategies and feeling less helpless. 
 
P: I’ve felt more enabled, I’ve developed more coping strategies, I’ve 
developed more of an insight into things. And more importantly 
more of an acceptance things. Because I very heavily kicked against 
things. Up until about a year ago now actually. And. 
R: Do you know, sorry, I was just going to ask you, is there a reason 
why you changed? Is there something that happened or is it just 
passage of time or? 
P: It was, I think a lot of it was to do with the psychology and 
psychotherapy sessions.   
R: Ah, okay. 
P: Were very sort of important.  
Ben, Birmingham – Minimal Negative Symptoms 
 
R: Okay, did you find it helpful then that the CBT [Cognitive 
Behavioural Therapy] was erm - was offered to you at [EIP]?  
P: Yeah, definitely.  
R: In what ways, what did it help with?  
P: Just with that other, with that other feeling like you don’t have to 
feel helpless there is things you can do, you know.  
R: Yeah, yeah. Yeah it gave you back that control?  
P: Yeah, yeah.  
Jack, Cambridgeshire – Minimal Negative Symptoms 
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Jennifer spoke in detail about the specific cognitive techniques employed by her 
therapist. For instance, she described how her therapist encouraged her to challenge 
her belief that she should kill herself if it was not possible for her to look like 
Marilyn Monroe. 
 
There was a cognitive behavioural therapist called [name]. She was really 
really good and she did loads of good stuff where she talked about all these 
special techniques like … I was saying I was going to kill myself if I couldn’t 
look like Marilyn Monroe so they said, ‘what about other girls? If you see 
this girl – point to someone like – do you think she should kill herself 
because she’s not as good looking?’ I said no. They said ‘Do you think this 
person is like ugly or fat, or something different she should kill herself.’ I 
thought no, and said, ‘Well why would you think you should kill yourself?’ 
And it really worked. That’s just one of the things she said. She said millions 
of different special tricks.  
Jennifer, Cambridgeshire – Minimal Negative Symptoms 
 
Jennifer said that she continued to use the techniques she learnt during her CBT to 
keep herself well. Several other participants who had received CBT also commented 
that the techniques they were taught by their therapist continued to be of use to them 
in managing their symptoms or preventing relapse.  
 
Only one participant, Isabella, expressed a negative opinion of psychological 
therapy. She explained that she did not feel CBT (the only model of therapy offered 
to her by EIP) was suitable for her as it required her to think of her experiences as 
symptoms. 
 
I did get the impression on one occasion where he was trying to fit all my 
symptoms into one model, this what do they call it, er, cognitive behavioural 
model and I kept thinking there’s only one problem with this it’s taking your 
perspective of what’s happened to me [inaudible] it’s not taking it from my 
perspective and it was fundamentally wrong because I’m the one that’s, I’m 
the one that’s been through this, I know way more than you how this has 
affected me.  
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
For Isabella, who saw her psychosis as a spiritual experience, fitting her experiences 
into a CBT model involved denying the meaning she attributed to them. Since leaving 
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EIP she had sought out person-centred psychotherapy and reported that she found it 
beneficial ‘just to have somebody sit there and appreciate from your perspective what 
it’s like’.   
 
Participants’ accounts point to some potential explanations for the scarcity of 
references to having received psychological therapy by those with higher levels of 
negative symptoms. One possibility suggested is that participants presenting with 
negative symptoms were less likely to be offered psychological therapy; the 
participants’ accounts suggest that at least some members of the Elevated negative 
symptoms group were not offered psychological therapy. For example, Yasmin made 
clear that she would like to have been offered therapy but was not.  
 
R: Do you feel as though they could have helped you in any way; that 
the Early Intervention Service could have helped you in any way 
that would have been better, or from what you’ve just said? 
P: Erm, probably, yeah … They didn’t, like, offer me, like, therapy and 
stuff, and they just, like, being, just getting me sectioned and, you 
know, giving you medication and things like that. 
Yasmin, Lancashire – Elevated Negative Symptoms 
 
Another possible explanation is that participants were offered psychological therapy 
but chose not to take it up, as was the case for Tom. 
 
R: And was there anything whilst you were with [EIP] that you wish 
you could have explored further?  
P: Erm I wish I'd gone through with sort of psychology aspect of things 
and just talked and tried - like regression or whatever it's called and 
just talked more and gained a better understanding, but that wasn’t 
through them not making it available, that was through me not 
taking up on the offer. 
R: Right, I see.  
P: I was able to do it, it's just I chose not to at the time. I mean looking 
back at it I wish I had but I know I wasn’t in a comfortable position 
to do it anyway.  
R: You didn't feel ready? 
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P: Yeah. But it was there, it wasn’t that I wanted to do it but they said 
no or they couldn't do it, it was that I wish I'd done it now in 
hindsight.  
Tom, Cambridgeshire – Elevated Negative Symptoms 
 
Tom turned down the offer of therapy as he was not in a ‘comfortable position’ to 
participate but, with hindsight, wishes he’d taken up the offer. This suggests that 
individuals experiencing high levels of negative symptoms might feel less able to 
engage in a psychological intervention. One Elevated negative symptom group 
participant who was offered psychological therapy and took up this offer expressed a 
belief that he was not ready to participate in a psychological intervention.  
 
I don’t think it was the right time. I think I was, I was in, I was too unwell 
when, when I had it before … I think I’d be more open to it now. And I’m, 
I’m more able to discuss my problems. When, when I had psychology before 
I used to hardly talk. I used to find it hard to put a sentence together. Erm and 
a lot of the time it was just the psychologist talking to me. And she’d ask me 
questions and I just didn’t feel like I could answer them.  
John, Birmingham – Elevated Negative Symptoms 
 
John reflected that his therapy took place too early in his recovery, at a time when he 
was not able to fully engage in the process due to difficulty expressing himself. He 
indicated that his difficulty talking has since largely resolved and he would now be 
more able to engage in a conversation. Nonetheless, during a later interview, John 
mentioned that his experience of therapy had some positive impact in the longer-
term despite his difficulties engaging at the time.  
 
I had psychology sessions and err a lot of the things we talked about didn’t 
really improve straight away but I remember the things we talked about and 
even today like they help with some things.  
John, Birmingham – Elevated Negative Symptoms 
 
Experiences of hospitalisation 
 
The majority of participants from the Elevated negative symptoms group spoke 
about having experienced inpatient care during or immediately before their time with 
203 
 
EIP. This was in contrast to members of the Decreasing or Minimal negative 
symptom groups who rarely spoke about having experienced inpatient care. In 
keeping with the general brevity of these participants’ accounts, only a couple of the 
majority of Elevated negative symptom participants who mentioned having spent 
time in a psychiatric hospital spoke about this experience in any detail. Those who 
did discuss it in detail were in agreement that the experience was not a positive one. 
 
Well I’ve been to [psychiatric hospital] and the first time I was there, it was 
horrible, it wasn’t a great place to be. They had communal rooms, so you 
were sharing four to six people. They were people the same as me, who 
weren’t very well at all so it’s very hard to sleep or do anything so you’re put 
on edge. The food wasn’t great; there really wasn’t much you could do there.  
Nathan, Birmingham – Elevated Negative Symptoms 
 
I don’t like that environment and it’s just, you can’t do anything and then 
[inaudible] medication and it makes you lethargic, and you feel depressed 
and all sorts and I don’t wanna go through that again. It’s just a waste of life.  
Yasmin, Lancashire – Elevated Negative Symptoms 
 
The negative opinions of inpatient care expressed by Yasmin and Nathan were in 
accord with the views expressed by the minority of members of the other negative 
symptom groups who had spent time in a psychiatric hospitals. A particularly vivid 
description of an experience of inpatient care was given by Clara who spent six 
months on an inpatient unit in London.  
 
The whole way it was done, and you go there and you, you know, and the, 
the activities that you do in there are really - just felt so flat … It was every 
day the same. You just want to sleep, and you don't want to get up. And when 
you get up obviously you're hungry, so you go and queue with your tray and 
you get your slop on your, on your tray, and then you go and sleep on a PE 
mat, you know, with a sheet kind of thing. Erm and I, you know, I, you 
know, I just don't think that's probably the best. I don't think it was actually 
very good for me erm at all … But the people in, in the ward just they, they 
didn't seem passionate about us and about what we were going through, and 
about helping us.  
Clara, Cornwall – Minimal Negative Symptoms 
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Given Clara’s description of the monotonous and lacklustre daily routine on the 
ward, and apparent indifference of the staff, it is perhaps not surprising that she 
describes not wanting to get out of bed. It is quite possible choosing to lie in bed all 
day rather than get up and participate in activities would be deemed indicative of 
avolition; this perhaps suggests a possible explanation for experiences of 
hospitalisation being more commonly mentioned by those who presented with more 
severe negative symptoms. 
 
7.4.3. The Process of Recovery 
 
High benchmarks for recovery 
 
The majority of participants from all negative symptom groups considered 
themselves to be partially, but not fully recovered. Definitions of what it would mean 
to be fully recovered were idiosyncratic but most often centered on either absence of 
symptoms, increased social and occupational functioning, or a combination of the 
two.  
 
Interestingly, members of the Elevated and Decreasing negative symptom groups 
tended to set higher benchmarks for recovery than did the Minimal negative 
symptoms group. Many participants from the Elevated and Decreasing groups 
expressed that they considered recovery to encompass complete remission of 
symptoms and/or securing full-time paid employment. In contrast, members of the 
Minimal negative symptom group expressed a willingness to tolerate residual 
symptoms and some limitations in functioning within their definitions of recovery. 
For instance, Jennifer gave the following definition when asked to explain what she 
understood by the term ‘recovery’: 
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I think it’s, erm, being able to, erm, enjoy stuff in your day again … being 
able to do part time work or voluntary work. Obviously, full time work 
would be the main thing, but I still think it’s if you just do voluntary work, 
really. Er, being able to meet people and stuff, erm, and being able to not 
have symptoms all day, and stuff like that. Being able to, like, have, have a 
lot of the day, like, er, more than 50% of the day where you didn’t have 
symptoms. That’s what I’d say it was. 
Jennifer, Lancashire – Minimal Negative Symptoms 
 
Many of Jennifer’s fellow Minimal negative symptom group members also 
expressed the view that full-time paid work and complete remission of symptoms are 
not necessary for a person to be deemed ‘recovered’. For these participants, 
engagement in part-time or voluntary work and the ability to manage any ongoing 
symptoms was viewed as sufficient for recovery.   
 
‘It’s a matter of coping’ 
 
Participants from the Minimal negative symptoms groups placed greater emphasis 
on the concept of coping than did other participants. These participants expressed 
that they anticipated they would continue to experience some symptoms indefinitely, 
thus their ability to cope with and manage these symptoms was of central 
importance. For instance, Philip expressed a belief that he would always experience 
psychotic symptoms but that he could recover nonetheless by learning to manage 
these symptoms. 
 
P: I think I’ll always have, erm, these experiences [hallucinations] but 
erm I think over time they’ll become easier to manage and erm, 
yeah, not, not say I’ve become blasé about it but I just think erm 
yeah, over the course of time … 
R: Ok, so you feel that probably erm you’ll continue to have the 
experiences, but that over time you’ll be able to sort of better cope 
with them and [inaudible]. 
P: Yeah, that’s right yeah, yeah.  
Philip, Norfolk – Minimal Negative Symptoms 
 
For participants who were no longer experiencing symptoms, confidence in the 
ability to cope with any future recurrence of symptoms reduced the fear associated 
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with the possibility of relapse. Isabella had experienced a second episode of 
psychosis following the birth of her son and so was mindful of the possibility of 
further episodes but stated that she was not worried about this possibility because she 
has the ‘skills to deal with it’. 
 
R: I mean are there any concerns about feeling that way again? 
P: … I think as long as I’m in control of it I feel it’s not going to be a 
problem, like I say as long as I’ve got skills to deal with it I – I don’t 
think it would be a problem. 
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
Similarly, Callum, who was interviewed shortly after being discharged from EIP 
back to the care of his GP, was asked whether he had any concerns about no longer 
being under the care of EIP.  
 
R: Do you feel safe though just being under the care of the GP now that 
kind of Early Intervention has gone away, I guess, in the last week? 
P: No because they didn’t just like go ‘right see you later’ … they’ve 
set up support and they’ve made sure that I am capable. Before 
they’ve gone off like, you know what I mean, sort of thing. And 
that’s what they’re there for. To give you the skills to cope with it 
yourself. That’s what it’s for so that it doesn’t happen again.  
(Callum, Cheshire – Minimal Negative Symptoms) 
 
Callum made clear that he felt equipped with the skills to cope with future symptoms 
and so no longer felt the need for the input of secondary mental health services.    
 
‘Well, actually, I’m in control of this’ 
 
The equation of recovery with the ability to cope with ongoing symptoms fits within 
a wider theme of agency in recovery that was characteristic of the accounts given by 
members of the Minimal negative symptoms group. Several participants in this 
group described using the knowledge and skills they acquired during their time with 
the EIP service to actively promote their recovery. For instance, Jennifer spoke about 
using the awareness she developed during her CBT sessions to guard against 
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developing further unusual beliefs about her relationship with high status 
individuals. 
 
P: I know when I’m getting it now, and I just go, ‘No, you’re getting it 
again.’ 
R: How do you know you’re getting it? 
P: Well, I started thinking this MP, like, erm, I started thinking, ‘Oh, 
he’s, he’s sending me messages.’ He was sending me messages on 
Facebook, wanting me to vote for him and stuff and, like, being 
friendly, because he’s trying to make friends on Facebook with other 
people to get them all to vote for him. And I started thinking, ‘Oh is 
it special. Is it just me and him?’ you know, and all this lot. And I 
started thinking, ‘No, it’s because he’s an’ … they’ve got status, 
authority, and power about them. And it’s, like, you want to get a bit 
of that power or something, so you want them to like you so you’re 
special, like, sort of, thing. Erm, and so I start thinking that, and I’ve 
stopped myself, I stopped that.  
Jennifer, Lancashire – Minimal Negative Symptoms 
 
Similarly, several participants from the Minimal negative symptoms group spoke 
about EIP empowering them. They described EIP services as helping them to 
understanding themselves better and thus to make changes themselves, rather than 
professionals solving problems on their behalf. 
 
It hasn’t waved a magic wand and made everything better, but it’s enabled 
me to understand things more. And when you understand things more they’re 
not quite as intimidating, and so that in itself was quite empowering.  
Ben, Birmingham – Minimal Negative Symptoms 
 
In contrast, an apparently more passive attitude to recovery was evident amongst 
members of the Elevated, and to a lesser extent the Decreasing, negative symptom 
group. Compare the responses of two participants – Daniel, a member of the 
Elevated negative symptoms group, and Alexander, a member of the Minimal 
negative symptoms group – to similar questions about their role in creating a plan for 
identifying and dealing with any future deterioration in their mental health (known as 
a ‘staying well’ or ‘relapse’ plan). 
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R: So, are you saying that you’ve been shown a, sort of, staying well 
plan? 
P: Yeah, I’ve been shown them, yeah.  
R: But you’re not saying you were that active in creating it? 
P: No, not really, no, no. 
R: Do you agree with what the plan says, or? 
P: I can’t really remember, to be honest. 
Daniel, Norfolk – Elevated Negative Symptoms 
 
P: Yeah, I have a relapse plan, and I devised something with the four 
pillar model. 
R: Right, okay. 
P: Where you imagine that you have four pillars, which hold up the 
roof, and the roof is the level playing field of your mental health, 
and if any one of the pillars gets too tall or too short, the roof 
becomes unstable and it slides … 
R: And did you see yourself as active in creating, creating it? 
P: Yeah. It was, I was given the chance to develop whatever kind of 
relapse plan I thought was appropriate, and we did in fact, develop 
an appropriate relapse plan. 
R: Excellent. 
P: Okay. I think it’s in my folder upstairs, last year’s folder. I will just 
grab it and show you, before you go out the door. 
Alexander, Devon – Minimal Negative Symptoms   
 
Whilst Daniel recalled a relapse plan having been created, he didn’t consider himself 
to have been an active participant in its creation. Perhaps because of his lack of 
active participation in its creation, he was unable to remember the plan’s content. In 
contrast, Alexander seems to have been a very active participant in the creation of 
his relapse plan. His choice of the first-person singular pronoun in the utterance ‘I 
devised something with a four pillar model’ indicates that he viewed himself as the 
primary author of the plan. He expressed satisfaction with the relapse plan created, 
apparently recalled its content clearly, and was even keen to show it to the 
researcher. This is a particularly concreate example of a wider pattern of the 
relatively active approaches to recovery evident in the narratives of participants from 
the Minimal negative symptoms group.      
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Recovery contingent on medication 
 
Members of the Elevated and the Decreasing groups often appeared quite passive in 
their attitudes to recovery when their accounts were considered alongside those of 
the Minimal group. Several Elevated and Decreasing participants expressed the view 
that their recovery was contingent on their continuing to take medication.  
 
R: And do you have any fears of having another episode at all, is that 
something that bothers you? 
P: Err I don’t think I would as long as I’m on the medication. 
R: Ok so you feel like as long as you’re on the medication then that will 
be ok. 
P: Be fine, yeah. 
Daniel, Norfolk – Elevated Negative Symptoms 
 
R: So do you feel in order to recover that you need to see psychosis as 
something separate from you or do you think that's not necessary? 
P: Um, how can I explain it, psychosis, I suppose you have to see it as 
an illness you've had but I don't think you have to see it as part of 
you because you're taking tablets to stop it. 
Nathan, Birmingham – Elevated Negative Symptoms 
 
For such participants, medication compliance appeared to be what they considered to 
be their primary role in promoting their recovery. The belief that medication is 
primarily responsible for one’s recovery leaves little room for personal agency. An 
Elevated negative symptoms group participant, Hayley, employed a metaphor of 
being driven through life in a horse drawn carriage to describe the reduction in 
agency she felt as a result of trusting her recovery to medication.  
 
Whilst on medication it’s as if – I always see myself in one of these – er, it’s 
just one of my visual things – erm, like a horse-drawn carriage, and 
someone’s, erm, driving. Erm, and you’re just sitting there and you’re 
watching everything, and the ride’s nice and it’s smooth, and you go through 
things, and they whisk you through bad places, good places, but you’re not 
quite in control. And it’s nice to think, ‘Well, actually, I’m in control of this, 
and I’m gonna go the way I want to go’, and I find that medication is that 
driver. So it takes you one step back from being in full control of your life.  
Hayley, Cornwall – Elevated Negative Symptoms  
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7.5. DISCUSSION 
 
7.5.1. Review of Study Findings in Relation to Research Questions 
 
Are there differences in the way those who followed differing negative symptom 
trajectories understood their experience of psychosis? 
 
There appeared to be differences in the way in which members of the different 
negative symptom trajectory groups made sense of their experience of psychosis. 
Participants who were members of the Elevated and Decreasing groups gave 
primarily biomedical explanations of psychosis: they tended to view psychosis as an 
illness caused by aberrant neurochemistry. Members of the Minimal negative 
symptoms group preferred psychosocial explanations of their experience; their 
understandings of the development of their psychoses generally gave stress and 
adverse experiences a central role. Members of this group often gave relatively 
complex accounts of how their psychosis developed and was sustained, often 
resembling longitudinal formulations.   
 
Do individuals who followed differing negative symptom trajectories give divergent 
accounts of the treatment they received from EIP services?  
 
Participants from all negative symptom groups expressed largely positive opinions 
of the service they received from their EIP team. Most participants from all three 
groups felt that the treatment they had received had been beneficial and were 
complimentary about the staff who delivered it. However, beyond this general 
approval, several differences emerged in the treatment members of the three negative 
symptoms groups described having received.  
 
Participants from the Elevated negative symptom group frequently mentioned 
inpatient care as having been part of their treatment. This was in contrast to the other 
groups, members of which rarely reported having spent time as inpatients. 
Participants from all groups expressed negative views of inpatient care: as something 
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to be avoided if at all possible. Elevated negative symptom group participants rarely 
spoke about having participated in psychological therapy whereas this was a 
prominent theme of the Minimal negative symptoms group’s accounts. Members of 
the Minimal and Decreasing groups expressed that they had been able to make 
choices and exercise control in relation to their treatment. Members of the Elevated 
group rarely described having been active in deciding the treatment they would 
receive and sometimes expressed frustration at having control over their life taken 
away from them during the course of treatment.   
 
Are their differences in the way those who followed differing negative symptom 
trajectories understood and experienced the process of recovery? 
 
Most members of all groups described themselves as partially, but not fully, 
recovered. However, their personal understandings of recovery differed. Members of 
the Elevated and Decreasing groups often set stringent benchmarks for recovery, 
including both complete remission of symptoms and return to full-time paid 
employment. These participants mostly felt their own role in their recovery to be 
limited; some expressed the belief that taking their prescribed medication was the 
primary means by which they could participate in their recovery.  
 
Members of the Minimal negative symptoms group often deemed reduction in the 
severity or frequency of symptoms to be sufficient for recovery. Several participants 
from this group also spoke about part-time or voluntary work – rather than full-time 
paid work – as being more realistic for them and did not see this concession as being 
incompatible with recovery. Participants from the Minimal negative symptoms 
group often described recovery as a matter of learning to cope with ongoing 
symptoms. They saw their role in the process of recovery as an active, ongoing one: 
they felt that their recovery was ultimately in their hands: professionals could 
provide them with the tools but it was up to them to use them. 
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7.5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
 
As in previous studies of personal explanations of psychosis (J. A. Larsen, 2004; 
Werbart & Levander, 2005), the two modes of explanation favoured by participants 
in the current study can be related to the previously discussed contrasting recovery 
styles – ‘sealing over’ and ‘integration’ – distinguished by McGlashan et al. (1975). 
The relatively complex psychosocially focused explanations favoured by most 
members of the Minimal group can be seen as evidence of an integrative recovery 
strategy. Participants from the Elevated and Decreasing groups who held a 
biomedical view of their psychosis might be thought of as sealing over their 
experience: through adopting a biomedical explanation of their unusual experiences, 
they were able to avoid linking these experiences to other aspects of their life. 
Interestingly, Thompson et al. (2003) found that a sealing over recovery style 
predicted poorer functional outcome at 12 months post stabilisation of a first 
psychotic episode. Thus, it could be hypothesised that a tendency towards a sealing 
over recovery style may be implicated in the relatively poor social recovery observed 
in members of the Elevated and Decreasing groups. 
 
However, the biomedical understandings of psychosis expressed by many members 
of the Elevated and Decreasing groups appeared to have conferred some advantages. 
One advantage mentioned by participants was that understanding their experiences 
as being due to an illness absolved them of blame for their problems. Unlike suffers 
of physical health problems, those experiencing mental health problems are often 
held responsible for their illness. The view that those with mental health problems 
are ‘weak not sick’ has been identified as an important component of mental health 
stigma (Jorm & Wright, 2008). It has been suggested that such attitudes are the 
remnants of traditional Christian notions of insanity being a consequence of personal 
sin (Dain, 1992). Prior to enlightenment rationalism, all forms of misfortune, 
including physical ill health, were commonly viewed as ‘the wages of sin’. However, 
as modern science began to offer alternative explanatory models, the idea that 
physical illnesses could be attributed to personal sin fell out of favour. Making 
mental health problems akin to physical illness by attributing biological aetiologies 
213 
 
absolves the individual of personal responsibility for their condition since a person 
cannot be held blameworthy for being ill.  
 
The legitimation of illness offered by the biomedical model of illness is closely 
related to the concept of the ‘sick role’ (Parsons, 1991). The ‘sick role’ absolves the 
individual of personal responsibility for their condition since a sick person cannot be 
expected to get well by an act of will. The sick role also grants exemption from 
normal social role responsibilities, typically involving withdrawal from work or 
school and entering into a state of passive dependence. This legitimation of 
withdrawal might make the sick role particularly attractive to individuals with the 
most severe negative symptoms. However, it might also serve to maintain negative 
symptoms since the sick role does not just legitimise withdrawal and passivity but 
requires it: the sick person is under a social obligation to limit their usual activities, 
accept medical treatment, and enter into a dependent social role in which they are 
looked after by others. Failing to meet these obligations may mean the individual is 
no longer afforded the privileges of the role. 
 
Kvaale et al. (2013) reviewed and undertook meta-analysis of 28 experimental 
studies that examined the effect of biomedical explanations of psychological 
problems on stigma. In line with the results of the current study, Kvaale et al. found 
that biomedical explanations tend to lead to reductions in blaming attributions. 
However, they also found that these explanations tend to result in greater prognostic 
pessimism. It should be noted that these findings relate to the stigmatisation of others 
rather than to self-stigma. However, since those who experience FEP are part of the 
wider population and influenced by the same cultural milieu as other members of the 
population, it is possible that these findings also apply to individuals’ attitudes to 
their own psychological difficulties. Thus it is plausible that while adoption of a 
biomedical theory of psychosis might serve to alleviate self-blame, it might also 
induce pessimism regarding the prospect of recovery. 
 
The finding that members of the Minimal negative symptoms group tended to offer 
relatively complex explanations of the genesis of their psychosis recalls the results of 
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a quantitative study by Lysaker et al. (2012). The authors explored the relationship 
between negative symptom severity and personal narrative development in 
individuals diagnosed with schizophrenia. Participants were prompted to tell the 
story of their life, and to discuss the role of their mental health problems within this 
story. Transcripts of the resulting accounts were subsequently rated for the extent to 
which four key aspects of the narrative were developed. Narrative development was 
found to be significantly associated with negative symptom severity, with well-
developed personal narratives being associated with less severe negative symptoms. 
The findings of the current study suggest that there may be a similar association 
between narrative development and negative symptom severity in FEP. Lysaker et 
al. speculate that their findings might indicate that diminished narrative complexity 
leads to negative symptoms or vice versa. However, further research is necessary 
before we can conclude that there is a causal relationship between negative 
symptoms and personal narrative development. 
 
A plausible explanation of the finding that more members of the Elevated group 
spoke about having been hospitalised than members of other groups, is that those 
with persistent negative symptoms are more likely to experience hospitalisation than 
other FEP patients. Cognitive models of negative symptoms suggest that 
discouraging life events can precipitate the dysfunctional beliefs proposed to 
underlie negative symptoms; the experience of hospitalisation might be one such life 
event. Some participants in the current study expressed that hospitalisation was an 
unpleasant and demoralising experience. This accords with previous qualitative 
findings regarding the experience of inpatient care. For instance, Perry et al. (2007) 
found that participants described feeling trapped, powerless and dehumanised during 
their inpatient stays. Fear and vulnerability have also been found to be characteristic 
of patients’ experience of psychiatric hospitalisation (Fenton et al., 2014). Thus the 
experience of hospitalisation might be hypothesised to play a causal role in the 
aetiology of negative symptoms. While this it is far from the only possible 
explanation of this study’s findings, it is a particularly interesting one and warrants 
further investigation.  
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There are a number of plausible explanations for the prominence of psychological 
interventions within the accounts of members of the Minimal group relative to other 
negative symptom groups. As previously discussed, it might be that those with 
greater negative symptom severity are not offered psychological therapy as often as 
counterparts presenting with fewer negative symptoms. This could be explained by a 
belief among those referring service-users for psychological interventions that 
negative symptoms act as a barrier to successful engagement in talking therapies.  
 
Such a belief may not be entirely unfounded. Baseline negative symptom severity 
was found to be a significant predictor of outcomes in a small non-controlled trial of 
CBT for auditory hallucinations (Thomas, Rossell, Farhall, Shawyer, & Castle, 
2011). However, it is unclear whether this finding can be taken as evidence that 
negative symptoms act as a barrier to effective utilisation of CBTp. An analysis of 
data from an RCT of CBTp found that, while negative symptom severity was a 
significant predictor of change across time, it was not a significant predictor of 
change in the treatment group relative to the control group (Lincoln, Mehl, Kesting, 
& Rief, 2011). This suggests that limited improvements following CBTp made by 
those with elevated negative symptoms might be accounted for by the poorer overall 
outcomes of those with more severe negative symptoms as opposed to their 
benefiting less from CBT.  
 
Another possible explanation for the relative prominence of psychological 
interventions within the treatment accounts of members of the Minimal group is that 
individuals with more severe negative symptoms were more likely to decline 
psychological therapy. It is reasonable to assume that those with more severe 
negative symptoms, particularly those who find expressing themselves or being in 
the company of other people difficult, might find the prospect of participating in 
talking therapy less appealing than those who do not have these difficulties. 
Alternatively, this finding could be explained by a lesser propensity amongst 
members of the Elevated and Decreasing group to discuss the psychological therapy 
they received. This could be because these participants less often regarded 
psychological therapy as an important element of their treatment, perhaps linked to 
their more often embracing a biomedical model of psychosis.  
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The high degree of choice and power in relationship to their treatment experienced 
by the Minimal and Decreasing groups contrasts with the findings of most previous 
research investigating the experiences of mental health service-users. Instead, the 
picture painted by previous studies is of limited choice and lack of empowerment, 
mirroring the experience of the Elevated group in this study. For instance, Laugharne 
et al. (2012) interviewed people with chronic psychosis (median length of illness 25 
years) about their experiences of choice and power within mental health services and 
found that very few participants felt they had any power over the services they 
received. Indeed, most had not even considered that their having choice in their 
treatment might be a possibility.  
 
Studies of EIP service-users have found evidence of a perception of greater 
involvement in treatment decisions (Harris et al., 2012; Lester et al., 2012; O’Toole 
et al., 2004), in line with the philosophy of responsive, person-centred care 
underpinning the EIP service model. The treatment experiences of the Minimal and 
Decreasing groups thus correspond to both the experiences reported by EIP service-
users in previous research and to the aspirations of the EIP service model. This raises 
the question why the treatment experiences of members of the Elevated negative 
symptom group did not live up to these aspirations. It might be that members of the 
Elevated group were less able to exercise control over their treatment as a result of 
being less expressive and so less able to articulate their preferences. Alternatively, it 
might be that, because this group were generally more unwell, professionals 
prioritised symptom control over involving the service-user in treatment decisions. 
 
The understanding of recovery expressed by most participants from the Minimal 
negative symptoms group – that recovery is an active process of learning to cope – 
corresponds closely with those of a group of FEP service-users in Hong Kong. Lam 
et al. (2010) concluded that their participants understood recovery to be ‘learning 
lessons about priorities in living, envisaging a future where they have a valued role, 
being respected and respecting others’. This view resonates with modern conceptions 
of personal recovery (Leamy et al., 2011). The convenience sampling method 
employed by Lam et al. may well have resulted in a sample with generally low levels 
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of negative symptoms; this might account for the resemblance between the 
understandings of recovery articulated by Lam et al.’s sample and the Minimal group 
in the current study. This attitude to recovery is in line with the integration recovery 
style which involves accepting the experience of psychosis as part of one’s identity.  
 
Lam et al. compared the views of recovery expressed by FEP patients to those 
expressed by psychiatrists in a similar study (Ng, Pearson, & Chen, 2008). They 
concluded that FEP patients’ ideas of what constitutes recovery tend to be very 
different to those of psychiatrists. They found that most psychiatrists held a ‘narrow’ 
and ‘idealistic’ view of recovery, emphasising remission of symptoms, medication 
compliance and return to premorbid functioning. However, the views expressed by 
psychiatrists in Ng et al.’s study are very much in line with the views of recovery 
expressed by many members of the Elevated and Decreasing groups in the current 
study. Given that members of these groups tended to ascribe to a biomedical view of 
psychosis, it makes sense that their understandings of recovery should mirror those 
of psychiatrists whose training is rooted in such a biomedical approach. This attitude 
to recovery can be related to the sealing over recovery style with its emphasis of 
moving on from the experience of psychosis and returning to one’s former life. 
   
The themes found to characterise the accounts of each negative symptom trajectory 
group can be seen as forming a coherent set. In the case of the Elevated group’s 
themes, if a participant has received care in an inpatient setting, and received 
medication but not psychological interventions, it would not be surprising were he or 
she to adopt a biomedical view of his or her difficulties. In turn, this biomedical 
understanding of his or her psychosis might incline him or her towards viewing 
recovery as a process contingent on medication in which the patient’s role is mostly 
passive. Holding stringent benchmarks for recovery might also contribute to a less 
active attitude towards recovery since a participant is less likely to be motivated to 
actively work towards a goal that is perceived as unachievable. Similarly in the case 
of the Minimal group’s themes, it follows that a participant seen in the community 
whose treatment included psychological therapy might tend towards a psychosocial 
understanding of his or her difficulties. Having adopted such a psychosocial stance, 
the participant might come to view recovery as an active process of learning to cope 
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with any ongoing difficulties. Having been offered choices over the treatment he or 
she received is also likely to contribute to the participant considering him or herself 
to have an active role in his or her recovery.  
 
7.5.3. Limitations  
 
As in the study described in the previous chapter, the use of secondary qualitative 
data imposed a number of limitations. Specifically, the use of secondary data 
narrowed the research question that could be answered: only aspects of the 
experience of psychosis that were addressed in the topic guides could be considered 
and no insight into participants’ own views of the impact of negative symptoms on 
their experience of psychosis could be gained. In addition, the findings of the study 
posed many questions that it was not possible to answer given the data available. It 
might have been possible to address some of these questions had the topic guides for 
later interviews been updated to address emerging themes; since data collection was 
completed before my analysis commenced this was not possible. Other questions 
could not be addressed using qualitative methods and will require investigation in 
future quantitative work.  
 
Although the retrospective nature of data collection could be viewed as a limitation 
of the study for the reasons previously outlined (section 6.5.3), the timing of the 
interviews had several advantages in relation to the current study. Since interviews 
were mostly conducted after the participants time with EIP had come to an end, 
participants were able to look back over their whole period of EIP treatment rather 
than just the initial phases of treatment. The timing of interviews might also have 
allowed participants to talk more meaningfully about their experience of recovery 
than had they been interviewed soon after their first episode.  
 
7.6. CONCLUSION 
 
There were notable differences between the lived-experiences of those whose 
negative symptoms took differing courses during their first 12 months of EIP 
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treatment. Members of the three trajectory groups compared expressed differing 
understandings of psychosis, gave different accounts of the treatment they received 
and the degree of control they felt able to exercise over it, and displayed distinct 
understandings and experiences of recovery. It is not possible to draw any firm 
conclusions regarding the generative mechanisms underlying these findings. 
However, they can contribute to the generation of hypotheses which, if supported, 
may clarify the factors involved in the development and maintenance of negative 
symptoms, and help explain their relationship with poor social recovery. 
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PART FOUR 
 
Discussion 
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Chapter Eight – General Discussion: Towards a Psychosocial Model of the 
Relationship between Negative Symptoms and Poor Social Recovery in First-
Episode Psychosis 
 
8.1. OVERVIEW 
 
This thesis has explored negative symptoms occurring early in the course of 
psychosis using data from a large observational study of individuals who received 
care from EIP services in the UK. The research aimed to identify distinct trajectories 
of negative symptom progression and to explore the lived-experiences of those 
whose negative symptoms followed these distinct courses, as well as identifying 
predictors of these trajectories and examining their relationship with early social 
disability. The mixed methods design of the research carried out provided rich, 
multifaceted insights into the nature of negative symptoms in FEP. After first 
summarising the findings of quantitative and qualitative studies conducted in turn, 
this chapter will turn its focus to the integration of these findings. These integrated 
findings will be related to the wider literature on negative symptoms, and their 
theoretical and clinical implications discussed. Finally, the strengths and limitations 
of the research will be considered and suggestions made regarding directions for 
future research. 
 
8.2. SUMMARY OF FINDINGS 
 
8.2.1. Quantitative Studies 
 
The studies described in Part Two aimed to explore early heterogeneity in the course 
of negative symptoms and to investigate the relationship between negative symptom 
course and social recovery. The first study undertaken, an investigation of the factor 
structure of the PANSS, produced a five-factor solution with a single negative 
symptoms factor. The items indicating this negative symptoms factor – ‘blunted 
affect’, ‘emotional withdrawal’, ‘poor rapport’, ‘passive social withdrawal’, ‘lack of 
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spontaneity and flow of conversation’, ‘motor retardation’ and ‘active social 
avoidance’ – were used to measure negative symptom severity in the remainder of 
the thesis.  
 
In the next study, longitudinal modelling techniques were used to investigate the 
degree of heterogeneity in negative symptom progression and to marshal this 
heterogeneity by identifying groups with similar patterns of change within the 
cohort. Four latent classes, each with distinct negative symptom trajectories during 
the first 12 months of EIP service use, were identified. Only a small proportion of 
the cohort were identified as belonging to a latent class characterised by persistently 
high levels of negative symptoms throughout the 12 month study period. A slightly 
larger proportion of the sample were identified as belonging to a class with persistent 
negative symptoms of lesser severity. The second largest class was characterised by 
initially high but decreasing negative symptoms, suggesting that many of those with 
elevated negative symptoms on entry to EIP services will experience remission of 
these symptoms within 12 months. The largest class identified presented with 
consistently minimal negative symptoms throughout the study period. This group 
comprised the majority of the cohort, suggesting that most EIP patients do not 
present with notable negative symptoms at any point during their first year of 
treatment. 
 
Membership of the class with the highest levels of persistent negative symptoms was 
predicted by male gender and family history of non-affective psychosis. Initially 
high but remitting negative symptoms were predicted by poor premorbid social 
adjustment during adolescence despite relatively good social adjustment during 
childhood. Family history of non-affective psychosis and baseline depression were 
also significant predictors of membership of this group.  
 
In line with previous research linking persistent negative symptoms and poor 
outcome, those with stably elevated negative symptoms were found to be at 
increased risk of experiencing stably low social functioning during their first year 
with EIP than would be expected were negative symptom trajectory and social 
223 
 
recovery independent. Participants with initially elevated but decreasing negative 
symptoms were also at increased risk of stably low social functioning. These 
participants were less likely to experience improving social functioning than those 
whose negative symptoms were consistently minimal, despite the swift remission of 
their negative symptoms.  
 
Given that much of the concern around negative symptoms centres on their 
connection with poor functional outcome, this qualifies any optimism that might be 
generated by the finding that many of those with elevated negative symptoms at 
baseline will experience a remission of these symptoms soon after entering EIP 
services. Similarly, whilst those with consistently minimal negative symptoms were 
more likely to recover socially within 12 months than members of other classes, 
more than half of this group did not make a good social recovery within this period.  
 
8.2.2. Qualitative Studies 
 
The studies described in Part Three aimed to explore the lived-experiences of 
members of the negative symptom trajectory classes identified in Part Two. The 
overarching aim was to better understand the lives of EIP service-users who 
experienced negative symptoms of varying severity and persistence. It was hoped 
that the insight gained would provide clues as to the mechanisms that sustain 
negative symptoms in FEP, and help explain what drives the relationship between 
elevated negative symptoms on entry to EIP and delayed social recovery. In order to 
facilitate these aims, comparisons were made between the experiences of participants 
who were members of different negative symptom trajectory classes. Those with 
stably high negative symptoms and stably mild negative symptoms were merged into 
a single ‘Elevated’ negative symptom group for the purpose of the qualitative studies 
due to the small number of those with the most severe negative symptoms opting to 
take part in the qualitative sub-study. Thus, three groups of participants were 
compared: the ‘Elevated’ group (members of the High Stable or Mild Stable 
trajectory classes), the ‘Decreasing’ group (members of the High Decreasing class), 
and the ‘Minimal’ group (members of the Minimal Decreasing class).  
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Experiences and understandings of negative symptoms themselves were the focus of 
the first qualitative study. Descriptions of phenomena corresponding to the negative 
symptoms construct featured in the accounts provided by members of each of the 
three negative symptom trajectory groups. There were not marked differences in the 
extent to which descriptions of negative symptoms featured in the accounts given by 
members of different trajectory groups, or in the content of these descriptions. Some 
participants described being unable to react to events and other people as they 
usually would, leading to them feeling separated off from the world around them. 
This sense of detachment was encapsulated by the simile ‘like a zombie’, which was 
used by several participants. A minority of participants described decreased internal 
experience, i.e. decreased emotion, thought or drive, during their psychosis. Whilst a 
minority of participants put their negative symptoms down to decreased emotional, 
cognitive or motivation capacity, most participants explained the negative symptoms 
they described as related to medication side-effects, lack of confidence or attempts to 
cope with their difficulties through avoiding challenging or stressful situations.    
 
The second qualitative study explored wider aspects of participants’ experiences of 
FEP, including their understanding of their psychosis, treatment experiences and 
understandings and experiences of recovery. There appeared to be differences in the 
ways in which members of the different negative symptom trajectory groups made 
sense of their experience of psychosis. Elevated and Decreasing group participants 
preferred primarily biomedical explanations of their experiences, whereas Minimal 
participants often expressed more complex, primarily psychosocial explanations. 
Whilst there were many commonalities in the treatment experiences of members of 
different groups, there were also several interesting differences. Participants from the 
Elevated negative symptom group frequently mentioned experiences of 
hospitalisation, whereas members of other groups rarely reported having spent time 
as inpatients. Similarly, members of the Elevated group rarely described having been 
active in deciding the treatment they would receive, whereas Minimal and 
Decreasing group members often expressed that they had been able to exercise a 
good deal of control in relation to their treatment. Conversely, Elevated participants 
rarely spoke about having participated in psychological therapy, whereas this was a 
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prominent theme in the accounts given by members of the Minimal negative 
symptoms group.  
 
The majority of participants from all three groups described themselves as partially 
but not fully recovered. However, there appeared to be differences between groups in 
their members’ understandings of what it means to be in recovery from psychosis. 
The Elevated and Decreasing groups tended to set stringent benchmarks for 
recovery, including both complete remission of symptoms and return to full-time 
paid employment. These participants sometimes felt their role in their recovery to be 
limited to compliance with medical treatment. Members of the Minimal group often 
deemed reduction in the severity or frequency of symptoms, and part-time or 
voluntary work to be sufficient for recovery. The majority of participants from this 
group viewed their role in the recovery process to be an active, ongoing one, 
involving learning to cope with any ongoing or recurring symptoms. 
 
The themes from both qualitative studies that characterised the experiences of each 
negative symptom trajectory group are summarised in Figure 8.1.  
 
 
 
  
 
  
 Figure 8.1. Themes identified in relation to each research question by negative symptom trajectory group.    
 
 
Negative   
Symptoms 
 
 Understandings of  
 Psychosis 
 
  Treatment 
 
Recovery 
 
Elevated Negative 
Symptoms 
 
 
 
 
 
 
 
    
Decreasing Negative 
Symptoms 
 
 
 
 
 
 
 
    
Minimal Negative 
Symptoms 
 
 
 
 
 
 
 
 
 
    
 
 
 
Like a zombie 
 
Medication 
side-effects 
 
A confidence 
thing  
 
Active 
avoidance 
 
 
 
 
 
 
 
 
T
h
e
 
e
a
r
l
y
 
i
n
t
e
r
v
e
n
t
i
o
n
 
t
e
a
m
 
w
a
s
 
a
 
n
i
c
e
 
s
e
t
 
o
f
 
a
r
m
b
a
n
d
s
 
 
 
Just chemical 
imbalances in 
your head 
 
 
It starts with stress 
that’s in your life 
 
 
 
I would like to 
be able to 
make the 
choices 
which led to 
my recovery 
 
Ongoing 
alogia? 
Experiences 
of 
psychological 
therapy 
 
Experiences of 
hospitalisation 
 
 
 
High 
benchmarks for 
recovery 
 
Recovery 
contingent on 
medication 
 
 
 
 
It’s a matter of 
coping 
 
Well, actually, 
I’m in control of 
this 
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8.3. INTEGRATION AND THEORETICAL SIGNIFICANCE OF 
QUANTITATIVE AND QUALITATIVE FINDINGS 
 
Mixed methods research offers the potential to synergise the strengths of quantitative 
and qualitative methods, providing greater advantages than equivalent discrete 
quantitative and qualitative studies. However, it is only through integration of the 
quantitative and qualitative components of a mixed methods investigation that this 
potential can be realised. As such, the aim of this section is to integrate the 
quantitative and qualitative findings described in the previous section in the context 
of the wider negative symptoms literature. Through drawing together these findings 
a conceptual model of negative symptoms and their relationship with poor social 
recovery is proposed. This model is intended to generate hypotheses that might be 
the subject of future empirical investigations.  
  
The quantitative research conducted established that male gender and family history 
of non-affective psychosis predict negative symptom trajectories characterised by 
elevated negative symptoms on entry to EIP. These findings might be interpreted as 
evidence of biological vulnerability to negative symptoms. This interpretation fits 
with neurodevelopmental models of negative symptoms which propose that negative 
symptoms are manifestations of an underlying biological pathology. However, such 
models struggle to explain the swift remission of negative symptoms experienced by 
many participants; if negative symptoms are the manifestation of 
neurodevelopmental pathology then they would be expected to remain stably 
elevated once they emerge. A neurodevelopmental model also struggles to 
accommodate the superior social adjustment during childhood of those who 
presented with initially high but decreasing negative symptom severity relative to 
those with consistently minimal negative symptoms. Such superior adjustment does 
not support the existence of an underlying neurodevelopmental pathology.  
 
Participants’ personal explanations of the negative symptoms they experienced also 
cast doubts on the claim that negative symptoms are direct manifestations of 
neurodevelopmental pathology. Instead, participants’ accounts support the central 
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tenant of cognitive models of negative symptoms: that negative symptoms often 
reflect active coping in the face of difficult psychological and social circumstances. 
If a cognitive approach to understanding negative symptoms is embraced then a 
number of potential non-biological explanations of the predictive relationship 
between family history of non-affective psychosis and negative symptom course 
become available. As previously discussed (section 4.5.2.2), these include the 
possibility that having a close relative with non-affective psychosis might increase 
the risk of experiencing difficult life-events, or of developing maladaptive coping 
strategies. Although neurocognitive factors were not considered in the current 
research, it might also be that a family history of non-affective psychosis is 
associated with neurocognitive impairments. Such neurocognitive impairments 
might be implicated in negative symptoms via their propensity to result in 
discouraging life events, as per Beck et al.’s cognitive model.    
 
It is also possible that having a family history of non-affective psychosis might be 
associated with personality traits that predispose an individual to negative symptoms. 
The aspect of the qualitative work carried out focusing on participants’ identities 
(Appendix D) found that those who experienced persistently elevated negative 
symptoms described themselves in strikingly similar ways. Adjectives such as shy, 
quiet and serious reoccurred across these participants’ self-descriptions and 
participants reported that they would have described themselves similarly even 
before their FEP. This theme might be taken as indicative of a preponderance of 
schizoid personality traits in those who present with persistently elevated negative 
symptoms. This interpretation is supported by evidence that premorbid schizoid 
personality traits are specifically associated with later negative symptom severity in 
both schizophrenia (Cannon, Mednick, & Parnas, 1990; Cuesta, Peralta, & Caro, 
1999) and FEP (Cuesta, Gil, Artamendi, Serrano, & Peralta, 2002). Further, such 
personality traits have been found to be more common among unaffected relatives of 
those with psychosis than in the general population (Shih, Belmonte, & Zandi, 
2004), providing support for the theory that there may be a familial vulnerability to 
schizoid traits. 
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A number of mechanisms might account for this association between schizoid 
personality traits and negative symptom severity. It might be that, in line with 
neurodevelopmental models of negative symptoms, schizoid personality traits are the 
premorbid manifestation of the neurodevelopmental abnormalities that later manifest 
as negative symptoms. There is considerable overlap between schizoid personality 
traits, which include taking limited interest and pleasure in experiences and 
activities, having few close relationships, a preference for solitary activities and 
emotional detachment or affective flattening (American Psychiatric Association, 
2013), and negative symptoms. The degree of overlap is such that it often difficult to 
distinguish between these personality traits and emergent negative symptoms 
(Cuesta et al., 2007). Alternatively, schizoid traits might be linked to negative 
symptoms more indirectly. For instance, it might be that individuals with these traits 
are more likely to have discouraging experiences and thus to develop the 
dysfunctional beliefs and negative expectancies proposed by cognitive models to lie 
behind negative symptoms. This is in line with Staring et al.’s (2013) suggestion that 
impairments in behavioural and emotional functioning, as well as in cognition, might 
lead to the discouraging experiences that contribute to negative expectancies.  
 
The association between schizoid personality traits and negative symptoms might 
also be relevant to understanding why those who present with persistently elevated 
negative symptoms are more often male. Schizoid personality disorder is more 
common in men than in women (Corbitt & Widiger, 1995; Samuels et al., 2002); 
given that personality disorders and traits lie on a continuum with one another, it is 
reasonable to assume that gender differences in disorders reflect gender differences 
in personality traits (Paris, 2004). Thus, the relationship between following a 
trajectory of stably high negative symptoms and male gender observed in this study 
might be explained by population level differences in the personality traits of men 
and women.  
 
The quantitative findings described in this thesis suggest that a swift reduction in 
negative symptoms during the first 12 months of treatment is not associated with a 
corresponding improvement in functioning. The findings of the qualitative research 
suggest a possible explanation of this finding. Those who presented with a negative 
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symptom course characterised by elevated baseline negative symptoms tended to 
express a more passive attitude to their recovery than those who negative symptoms 
were consistently minimal. Participants from groups with more severe negative 
symptoms often conveyed a sense of having little agency in relation to their 
recovery, believing their role to be largely limited to complying with medical 
treatment. Their attitudes contrasted with those of most participants who presented 
with consistently minimal negative symptoms who spoke about recovery as an active 
process of learning to cope. As such, it might be that the relationship between 
negative symptoms and social recovery is, in part, explained by the attitudes towards 
and beliefs about recovery of those who have experienced more prominent negative 
symptoms. If this were the case, then it would be possible for negative symptoms to 
decrease but the beliefs and attitudes associated with them to have an ongoing 
impact on social recovery.  
 
While it is not clear why negative symptoms should be associated with more passive 
attitudes to recovery, one possibility already discussed is that the understanding of 
psychosis an individual holds affects their sense of agency in their recovery. Those 
with a biomedical view of psychosis might feel that there is not much they can do to 
assist their recovery beyond taking their medication, whereas those who view 
psychosis as an experience with a psychosocial cause may believe themselves to be 
more able to alter the course of their recovery. Thus, the predominantly biomedical 
understandings of psychosis expressed by those who presented with elevated 
negative symptoms might account for their relatively passive attitude to recovery. 
Further, it is plausible that having little control over the treatment you receive, found 
in the qualitative research to be a common experience of those with elevated 
negative symptoms, might engender a passive attitude to recovery. Conversely, it 
might also be that having a passive attitude to recovery makes one less likely to 
exercise control over one’s treatment.  
 
These considerations led to the development of a conceptual model of the 
relationship between negative symptoms and poor social recovery in FEP. The 
model integrates both quantitative and qualitative findings from this thesis and posits 
231 
 
possible causal mechanisms on the basis of existing theory as outlined above. The 
model is depicted graphically in Figure 8.2. 
 
 
Figure 8.2. Conceptual model of the relationship between negative symptoms and 
poor social recovery in FEP. 
 
 
According to this model, avoidant coping strategies, lack of self-confidence and 
medication side-effects are the most proximal contributors to negative symptoms. 
Medication side-effects, for instance weight-gain, are also proposed to feed into lack 
of confidence and avoidance, contributing to negative symptoms indirectly as well as 
directly. Schizoid personality traits, perhaps related to familial vulnerability and 
male gender, are proposed to predispose an individual towards avoidant coping 
strategies, and to lead indirectly to lack of confidence via poor premorbid 
adjustment. This poor premorbid adjustment is proposed to directly contribute to 
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poor social recovery: an individual who has struggled to function effectively prior to 
an episode of psychosis is likely to find it difficult to recover a good level of 
functioning in its aftermath. However, there is also a hypothesised indirect pathway 
from poor premorbid adjustment to poor social recovery via negative symptoms.  
 
A passive attitude to recovery, in which the participant sees compliance with medical 
treatment as their primary role in their recovery, is also hypothesised to contribute to 
poor social recovery. This passive attitude to recovery is proposed to stem both from 
negative symptoms themselves and also factors relating to the treatment of FEP 
patients with elevated negative symptoms, including exercising little control over the 
treatment they receive, experiences of hospitalisation, and lack of engagement with 
psychological therapies. Having limited control over treatment decisions is 
hypothesised to have a direct, bidirectional relationship with passive attitudes to 
recovery. Experiences of hospitalisation and lack of psychological therapy are 
proposed to contribute to a passive attitude to recovery indirectly by fostering a 
biomedical understanding of psychosis.   
 
This model is not intended to be definitive: it is almost certainly flawed and 
incomplete. Instead, it is intended to generate hypotheses that can be the subject of 
empirical investigation; the model might then be refined and adapted accordingly. 
While only concepts that figured in the current research are included in the present 
version of the model, other factors not featuring in the current research could also be 
incorporated. For instance, neurocognitive impairment might be included as a 
premorbid factor that contributes to poor social functioning directly and to negative 
symptoms indirectly via low confidence and avoidant coping. Wider societal factors 
could also be incorporated, for instance cultural beliefs about the nature of mental 
health problems and those who experience them.   
 
8.4. CLINICAL IMPLICATIONS 
 
Negative symptoms are a key area of clinical concern due to their well-established 
relationship with poor outcomes and the currently limited options for their treatment. 
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The findings of this thesis suggest that individuals whose negative symptoms follow 
a trajectory characterised by elevated negative symptoms at baseline, regardless of 
the path of those symptoms over the next 12 months, are at increased risk of delayed 
social recovery. As such, a case could be made for providing targeted interventions 
for those who present with notable negative symptoms on entry to EIP services in an 
effort to improve rates of social recovery. However, given the poor social recovery 
of those in the present research whose negative symptoms remitted, it is not clear 
that successfully reducing negative symptoms would meet the aim of improving 
social recovery following FEP.  
   
Given that elevated negative symptoms at treatment onset are associated with 
persistent social disability over the subsequent year whether or not they then remit, it 
may be that we need to interrupt the formation of negative symptoms before the 
onset of psychosis in order to have a significant impact on later functioning. This 
would require intervening at the first signs of non-specific negative symptoms: likely 
before the emergence of attenuated positive symptoms. Given the likelihood that 
most individuals identified at such an early stage will never go on to develop 
psychosis, intervening at this stage might be deemed disproportionate. However, 
there is evidence that even amongst individuals who do not go on to develop 
psychosis, prodromal negative symptoms are an important predictor of poor long-
term outcomes (Lin et al., 2011). Therefore, if our aim is to prevent suffering and 
disability regardless of diagnostic categorisation, offering appropriate help at the first 
signs of emerging negative symptoms may well be justified. This might be achieved 
by screening young people seeking help from mental health services, and perhaps 
other at risk groups, for negative symptoms.  
 
The conceptual model set out in the previous section would suggest that the 
development of psychosocial interventions designed to increase confidence, and 
reduce the use of avoidant coping strategies through behavioural experiments 
designed to challenge negative expectancies and increase positive self-concept may 
be fruitful in reducing early negative symptoms. Social Recovery Cognitive 
Behavioural Therapy is a new psychological intervention with a strong behavioural 
focus which aims to improve social functioning through instilling hope and fostering 
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a more positive self-concept (Fowler et al., 2013; Fowler et al., 2009b). Individuals 
are encouraged to test their beliefs about increasing activity in behavioural 
experiments and are supported to engage in activities in line with their values and 
goals. The intervention is currently being trialled in a group of young people at risk 
of socially disabling severe mental illness, including those at high risk of psychosis, 
and has been found to be well accepted by this group (Gee et al., 2016; see Appendix 
E). If this intervention is successful in improving social functioning in this group, it 
would be interesting to explore whether the amelioration of negative symptoms has a 
role in this improvement.  
      
The model proposed suggests that instilling a less passive attitude to recovery may 
be important to improving social functioning once an individual has experienced 
their first psychotic episode. Psychological therapies similar to that just described 
might conceivably be effective in creating a more active stance towards recovery. 
However, if the conceptual model proposed is correct, the services provided to 
individuals with persistently elevated negative symptoms must also be considered. 
Further research is necessary both before we can conclude that there are differences 
in the services offered and/or utilised by those with persistently elevated negative 
symptoms relative to those without and before we can be sure of the role of attitudes 
to recovery in the rate of social recovery following FEP. In the interim, it may be 
worth encouraging clinicians to be mindful of any differences in the services 
provided to individuals who present with prominent negative symptoms versus those 
who do not, and to consider whether any differences are clinically warranted.  
 
Key findings of the current research were presented at a seminar for local clinicians 
held on 23 May 2016. The seminar was organised in conjunction with a clinical 
psychologist from CNEIT and was well attended by clinicians from a range of 
professional backgrounds working with young people experiencing psychotic 
symptoms. The aim of the seminar was to disseminating the findings of the research 
in order to maximise its impact locally, and to facilitate the exchange of knowledge 
and ideas regarding the nature of early negative symptoms and how services can best 
support young people who experience them. This knowledge exchange process also 
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enabled feedback on the clinical relevance of the research findings, and potential 
future directions, to be gathered.  
 
8.5. EVALUATION  
 
8.5.1. Strengths 
 
A key strength of the research described in this thesis is the large, ecologically valid 
cohort from which its participants were drawn. EDEN is the largest cohort study of 
UK EIP service-users to be carried out to date and negative symptom data were 
available at one time point or more for 98% of the cohort. The large sample sizes this 
facilitated were particularly advantageous for the quantitative research, providing 
good statistical power and increasing the generalisability of the studies’ findings. 
The large number of participants also allowed for statistical techniques not 
appropriate for use with smaller sample sizes to be employed. Recruitment rates to 
EDEN were good – the study succeeded in recruiting 49% of all EIP service-users in 
the participating regions during the 3.5 year recruitment window – and the available 
data on non-participating service-users did not suggest any major socio-demographic 
differences between participants and non-participants (Birchwood et al., 2014) 
suggesting the cohort was broadly representative of EIP service-users in the UK. No 
special inclusion criteria beyond the participant being an EIP service-user were 
imposed and the study was purely observational, minimising selection bias and 
increasing ecological validity.  
 
The sampling frame for the qualitative studies comprised transcripts of in-depth 
interviews with 162 EDEN participants, many of whom participated in multiple 
interviews. Sample size is generally considered to be a less relevant consideration in 
the evaluation of qualitative research. However, in the case of the qualitative 
research described in this thesis, the large sampling frame was a distinct advantage. 
Given the extremely small proportion of High Stable class participants who took part 
in a qualitative interview (4%), it is likely that a smaller scale study with fewer 
resources would have failed to capture the views of any such participants. The 
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relatively large sample sizes afforded by the wealth of available transcripts was also 
important to fulfilling the comparative aims of the qualitative studies; only by 
sampling a sufficiently diverse range of participants from each negative symptom 
trajectory class could meaningful comparisons between groups be made.   
 
Further strengths of the research stem from its mixed methods design. Use of mixed 
methods allowed a broader range of research questions to be addressed than would 
have been possible if only either quantitative or qualitative methods had been 
employed. Further, the use of qualitative methods gave voice to the experiences of 
individual service-users, avoiding the research becoming divorced from the lived-
experience of its participants and countering the somewhat normative approach to 
understanding negative symptoms and social recovery adopted in the quantitative 
studies. Integration of the quantitative and qualitative findings prompted the 
development of a conceptual model of negative symptoms and their relationship with 
poor social recovery that might be the subject of future empirical investigations. 
 
8.5.2. Limitations 
 
Since major limitations specific to each of the studies described in this thesis have 
been outlined in their respective chapters, this section will focus on limitations that 
apply to the research as a whole.  
 
All of the studies outlined in this thesis suffer as a result of the relationship between 
negative symptom severity and the likelihood of participation (or continued 
participation) in the research. In the case of the quantitative studies, the greater 
attrition of members of the cohort with less severe negative symptoms undermined 
the assumption that data were missing at random, making it almost certain that some 
bias will have been introduced. In the case of the qualitative research, the small 
number of participants within the sampling frame who had presented with 
persistently high levels of negative symptoms resulted in the experiences of only a 
small number of such participants being included in the analysis.  
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The reluctance of those who had the most severe negative symptoms to participate in 
qualitative interviews is hardly surprising. However, the greater loss to follow-up of 
participants with fewer negative symptoms was entirely unexpected. Indeed, it was 
anticipated that the reverse may be a problem: that those with more severe negative 
symptoms might be more likely to decline participation as a result of low motivation 
and reluctance to meet with an unfamiliar Research Assistant. However, reflection 
on my personal experience of following-up EDEN participants generated a number 
of potential explanations of the better retention of those with higher levels of 
negative symptoms.  
 
First, individuals who had apparently made a good recovery from their psychosis 
were generally no longer in touch with mental health services, meaning contacting 
them to invite them to participate was more difficult. Additionally, those who had 
apparently made a good recovery were often working full-time, and had busy social 
and family lives. As a result, they were not always willing or able to spare the time 
to take part in follow-up assessments. In contrast, those participants I met who 
presented with pronounced negative symptoms were still under the care of mental 
health services, and often had few daily activities to fill their time. As such, they 
were generally easily contactable and available to participate in follow-up 
assessments.  
 
Negative symptoms were treated as a unitary phenomenon for the purpose of this 
thesis. The coherence of the symptoms identified as negative symptoms in this study 
was supported by the initial factor analyses. However, it is possible that this might 
have been an artefact of the methods employed. Given that the negative symptoms 
construct encompasses a broad range of different behaviours and experiences, a 
single symptom approach might arguably have yielded more nuanced findings. In 
particular, given the recent consensus that negative symptoms reflect deficits in two 
distinct domains (see section 1.4.3), not having distinguished between the expressive 
and motivational domains is a significant limitation of this thesis. It is possible that 
these two types of negative symptoms change independently over time, have 
differing patterns of association with other variables, differ in their relationship to 
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social recovery, and give rise to quite different lived-experiences. These possibilities 
may provide fruitful topics of future investigations.   
 
Since the design of the research was purely observational, its findings are unable to 
justify any causal claims. Members of the latent trajectory classes identified differed 
in respect to many factors in addition to their negative symptom course. As such, it is 
quite possible that features found to characterise members of the classes identified 
were only indirectly related to their negative symptom trajectories. For instance, it is 
possible that those who presented with stably elevated negative symptoms also 
presented with more severe psychopathology in other domains. Thus, factors found 
to predict membership of this class, and the features found to be characteristic of 
group members’ lived-experiences, might be accounted for by their greater overall 
psychopathology as opposed to their negative symptom course per se. More 
sophisticated study designs will be required to begin to unpick the nature of the 
relationships observed in the current research.  
 
Whilst the utilisation of pre-existing data was the source of many of the strengths of 
the work described in this thesis, it also imposed constraints. In an inversion of the 
standard research process, the research questions were shaped by the data that was 
available; the measurement of variables, the timing of assessments and the content of 
topic guides were all fixed prior to the conception of the studies. These constraints 
resulted in several of the weaknesses described in previous chapters. For instance, as 
previously discussed (sections 1.4.1 and 3.1), the use of the PANSS to measure 
negative symptoms has been criticised. Although efforts were made to overcome 
these limitations to the extent possible, its use to measure negative symptoms 
remains an important limitation of the research.  
 
A further limitation attributable to the use of secondary data is that some of the data 
on which this thesis is based were collected as much as a decade ago. The majority 
of participants received EIP care in the latter half of the 2000s. NHS mental health 
services have faced significant financial challenges since the turn of the decade, 
leading to sizeable decreases in EIP service budgets. EIP services experienced a £16 
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million (26%) reduction in their budget over the course of the 2010 – 2015 
parliament, despite an increase in referrals over this period (McNicoll, 2015). In a 
survey conducted by Rethink Mental Illness in 2014, 58% of EIP teams reported a 
reduction in staff members in the previous 12 months and 53% said that they 
believed the quality of the service they were able to provide had deteriorated 
(Rethink Mental Illness, 2014). The report also highlighted that some regions have 
merged their EIP services into Community Mental Health Teams in order to reduce 
costs. As a result, it is likely that the experiences of young people currently 
experiencing FEP will be somewhat different from the experiences of the 
participants in the research presented in this thesis. As such, a degree of caution 
should be exercised in generalising the findings of this thesis to current service-
users. 
 
8.6. FUTURE DIRECTIONS 
 
This thesis has focused on the trajectory of overall negative symptom severity over 
the 12 months immediately following the initiation of EIP treatment. Future research 
might consider whether patterns of negative symptom change observed during the 
first 12 months of treatment are sustained in the longer term, and whether they are 
prognostic of longer-term functioning or other clinically important outcomes. 
Exploration of trajectories of change in each of the two negative symptoms 
subdomains – diminished expression and withdrawal – taken separately would also 
be a worthwhile endeavour, since it is plausible that one subdomain may be more 
stable than the other. Relatedly, if it were to prove possible to identify subgroups of 
FEP patients with distinct profiles of negative symptoms (characterised by either 
predominant expressive deficits or predominant motivational deficits), it would be 
interesting to compare the negative symptom trajectories of these subgroups.   
 
Future research should also focus on the course of negative symptoms during the 
prodromal phase of the disorder and consider the relationship between these earliest 
trajectories and the course of an individual’s negative symptoms following transition 
to psychosis. Research exploring the nature and course of negative symptoms as they 
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manifest prior to the onset of frank psychotic symptoms will be of crucial 
importance in understanding how and why they develop. Considering the 
relationship between prodromal negative symptom trajectories, concurrent 
functioning and later social recovery will also be important in understanding the 
long-term impact of early negative symptoms.  
 
The quantitative research undertaken for this thesis focused on baseline predictors of 
negative symptom course and as such did not consider the potential influence of 
treatment on negative symptom course. EIP services offer a range of evidence-based 
treatments depending on the needs and preferences of individual service-users. As 
such, members of an FEP cohort are likely to have received a wide variety of 
interventions, including antipsychotic medications, mood stabilisers and 
antidepressants, psychological therapies, family interventions, and occupational 
support. Further, levels of service engagement and medication concordance vary 
across individuals. Previous research suggests that EIP treatment might have a 
beneficial impact on negative symptoms (Thorup et al., 2005) but it is not clear 
which elements of the service are responsible for this. It is possible that differences 
in treatment contribute to subsequent differences in negative symptoms course. 
However, as previously discussed, it might also be that the course of an individual’s 
negative symptoms impacts the treatments he or she receives. Research investigating 
this potentially bi-directional relationship is needed to establish the impact of EIP 
treatment on negative symptoms and vice versa.    
 
A central component of the model developed to explain the findings of this thesis 
suggests that the course of an individual’s negative symptoms may influence their 
attitude to recovery and, in turn, their social recovery. However, this theory remains 
in need of empirical support. Future research should investigate whether beliefs 
about recovery are relevant to understanding the relationship between negative 
symptom course and social recovery. There were close parallels between the 
understandings of psychosis and attitudes to recovery found to be characteristic of 
those with differing negative symptom courses in the current research and 
McGlashan’s recovery styles. As such, investigating whether there are differences in 
the recovery styles of those with and without persistent negative symptoms, and 
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whether any such differences can account for discrepancies in social recovery rates, 
might be a fruitful line of research. If the hypothesis that the relationship between 
negative symptom course and social recovery is mediated by attitude to recovery is 
supported, this would offer hope that social recovery rates following FEP could be 
improved by intervening to help those presenting with elevated negative symptoms 
on entry to EIP to develop more adaptive attitudes to recovery. 
 
Ultimately, there is little merit in gaining a better understanding of negative 
symptoms in FEP if this is not translated into better outcomes for service-users. 
Therefore, further research seeking to develop and evaluate treatment options for 
individuals who experience debilitating negative symptoms in the context of early 
psychosis is vital. It is hoped that the work described in this thesis might be of some 
assistance to those working to develop interventions with the potential to improve 
the lives of those who experience negative symptoms.  
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APPENDIX A. Supplementary Material 
 
Supplementary Table. Factors and standardised item loadings for EFA six-factor 
solution, factors 2 and 6 (with identical indicating items to the factors labelled 
‘Negative’ and ‘Withdrawn’ in van den Oord et al.’s model). 
PANSS Items 
 
Factor Loading 
 
Factor 2 – Negative Symptoms (Expression) 
N6 Lack of spontaneity and flow of 
conversation 
N1 Blunted affect 
N3 Poor rapport 
G7 Motor retardation 
 
Factor 6 – Negative Symptoms (Withdrawal) 
N4 Passive social withdrawal 
G16 Active social avoidance  
N2 Emotional withdrawal 
 
 
0.797 
 
0.745 
0.697 
0.684 
 
 
0.738 
0.546 
0.506 
 
 
 
 
Supplementary Figure. LCGA with Four Latent Classes for Participants with 
Complete Data at Baseline and At Least One Subsequent Time Point: Average 
Negative Symptom Score Estimated Means.  
  
  
APPENDIX B. Ethics Documentation 
 
B1. Letter of ethical approval 
B2. Participant information sheets 
B3. Consent and assent forms  
 




  
 
PATIENT INFORMATION SHEET 
(Over 16 years) 
May 2005: Version 2. 
 
Study Title: A National Evaluation of Early Intervention in Psychosis Services: DUP, Service 
Engagement and Outcome  (The National EDEN Project).  
 
You are being invited to take part in a research study.  Before you decide whether or not you wish to take 
part, it is important for you to understand why the research is being done and what it will involve.  Please 
take time to read the following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.   
 
The purpose of the study: 
The aim of the project is to evaluate the implementation and impact of Early Intervention Services (EIS) 
for people aged between 14-35 years of age in different areas of the country. 
 
Why have I been chosen? 
We are inviting everyone aged between 14-35 years of age who has been referred to the Early 
Intervention Service to take part in this study. This will involve approximately 800 young people across 
the country. 
 
Do I have to take part? 
No - involvement in this study is entirely voluntary.  However if you decide to take part, you are still free 
to withdraw at any time without giving a reason.  A decision to withdraw at any time, or a decision not to 
take part, will not affect the standard of health care you receive now or in the future. 
 
What will happen to me if I take part? 
If you agree to take part in the study, we will use the data from assessments that have been completed 
with you by the clinical team.  The data will be put into a database and analysed together with data from 
other clients of the Early Intervention Service (EIS).  All data will be anonymised.  We would also like to 
ask you some questions about when you first became unwell, including any incidences of self-harm or 
violence.  This is to determine how you came into contact with the EIS, and also how long you were 
unwell before contact was made with services.   
 
At this stage we will ask a small number of people (20 in each service, over 2 years) to also take part in a 
face-to-face interview with a trained researcher who is part of the research team, about their experiences 
of the Early Intervention Service. The researcher will ask you questions about how easy services are to 
access, the types of treatments you have been offered, and your general observations on the treatment you 
have received. The interview will be in a place where you feel comfortable, for example in a quiet room 
in the Early Intervention Service or in your own home. If you like, you can invite a relative or carer to be 
present during the interview.   
 
You may also be asked whether you feel that it is appropriate for the research team to contact a friend or 
relative to ask similar questions.  However, this contact will only be made with your permission and the 
purpose of this contact is to provide them with an opportunity to share their perceptions of how the Early 
Intervention Service has responded to your needs. 
  
What are the possible side effects of taking part? 
Some of the questionnaires may cover issues that are sensitive and/or distressing for you – you can stop if 
you feel uncomfortable at any stage of the interview, and refuse to answer questionnaires that you feel are 
too distressing. 
 
What are the possible benefits of taking part? 
At a national level, since up to 3% of people in the UK develop a serious mental illness, access to good 
quality mental health services at an early stage of developing an illness may improve an individual’s 
chances of recovery and the quality of life for individuals and their families. On a personal level, 
involvement in the project may help you think about and reflect more on your treatment and the treatment 
you would like to receive in future. 
 
What will happen when the research study stops? 
This research study lasts for 2 years from July 2005. There will be no change to your care or to services 
when the study stops, but we hope that the final results of the study will help the health professionals 
involved in running Early Intervention Services to make changes in the medium to longer term to further 
improve services. The results of the study will be written up in 2008, you will be able to obtain findings 
from this project on www.iris-initiative.org.uk and the Rethink website www.rethink.org  
 
Will my taking part in this study be kept confidential? 
All information collected as part of this research, including questionnaires, typed up notes of interviews 
and tape recordings of interviews will be kept in a locked filing cabinet in the Department of Primary 
Care and General Practice at the University of Birmingham.  Any information from or about you will 
have your name, address and any other identifying features removed, so that you cannot be recognised 
from it. This means that your anonymity will be preserved at all times during and after the study time 
period. The tapes will be destroyed 5 years after the study has been completed in line with University of 
Birmingham research policy. 
 
What will happen to the results of the research study? 
The results of the study will be written up for publication in health professional journals and will be 
presented at conferences in the UK and abroad. However your anonymity will be preserved at all times. 
 
Who is organising and funding the research? 
The research is organised by The University of Birmingham, Department of Primary Care and General 
Practice and funded by a grant from the Department and Health and NIMHE (National Institute for 
Mental Health in England).  Indemnity is provided by the University of Birmingham. The protocol has 
been reviewed by the Suffolk Local Research Ethics Committee. 
 
Contact for Further Information 
Dr Helen Lester, Senior Lecturer in Primary Care, on 0121 414 2684, or Dr Natasha Posner, (National 
EDEN Project Evaluation Coordinator), on 0121 414 8581, Department of Primary Care and General 
Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT.  If you agree to participate, you 
will be given a copy of this Patient Information Sheet and a copy the signed consent form to keep. 
 
If you have any concerns about the study and wish to contact someone independent, please telephone Ella 
Wright, the local ethics committee co-ordinator on 0121 507 5712 between 9am and 5pm.  
 
Thank you for reading this. 
 
 
 
 
 
 
PATIENT INFORMATION SHEET 
(Under 16 years) 
May 2005: Version 2. 
 
Study Title: A National Evaluation of Early Intervention in Psychosis Services: DUP, Service 
Engagement and Outcome  (The National EDEN Project).  
You are being invited to take part in a research study.  Before you decide whether or not you wish to 
take part, it is important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if you wish.  
Ask us if there is anything that is not clear or if you would like more information.   
 
The purpose of the study: 
The aim of the project is to evaluate the implementation and impact of Early Intervention Services 
(EIS) for people aged between 14-35 years of age in different areas of the country. 
 
Why have I been chosen? 
We are inviting everyone aged between 14-35 years of age who has been referred to the Early 
Intervention Service to take part in this study. This will involve approximately 800 young people 
across the country. 
 
Do I have to take part? 
No – involvement in this study is entirely voluntary.  However if you decide to take part, you are still 
free to withdraw at any time without giving a reason.  A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of health care you receive now or in the future. 
 
What will happen to me if I take part? 
If you agree to take part in the study, we will use the data from assessments that have been completed 
with you by the clinical team.  The data will be put into a database and analysed together with data 
from other clients of the Early Intervention Service (EIS).  All data will be annonymised.  We would 
also like to ask you some questions about when you first became unwell, including any incidences of 
self-harm or violence.  This is to determine how you came into contact with the EIS and also how long 
you were unwell before contact was made with services.   
 
At this stage we will ask a small number of people (20 in each service, over 2 years) to also take part 
in a face-to-face interview with a trained researcher who is of the research team, about their 
experiences of the Early Intervention Service. The researcher will ask you questions about how easy 
services are to access, the types of treatments you have been offered and your general observations on 
the treatment you have received. The interview will be in a place where you feel comfortable, for 
example in a quiet room in the Early Intervention Service or in your own home. If you like, you can 
invite a relative or carer to be present during the interview.   
 
You may also be asked whether you feel that it is appropriate for the research team to contact a friend 
or relative to ask similar questions.  However, this contact will only be made with your permission and 
the purpose of this contact is to provide them with an opportunity to share their perceptions of how the 
Early Intervention Service has responded to your needs. 
What are the possible side effects of taking part? 
Some of the questionnaires may cover issues that are sensitive and/or distressing for you – you can 
stop if you feel uncomfortable at any stage of the interview, and refuse to answer questionnaires that 
you feel are too distressing. 
 
What are the possible benefits of taking part? 
At a national level, since up to 3% of people in the UK develop a serious mental illness, access to 
good quality mental health services at an early stage of developing an illness may improve an 
individual’s chances of recovery and the quality of life for individuals and their families. On a 
personal level, involvement in the project may help you think about and reflect more on your treatment 
and the treatment you would like to receive in future. 
 
What will happen when the research study stops? 
This research study lasts for 2 years from July 2005. There will be no change to your care or to 
services when the study stops, but we hope that the final results of the study will help the health 
professionals involved in running Early Intervention Services to make changes in the medium to 
longer term to further improve services. The results of the study will be written up in 2008, you will be 
able to obtain findings from this project on www.iris-initiative.org.uk and the Rethink website 
www.rethink.org  
 
Will my taking part in this study be kept confidential? 
All information collected as part of this research including questionnaires, typed up notes of interviews 
and tape recording of interviews will be kept in a locked filing cabinet in the Department of Primary 
Care and General Practice at the University of Birmingham.  Any information from or about you will 
have your name, address and any other identifying features removed so that you cannot be recognised 
from it. This means that your anonymity will be preserved at all times during and after the study time 
period. The tapes will be destroyed 5 years after the study has been completed in line with University 
of Birmingham research policy. 
 
What will happen to the results of the research study? 
The results of the study will be written up for publication in health professional journals and will be 
presented at conferences in the UK and abroad. However your anonymity will be preserved at all 
times. 
 
Who is organising and funding the research? 
The research is organised by The University of Birmingham, Department of Primary Care and General 
Practice and funded by a grant from the Department and Health and NIMHE (National Institute for 
Mental Health in England).  Indemnity is provided by the University of Birmingham. The protocol has 
been reviewed by the Suffolk Local Research Ethics Committee. 
 
Contact for Further Information 
Dr Helen Lester, Senior Lecturer in Primary Care, on 0121 414 2684, or Dr Natasha Posner, (National 
EDEN Project Evaluation Coordinator), on 0121 414 8581, Department of Primary Care and General 
Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT. If you agree to participate, 
you will be given a copy of the Patient Information Sheet and a copy the signed consent form to keep. 
If you have any concerns about the study and wish to contact someone independent, please telephone 
Ella Wright, the local ethics committee co-ordinator on 0121 507 5712 between 9am and 5pm.  
 
Thank you for reading this. 
 
  
 
 
 
Centre No: 
Patient Identification No for this study: 
 
PATIENT CONSENT FORM 
 
May 2005- Version 2. 
 
Study Title: 
A National Evaluation of Early Intervention in Psychosis Services: Dup, Service Engagement and 
Outcome (The National EDEN Project). 
 
Name of Researcher: 
 
 Please initial box 
 
1. I confirm that I have read and understand the information sheet dated May 2005 (version 2) for 
the above study and have had the opportunity   to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by responsible individual 
from the Early Intervention service, and/or research staff from the University of Birmingham or 
from regulatory authorities where it is relevant to my taking part in research.  I give permission 
for these individuals to have access to my records. 
 
4. I agree to take part in the above study. 
 
 
 
____________________     ________________  _______________ 
Name of Patient    Date    Signature 
 
____________________   ________________  _______________ 
Name of Person taking consent  Date    Signature 
(if different from researcher) 
 
 
______________________   _________________  ________________ 
Researcher     Date    Signature 
 
 
 
 
 
 
 
 
 
 
 
Centre No: 
Patient Identification No for this study: 
 
PATIENT ASSENT FORM 
May 2005 - Version 2. 
 
Study Title: 
A National Evaluation of Early Intervention in Psychosis Services: Dup, Service Engagement and 
Outcome (The National EDEN Project). 
 
Name of Researcher: 
 
The relative/legal guardian should complete the whole of this sheet himself/herself 
 
 Please initial box 
 
1. I confirm that I have read and understand the information sheet dated May 2005 (version 2) for  
the above study and have had the opportunity to ask questions. 
 
2. I understand that my relative’s participation is voluntary and that s/he is free to withdrawal any 
time, without giving any reason, and without her/his medical care or legal rights being affected. 
 
3. I understand that sections of any of my relative’s medical notes may be looked at by responsible 
individuals from the Early Intervention Service, and/or research staff from the University of 
Birmingham or from regulatory authorities, where it is relevant to my taking part in research.  I  
give permission for these individuals to have access to my relative’s records. 
 
4. I agree to my relative taking part in the above study.     
 
 
 
 
____________________     ________________  _______________ 
Name of Carer    Date    Signature 
 
 
____________________  ________________  _______________ 
Name of Person taking consent  Date    Signature 
(if different from researcher) 
 
 
______________________  _________________  ________________ 
Researcher    Date    Signature 
 
 
 
 
 
 
Centre No: 
Patient Identification No for this study: 
 
PATIENT CONSENT FORM (Under 16 years) 
May 2005- Version 2. 
 
Study Title: 
A National Evaluation of Early Intervention in Psychosis Services: Dup, Service Engagement and 
Outcome (The National EDEN Project). 
 
Name of Researcher: 
 
 Please initial box 
 
1. I confirm that I have read and understand the information sheet dated May 2005 (version 2) for 
the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, and without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by responsible 
individuals from the Early Intervention Service, and/or research staff from the University of 
Birmingham or from regulatory authorities where it is relevant to my taking part in research.  I 
give permission for these individuals to have access to my records. 
 
4. I agree to take part in the above study. 
 
 
 
 
____________________     ________________  _______________ 
Name of Patient   Date    Signature 
 
 
____________________  ________________  _______________ 
Name of Person taking consent  Date    Signature 
(if different from researcher) 
 
 
______________________  _________________  ________________ 
Researcher    Date    Signature 
 
 
 
 
 
  
APPENDIX C. Topic Guides for Qualitative Interviews 
 
C1. Super EDEN Topic Guide Version 1 
C2. Super EDEN Topic Guide Version 2 
C3.  Super EDEN Topic Guide Version 3 
 
  
Super EDEN Topic Guide Version 1 
 
Topic Guide for Service Users 
 
Sustaining positive engagement and recovery (SuperEDEN) - the next step after 
early intervention for psychosis 
 
SITE:     PARTICIPANT:  
 
Interviewer: 
 
Date:  
 
Build rapport 
 
Be sure to introduce yourself and explain the project 
 
Help the Service User feel at ease 
 
General situation 
 
How have you been feeling recently? 
 
Please can you describe what you do at the moment and where you live (explore 
activities, income and interests) 
 
Can you describe the things that are most important to you at the moment? 
 
Tell me about your experience with the EIS… 
 
What was the background for you starting in EIS? 
 
When you started, what did you think of the EIS? (Prompt: has your view changed over 
time? If so, how?) 
 
If you were talking to another person that was about to start with the EIS, what would 
you tell him/her? 
 
Compared to before you started, has EIS made a difference to you? (Prompt: What you 
do and how you feel?)  
 
What do you like most about the EIS? 
 
What do you like least about the EIS? 
 
How could the EIS work better for you? (Prompt: what should change, how?) 
 
How long do you think people should spend with EIS? 
 
 
 
 
 
Super EDEN Topic Guide Version 1 
 
Other services 
 
How does the EIS compare to other types of services you have experienced? (Please 
also include services for physical health problems) 
 
How often do you see your GP? 
In which situations do you see your GP? (Prompt: for which problems and illnesses) 
Does your GP support your mental health? (Explore reasons for views) 
 
Support 
 
How does your family view your problem? 
What sorts of things do your family help you with? 
Who do you feel give you most support? 
Is there any kind of support you feel is missing from your life? 
 
Illness perception 
How do you understand your problem/what happened to you? 
 
What does this experience mean to you? 
 
Has it influenced how you see yourself and your life? 
 
 
Relapse plan 
 
If your mental health would get worse, would you know what to do? (Prompt: Do you 
have a relapse plan?) 
 
Can you describe how the plan was created? 
 
To what extent do you consider yourself active in creating the plan? 
 
Does the plan meet your needs? (Explore answers and thinking behind) 
 
 
Goals and Recovery 
 
How do you see yourself in the future? 
 
What role do you see mental health playing in your life? 
 
What do you feel you will be doing in 12 months? 
 
Thank you for speaking with me - Is there anything else you would like to say about the 
EIS that was not covered in these questions? 
 
 
Super EDEN Topic Guide Version 2 
 
 
 
 
 
SUPEREDEN STUDY TWO: Exploring Service Users’ and Caregivers’ Lived Experiences of 
Psychosis and its Treatment through Early Intervention Services 
 
 
 Interview Information Sheet for Participants:   Service Users 
In this round of interviews we would particularly like to gain an understanding of the experience of 
psychosis, and to explore ways in which a person’s life, or their sense of who they are, might 
change during an episode, through recovery, and beyond. We want to listen to what is important to 
you about psychosis, recovery or treatment and to learn about daily life during these experiences.  
With all participants, we would like to briefly explore any issues around physical health and/or 
medications that you may have.  
However, there are also four other main interview themes to this part of the study. These are 1) 
Identity 2) Psychosis 3) Recovery and 4) Family. From these we would like you to choose 
which theme or themes you’d like to discuss during the interview today. You could talk about only 
one or two themes or you could discuss all of them; it’s entirely up to you. 
Although the interviewer does have a list of possible questions to ask, each question will only be a 
guide; please feel free to say as much or as little as you like about the theme(s) that you select. 
 
 
• Theme One: Aspects of Identity 
This theme focuses on exploring how you feel about yourself and whether your identity has 
changed during the course of psychosis and its treatment.  
 
 
 
 
• Theme Two: Experiences of Psychosis 
This theme aims to find out in more detail what it is like to live through an episode of psychosis. In 
particular, now that it may be some time since the episode, we’d like to know whether your 
feelings about, and views on, psychosis have changed at all. 
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• Theme Three: Recovery 
The aim of this theme is to gain an understanding of the many things that recovery might mean for 
different people. It explores what helped you recover, and the kinds of things that happened in life 
to make you feel that you were beginning to recover. 
 
 
  
 
• Theme Four: Relationships with Family and Friends 
We would like to know whether you feel that your relationships with your family or friends have 
changed as a result of your psychosis. And, we would like to understand how people feel about 
their families, and sometimes friends, being involved in their care. 
 
 
 
 
• Physical Health and Medications 
This theme explores how you feel about medications that you may have taken for psychosis and 
also about physical health more generally. It asks whether treatment professionals discuss any 
side-effects from, of worries about, medications that you may have, and whether how you feel 
about your body has been changed either by the episode of psychosis or its treatment 
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Interview Guide: Service Users  
 
 
 For all participants during the interview:  
 
 
 
• Physical Health and Medications: 
This theme explores how you feel about medications that you may have taken for psychosis 
and also about physical health more generally. It asks whether treatment professionals 
discuss any side-effects from, of worries about, medications that you may have, and 
whether how you feel about your body has been changed either by the episode of 
psychosis or its treatment 
 
1) Has this experience of psychosis also had any impact on your physical health or the way 
that you feel about your body? 
2) Do you consider your physical health important? 
3) Do you ever think, or worry, about your physical health in the future? 
4) Have your GP or any treatment professionals (eg. EIS, CMHT) ever discussed any 
aspects of future physical health with you? 
5) If you have taken medications for your psychosis, how do you feel about these (do they 
help or hinder)? 
- (If yes to having taken medications): Do you think that the medications that you have 
taken for psychosis have had any effect on: 
a) How you feel about your body? 
b)  Your physical health? 
6) Has a treatment professional ever discussed your medications or possible side-effects 
with you? 
7) Do you ever feel that you’d like to discuss aspects of your physical health or medications 
with a treatment professional?  
- (If yes): Do you have someone with whom you can talk about your medications, any 
side-effects or worries that you might have? 
 
 
 
• Transition from Services – At least  five minutes at the end: 
1) Based on what we have talked about today, how do you feel about leaving Early 
Intervention Services? 
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 Possible Interview Questions for the Other Four Main Themes: 
 
 
 
 
 
 
• Theme One: Aspects of Identity 
1) Describe yourself in a few words. 
Are these the same words that you might have used: 
 a) Before your episode of psychosis? 
 b) During the episode? 
2) Has your sense of who you are changed at all since the episode of psychosis? 
3) Do you feel, or have you ever felt, that psychosis is part of who you are – of your 
personality or identity? 
4) Have any treatment professionals (such as EIS, CMHT, GP) had an influence on how 
you view the relationship between psychosis and your identity? 
5) Can you describe the most important things in your life at the moment? 
6) What are your aims for the future? 
- Have these changed at all since the episode of psychosis? 
 
 
 
 
 
 
• Theme Two: Experiences of Psychosis 
1) Describe psychosis in a few words.  
Are these the same words that you might have used: 
a) Before your episode of psychosis?  
b) During the episode? 
2) Looking back at your episode of psychosis, was there anything positive about this 
experience? 
3) Is there anything about either psychosis or the treatment that have become a part of 
your life more widely, or of who you are?  
4) Have any treatment professionals (such as EIS, CMHT, GP) had an influence on how 
you understand or view psychosis? 
5) Do you feel that you can be, or want to be, honest with treatment professionals about 
how you are feeling or any symptoms you experience? 
6) Have you always felt listened to by professionals that you have been in contact with? 
7) Have you ever encountered any issues around confidentiality? (eg. Professionals being 
unable, legally, to talk to your family even if you would like them to). 
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• Theme Three: Recovery  
1) Describe recovery in a few words.  
Are these the same words that you might have used: 
a) Before your episode of psychosis? 
b) During the episode? 
2) Are recovery and cure the same thing? 
3) On a day-to-day level, how did you know that you were beginning to recover? 
4) Is recovery completely desirable or do you ever feel unsure that you want it? 
5) To recover do you need to accept psychosis, separate yourself from it, or neither/both of 
these? 
6) If early intervention services provided support in various forms during your episode – 
such as talk, medication, activities or other stuff – which, if any, of these do you feel 
helped you recover? 
7) Do you have any fears of having another episode of psychosis?  
8) Have any treatment professionals (such as EIS, CMHT, GP) influenced how you 
understand or view recovery? 
 
 
 
 
 
 
• Theme Four: Relationships with Family and Friends 
1) Have your relationships with family or friends changed since your episode of psychosis? 
2) Do you think that the psychosis has changed how your friends or family behave towards 
you?  
3) Have you ever felt since your episode that you need to behave in a certain way with 
your family or friends? 
4) It seems that the involvement of family, and sometimes friends, in a person’s care is part 
of the way that Early Intervention Services care for people. What do you think of this 
involvement? 
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SUPEREDEN STUDY TWO: Exploring Service Users’ and Caregivers’ Lived Experiences of 
Psychosis and its treatment through Early Intervention Services 
 
 
 Interview Information Sheet for Participants:   Service Users 
In this round of interviews we would like to gain an understanding of your day-to-day experiences 
of psychosis and recovery, as well as transitions between different healthcare services.  
 
With all participants, we would like to briefly explore experiences of 1) recovery and, if relevant, 
also of discharge from EIS. However, there are also four other main interview themes to this part 
of the study. These are 2) Identity; 3) Experiences of Psychosis; 4) Family Life; 5) Physical 
Health. From these we would like you to choose which theme or themes you’d like to discuss 
during the interview today. You could talk about only one or two themes or you could discuss all of 
them; it’s entirely up to you. 
 
Although the interviewer does have a list of possible questions to ask, each question will only be a 
guide; please feel free to say as much or as little as you like about the theme(s) that you select. 
 
 
• Theme One: Recovery and Transitions from EIS 
The aim of this theme is to gain an understanding of the many things that recovery might mean to 
different people. It explores what helped you recover, and the kinds of things that made you feel 
that you were beginning to recover. If you have been discharged from EIS, we would also like to 
know what life has been like since leaving the service and to explore your opinions about any 
other services - such as a CMHT or GP - that you have engaged with.   
 
• Theme Two: Aspects of Identity 
This theme focuses on exploring how you feel about yourself and whether your identity has 
changed during the course of psychosis and its treatment or through your recovery process.  
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• Theme Three: Experiences of Psychosis 
This theme aims to find out what it is like to live through an episode of psychosis. In particular, 
now that it may be some time since the episode, we’d like to know whether your feelings about, 
and views of, the illness have changed at all. 
 
 
 
• Theme Four: Relationships with Family and Friends 
We would like to know whether you feel that your relationships with your family or friends have 
changed as a result of your psychosis. We would also like to understand how people feel about 
their families being involved in their care and whether family members are supported enough by 
services. 
 
 
 
• Theme Five: Physical Health and Medications 
This theme explores how you feel about medications that you may have taken for psychosis and 
also about physical health more generally. It asks if you have experienced any side-effects from 
your medication and whether any treatment professionals have discussed these side-effects, or 
any worries that you may have about medications, with you.  
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 Interview Guide: Service Users  
 
• For all participants during the interview:  
 
Theme One: Recovery and Transitions from EIS 
 
Part One: Recovery Experiences 
1) How has life been since we last saw you? 
2) Are you happy with how your life is going at the moment? 
3) Do you feel that your life has been changed at all by having gone through your episode? 
4) Where do you feel that you are in the process of recovery?  
5) What words would you use to describe recovery?  
 - Are these the same words that you might have used: 
a) Before your episode of psychosis? 
b) During the episode? 
6) On a day-to-day level, how did you know that you were beginning to recover? 
7) Have you experienced any obstacles to your recovery? 
8) Is recovery completely desirable or do you ever feel unsure that you want it? 
9) To recover, do you need to accept psychosis, separate yourself from it, or neither/both of 
these? 
10) Is your experience of illness something that you’d like to forget? 
11) Do you see recovery and cure as the same thing? 
12) Do you have any fears of having another episode of psychosis?  
 - (if yes): what is it about this that ‘scares’ (use word SU has used) you? 
13)  Do you feel that you still need the input/support of professionals for your mental health? 
 
Part Two: Recovery and EIS and (if relevant) Other Services  
1) If EIS provided support in various forms during your episode – such as talk, medication, 
activities or other stuff – which, if any, of these do you feel helped you recover? 
2) Did EIS have any influence on how you understood or viewed recovery? 
3)  Did you feel that EIS shared your ideas of what recovery means? 
- (if not:) explore: Too much/little expectation on behalf of services? 
4) How did you feel about leaving EIS? 
5) How have you felt since leaving EIS? 
6) Have you missed anything about EIS? 
7) From EIS where were you discharged to? 
- and, have you been with this service since? (explore for re-referrals)  
8) How did this/these service(s) compare to EIS? 
9)  Have you always felt listened to by professionals in this/these new service(s)? 
10) Do you feel that this new service shares your idea of what recovery means? 
-  (if not:) explore: Too much/little expectation on behalf of services? 
11) Is the way in which the service you are with now talks about psychosis or recovery the 
same as, or different from, how EIS described these? 
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• For all service users not yet discharged from EIS: At least  five minutes at the end: 
1) Based on what we have talked about today, how do you feel about leaving Early 
Intervention Services? 
 
 
 Possible Interview Questions for the Other Four Main Themes: 
 
 
• Theme Two: Aspects of Identity 
1) What kinds of words would you use to describe yourself? 
Are these the same words that you might have used: 
 a) Before your episode of psychosis? 
 b) During the episode? 
2) Has your sense of who you are changed at all since the episode of psychosis? 
- (if yes:) Are you still changing? 
3) Do you feel, or have you ever felt, that psychosis is part of who you are – of your 
personality or identity? 
4) Have any treatment professionals (such as EIS, CMHT, GP) had an influence on how 
you view the relationship between psychosis and your identity? 
5) Have you always felt you could be, or wanted to be, honest with EIS professionals about 
how you were feeling or any symptoms you experienced? 
6) Can you describe the most important things in your life at the moment? 
7) What are your aims for the future? 
- Have these changed at all since the episode of psychosis? 
- have these changed over the last year? 
8) Is there anything that you’d like to do that you feel your illness experiences may prevent 
or alter? 
9) Is there anything that you’d like to do that you feel your illness experience may help 
with? 
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• Theme Three: Experiences of Psychosis 
1) How have you been feeling since we last saw you? 
2) What words would you use to describe psychosis?  
 - Are these the same words that you might have used: 
a) Before your episode of psychosis?  
b) During the episode? 
3) What do you feel may have caused your illness? 
4) Looking back at your episode of psychosis, was there anything positive about this 
experience? 
5) Is there anything about either psychosis or the treatment that have become a part of 
your life more widely, or of who you are?  
6) Have any treatment professionals (such as EIS, CMHT, GP) had an influence on how 
you understand or view psychosis? 
7) Do you feel that treatment professionals have always shared your idea of what 
psychosis is? 
- (if not:) explore these differences – in EIS or later services, or both? 
8) Have you ever experienced any prejudice related to your mental health during or since 
your illness?  
9) What do you think about how the media talks about mental health?  
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• Theme Four: Relationships with Family and Friends 
1) Have you always felt able to tell family or friends about your diagnosis? 
2) Were your family or friends part of what helped you to get through illness and recovery? 
- (if yes:) Looking back now, in what ways do you think that your episode may have 
affected their lives? 
3) It seems that the involvement of family, and sometimes friends, in a person’s care is part 
of the way that Early Intervention Services care for people. What do you think of this 
involvement? 
4) Do you feel that EIS supported your family? 
5) (For individuals already discharged from EIS:) Do you feel that the service(s) that you 
are with now involve family members in your care as much as EIS did? 
6) (For individuals already discharged from EIS:) Do you feel that the service(s) that you 
are with now support family members enough? 
7) Have you ever encountered any issues around confidentiality? (eg. Professionals being 
unable, legally, to talk to your family even if you would like them to) in any of the 
services that you have engaged with for your mental health? 
8) Have any of your relationships with family or friends changed since your episode of 
psychosis? 
9) Do you think that the psychosis has changed how your friends or family behave towards 
you?  
10) Have you ever felt since your episode that you need to behave in a certain way with 
your family or friends? 
11) Do you think that any relationships around you – like those between other members of 
your family –  have changed since your episode of psychosis?  
12) Since going through the episode and a process of recovery, do you feel that you want 
to tell new people you meet about having been through psychosis (or not)?  
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• Theme Five: Physical Health and Medications 
 
1) If you have taken medications for your psychosis, how do you feel about these (do they 
help or hinder)? 
2) If you have taken medications for your psychosis, have you experienced any side 
effects? 
- (if yes): how do/did you feel about these?  
3) Has a treatment professional ever discussed your medications or possible side-effects 
with you? 
4) Have your GP or any treatment professionals (eg. EIS, CMHT) ever discussed any 
aspects of future physical health with you? 
5) If you have taken medications for your psychosis, do you feel that these have had any 
effect on: 
 a) How you feel about your body? 
 b)  Your physical health? 
6) Do you feel that your illness itself has had any impact on your physical health or the way 
that you feel about your body? 
7) Do you consider your physical health important? 
8) Do you ever think, or worry, about your physical health in the future? 
9)  Do you ever feel that you’d like to discuss aspects of your physical health or medications  
with a treatment professional?  
- (if yes): Do you have someone with whom you can talk about your medications, any 
side-effects or worries that you might have? 
APPENDIX D: Supplementary Chapter 
 
Identity, Self and Negative Symptoms 
 
1. BACKGROUND AND RATIONALE 
 
Identity comprises the traits and characteristics, social roles, and group memberships 
that define who an individual is (Oyserman, Elmore, & Smith, 2012). A person’s 
identity provides the content of his or her self-concept: beliefs about who he or she 
is, has been, and might become. Understanding self and identity has been proposed 
to be fundamental to making sense of individuals’ thoughts, feelings and behaviours 
(Ashmore & Jussim, 1997). Disruption of identity is a widely recognised 
consequence of the experience of severe mental health problems (Yanos, Roe, & 
Lysaker, 2010) and is acknowledged to be an almost universal experience among 
those diagnosed with schizophrenia (Lysaker & Lysaker, 2002). The experience of 
schizophrenia has been described as ‘an ever-present sense that one’s personal 
identity stands on the brink of collapse, or the experience that such a catastrophe has 
occurred and only miscellaneous fragments remain’ (ibid).  
 
Similar disruption to the sense of self has been reported in individuals experiencing 
FEP. Research focusing on lived-experiences of FEP has highlighted that individuals 
often feel disconnected from their former identity, perceiving a loss of their former 
self and the emergence of a new self-concept (Dunkley, Bates, & Findlay, 2015; 
Lester et al., 2011; Tan, Gould, Combes, & Lehmann, 2014). Some of these identity 
changes are perceived as positive; for instance, Hirschfeld et al. (2005) reported that 
some participants described having grown and developed as a result of their 
experience of psychosis, gaining maturity, understanding and confidence. However, 
the majority of studies have found the impact of psychosis on identity to be 
predominantly negative; loss of occupational roles, changed relationships with 
others, stigma, negative treatment experiences and changes in physical appearance 
have all be identified as contributors to profound negative changes in the sense of 
self of those who have experience of psychosis (McCarthy-Jones, Marriott, Knowles, 
Rowse, & Thompson, 2013). Consequently, recovery has been proposed to 
necessitate either reclaiming one’s former identity or working to build a new, more 
positive identity (Buck et al., 2013).       
   
Lysaker & Lysaker (2004) theorise that the identity disturbance experienced by 
individuals with psychosis is causally linked to the development and maintenance of 
negative symptoms. They argue that dialogue, both internal and external, is the 
foundation of the sense of self, and that disruption of dialogue is what underlies the 
collapse of identity following psychosis onset. Negative symptoms are hypothesised 
to have a bidirectional relationship with lack of internal and external dialogical, and 
thus with identity disturbance. They suggest that a person who experiences reduced 
emotion and motivation would likely have little to say to themselves or anyone else 
and, as such, would struggle to maintain a strong sense of self. Equally, lack of a 
strong, multifaceted identity would incline an individual to withdraw from other 
people and abandon projects about which they were previously enthusiastic in an 
attempt to reduce feelings of confusion and failure. They suggest that these processes 
come together to create a cycle of decline: negative symptoms curtailed dialogue and 
as this dialogue dwindles, so does one’s sense of direction and drive, resulting in 
further increases in negative symptom severity. 
 
If the theory that negative symptoms both stem from and contribute to a disrupted 
identity is true, we might expect there to be differences in the way those who 
experience negative symptoms of differing severity and persistence perceive 
themselves. The aim of the current study was to investigate whether there were 
differences in the identities articulated by members of each of the negative symptom 
trajectory groups described in the body of this thesis. Further, the perceived role of 
the experience of psychosis in shaping group member’s identities was explored. 
  
2. RESEARCH QUESTIONS 
 
1. Are there differences in the way those who followed differing negative 
symptom trajectories described themselves? 
2. Do those who followed differing negative symptom trajectories differ in the 
impact they believed their experience of psychosis to have had on their 
identities? 
 
3. METHODS 
 
The method for this study was as outlined in Chapter Six (section 6.3). An identical 
set of transcripts formed the dataset, and analysis proceeded alongside analyses for 
the studies reported in Chapters Six and Seven. In order to answer the current study’s 
research questions, sections of the transcripts in which participants described 
themselves or discussed how their identity had changed over time were the focus of 
the analysis. Later iterations of the topic guide included the optional theme ‘aspects 
of identity’, exploring how participants perceived themselves and whether your felt 
their identity has changed during the course of their psychosis and its treatment. 
Sections of interviews during which this theme was explicitly discussed provided 
much of the data of relevance to the research questions. However, discussions 
focused on other topics, for instance relationships with family and friends, also 
contained relevant material.  
 
4. RESULTS 
 
Indicators of introversion  
 
Participants who chose to speak about the ‘aspects of identity’ theme were asked to 
begin the discussion by describing themselves in a few words. The set of adjectives 
chosen by participants from the Elevated negative symptoms group were strikingly 
similar to one another; the most commonly recurring words were ‘quiet’, ‘shy’ and 
‘serious’. The following self-descriptions were typical of this group: 
 
R: Can you describe yourself in a few words? 
P: Quiet, serious, shy, honest.  
 Max, Cheshire – Elevated Negative Symptoms 
 
R: So if I ask you to describe yourself in a few words, not always easy, 
but how would you, what would you, what sort of words would you 
use or what would you say about yourself? 
P: Erm, err, err, quiet, shy and polite probably, yeah. 
Daniel, Norfolk – Elevated Negative Symptoms 
 
R: Okay and if you were to describe yourself in a few words, what 
words would come to mind, how do you see yourself? 
P: Shy I suppose, yeah, um, don't know, um, I can't think of anything 
else.  
Nathan, Birmingham – Elevated Negative Symptoms 
 
These self-descriptions would suggest that such participants saw themselves as 
introverted. If might be hypothesised that these participants had come to think of 
themselves in this way as a result of having experienced persistently elevated 
negative symptoms during their psychosis. However, this theory is drawn into 
question by the observation that most participants who described themselves in this 
way indicated that they had a similar self-concept prior to the onset of their 
psychosis. For instance, when asked how a family member would describe him, Tom 
indicated that he had always been different from other and was something of a loner 
as a child: that he had few friends and preferred solitary activities. 
 
R: If your, somebody in the family had to describe you, how would 
they describe you? What words would they use?  
P: I don't know, probably if they were to be polite, I don't know, they'd 
probably say quirky or strange. I'm not - I'm not quiet, but I'm not - I 
don't know, I'm, much to myself … I've always been - I've been - I 
always was quiet as a child, I didn't really have many friends, I was 
quite quirky and strange, I'd much rather sort of hide away and do 
my own things, reading and things like that.   
Tom, Cambridgeshire – Elevated Negative Symptoms 
 These traits appeared to have continued into adulthood. He commented later in the 
interview: 
 
I'm not big on socialising at all, unless - it has to be the right person because I 
mean I don’t like to - if I don’t get on with someone 100% I don’t see the 
point in sort of going out, that sort of thing, do you know what I mean?  
Tom, Cambridgeshire – Elevated Negative Symptoms  
 
This suggests that, for at least some participants, an earlier tendency towards 
introversion might have foreshadowed later asocial attitudes and social withdrawal.  
 
Degrees of self-complexity 
 
The ways in which members of the Minimal and Decreasing negative symptom 
groups chose to describe themselves were highly idiosyncratic; as a result, it was not 
possible to identify themes in the content of the descriptions given by members of 
either group. However, there did appear to be differences between groups in the 
relative richness and complexity of the descriptions given. Members of both the 
Elevated and Decreasing negative symptoms groups gave relatively thin descriptions 
of themselves, often offering only a few words and faltering when prompted by the 
interviewer to elaborate on their descriptions. 
 
R: So how would you describe yourself?  
P: Erm, a nice person really.  
R: Okay. Good. What else do you think maybe friends and family 
would say about you?  
P: Erm that I'm a very nice person.  
R: Okay, would they say anything else?  
P: Erm, [inaudible] that would be it.  
Steve, Lancashire – Decreasing Negative Symptoms 
 
 
 
R: How would you describe yourself? 
P: I don’t know; same as everybody else.   
R: Yeah. 
P: Mmm. 
Aidan, Norfolk – Decreasing Negative Symptoms 
 
 
These descriptions contrasted with the comparatively extensive self-descriptions 
offered by participants from the Minimal negative symptoms group. Whereas 
members of the Elevated and Decreasing groups tended to focus predominantly on 
personality traits when describing themselves, members of the Minimal group 
frequently incorporated family relationships, social roles, and group memberships 
into their self-descriptions, in addition to personal traits and characteristics.  
 
R: In a few words, how would you describe yourself, what words 
would you use to describe yourself? 
P: Reliable, interesting, erm, relaxed, certain, definite, defined, a 
character, humble, erm erm erm erm, creator and novelist and, erm 
erm, a relaxed person who loves to enjoy other people’s company as 
well as their own. 
Shelly, Birmingham – Minimal Negative Symptoms 
 
R: Describe yourself in a few words if you can.  
P: Pagan, Hindu, Sikh, pro-active, communicator, activist … I’ve 
always been a proactive communicator, I’ve always been Pagan in 
my roots, Hindu in my [inaudible] and Sikh in my behaviour … and 
then finally I am an activist and that means that I like to actively 
participate … whether you’re playing tennis, helping old ladies with 
their shopping, being an active person is about being active.   
Alexander, Devon – Minimal Negative Symptoms 
 
R: So I wondered if you could start by saying a little bit about yourself, 
so describe yourself in a few words.   
P: Um, I'm a generally very happy mum of two lovely boys, um, I feel 
very lucky that I can stay at home and look after my sons and I haven't 
got to work at the moment, um, and, um, yeah I like to keep busy, I 
like to do course, like to learn new things, um, um, yeah and pretty 
much, you know, quite kind of would give anything a try really.  
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
In addition to giving more comprehensive self-descriptions when asked to describe 
themselves, members of the Minimal group more often laced discussion of their 
identities into their broader narratives than did members of other trajectory groups. 
Perhaps as a result of their discussing their self-concepts at greater length, 
participants from the Minimal group were more likely than members of other groups 
to discuss potential contradictions between different aspects of their self-concept. 
For instance, Clara noted a potential contradiction inherent in viewing herself as both 
confident and anxious.  
 
R: How would you describe yourself now? 
P: Kind. Erm, positive sort of kind and caring. Erm anxious, erm but 
quite proactive. 
R: Huh-huh. So does that suggest a little bit more confidence? 
P: Hmm, yeah. Yeah, a - yeah. I, I think I would say I've got a lot of 
confidence for the anxiety that I go through. So it's err. 
R: Contra, contradiction. 
P: Yeah. That's the word I was going to say. Now, I think I'm a 
contradiction, complete contradiction.  
Clara, Cornwall – Minimal Negative Symptoms 
 
She went on to note several other ways in which she would describe herself as 
possessing two seemingly opposing traits simultaneously. Similarly, Kelly discussed 
being both extremely social anxious but also very confident depending on the social 
role she is inhabiting.  
 
P: When it’s just normal chit-chat conversation, I get sort of a bit 
tongue-tied and stuck on what to say. Where if it’s about like what 
we’re doing now, or if it’s about work in my job role, I’m fine. 
R: Yeah, you’ve said that before. You said that you feel almost a 
different person in your job role. 
P: Yeah, yeah, I’m fine, I can talk to whoever and it don’t bother me. I 
can go – I’ve taken – I’ve escorted people to their hospitals and GP 
surgeries all on me own, and that doesn’t bother me whatsoever. But 
to be out of that uniform, to be out of my comfort zone, I’m 
completely different. 
Kelly, Norfolk – Minimal Negative Symptoms 
 
Kelly explained that, because the people she is responsible for supporting in her role 
as a care worker are vulnerable, this pushed her to be a ‘completely different’ 
version of herself. It appears that this more confident side of her was more than just a 
front; rather than speaking of pretending not to be anxious whilst at work, she 
explained that situations in which she would otherwise feel extremely anxious do not 
bother her ‘whatsoever’ when she is working. Kelly’s account demonstrates the 
powerful influence of a person’s social role on their identity, and in turn their 
feelings and behaviour.  
 
‘It’s changed me into a better person’ 
 
Participants were asked whether they felt they had changed as a person as a result of 
their experience of psychosis. Most participants from the Elevated and Decreasing 
Negative Symptoms groups expressed that they did not feel they had been 
fundamentally altered by their experience of psychosis. When they did describe 
having changed in some way, members of these groups most often expressed a belief 
that their experience of psychosis as having made them a better person in some way, 
for instance a stronger or more tolerant person.  
 
I’ve experienced things people will never experience, and, in a way, that 
makes me stronger … it sounds, it sounds funny, but character building. Erm, 
it makes you quite resilient, when you’re well, it makes you very resilient.  
Hayley, Cornwall – Elevated Negative Symptoms 
 
I’m a stronger person now, yeah. When you have bad or stressful experiences 
I think over time you, it’s made me, I’m still a sensitive person but I think it’s 
made me less sensitive because the more bad experiences you have, y’know 
what I mean?  
Max, Cheshire – Elevated Negative Symptoms 
 
It’s kind of made me more tolerant and more aware of other people and that, 
you know I can look at somebody and say, well maybe they’ve got a bit of a 
problem or you know maybe they are struggling and I can be a bit more 
sympathetic. So I think that’s made me more, I don’t know what the word is, 
not kind but of that ilk.  
Stacey, Cornwall – Decreasing Negative Symptoms 
 
Accounts of having become a better person as a result of the experience of psychosis 
were also found in transcripts of interviews with members of the Minimal negative 
symptoms group. 
 
‘I do a rather poor caricature of myself’ 
 
Whilst accounts of having become a better person as a result of the experience of 
psychosis were a frequent occurrence in the transcripts of all negative symptom 
groups, the transcripts of interviews with the Minimal group were distinctive in that 
they also frequently included discussions of the negative impact psychosis had had 
on their identity. Several participants articulated that they considered themselves to 
be a somewhat inferior version of their former selves in the wake of their psychosis, 
or expressed that a part of them had been lost or was missing as a result of their 
experiences. Such sentiments were expressed particularly poignantly by Ben and by 
Isabella.   
 
P: And how narcissistic does this sound, but it’s really not, I’m still 
kind of grieving for myself, if that makes sense. 
R: Yeah, totally understandable. 
P: So do you feel you’re a different person then and you’re grieving for 
the person that you were? 
R: Yeah. 
P: Yeah. And do you think you’ll always be a different person? Or do 
you think that you will in time be back to how you were? 
R: Wishful thinking. All I can say is that I think for the past few years 
when I’ve been, you know, okay, I do a rather poor caricature of 
myself. 
Ben, Birmingham – Minimal Negative Symptoms 
 
I feel like so much of me has been sucked out from this awful experience, not 
just the psychosis but what’s happened afterwards and the system that I just 
don’t have it in me, I’m kind of a bit, like your soul has been do you know 
what I mean, it’s been, someone’s tried to murder it … it’s like that inner 
child it’s a bit like someone’s taken it by the neck, strangled it, it’s just 
survived and then shaken it again and then said, right your life’s never going 
to be the same again.  
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 For some participants from the Minimal negative symptoms group, it was 
involvement with the mental health system and the fact of having been diagnosed 
with a mental illness, as opposed to the symptoms they experienced, that they felt 
was responsible for the perceived negative impact on their identity. For instance, 
Isabella spoke about being ‘forced’ to incorporate psychosis into her identity as a 
result of being given a ‘label’. 
 
R: You talked about the label of being unwell, how has that influenced 
you on your view of the relationship between psychosis and your 
identity? 
P: Um, I think it has significantly affected my identity because I always 
was very much an individual. Yes I compromised to fit in with other 
people but I was very much a sort of take me or leave me person and 
I feel this label now has, yeah I'm almost forced to take it on as part 
of my identity … I can't, I can't sort of separate myself from it 
because it's, you know, it's kind of, you know, it's quite a personal to 
have mental health problem and it's very difficult to just sort of 
separate it off from yourself. 
Isabella, Cambridgeshire – Minimal Negative Symptoms 
 
For other participants, it was the nature of the symptoms they experienced that were 
detrimental to their identity. In Clara’s case, she struggled to reintegrate her identity 
after holding grandiose beliefs during her psychosis.   
 
R: I mean do you feel that the - that sense of who you are has changed, 
then, since, since your psychosis? I mean is that what you're saying, 
that the sense of who you are has changed? 
P: Actually, during my psychosis … I thought I'd been taken over by, 
by something, so I was living with that for years, and it's only in the 
recent past that I've sort of, you know, tried to put it to one side and 
finally I feel a bit more like [Clara] again than whoever the hell I 
was, or whatever happened. It was - yeah, I haven't married - I 
haven't got to that point where I can marry it all up as just one 
process because of everything that's happened. But still very 
different, very separate things: who I was before, who I was during, 
who I was after. Completely separate. 
Clara, Cornwall – Minimal Negative Symptoms 
 
5. DISCUSSION 
 
5.1. Review of Study Findings in Relation to Research Questions 
 
Are there differences in the way those who followed differing negative symptom 
trajectories described themselves? 
 
Members of the Elevated negative symptom group gave brief descriptions of 
themselves focused primarily on aspects of their personality. Members of this group 
often chose adjectives such as ‘quiet’, ‘shy’ and ‘serious’ to describe themselves, 
suggesting they would regard themselves as introverted. Members of the Decreasing 
negative symptom group also tended to give brief descriptions of themselves, often 
comprised solely of personality traits they would attribute to themselves. No themes 
related to the content of the Decreasing groups self-descriptions were evident. 
Likewise, no themes relating to the content of the Minimal negative symptoms 
group’s self-descriptions were identified. However, the self-descriptions provided by 
the Minimal group were distinctive in being relatively lengthy and offering a 
complex, multi-faceted account of their identity, often incorporating family 
relationships, social roles, and group memberships in addition to personality traits.   
 
Do those who followed differing negative symptom trajectories differ in the impact 
they believed their experience of psychosis to have had on their identities? 
 
Participants from the Elevated and Decreasing groups often said that they felt 
psychosis had not impacted their identity in any way. Those from these groups who 
did report that their experience of psychosis had changed them expressed that it had 
made them a stronger person or otherwise changed them for the better. Some 
members of the Minimal negative symptoms group also spoke about psychosis 
having changed them for the better but several also felt that the experience had been 
damaging to their identity. For instance, several participants spoke about feeling they 
were an inferior version of themselves since their experience of psychosis. This 
negative change in their identities was attributed to the treatment received for their 
psychosis as well as to the symptoms they experienced.  
 
5.2. Interpretation, Relevance to the Literature and Theoretical Significance 
 
An early theory dating back to Bleuler (1950/1911) and Kraepelin (1971/1919) 
linked schizophrenia to a premorbid personality characterised by introversion. It was 
observed that many of those diagnosed with schizophrenia presented with introverted 
traits after the onset of the disorder and it was hypothesised that this introversion 
may be a legacy of premorbid schizoid personality traits (Bellak & Parcell, 1945). 
Early research failed to confirm a link between introversion in childhood and 
diagnosis of schizophrenia in adulthood (Offord & Cross, 1969). However, many 
such studies relied on the researcher’s subjective judgments to classify participants 
as either introverts or extroversion, without reference to clear operationalised criteria 
or use of validated rating scales (e.g. Bellak & Parcell, 1945; Michael, Morris, & 
Soroker, 1955). Later work, utilising validated personality measures has provided 
evidence of an association between Cluster A (schizoid, paranoid and schizotypal) 
personality traits and psychosis (Dalkin, Murphy, Glazebrook, Mendey, & Harrison, 
1994; Keshavan et al., 2005).  
  
Furthermore, there is evidence that premorbid schizoid personality traits may be 
specifically associated with later negative symptom severity in both schizophrenia 
(Cannon, Mednick, & Parnas, 1990; Cuesta, Peralta, & Caro, 1999) and FEP 
(Cuesta, Gil, Artamendi, Serrano, & Peralta, 2002). Schizoid personality traits 
include preference for solitary activities, limited interest in and enjoyment of 
experiences and activities, having few close relationships, apparent indifference to 
the praise or criticism of others, and emotional detachment or affective flattening  
(DSM-5; American Psychiatric Association, 2013). It has been noted that such 
personality traits overlap considerably with the deficits categorised as negative 
symptoms, with the effect that it is near impossible to differentiate between these 
traits and emerging negative symptoms (Cuesta, Peralta, Gil, & Artamendi, 2007).  
This overlap between schizoid traits and negative symptoms makes the task of 
establishing whether such personality traits impose vulnerability for the development 
of psychotic disorders or, alternatively, are the early manifestations of disorder, 
extremely difficult. This task is further complicated by the fact that psychosis 
typically begins early in the life course, at a time when the personality is still 
developing. However, evidence that Cluster A personality traits are more common 
amongst unaffected relatives of those with psychosis than in the general population 
(Shih, Belmonte, & Zandi, 2004) provides some support for the theory that such 
traits may reflect an underlying biological vulnerability.  
 
The traits found to be central to the self-descriptions of participants who presented 
with persistently elevated negative symptoms in the current study – quiet, shy, 
serious, a loner –whilst they were construed as indicative of introversion during the 
analysis, might equally be seen as reflecting schizoid personality traits. If this is the 
case, it would suggest that individuals with elevated negative symptoms not only 
present with schizoid personality traits, as indicated by previous research, but that 
these traits are central to their self-concept. The finding that participants from the 
Elevated negative symptoms group tended to report that they would have described 
themselves in similar terms before they experienced FEP suggests that these 
participants experienced a high degree of continuity between their pre- and post-
morbid self-concept. 
 
Noting the link between premorbid schizoid traits and negative symptoms, Rector et 
al. (2005) proposed a continuum theory of negative symptoms. They suggest that the 
lack of emotional and verbal expression, social withdrawal and reduced motivation 
that come to be classified as negative symptoms following a psychotic episode 
represent a continuation, and perhaps exacerbation, of personality traits that might 
have been classified as schizoid prior to the onset of FEP. Further, they suggest that 
these characteristics, both as they manifest prior to the onset of psychosis as schizoid 
personality traits and following psychosis onset as negative symptoms, are rooted in 
the same negative beliefs and avoidant coping strategies. Whilst the current study is 
unable to provide firm support for this theory, some participants’ accounts align with 
it. For instance, Tom’s belief that it’s not worth meeting up with someone who he 
doesn’t get on with ‘100%’, might be seen as an example of a defeatist performance 
belief and is of clear relevance to his reported infrequent social contact with those 
outside his immediate family. His description of his childhood self as having 
preferred to ‘hide away’ and ‘do [his] own thing’, rather than spend time with others 
would fit with the interpretation that such asocial beliefs post-FEP were an extension 
of asocial attitudes held prior to the onset of his psychosis.   
 
The Elevated negative symptoms group’s apparent lack of self-complexity relative to 
members of the Minimal group might be taken as support for Lysaker & Lysaker’s 
(2002) theory of the link between negative symptoms and lack of a strong, 
multifaceted identity. Plausibly, this group’s persistent negative symptoms might 
have served to disrupt internal and external dialogue, thereby depleting the self-
concept, in turn decreasing their affect and drive. However, the finding that the 
identities of those whose negative symptoms remitted early on appeared to be 
similarly lacking in complexity raises doubts about this explanation. That it was 
social aspects of identity in particular that were less developed in the accounts of the 
Elevated and Decreasing groups is notable. The relatively poor early social recovery 
of members of both these groups provides a possible explanation for this finding. 
Individuals whose social functioning is impaired are likely to have fewer 
relationships, social roles and group memberships than those who make a better 
social recovery. If such relationships, roles and group memberships have fallen 
away, then the facets from which identity is typically formed are greatly reduced, 
resulting in a depleted self-concept.   
 
Given that identity disruption has been acknowledged as a universal feature of 
schizophrenia (Lysaker & Lysaker, 2002), it is interesting that members of the 
Elevated negative symptoms group in this study often denied that their identity had 
been impacted by the experience of psychosis. While some members of this group 
did report that psychosis had changed them for the better in some respects, they did 
not acknowledge that psychosis might have had any detrimental impact on their 
identity. In contrast, members of the Minimal group often spoke at some length 
about the way in which their experience had undermined their sense of self. It is 
possible that members of the Minimal group experienced the disruption of their lives 
by their psychotic episode as more damaging to their identity than participants who 
were lower functioning prior to psychosis onset. According to the theory of temporal 
self-appraisals, favourable comparisons of current selves with past selves are 
important to maintaining a positive self-identity (Wilson & Ross, 2001). However, 
individuals diagnosed with schizophrenia often engage in upwards comparisons with 
past selves, particularly more distant past selves (Dinos, Lyons, & Finlay, 2005). It is 
possible that this maladaptive pattern of self-appraisals might be more pronounced in 
individuals who were functioning relatively well adapted prior to their psychosis and 
so experienced a significant drop in their functioning following the onset of their 
psychosis. Alternatively, it may be that participants from all groups experienced their 
identity as damaged by their experience of psychosis but only members of the 
Minimal group were able or willing to articulate this. 
 
5.3. Limitations  
 
In addition to the limitations this study shares with the qualitative studies described 
in the body of this thesis, there are a number of limitations specific to this study 
which should also be borne in mind when interpreting its findings.   
 
Since identity is multifaceted and dynamic, the words as person chooses when asked 
to describe themselves are likely to be time and context dependent. For instance, if 
asked to describe oneself during a job interview one would likely mention quite 
different attributes than one might include in a profile for a dating website, but this 
would not make either description necessarily false. Context influences the social 
desirability of disclosing certain parts of one’s self-concept, as well as altering the 
relative salience of the various aspects of one’s identity. The participants in the 
current study were asked to describe their identity in the context of an interview 
about their experiences of mental health services. The impact of this (rather unusual) 
situation on the self-descriptions offered by participants should not be 
underestimated.   
  
A further limitation of the study arises from the fact that all interviews were carried 
out after the participants’ experience of FEP. It is inevitable that participants’ 
experiences after psychosis onset will have influenced how they recall their previous 
sense of self. It is possible, for instance, that members of the Elevated group would 
have described themselves quite differently before they became unwell; they might 
only have come to see themselves as having always been quiet and withdrawn in the 
light of their experience of negative symptoms. This limitation could be addressed 
by future prospective research exploring the development of the identities of those at 
high risk of psychosis.  
 
6. CONCLUSION 
 
The findings of this study suggests that certain schizoid traits may be central to the 
self-concept of those who experience persistently elevated negative symptoms early 
in their psychosis. Individuals in this study whose negative symptoms followed this 
trajectory expressed less complex identities, incorporating fewer social roles and 
group memberships than did those who experienced consistently minimal negative 
symptoms. This might suggest that the experience of negative symptoms and/or poor 
social functioning had a detrimental impact on the identities of those who presented 
with more severe negative symptoms. However, it was participants who experienced 
minimal negative symptoms who were most likely to describe their identity as 
having been adversely impacted by their experience of psychosis. Where members of 
this group acknowledged their identity as having been impacted at all, those who 
presented with persistently elevated negative symptoms reported that their 
experience of psychosis had changed them for the better.  
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Abstract 
 
Aims: To investigate trajectories of negative symptoms during the first 12 months of 
treatment for first episode psychosis (FEP), their predictors and relationship to social 
recovery.  
 
Method: 1006 participants were followed up for 12 months following acceptance into Early 
Intervention in Psychosis services. Negative symptom trajectories were modelled using latent 
class growth analysis (LCGA) and predictors of trajectories examined using multinomial 
regression. Social recovery trajectories – also modelled using LCGA – of members of each 
negative symptom trajectory were ascertained and the relationship between negative 
symptom and social recovery trajectories examined.       
 
Results: Four negative symptom trajectories were identified: Minimal Decreasing (63.9%), 
Mild Stable (13.5%), High Decreasing (17.1%) and High Stable (5.4%). Male gender and 
family history of non-affective psychosis predicted stably high negative symptoms. Poor 
premorbid adolescent adjustment, family history of non-affective psychosis and baseline 
depression predicted initially high but decreasing negative symptoms. Members of the Mild 
Stable, High Stable and High Decreasing classes were more likely to experience stably low 
functioning than the Minimal Decreasing class.     
 
Conclusions: Distinct negative symptom trajectories are evident in FEP. Only a small 
subgroup present with persistently high levels of negative symptoms. A substantial 
proportion of FEP patients with elevated negative symptoms at baseline will achieve 
remission of these symptoms within 12 months. However, elevated negative symptoms at 
baseline, whether or not they remit, are associated with poor social recovery, suggesting 
targeted interventions for service users with elevated baseline negative symptoms may help 
improve functional outcomes.          
 
Key words: negative symptoms/early intervention/functioning/recovery/longitudinal 
 
1. Introduction 
 
Negative symptoms represent a significant unmet clinical need and the search for effective 
treatments has received renewed interest in recent years (Kirkpatrick et al., 2006). However, 
the mechanisms that underpin negative symptoms remain poorly understood. Negative 
symptoms can be subject to significant fluctuations over time, particularly in the early course 
of psychosis (Edwards et al., 1999; Ventura et al., 2004). Individuals vary in the stability of 
their negative symptoms (Kelley et al., 2008) and those with persistently elevated negative 
symptoms are at highest risk of poor outcome (Husted et al., 1992; Mäkinen et al., 2008). 
Increased understanding of variation in negative symptom course might help illuminate the 
mechanisms which underlie negative symptoms.  
 
The prevalence of persistent negative symptoms in first episode psychosis (FEP) remains 
unclear due to the use of inconsistent criteria for persistence. Moreover, grouping individuals 
into those with persistent negative symptoms and those without might mask the true 
complexity of individual variation in negative symptom course. Chen et al. (2013) found that 
variation in negative symptom course in a cohort of schizophrenia patients was best modelled 
by four distinct trajectory classes, characterised by differing levels of negative symptoms at 
baseline and a distinctive pattern of longitudinal change. It is not yet known whether multiple 
negative symptoms trajectories are similarly evident in FEP. This study examines negative 
symptom trajectories in a large FEP sample using latent class growth analysis (LCGA), a 
data-driven approach to identifying patterns of longitudinal change within a heterogeneous 
population. Predictors of the identified trajectories are then investigated. 
 
This study also explores the relationship between negative symptom course and social 
recovery. Although the association between negative symptoms during FEP and poor 
functional outcomes is well established (Evensen et al., 2012; Galderisi et al., 2013), the 
relationship between the trajectory of an individual’s negative symptoms and concurrent 
change in their functioning has yet to be investigated. Understanding the relationship between 
negative symptom course and contemporaneous changes in functioning might inform the 
development of targeted interventions to improve functional outcomes following FEP.   
 
2. Method 
 
2.1. Participants 
 The sample comprises participants in the National EDEN study: a national evaluation of the 
impact and cost-effectiveness of Early Intervention in Psychosis (EIP) services in the UK 
(Birchwood et al., 2014). All individuals accepted into EIP services in Birmingham, Bristol, 
Cambridge, Cornwall, Lancashire and Norfolk between August 2005 and April 2009 were 
invited to take part. The Policy Implementation Guide (Department of Health, 2001) provides 
details of the acceptance criteria for these services and the care they offer. In total, 1027 
individuals consented to take part: 80% were followed up at 6 months and 77% at 12 months. 
National EDEN participants assessed with the Positive and Negative Syndrome Scale 
(PANSS) at one time point or more (n = 1006) are included in the current study (see Table 1 
for sample characteristics and descriptive statistics). 
 
[Insert Table 1] 
 
2.2. Measures 
 
2.2.1. Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) 
 
Participants were assessed using the PANSS following acceptance into EIP (baseline) and 6 
and 12 months later. The PANSS is a 30-item instrument designed to measure the severity of 
symptoms associated with schizophrenia. Symptom severity over the previous seven days is 
assessed by a trained rater following a semi-structured interview with the participant. Each 
symptom is rated on a 7-point scale from 1 (absent) to 7 (extreme).   
 
2.2.2. Time Use Survey (TUS; Fowler et al., 2009; Short, 2003) 
 
Time spent in ‘structured activity’ at baseline, 6 and 12 months, as measured by the Time Use 
Survey (TUS), was used as an index of social recovery. The TUS is a semi-structured 
interview designed to assess time spent participating in structured activity on average over 
the previous month. Structured activity is defined as time spent in paid employment, 
voluntary work, education, childcare, housework, sport and structured leisure activities. The 
number of hours per week spent engaged in structured activity on average over the previous 
month was the measure of functioning used to model social recovery trajectories. Social and 
occupational functioning have been deemed among the most important markers of recovery 
by experts by both professional (Kane et al., 2003) and lived experience (Pitt et al., 2007). 
Unlike many measures of functioning employed in psychosis research, the TUS has limited 
conceptual overlap with negative symptoms, reducing the risk of confounding.  
 
2.2.3. Other Measures Administered at Baseline 
 
Variables hypothesised to be associated with negative symptom course were measured at 
baseline. Self-reported social and academic adjustment in childhood (up to 11 years) and 
early adolescence (11 – 15 years) was assessed using the Premorbid Adjustment Scale (PAS; 
Cannon-Spoor et al., 1982). Duration of untreated psychosis was assessed retrospectively 
using the method described by Larsen et al. (1996). DUP was defined as the interval between 
onset of frank psychosis and commencement of criterion antipsychotic treatment, ascertained 
using participant report and examination of clinical notes. Continuous data were 
dichotomised to create a binary DUP variable (long DUP ≥ 9 months) due to the non-linear 
relationship between DUP and negative symptoms (Boonstra et al., 2012). The Calgary 
Depression Scale (CDSS; Addington et al., 1994) was used to measure depression and the 
Drug Check (Kavanagh et al., 1999) to assess illicit substance use. Family history of non-
affective psychosis was ascertained through participant report and diagnoses at baseline 
obtained from clinical notes.     
  
2.3. Analysis Plan 
 
Since it is now accepted that the factor structure of the PANSS is not well represented by the 
three original subscales (Kay et al., 2000; White et al., 1997), the PANSS items used to 
measure negative symptoms in this study were determined using Exploratory Structural 
Equation Modelling (ESEM; Asparouhov and Muthén, 2009). Whilst much work has been 
carried out to determine the factor structure of the PANSS in schizophrenia samples, fewer 
studies have examined its factor structure in FEP samples.ESEM is a factor analytic 
technique which both allows items to load on multiple factors and provides model fit indices, 
enabling adequate model fit to be verified. This approach was chosen since it has been argued 
that free estimation of cross-loadings is necessary to adequately reflect clinical reality and 
thus obtain satisfactory model fit (van der Gaag et al., 2006; van den Oord et al., 2006). 
ESEM with geomin rotation was conducted and the adequacy of model fit accessed using 
three indices. A five-factor model was specified based on the results of exploratory factor 
analysis.   
 
The study used latent class growth analysis (LCGA; Nagin, 2005) to identify distinct 
trajectories of change in negative symptom severity. LCGA is a technique used to identify 
homogenous sub-groups (latent classes) of individuals with distinct patterns of change over 
time (Andruff et al., 2009). Missing data were estimated using full information maximum 
likelihood under the assumption that data were missing at random. Models with increasing 
numbers of latent classes were fitted to the data and the best model selected according to a 
number of considerations including fit indices, entropy (a measure of the distinctness of 
classes), accuracy of posterior classifications (probability that participants were assigned to 
the correct latent class by the model), parsimony and interpretability (Jung and Wickrama, 
2008).  
 
Multinomial regression, with latent class according to the selected LCGA model as the 
dependent variable, was used to examine predictors of negative symptom course. There were 
twelve candidate exploratory variables: age at psychosis onset; gender; ethnicity; family 
history of non-affective psychosis; schizophrenia diagnosis; duration of untreated psychosis; 
premorbid social adjustment in childhood; premorbid social adjustment in adolescence; 
premorbid academic adjustment in childhood; premorbid academic adjustment in 
adolescence; baseline depression; and history of substance use.  Only variables that differed 
significantly between latent classes (according to Pearson’s Chi-Squared tests and one-way 
ANOVAs with Bonferroni correction) were entered into the multinomial regression model. 
An additional, post-hoc one-way ANOVA was conducted to explore whether members of the 
identified trajectory classes differed with respect to the severity of expressive deficit versus 
withdrawal symptoms (as identified through exploratory factor analysis) at baseline. 
 
Trajectories of social recovery were identified by using LCGA to model hours per week in 
structured activity as measure by the TUS, as described by Hodgekins et al. (2015b). The 
social recovery trajectory classes of each member of the identified negative symptom 
trajectory classes were determined by matching the participants in the current study with 
those included in Hodgekins et al.’s analysis using their identifier code. A matrix of negative 
symptom versus social recovery trajectories was constructed and individuals assigned to cells 
of the matrix according to their trajectory permutation. The independence of the trajectories 
was tested statistically using Pearson’s Chi-Squared test and adjusted standardised residuals 
of the test examined to interpret the results.   
 
Analyses were conducted using SPSS for Windows, Version 22 (IBM Corp., 2013) and 
Mplus for Windows, Version 7.1 (Muthén & Muthén, 1998-2012).  
 
3. Results 
 
3.1. Exploratory Structural Equation Modelling  
 
A five-factor model which fit the data adequately (RMSEA = 0.054; CFI = 0.914; TLI = 
0.874) resulted in a negative symptoms factor including the items ‘Blunted affect’, ‘Lack of 
spontaneity’, ‘Emotional withdrawal’, ‘Passive social withdrawal’, ‘Poor rapport’, ‘Motor 
retardation’ and ‘Active social avoidance’. The mean rating of these items was used to 
measure negative symptom severity. The identified factor structure was similar to that found 
in van der Gaag et al.’s (2006) study employing similar methods. Mirroring the findings of 
van de Gaag et al., ‘Active social avoidance’ was found to load on both the negative 
symptoms and affective symptoms factors.    
  
3.2.Negative Symptom Trajectories 
 
LCGA models with increasing numbers of latent classes were fitted to the data. Fit indices, 
entropy, accuracy of posterior classifications, and the size of each class were compared 
(Table 2) and the four class model selected. The four-class model (Figure 1) fit the data 
significantly better than the models with one, two or three latent classes according to all fit 
indices. Further, each of the four latent classes represented a distinct trajectory with 
theoretical relevance. Mean posterior probabilities were adequate (> 0.70), indicating high 
probability of classification to the correct latent class and no latent class was made up of less 
than 5% of the sample. Although the majority of fit indices suggested that the more latent 
classes included the better model fit, models with five or more latent classes were rejected for 
reasons of parsimony and interpretability. Models with five or more latent classes included 
classes comprising a very small proportion of the sample (less than 5%) and these additional 
trajectories were not sufficiently unique and distinct to add interpretive value.   
 
[Insert Table 2] 
[Insert Figure 1] 
 
3.3.Characteristics of Latent Classes 
 
The class size, unstandardised mean intercept, unstandardised mean gradient, the significance 
of this gradient (and corresponding p-value) for each trajectory class is presented in Table 3. 
 
[Insert Table 3] 
 
3.4. Predictors of Negative Symptom Course 
 
The four negative symptom trajectory classes were compared on demographic and baseline 
variables.  Descriptive statistics for each class are presented in Table 4.   
 
[Insert Table 4] 
 
Class differences were found in gender (χ2 (3) = 9.253, p = 0.026), baseline clinical diagnosis 
(Fisher’s Exact Test, p = 0.019), family history of non-affective psychosis (Fisher’s Exact 
Test, p = 0.001), premorbid social adjustment in childhood (F (3, 904) = 5.116, p = 0.002) 
and early adolescence (F (3, 864) = 7.240, p = <0.001), premorbid academic adjustment in 
childhood (F (3, 904) = 7.270, p = <0.001) and early adolescence (F (3, 899) = 10.236, p = 
<0.001), and baseline depression (F(3, 943) = 11.285, p = <0.001). These variables were 
entered into a multinomial regression with negative symptom trajectory class as the 
dependent variable. The Minimal Decreasing trajectory class served as the reference 
category.  
 
Compared to individuals in the Minimal Decreasing class, those in the High Stable class were 
more likely to be male (Β = -1.04, p = 0.03) and more likely to have a family history of non-
affective psychosis (Β = -1.18, p = 0.01). Compared to the Minimal Decreasing class, those 
in the High Decreasing class were more likely have a family history of non-affective 
psychosis (Β = -0.68, p = 0.046) and had higher levels of depression (Β = 0.09, p = <0.001). 
Members of the High Decreasing class also had better premorbid social adjustment during 
childhood than the Minimal Decreasing Group (Β = -2.21, p = 0.004) but poorer premorbid 
social adjustment in adolescence (Β = 2.11, p = 0.003). Full results of the multinomial 
regression are available as supplementary material.  
 
3.5. Relationships between Negative Symptom Trajectory and Social Recovery  
 
Three functioning trajectories were identified by Hodgekins et al.: (1) low levels of 
functioning sustained over the course of the study (‘Low Stable’); (2) moderate functioning 
which increased over the course of the study (‘Moderate Increasing’); and (3) initially high 
functioning which decreased slightly but remained high (‘High Decreasing’). The trajectories 
are depicted graphically in Hodgekins et al. (2015b; figure 1). Both the Moderate Increasing 
and High Decreasing classes, but not the Low Stable class, were engaging in levels of 
structured activity within the non-clinical range by 12 months and were therefore deemed to 
have made a good social recovery (Hodgekins et al., 2015b). Of the participants in the current 
study, 759 were also included in Hodgekins et al.’s analysis. These participants were assigned 
to cells of a matrix according to their permutation of negative symptom versus functioning 
trajectory (Table 5). 
 
[Insert Table 5] 
 
Negative symptom trajectories and functioning trajectories were not independent of one 
another (χ2 = 57.06, p = <0.001). Those in the High Stable, Mild Stable and High Decreasing 
negative symptom classes were over-represented in the Low Stable functioning class, 
indicating that those who followed a trajectory characterised by elevated negative symptoms 
at baseline, regardless of whether those negative symptoms decreased, were less likely to 
recover socially within 12 months. The Minimal Decreasing negative symptoms class were 
more likely to make a good social recovery within 12 months than members of other classes; 
nonetheless, the majority (56.9%) fell into the Stable Low functioning class. The proportion 
of each negative symptom trajectory class that made a good social recovery within the study 
period is presented graphically in Figure 2. 
 
[Insert Figure 2] 
   
4. Discussion 
 
4.1. General Discussion 
 
This study identified four distinct negative symptom trajectories in a large sample of 
individuals receiving treatment for FEP. Only a small proportion of the sample (5.4%) had 
persistently high levels of negative symptoms. A further 13.5% of the sample presented with 
consistently elevated negative symptoms of lesser severity. The mean intercept of both these 
trajectories was sufficiently high to indicate multiple clinically significant negative 
symptoms. Membership of the class with the highest levels of persistent negative symptoms 
was predicted by male gender and family history of non-affective psychosis. In line with 
previous research linking persistent negative symptoms and poor outcome, those with stably 
elevated negative symptoms were over-represented among those with poor social recovery.   
 
A trajectory of initially high but decreasing negative symptoms was followed by 17.1% of the 
sample. This supports a suggestion in the literature that initially elevated negative symptoms 
often decrease over time (Savill et al., 2015). Those with remitting negative symptoms were 
distinguished from those with consistently minimal negative symptoms by poorer premorbid 
social adjustment during adolescence despite better social adjustment during childhood. They 
were also more likely to have a family history of non-affective psychosis and had higher 
baseline depression. Despite the remission of their negative symptoms, this trajectory class 
were less likely to make a good social recovery than those with minimal negative symptoms 
at baseline. One possible explanation is that functioning disrupted by negative symptoms 
takes time to return to optimal levels following remission of those symptoms, resulting in 
delayed improvement in functioning relative to negative symptoms. Alternatively, given their 
poor premorbid adolescent functioning, it might be that the poor social recovery of this group 
is a legacy of low baseline functioning.   
 
Two subdomains of negative symptoms – expressive deficits and withdrawal 
(avolition/asociality) – have now been established (Liemburg et al., 2013). Therefore, a 
question arose whether the relative prominence of the two subdomains differed between 
trajectory classes. However a post-hoc one-way ANOVA revealed no significant differences 
between trajectory classes in the proportion of expressive deficit versus withdrawal 
symptoms at baseline (F = 2.22, p = 0.085), suggesting negative symptom trajectories were 
not associated with the type of negative symptoms present at baseline.    
      
The majority of the sample (63.9%) presented with consistently minimal negative symptoms. 
These participants were more likely to recover socially within 12 months than members of 
other classes. Nonetheless, more than half of this group did not make a good social recovery; 
whilst negative symptoms might be an important barrier to social recovery in some 
individuals, they are by no means necessary for poor social recovery.     
   
  
4.2. Clinical Implications 
 
The results of this study indicate that a substantial proportion of those with elevated negative 
symptoms at baseline will achieve remission of these symptoms within 12 months. However, 
even when negative symptoms remit, they are associated with poor social recovery. As such, 
those who present with elevated negative symptoms on entry to EIP services might benefit 
from close monitoring of their functioning and the provision of targeted interventions. Given 
that those with initially high but decreasing negative symptoms were often functioning poorly 
prior to psychosis, it is perhaps not surprising that they struggle to recover socially after its 
onset. Further research focusing on emerging negative symptoms and social disability during 
the prodromal phase would be helpful in understanding how these difficulties develop. It 
might be that intervention at this early stage – after the onset of non-specific negative 
symptoms and early signs of social disability but before the emergence of positive symptoms 
– is warranted (Fowler et al., 2010). Additionally, it might be that it is beneficial to engage 
the children of parents with psychosis in interventions designed to prevent early social 
disability.          
 
4.3. Limitations  
 
Although the PANSS is one of the most widely used measures of negative symptoms 
severity, it has significant limitations, both in its item content and reliance on behavioural 
observations for the assessment of experiential deficits (Blanchard et al., 2011). Measures 
developed since data collection for this study began (e.g. the Clinical Assessment Interview 
for Negative Symptoms (CAINS; Kring et al., 2013)) have sought to address these 
limitations; it would be interesting to compare the results of the current study with those of 
similar future studies that utilise these recently developed negative symptom measures. 
Similarly, whilst the TUS provides a valuable index of social recovery, it is limited in that it 
measures only quantity of engagement in activity, not quality of engagement or the personal 
meaning attributed to it. Considering personal recovery – a concept encompassing 
connectedness, hope, identity, meaning, and empowerment (Leamy et al., 2011) – in addition 
to functioning in future research could help minimise this limitation. 
 
Complete PANSS data at all three time points were only available for 63.4% of participants. 
As previously mentioned, missing data were estimated using full information maximum 
likelihood under the assumption that data were missing at random (MAR). However, there 
was evidence that those with lower levels of negative symptoms at baseline were more likely 
to have missing data: as such, the MAR assumption is not supported. It is arguably preferable 
for a study of negative symptoms to have higher attrition of participants with lower levels of 
baseline negative symptoms than vice versa. Nonetheless, since accepting the unsupported 
assumption that data are MAR introduces bias, the results of the study are in need of 
replication. 
 
Since participants were assessed at only three time points, the model forms that could be 
fitted to the data were limited. Further, the follow-up period of the current study was 
relatively short. Whilst the first 12 months of treatment are an important period for research 
given EIP services’ focus on providing intensive support soon after psychosis onset, it is 
possible that further trajectories would emerge if participants were followed over a longer 
period. A longer term follow-up incorporating more frequent assessment would provide a 
more nuanced picture of variation in negative symptom course. Since pharmacological 
treatment and other interventions could be important factors influencing negative symptom 
trajectories, the impact of treatment variables (including service engagement) on negative 
symptom trajectories should be explored in future research.       
 
4.4. Conclusions 
 
Distinct negative symptom trajectories can be identified within a FEP cohort. Persistent 
negative symptoms are observed in only a small proportion; many of those with high levels 
of negative symptoms at baseline will attain remission of these symptoms within 12 months. 
However where elevated negative symptoms are present at baseline, whether or not they 
remit, they are associated with poor social recovery. Further, even those with consistently low 
levels of negative symptoms mostly do not make a good social recovery following 12 months 
of EIP.   
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Tables: 
 
Table 1.  Sample characteristics and descriptive statistics 
 
 
Percentage Mean (SD) 
 
Median (Q1, Q3) 
 
 
Age at Onset  
 
Male Gender  
     
Ethnicity 
     White British 
     Asian 
     Black  
     Mixed 
     Other 
 
Family History of Non-Affective  
Psychosis  
 
Initial Clinical Diagnosis  
     Unspecified Psychosis 
     Schizophrenia 
     Bipolar 
     Drug Induced Psychosis 
     Paranoid Psychosis       
     Schizoaffective Disorder 
 
Antipsychotic Use at Baseline 
     Typical 
     Atypical 
     Both Typical and Atypical  
     No Antipsychotic 
      
Antipsychotic Use at 12 Months 
     Typical 
     Atypical 
     Both Typical and Atypical  
     No Antipsychotic 
 
Baseline PANSS  
     Positive Subscale 
     Negative Subscale 
     General Subscale 
     Negative Factor Item Average 
 
 
 
- 
 
69.1 
 
 
70.3 
15.5 
6.8 
4.2 
3.3 
 
8.9 
 
 
 
72.0 
10.6 
5.2 
6.7 
3.7 
1.7 
 
 
1.6 
78.7 
7.9 
12.7 
 
 
2.2 
76.5 
2.3 
18.9 
 
 
- 
- 
- 
- 
 
 
 
20.07 (7.78) 
 
- 
 
 
- 
- 
- 
- 
- 
 
- 
 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
15.28 (6.03) 
14.80 (6.52) 
32.85 (9.95) 
2.16 (1.00) 
 
 
 
20 (18, 24) 
 
- 
- 
 
- 
- 
- 
- 
- 
 
- 
 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
15 (10, 19) 
13 (9, 19) 
32 (25, 39) 
1.86 (1.29, 2.86) 
 
 
 PAS Social  
     Childhood 
     Adolescence 
 
PAS Academic 
     Childhood 
     Adolescence 
 
Baseline Calgary Depression 
 
 
 
- 
- 
 
 
- 
- 
 
- 
 
 
 
0.20 (0.21) 
0.23 (0.19) 
 
 
0.26 (0.21) 
0.36 (0.24) 
 
6.30 (5.38) 
 
 
0.17 (0, 0.33) 
0.17 (0.06, 0.33) 
 
 
0.25 (0.08, 0.42) 
0.33 (0.17, 0.50) 
 
5 (2, 10) 
Note. PANSS = Positive and Negative Syndrome Scale; PAS = Premorbid Adjustment Scale  
 
Table 2. Comparison of LCGA models with two to six latent classes 
 2 3 4 5 6 
AIC 5893.21 5740.96 5639.24 5564.28 5464.70 
BIC 5932.52 5795.01 5708.03 5647.81 5562.98 
BLRT 0.00 0.00 0.00 0.00 0.00 
LMR-LRT 0.00 0.06 0.03 0.13 0.06 
Entropy 0.83 0.81 0.79 0.79 0.79 
Classification 
Probabilities 
0.96, 0.90 0.84, 0.94, 
0.89 
0.84, 0.92, 
0.91, 0.79 
0.89, 0.77, 0.91, 
0.83, 0.80 
0.83, 0.76, 0.91, 
0.84, 0.88, 0.87 
Class Size 
(%) 
81, 19 21, 74, 5  14, 64, 5, 17 3, 17, 64, 11, 5 15, 14, 3, 7, 57, 
3 
Note. AIC = Akaike’s Information Criterion, BIC = Bayesian Information Criterion, BLRT = 
Bootstrap Likelihood Ratio Test, LMR-LRT = Lo–Mendell–Rubin Likelihood Ratio Test. 
Lower AIC and BIC values indicate superior fit. A significant BLRT or LMR-LRT value is 
indicative of the model being a better fit than the model with one fewer latent classes. 
Classification Probabilities = mean posterior probabilities for each class, Class Size = 
proportion of the sample making up the membership of each class.  
 
Table 3. Characteristics of latent classes 
Name Class size Unstandardised 
mean intercept 
Unstandardised 
mean gradient 
Significance 
of gradient 
Minimal Decreasing 
 
n = 674 
(63.9%) 
1.62 -0.17  Sig.  
(p = <0.001) 
Mild Stable 
 
n = 108 
(13.5%) 
2.19 0.24  Non sig. 
(p = 0.08) 
High Decreasing 
 
n = 174 
(17.1%) 
3.35 -0.89  Sig. 
(p = <0.001) 
High Stable 
 
n = 50  
(5.4%) 
 
3.58 0.05  Non sig. 
(p = 0.70) 
 
Table 4. Descriptive statistics (mean (SD) unless otherwise indicated) by negative symptom 
trajectory class.  
 Minimal 
Decreasing 
(n = 674) 
Mild Stable 
(n = 108) 
High 
Decreasing 
(n = 174) 
High Stable 
(n = 50) 
Age at Onset 
 
19.99 (8.45) 20.65 (5.27) 20.48 (6.54) 18.46 (6.78) 
Male Gender 
 
66.9% 77.8% 68.4% 82.0% 
White British Ethnicity 
 
70.9% 68.5% 72.4% 58.0% 
Family History 
 
6.9% 9.4% 11.5% 25.5% 
Schizophrenia 
Diagnosis 
 
9.8% 10.8% 9.6% 23.4% 
DUP ≥ 9 months 
 
27.8% 31.8% 28.3% 26.0% 
PAS Social - Childhood 
PAS Social - Adolescence 
          
0.19 (0.20) 
0.21 (0.18) 
 
0.25 (0.25) 
0.26 (0.23) 
 
0.17 (0.19) 
0.26 (0.21) 
 
0.27 (0.21) 
0.31 (0.17) 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
         
0.24 (0.21) 
0.33 (0.24) 
 
0.34 (0.21) 
0.45 (0.24) 
 
0.26 (0.19) 
0.41 (0.25) 
 
0.31 (0.21) 
0.41 (0.21) 
 
Calgary Depression 
 
5.61 (5.03) 
 
7.36 (5.62) 8.04 (5.66) 6.86 (6.60) 
 Substance Use 
 
66.3% 63.2% 68.5% 55.1% 
Note. Family History = Family History of Non-Affective Psychosis; DUP = Duration of 
Untreated Psychosis; PAS = Premorbid Adjustment Scale. 
 
 
 
 
 
 
 
 
 
Table 5. Matrix of intersections between negative symptom trajectory classes and social 
recovery trajectory classes.   
 
 
 High Decreasing 
 
Moderate 
Increasing 
Low Stable 
Minimal 
Decreasing 
 
n = 44 (9.0%) 
Significantly over-
represented 
n = 166 (34.1%) 
Significantly over-
represented 
n = 277 (56.9%) 
Significantly 
under-represented 
Mild Stable 
 
 
n = 4 (4.2%) 
Within expected 
range 
n = 12 (12.5%) 
Significantly under-
represented 
n = 80 (83.3%) 
Significantly over-
represented 
High Decreasing 
 
 
n = 4 (3.1%) 
Within expected 
range 
n = 23 (17.6%) 
Significantly under-
represented 
n = 104 (79.4%) 
Significantly over-
represented 
High Stable 
 
 
n = 1 (2.2%) 
Within expected 
range 
n = 2 (4.4%) 
Significantly under-
represented 
n = 42 (93.3%) 
Significantly over-
represented 
 
Note. The text in each cell refers to whether the class is over- or under-represented according 
to the adjusted standardised residual of the relevant Chi-Squared test.   
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Fig. 1. LCGA with four latent classes: average negative symptom score estimated means  
 
 
 
Fig. 2. Proportion of each negative symptoms trajectory class that followed a social recovery 
trajectory characterised by non-clinical levels of structured activity by 12 months (‘Good 
Social Recovery’) versus those with stably low levels of structured activity (‘Poor Social 
Recovery’).  
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Proposed Supplementary Material: 
 
Supplementary Table. Results of multinomial regression investigating predictors of negative 
symptom trajectories. 
 B (SE) Odds Ratio  
(95% CI) 
 
P Value 
Stable Mild vs. Minimal Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
Stable High vs. Minimal Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
High Decreasing vs. Minimal 
Decreasing 
 
Female vs. Male 
 
 
 
-0.36 (0.30) 
 
0.04 (0.44) 
 
 
0.24 (0.48) 
 
-0.03 (0.84) 
0.63 (0.84) 
 
1.70 (0.90) 
0.52 (0.76) 
 
0.02 (0.02) 
 
 
 
-1.04 (0.48) 
 
-0.86 (0.44) 
 
 
-1.18 (0.44) 
 
-0.12 (1.18) 
2.17 (1.12) 
 
0.79 (1.25) 
-0.07 (1.08) 
 
0.05 (0.03) 
 
 
 
 
-0.06 (0.24) 
 
 
 
 
0.70 (0.39 – 1.25) 
 
1.04 (0.44 – 2.45) 
 
 
1.27 (0.50 – 3.21) 
 
0.98 (0.19 – 5.02) 
1.87 (0.36 – 9.65) 
 
5.50 (0.94 – 32.14) 
1.68 (0.38 – 7.48) 
 
1.02 (0.98 – 1.07) 
 
 
 
0.35 (0.14 – 0.90) 
 
0.42 (0.18 – 1.00) 
 
 
0.31 (0.13 – 0.72) 
 
0.89 (0.09 – 8.95) 
8.79 (0.99 – 78.11) 
 
2.21 (0.19 – 25.74) 
0.93 (0.11 – 7.66) 
 
1.06 (0.99 – 1.12) 
 
 
 
 
0.94 (0.60 – 1.50) 
 
 
 
 
0.23 
 
0.94 
 
 
0.62 
 
0.98 
0.46 
 
0.06 
0.49 
 
0.35 
 
 
 
0.03 
 
0.05 
 
 
0.01 
 
0.92 
0.051 
 
0.53 
0.95 
 
0.09 
 
 
 
 
0.81 
 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
0.37 (0.40) 
 
 
-0.68 (0.34) 
 
-2.21 (0.76) 
2.11 (0.71) 
 
-0.26 (0.77) 
1.01 (0.62) 
 
0.09 (0.02) 
1.45 (0.66 – 3.19) 
 
 
0.51 (0.30 – 0.99) 
 
0.11 (0.03 – 0.49) 
8.26 (2.07 – 33.01) 
 
0.77 (0.16 – 3.67) 
2.75 (0.82 – 9.29) 
 
1.09 (1.05 – 1.14) 
0.35 
 
 
0.046 
 
0.004 
0.003 
 
0.74 
0.10 
 
<0.001 
 
Note. Model: χ2 (24) = 92.50, p <0.001. Family History = family history of non-affective 
psychosis; PAS = Premorbid Adjustment Scale  
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Abstract 
 
Aim:  The PRODIGY trial is an ongoing randomised controlled trial of Social Recovery 
Cognitive Behavioural Therapy (SRCBT), a new intervention designed to improve social 
functioning in young people at risk of long-term social disability due to severe and complex 
mental health problems. The aim of this qualitative sub-study was to understand trial 
participants’ experiences of SRCBT and the control condition, treatment as usual (TAU). 
Method:  Trial participants were aged 16 – 25 with socially disabling severe and complex 
mental health problems. A purposive sample of trial participants took part in in-depth 
qualitative interviews which were transcribed verbatim and analysed thematically.   
Results:  Participants from the SRCBT arm valued the relationship with their therapist, the 
flexibility of intervention delivery and the cognitive and behavioural techniques taught. They 
viewed SRCBT as challenging but worthwhile. Participants from the TAU arm reported 
receiving little support, both prior to and during their participation in the trial. Participants 
from both arms valued opportunities to talk about their difficulties during trial participation. 
Increased activity was an important goal of participants from both arms and most expressed 
high motivation and little hopelessness.  
Conclusions: Currently available services do not meet the needs of some young people with 
socially disabling mental health problems. Motivation to change appears high at this early 
stage of disorder, supporting the potential value of intervening early to prevent longer-term 
social disability. SRCBT was well accepted by participants and so is a promising intervention 
to meet this objective.   
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INTRODUCTION 
 
Three quarters of severe mental health problems are evident before 25 years of age1,2. Such 
disorder comes at high personal, social and economic cost, much of which is attributable to 
associated social disability3. However, the needs of young people with severe and complex 
mental health problems remain largely unmet4,5.  
 
This paper presents a qualitative sub-study of the PRODIGY trial (Prevention of long term 
social disability amongst young people with emerging psychological difficulties, 
ISRCTN47998710, UKCRN registration number: 13341). PRODIGY is a multi-site randomised 
controlled trial (RCT) testing the clinical and cost-effectiveness of Social Recovery Cognitive 
Behavioural Therapy (SRCBT) in young people with severe and complex non-psychotic 
mental health problems accompanied by social disability.  
 
SRCBT is designed to improve social functioning in young people at risk of long-term social 
disability6. Barriers to engagement in activity are formulated using a cognitive behavioural 
therapy approach. The intervention has a strong behavioural focus: individuals are 
encouraged to test their beliefs about increasing activity in behavioural experiments and 
therapists liaise with external agencies to support clients to find opportunities to engage in 
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valued activities. Emphasis is given to understanding individuals’ values and goals, and 
instilling hope.  
 
The use of qualitative methods alongside the PRODIGY trial is an important element of our 
approach to evaluation. Whilst RCTs are the most rigorous way to evaluate intervention 
effectiveness, qualitative methods can provide insights crucial to the successful 
implementation of complex interventions7. The current study focused particularly on 
experiences of SRCBT, aiming to assess acceptability and implementation from participants’ 
perspectives, but also explored experiences of the control condition, treatment as usual 
(TAU). This was deemed important since little is currently known about what support is 
accessed, and how this support is experienced, by socially disabled young people, and thus 
what constitutes TAU for this population. 
 
METHOD 
 
Eligible trial participants were: (a) aged 16–25 years, (b) had severe and complex mental 
health problems, defined as either meeting ‘At Risk Mental State’ criteria according to the 
CAARMS8 or scoring ≤50 on the Global Assessment of Function Scale9, and (c) spending less 
than 30 hours per week in structured activity (assessed by the Time Use Survey10,11). 
Exclusion criteria were psychosis, severe learning disability, organic disorder, and 
insufficient English language proficiency.  
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Following ethical approval from the Norfolk Research Ethics Committee, a purposive sample 
of participants from the RCT’s internal pilot who gave consent to be contacted regarding the 
qualitative sub-study was selected. The aim was to ensure approximately equal 
representation in terms of gender, study site, randomisation arm, and baseline ‘At Risk 
Mental State’. Further, we sought to recruit participants of a range of ages, with varied 
previous service-use, and to include looked-after children and the most socially disabled.  
 
After obtaining written informed consent, face-to-face in-depth semi-structured interviews 
were conducted (by BG in Norfolk and RB in Manchester) either in participants’ own homes 
or a community venue, according to participant preference. Flexible interview schedules 
focused on history of psychological difficulties, previous experiences of accessing services, 
experience of trial participation, views on the intervention received, perceived outcomes, 
and future psychological wellbeing. Interviewers attempted to elicit detailed accounts of 
treatment experiences and probed for negative as well as positive views. Interviews were 
audio recorded and transcribed verbatim.    
 
An inductive thematic analysis was undertaken12,13. Data analysis proceeded alongside data 
collection so that the developing analysis could inform subsequent interviews. We took a 
critical realist epistemological stance, seeking to understand participants’ realities through 
engagement with their individual perspectives. Analysis involved repeated reading of all 
transcripts and line-by-line thematic coding, drawing on participants’ own words rather than 
an a priori analytic framework. Each transcript was independently coded by at least two 
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analysis team members (BG, CN, RB and TC). Where there were discrepancies these were 
discussed and further analysis undertaken to achieve consensus.  
 
RESULTS 
 
Nineteen young people consented to participate. Of those invited to take part, none 
declined participation. Unfortunately, one of the nineteen participants did not engage with 
the interview and a second participant withdrew consent for audio-recording: as such, the 
final sample comprised seventeen participants (see Table 1 for demographic and clinical 
characteristics). Three participants had taken part in an earlier qualitative sub-study 
focusing on experiences of recruitment and randomisation14. Interviews typically lasted 
around 60 minutes.  
 
[Insert Table 1] 
 
Thematic analysis revealed four themes specific to the SRCBT arm, three specific to TAU, 
and three themes spanning the experiences of both arms (Table 2).  
 
[Insert Table 2] 
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Experiences of SRCBT 
 
‘She understood me on a personal level’: the therapeutic relationship 
The therapeutic relationship was central to participants’ experiences of the intervention. 
Participants consistently commented on the positive personal qualities of trial therapists, 
and described the relationship that developed as friendly, informal and genuine, whilst 
remaining professional and boundaried.  
 
I believe she understood me on a personal level as well obviously we didn’t go it 
wasn’t any it wasn’t unprofessional at all but we spoke about sort of things in 
general rather than just straight to the therapy it wasn’t as clinical as I can imagine 
some of these services can be with certain people (Liam) 
 
A good rapport appeared to have developed between participants and therapists: 
participants reported feeling able to talk openly and feeling understood. The way 
participants spoke about their relationship with their therapist suggested a dynamic of 
teamwork: participant and therapist working together towards a shared goal, sometimes in 
partnership with others. 
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 it wasn’t like I was being talked at, all my problems were being dissected in front of 
me without my sort of input, it was a conversation … it wasn’t sort of like someone 
was talking about the problems they thought I had, it was we were finding out what 
problems I had and then sorting them out together (Matthew) 
 
Several participants articulated that this strong therapeutic relationship facilitated their 
continued engagement when the intervention was experienced as challenging. However, for 
a minority, the closeness of the relationship contributed to difficulties ending therapy.  
 
 he was really dedicated to helping me I think he liked me you know and I really liked 
him so I really found a friend in him um which was really nice really, which has made 
it even more difficult that you know we had to finish (Harry)   
 
Flexibility 
Participants appreciated the flexible way in which the intervention was delivered. They 
described being offered a choice of locations for sessions and expressed that this helped 
them to feel comfortable attending and engaging with the intervention.  
 
 I just feel comfortable in college and it’s good that they can do it here cos if I couldn’t 
do it here I wouldn’t do it…I wouldn’t have done it otherwise (Abigail) 
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Some participants also commented that the frequency of sessions was tailored to their 
individual needs and circumstances.  
 
we continued meeting weekly cos I think in the end … we both agreed that it was a 
better idea cos obviously things were so manic and obviously in a hostel things would 
go from really really good to boff really really bad, so it was, yes, we both agreed 
that it was a really good idea to do it every week because then we could keep it up 
(Katie) 
 
‘It’s given me tools’: the CBT toolkit  
Participants spoke about the intervention having equipped them with cognitive and 
behavioural strategies for managing distress and increasing activity. The most commonly 
described behavioural strategies were behavioural experiments and activity scheduling. The 
most commonly described cognitive strategies involved identifying and challenging negative 
thoughts. A range of other techniques specific to participants’ personal difficulties were also 
mentioned. Participants described practicing these strategies with their therapists during 
sessions and most reported that they continued using these strategies independently after 
the intervention. Several participants believed that continued use of the strategies learnt 
during SRCBT contributed to continuing improvement after the intervention’s conclusion.  
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I’ve improved so much and it’s given me a lot of things that I can continue to improve 
on … there’s always going to be things that make me nervous so there’s always going 
to be things that I’m going to want to push myself to do if that makes sense so I 
wouldn’t say I’m over it but I’ve improved so much and it’s given me the building 
blocks to continue to improve (Matthew) 
 
However, one participant felt strongly that he was not ready to employ the strategies he 
had learnt independently and that gains from the intervention were not fully maintained as 
a result. He felt the intervention would need to have been longer for him to have felt 
confident using the techniques independently. 
 
I was worried that things would go sour after [the intervention ended] and it turns 
out that they didn’t stay quite as good after he left … I didn’t haven’t take quite long 
enough to really absorb [the techniques] (Harry) 
 
No pain, no gain: SRCBT as difficult 
Whilst participants generally expressed positive views of SRCBT, they were clear that 
engaging with the intervention was not easy: several said that the intervention was difficult, 
painful or overwhelming at times.  
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it was very difficult because it was dabbling into things that I think I’d just really, 
didn’t really even realise were there because … they were so painful to look at that I 
didn’t really want to so yes it was really tough at the beginning (Katie) 
 
However, the participants commonly felt that this pain was worthwhile. Several participants 
spoke about pushing themselves to complete exercises they knew they would find 
uncomfortable for the sake of their recovery.   
 
 I was nervous I and I was shaking but I thought I need to start somewhere, I could 
always say no but that’s not going to do any good that’s not going to help me 
(Matthew) 
 
Experiences of TAU 
 
Allocation ambivalence 
While two TAU participants expressed unambiguous disappointment about their treatment 
allocation, the majority expressed ambivalent views. Some participants spoke about being 
relieved to be randomised to TAU since they would not have to go through the anxiety 
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provoking experience of meeting a therapist and disclosing their problems. Others 
expressed that their disappointment was countered by altruism.  
 
 I’ll admit to thinking oh maybe that was a bit of a waste of time but … as a scientist 
this research may help other people so at the same time as much as I might not have 
received direct treatment … you need a control group (Ewan) 
 
No treatment, as usual 
The majority of TAU participants described having received little or no professional support 
since randomisation. In most cases, this continued a narrative of limited or inadequate 
support prior to their involvement in PRODIGY. Only two participants described receiving 
specialist mental health support since trial entry, and one of these reported that he was 
unable to sustain his engagement with this support as low mood and lack of motivation led 
him to not attend appointments. Several participants reported having received support 
from their GP but satisfaction with this was generally low. A number of participants 
expressed frustration that the only treatment option they had been offered by their GP was 
medication, illustrated by one participant’s comment that GPs ‘just give you tablets and 
guide you on your way’ (Max).  
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‘I was the one who had to do everything to help overcome it’ 
As most TAU participants received limited professional support, they had to manage their 
mental health independently. Participants who felt that their mental health had not 
improved or had deteriorated since entering the trial expressed frustration at the lack of 
support and a sense of having been abandoned (‘I didn’t even get a phone call … I’ve got no-
one’ (Joshua)). However, some participants had achieved considerable improvement in their 
mental health despite the lack of support and conveyed a sense of pride and achievement at 
having done this on their own. Asked what was responsible for her improvement, one 
participant said: 
 
I don’t want to sound big headed but I think myself … I was the one that had to do 
everything like to help sort of overcome it like sort of thing so and I have done it 
(Amelia) 
 
Overarching Themes 
 
‘It’s just the speaking to someone’: the value of talking 
Participants from both trial arms emphasised the value of speaking to someone about their 
problems, many having been reluctant to talk about their problems prior to participating in 
the trial (‘[I realised] talking to people about things isn’t a bad thing to do, it actually really 
Running Title: Young People’s Experiences in the PRODIGY Trial 
helps’ (Katie)). The noted benefits of talking formed two sub-themes: ‘it’s not boiled up in 
me no more’ and ‘it helped me recognise the things that I wanted to change’. The first sub-
theme included descriptions of the way in which talking about problems can provide a sense 
of release. The second sub-theme encompassed expressions that talking had facilitated 
greater self-understanding. 
 
it helped to identify little problems that I was having or little symptoms um and I feel 
like once they’d been identified to you then you can deal with them a lot better 
(Ewan) 
 
‘Just do it’: the importance of activity 
Meaningful activity was seen as important by participants from both trial arms. For 
participants who received SRCBT, ‘doing things’ was an important element of the 
intervention. Increasing occupation also appears to have been important for the TAU group 
with several describing making a concerted effort to increase their activity levels.  
 
 doing things that like I wouldn’t normally you know stuff that would make me feel 
really anxious just like I know I have to just do it like regardless of the feelings I’ve got 
or thoughts or anything I know I have to just do it (Amelia) 
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Amongst TAU participants who did not achieve such positive outcomes, continuing inactivity 
served as a marker of limited progress. Asked to elaborate on his statement that things had 
got worse for him, one participant responded: ‘[I’m] stuck in the house all day doing 
nothing, just eating and that, just doing nothing’ (Max). 
 
Motivation to change 
A determination to make changes was evident in nearly all participants’ interviews. This 
determination was evidenced in participant’s willingness to engage with challenging aspects 
of SRCBT, and in the resolve of members of the TAU group to move forward despite limited 
support. For a number of participants, high motivation appeared to be related to age: both 
impending adulthood and relative youth were cited as impetuses for change. The lack of 
hopelessness in participants’ accounts was notable.  
 
 I’ve always had a little bit of fight left inside me no matter what I’m going through, 
always wanted to be a better person and you know live a normal life, so no matter 
how depressed or sort of ill so to speak in those terms I can become there’s still 
something inside me that says you will, you need to beat this, you need to carry on 
(Liam) 
 
  
Running Title: Young People’s Experiences in the PRODIGY Trial 
DISCUSSION 
 
The themes identified suggest that participants in the PRODIGY trial found SRCBT acceptable 
and perceived it to be beneficial. The strength of the therapeutic relationships that 
developed between therapists and participants, and the flexible way in which the 
intervention was delivered, appear to have been key to successful engagement of a 
potentially hard to engage population. Although several participants described the 
intervention as sometimes difficult, this temporary discomfort was seen as necessary for 
achieving longer term gains. Participants expressed that the intervention had equipped 
them with a ‘toolkit’ of cognitive and behavioural strategies which most, but not all, felt able 
to use independently after the intervention’s conclusion.  
 
TAU participants expressed more mixed opinions of the support received. Most TAU 
participants reported having received limited professional support and were often 
dissatisfied with this support. Nonetheless some participants had made considerable gains 
since entering the trial and conveyed a sense of pride at having made these positive changes 
independently. 
 
The study’s findings indicate that it is possible to successfully engage young people with 
socially disabling mental health problems in treatment. The surprisingly high motivation to 
change and low hopelessness expressed by participants suggests that investing in 
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interventions for young people at this relatively early stage of disorder might pay dividends. 
The aspects of SRCBT participants valued mirror priorities for mental health services 
consistently identified in previous research: for instance the importance of service flexibility 
and accessibility, and practitioners able to establish supportive relationships with young 
people15. However, these consistent messages about what young people want have often 
failed to translate into service provision16. Given this, it is perhaps unsurprising that 
specialist mental health services are accessed by only a small proportion of young people in 
need17, reflected in the low mental health service utilisation of the TAU group. 
 
There is an increasing focus in psychotherapy research on acknowledging possible adverse 
effects of therapy18,19. Qualitative studies of CBT have identified a range of possible negative 
effects, usually described by study participants as short-term, acceptable consequences of 
addressing difficult issues20–22. Similarly, a number of participants in the present study 
identified some negative effects of SRCBT. Importantly, these were viewed as short-term 
and necessary; no participant described sustained negative effects of SRCBT.  
 
Limitations 
Since the study was qualitative, the findings cannot be assumed to generalise beyond the 
setting in which it was conducted. For instance, whilst we found participants were 
motivated and hopeful, this finding may be specific to those young people willing to engage 
in a RCT. In addition, although purposive sampling was intended to maximise the likelihood 
of capturing a wide range of views, it was only possible to select from the subset of 
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consented trial participants. Those with less positive experiences of trial participation may 
have been less likely to consent to being approached, resulting in failure to capture certain 
experiences.  
 
Some members of the study team were involved in the implementation of the RCT and may 
have unwittingly minimised negative views of trial participation and emphasised positives. 
We attempted to decrease this risk by remaining cognizant of and reflecting on our 
potential biases throughout and by involving researchers not involved in the RCT. Further, 
although efforts were made to encourage participants to express negative views, perceived 
lack of independence may have discouraged this.  
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Tables 
Table 1. Demographic and clinical information about participants.  
Pseudonyma Age 
Group 
Gender Group Site SCIDb Research 
Diagnoses 
At risk 
mental 
statec 
Social 
Functioningd 
Liam 20-25 Male SRCBT Manchester GAD 
 
No Very low 
Abigail 16-19 Female SRCBT Manchester Depression, Panic 
disorder, PTSD 
No Very low 
Ewan 20-25 Male TAU Manchester Dysthymia, OCD 
 
No Low 
Ben 20-25 Male TAU Manchester Social phobia 
 
No Very low 
Kirsty 16-19 Female TAU Manchester Agoraphobia without 
panic 
No Very low 
Sarah 20-25 Female SRCBT Manchester PTSD, Anxiety 
disorder not 
otherwise specified  
Yes Very low 
Joshua 20-25 Male TAU Manchester Depression, 
Agoraphobia, GAD 
Yes Low 
Maria 16-19 Female TAU Manchester Depression, OCD 
 
Yes Low 
Katie 16-19 Female SRCBT Norfolk Depression, Specific 
phobia 
Yes Very low 
Emma 16-19 Female SRCBT Norfolk Social phobia, Body 
dysmorphic disorder 
Yes Very low 
Harry 20-25 Male SRCBT Norfolk None 
 
No Low 
Sophia 16-19 Female TAU Norfolk Depression 
 
No Very low 
Matthew 16-19 Male SRCBT Norfolk Depression, Social 
phobia, GAD 
Yes Low 
Bethany 16-19 Female SRCBT* Norfolk Depression, Panic 
disorder, Social 
phobia  
No Low 
Max 
 
16-19 Male TAU Norfolk Agoraphobia without 
panic, GAD 
No Very low 
Luke 16-19 Male TAU Norfolk Social phobia 
 
No Very low 
Amelia 16-19 Female TAU Norfolk Depression, Panic 
disorder, GAD 
No Very low 
SRCBT, Social Recovery Cognitive Behavioural Therapy; TAU, Treatment As Usual; PTSD, Post-Traumatic 
Stress Disorder; OCD, Obsessive Compulsive Disorder; GAD, Generalised Anxiety Disorder 
aPseudonyms are used throughout to protect the anonymity of participants.  
bStructured Clinical Interview for DSM-IV.  
cAssessed using the Comprehensive Assessment for At Risk Mental States (CAARMS). 
dAssessed as hours per week of structured activity as reported in the Time Use Survey (low, 15-30 hours 
per week structured activity; very low, < 15 hours per week structured activity).  
*Did not receive a ‘dose’ of SRCBT due to difficulties with engagement. 
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Table 2. Themes identified as characteristic of the experience of SRCBT, TAU and both.   
SRCBT 
 
TAU 
‘She understood me on a personal level’: 
the therapeutic relationship  
 
Flexibility 
 
‘It’s given me tools’: the CBT toolkit 
  
No pain, no gain: SRCBT as difficult 
 
Allocation ambivalence  
 
No treatment, as usual 
 
‘I was the one who had to do everything to 
help overcome it’ 
Overarching Themes 
 
 
‘It’s just the speaking to someone’: the value of talking 
- ‘it’s not boiled up in me no more’ 
- ‘it helped me recognise the things that I wanted to change’ 
 
‘Just do it’: the importance of activity 
 
Motivation to change 
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Abstract  
 
Background: Understanding negative symptoms is important given their association with 
poor outcomes but lived-experiences of negative symptoms in first-episode psychosis have 
yet to be investigated.  
Aim: To explore the lived-experience of negative symptoms through secondary analysis of 
in-depth interviews conducted with individuals recovering from first-episode psychosis. 
Method: Transcripts of in-depth interviews with participants (n = 24) recruited from Early 
Intervention in Psychosis services were analysed thematically with a focus on participants’ 
experiences and personal understandings of negative symptoms. 
Results: Descriptions of reductions in communication, social withdrawal, lack of motivation 
and reduced enjoyment were common features of participants’ accounts. Several participants 
described the experience of having difficulty interacting as like being a ‘zombie’. Participants 
typically attributed these difficulties to medication side-effects, lack of confidence, and 
avoidance of potential rejection or ridicule. 
Conclusions: Personal accounts support the contention that deficit presentations are often 
underpinned by active psychological processes. 
Declaration of Interest: None.   
 
Key words: negative symptoms; psychosis; lived-experience; qualitative research; 
thematic analysis  
Introduction 
 
Negative symptoms are observed across the spectrum of functional psychoses1 and have been 
identified as a significant predictor of poor recovery following first-episode psychosis2–4. 
They are a treatment priority for many service-users; in a survey of people with lived-
experience of psychosis ‘reducing apathy and lack of initiative’ was ranked as the most 
important treatment goal5. However, current treatment options for negative symptoms are 
limited6. Psychosocial interventions for the treatment of negative symptoms show promise7 
but their development is hindered by our limited understanding of the psychosocial 
underpinnings of negative symptoms8.  
 
The potential for qualitative research to contribute to understanding psychosis has been 
increasingly recognised9,10. Qualitative methods have been used to explore, among other 
topics, the phenomenology of psychotic symptoms11–13, the personal meanings attributed to 
them14–16, experiences of treatment17–19, and the process of recovery20,21. Qualitative 
investigations of psychosis attempt to prioritise participants’ understandings and 
interpretations of their experiences. As such, they are able to provide insights into lived-
experiences of psychosis and the personal meanings attributed to these experiences.   
 
Little it currently known about personal constructions of negative symptoms since research 
has rarely examined negative symptoms from the perspective of those with lived-experience. 
Understanding lived-experiences of negative symptoms has the potential to offer insights into 
the complex psychosocial processes underlying these presentations, facilitating improved 
intervention. The current study aimed to explore lived-experiences of negative symptoms 
through thematic analysis of in-depth interviews conducted with individuals recovering from 
a first-episode of psychosis. 
 
Methods 
 
Context 
 
The study involved qualitative secondary analysis of transcripts of in-depth longitudinal 
interviews conducted for the Super EDEN study (Chief Investigator, MB; Qualitative Lead, 
AL). Super EDEN followed-up participants in the National EDEN study, a national 
evaluation of Early Intervention in Psychosis (EIP) services22, for a further two years. 
Participants in the study’s qualitative component were interviewed every 12 months during 
the follow-up period. All National EDEN participants were invited to take part in Super 
EDEN: 518 service-users consented, 207 of whom participated in the qualitative component. 
The study obtained NHS ethical approval before commencing and adhered to Good Clinical 
Practice guidelines.  
 
Participants and Sampling 
 
Participants were included in the cohort on the basis of having met the acceptance criteria for 
a participating EIP service; no special inclusion criteria were imposed. The acceptance 
criteria of the participating services were in line with the Department of Health’s Policy 
Implementation Guideline and included: presence of a psychotic disorder consistent with an 
ICD-10 diagnosis F20-29; aged 14 – 35 years; and no previous treatment for a psychotic 
episode.  
 
A purposive sample of Super EDEN participants was selected for inclusion in the current 
study. Participants were selected to maximise variation in gender, ethnicity and study site, as 
well as early negative symptom severity and stability (ascertained by establishing their 
negative symptom latent trajectory class membership23). The final sample comprised 24 
participants. Participants’ demographic characteristics and negative symptom severity scores 
are presented in Table 1. Pseudonyms are used to protect participant anonymity.   
 
[Insert Table 1] 
 
Data Collection 
 
Interviews explored various aspects of the lived-experience of psychosis, including 
experiences of symptoms, relationships with family and friends, treatment and recovery. 
Motivated by a desire to prioritise the interests and concerns of participants and underpinned 
by the interpretive qualitative framework of medical anthropology24,25, interview schedules 
were developed iteratively; schedules were amended to reflect themes participants had guided 
earlier interviews towards. Schedules were developed in collaboration with a panel of young 
people with personal experience of psychosis.  
 
Written, informed consent was sought before interviews commenced and reconfirmed 
verbally after completion. Interviews were conducted by trained research assistants, either in 
the participant’s home or a community venue according to participant preference. They were 
designed to take around one hour but varied in length according to the level of detail 
participants provided. Interviews were audio-recorded and transcribed verbatim by a 
professional transcription company.  
Analysis 
 
Qualitative secondary data analysis involves utilising previously collected qualitative data to 
answer new or additional research questions26. Since qualitative data collection is resource 
intensive and the resulting data often extremely rich, re-use of qualitative data is an important 
means of making efficient use of limited resources. Ways in which qualitative secondary 
analysis can generate new insights include ‘prioritising a concept or issue that was present in 
the original data but was not the analytical focus’ and selecting ‘purposively from the sample 
used in the original study’27. These strategies were used in tandem in the current study.  
 
The analysis took an inductive thematic approach28,29. Informed by critical realism which 
recognises that each individual has a unique experience of reality, we sought to understand 
participants’ realities through close engagement with their individual narratives. Analysis was 
data-driven with coding drawing on the words used by participants themselves rather than an 
a priori analytic framework. Initial coding was completed by hand and the codes refined and 
themes developed with the aid of qualitative data analysis software NVivo30. All transcripts 
were analysed by the first author and a small number of randomly selected transcripts 
independently analysed by the second author as a cross-check on the quality of the analysis.  
 
Results 
 
The phrase ‘negative symptoms’ featured in the transcripts only once, but descriptions of 
experiences corresponding to the negative symptom construct featured in all but four of the 
participants’ accounts.  
‘Like a zombie’ 
 
Many participants recounted difficulties interacting with others during their episode of 
psychosis. Participants frequently mentioned that they did not talk as much as usual and some 
described being unable to express appropriate emotions in response to significant life events. 
The simile ‘like a zombie’ was used by several participants when describing these 
experiences:  
  
 "I wasn't moving, I was sitting down … I wasn't talking. I was just like, you know, 
like a zombie, just sitting there … I'd just sit down and not interact with anyone". 
 Aisha, Birmingham 
 
"Before I was just sitting all day and not speaking at all and not showing any reaction 
when people were talking to me … I didn’t even like say anything when my sister had 
a baby. I wasn’t even interested. I was just like a zombie". 
Jennifer, Lancashire 
 
Through the use of this simile, participants evoked the sense of otherness they experienced. 
In addition to feeling remote from others, several participants also indicated that they felt 
remote from themselves. For instance, Callum commented that he was not himself whilst in 
this zombie-like state:  
 
"I’m a zombie. Like when I’m walking around. People ask me questions and I’m like 
‘err’ … I’m not me".  
Callum, Cheshire 
 
Thus for some participants, disruption in the ability to interact as usual appears to have led to 
a discontinuity in their identity. 
 
  
Diminished internal experience 
 
A small number of participants reported reduced internal experience resulting in reduced 
speech or emotional expression. For instance, Clara explained that she struggled to 
communicate because she felt ‘numb’ and ‘blocked’:  
 
P: "I couldn't really communicate with anybody. Erm it's difficult to describe 
myself". 
R: "Did you feel locked in? Or?" 
P: "I didn't feel like detached. And I, I didn't feel like anything". 
R: "Sort of empty? Or?" 
P: "Yeah. Erm numb. Blocked. My head was sort of blocked. I couldn't think, 
therefore couldn't speak, because I didn't know what to say".  
Clara, Cornwall  
 
For Jennifer, a lack of emotional expression was symptomatic of an inability to experience 
strong emotions:  
 
"I’d been not been able to have any feelings or anything and just like except to have 
feelings of anxiety but I didn’t have feelings like that. Do you know that twin towers, 
when it crashed, I didn’t care. I sat watching it, I was like, oh yeah boring. But now, 
when I watch programmes on it, I was nearly crying because I was like oh it’s so 
dramatic and emotional and everything. But I remember distinctly when it happened, I 
just sat there staring … I didn’t have any feelings for any of it. It was horrible. It was 
like I’d been possessed by a demon or something, it was really weird. It was like I 
wasn’t even in my own body".  
Jennifer, Lancashire 
 
Similarly, some participants explained decreased motivation as a consequence of a profound 
reduction in their enthusiasm for life:  
 
"it’s harder for me to enjoy [activities] because you do feel like you’ve had so much 
sucked out of you that, it’s like that inner child it’s a bit like someone’s taken it by the 
neck, strangled it, it’s just survived and then shaken it again and then said, right your 
life’s never going to be the same again … we go to the park, we go out for lunch, we 
go into town and go to groups or whatever and I do do that but just not with as much 
gusto as I did before". 
Isabella, Cambridgeshire  
Such accounts align with psychiatric characterisations of negative symptoms, which take 
reductions in expression and activity to be indicative of limited emotional range, reduced 
capacity for thought, lack of drive and reduced hedonic capacity. However, diminished 
internal experience was described by only a minority of participants who reported reductions 
in expression, motivation or sociability. 
 
Medication side-effects 
 
The explanation for decreased expression, motivation and sociability most frequently given 
by participants was that these were side-effects of prescribed medications. Participants 
commented that the sedative effect of medication decreased their drive to engage in activities 
requiring relatively more effort and energy. Some participants described a trade-off between 
controlling positive symptoms and the negative impact of sedation on their ability to socialise 
and participate in activities: 
 
"Because my thoughts were racing in really weird directions, they thought that a more 
sedative tablet would be better for me. But, of course, then that meant that I wasn’t 
going out very much. I wasn’t socialising. I wasn’t really doing the things that may 
have helped me, you know, in the other part, the not medication part".  
Hayley, Cornwall  
 
For other participants, lack of motivation was not seen as a direct side-effect of medication 
but of weight-gain associated with use of antipsychotics: 
 
"I feel like the heavier I am, the more harder for me to move around. And when I was 
lighter I was more active and doing loads of things and I had motivation and 
everything. And now like - my motivation - like before I had loads of motivation.  
Now that my motivation isn't really there. It's like someone has to push me to do 
things". 
Aisha, Birmingham 
 
‘A confidence thing’ 
 
Lack of self-confidence was another explanation participants gave for decreased expression, 
motivation and sociability. For Yasmin, this lack of confidence was linked to her behaviour 
during her episode of psychosis:     
 
"I don’t talk to anybody that much and I haven’t got confidence left in me, because I 
think, ‘Oh, my God.’ I’m not sure about things which I’m doing. Like, am I not, am I 
doing right or not, because, you know, like, when you’re unwell, you don’t realise, do 
you? So it made me think, like, I’ve got no confidence, like, I don’t know if what I’m 
doing is right or wrong".  
Yasmin, Lancashire  
 
Yasmin talked at some length about her experience of behaving in ways that she afterward 
viewed as inappropriate and thus experiencing crippling doubt about even simple everyday 
activities and interactions. She expressed that she no longer made plans for the future because 
she felt she wouldn’t be capable of carrying them out.  
 
Whilst Yasmin described a global lack of confidence, for other participants their lack of 
confidence was specific to a certain domain. For instance, Clara discussed her reluctance to 
engage in “intellectual” conversations due to reduced confidence in her cognitive capacities: 
 
"I found it very difficult to learn again when I started to get back into things. I 
couldn't process information … an intellectual conversation with someone, that scares 
me because I feel like I don't know. And perhaps that's a confidence thing. I know 
things that they don't know perhaps, but it just seems like I don't have that, that way of 
being able to process information or to capture the - to have that information that I 
had before".  
Clara, Cornwall 
 
  
Active avoidance 
 
Participants often presented social withdrawal as a deliberate strategy, intended to protect 
them from rejection or ridicule. Several participants spoke about deliberately cutting contact 
with friends or making fewer efforts to form new friendships than they would have done 
before experiencing psychosis: 
 
"When I had the psychosis and the problems I cut myself off from a lot of people, I 
withdrew and I lost a lot of friends through that".  
John, Birmingham 
 
"[I’m] perhaps not so likely to take the risk to get to know a lot more people I think. I 
tend to sort of see what happens and go with that rather than sort of try and make 
more, try and widen my social circle by talking to more people … before [the 
psychosis] I think perhaps I'd be a bit more keen to sort of get to know people better 
and perhaps be a little bit more intent on making friends I suppose in that way".   
Isabella, Cambridgeshire 
 
For Isabella, getting to know new people following her psychotic episode was a risk where 
before it had been an opportunity. Isabella was aware that her strategy of protecting herself 
through putting ‘the boundaries up’ had resulted in a smaller social network but saw this as a 
price worth paying for avoiding ‘trouble’.   
 
Some participants linked their decision to withdraw to the stigma surrounding psychotic 
disorders. For instance, Ben explained that his withdrawal from friendships was connected to 
the shame he felt about his psychosis: 
 
"My relationship with, erm, quite a few of my friends has changed in a negative way, 
and it’s not been because of prejudice or lack of understanding on their part, it’s 
because at first I felt very ashamed, and I deliberately cut them out of my life".  
Ben, Birmingham  
 
In common with Ben, participants generally expressed that it was not stigma from others, but 
internalised stigma or fear of stigma which contributed to their withdrawal. Participants were 
often acutely aware of negative media portrayals of psychosis and this fed their fears about 
how others would perceive them. Aidan, who had lost contact with all his former friends 
expressed that he believed others would find him ‘disgusting’ if they knew about his 
symptoms.  
 
Shame and stigma were also key to some participants’ decisions to avoid romantic 
relationships. Several participants shared Jennifer’s dilemma: 
 
"It’d be really really hard to establish a relationship because you wouldn’t know when 
to say to them, ‘I’ve got schizophrenia’ because if you leave it too late, they’ll say, 
‘Oh why didn’t you tell me, you’ve led me on.’ And if you say it too soon, they’d 
never even speak to you because they’ll just assume you’re mad and it’s very very, 
that’s very difficult".  
Jennifer, Lancashire 
 
Jennifer had ruled out the possibility of forming an intimate relationship and consequently 
believed she would never be in a position to marry or have children. Negative symptoms 
measures often consider lack of intimate relationships in individuals with psychosis to be 
indicative of diminished capacity for emotional closeness. Jennifer’s account offers the 
alternative explanation that some people with experience of psychosis may have given up 
hope of fulfilling their desire for an intimate relationship due to the perceived impossibility of 
establishing one.  
 
Some participants employed a strategy of avoidance in order to escape negative evaluation of 
their changed appearance following medication induced weight-gain. For instance, Clara 
explained that her weight increased rapidly whilst on antipsychotic medication and, as a 
result, she avoided social situations in order to protect herself from the critical gaze of others: 
 
P: "I think that [weight-gain] gave me a lot of the anxiety I had from err not 
going out, not wanting to see anybody that I knew, because I had my episode 
and was in the ward in London, then came back down. No one knew what 
had happened to me, but I was huge and I wasn't talking to anyone". 
R: "Okay.  So it made you more socially isolated?" 
P: "Oh yeah. I didn't want anyone to see me like that. I know it's sad, but I 
really didn't". 
Clara, Cornwall  
 
Clara described her fear that her sudden weight-gain would alert people to her use of 
antipsychotics, thus exposing her to the stigma associated with psychosis. 
 
Discussion 
 
In a purposive sample of EIP service-users who presented with varied negative symptom 
severity and stability during their first-episode of psychosis, experiences corresponding to the 
negative symptoms construct commonly featured in accounts of the experience of psychosis. 
Participants’ narratives challenge the widespread framing of negative symptoms as passive 
manifestations of diminished capacity and display the often profound personal and social 
impact of the experience of negative symptoms. 
 
Several participants used the simile ‘like a zombie’ to describe their experience of having 
difficulties interacting with the world around them, evoking a sense of otherness. For some, 
this experience led them to feel remote not only from other people, but also from themselves. 
Such accounts suggests that European phenomenological approaches to psychosis31 may 
continue to be of relevance in understanding the subjective experience of negative symptoms. 
These approaches suggest that negative symptoms are not straightforward deficit states but 
are instead characterised by positive experiential disturbances stemming from core 
disturbances in the sense of self32. 
 
Participants offered varying explanations of the negative symptom-like experiences they 
described. Consistent with research carried out with individuals with more chronic 
psychosis11,33, reduced communication and lack of motivation were often viewed as 
medication side-effects. As such, it is possible that the experiences described by some 
participants do not relate to primary negative symptoms but to negative symptoms secondary 
to medication side-effects.  
 
Some participants described decreased emotional experience, capacity for thought or drive as 
lying behind changes in their behaviour. This finding echoes Krupa et al.’s34 report that some 
individuals recovering from psychosis describe a deadening of emotions and increased 
apathy, turning participation in previously valued activities and social interactions into 
experiences to be endured. Participants also identified lack of confidence as a reason for 
negative symptom-like behaviour. Previous psychotic symptoms and the perception of 
decreased cognitive capacities undermined participants’ confidence in their abilities, leading 
to decreased activity and interaction. This finding supports quantitative evidence that 
pessimistic assessments of cognitive and social capabilities may be implicated in negative 
symptom maintenance35,36.  
 
Active avoidance was also frequently recounted. Several previous studies have identified 
withdrawal as a strategy used by individuals experiencing psychosis to minimise potential 
embarrassment or rejection33,37–39. The apparent contribution of internalised and perceived 
stigma to some participants’ active avoidance is in accord with previous research suggesting 
that withdrawal is a common reaction to feeling excluded from society as a result of mental 
health problems33. These findings highlight the role of agency in negative symptom 
presentations, echoing Corin’s reframing of negative symptoms as ‘positive withdrawal’40: a 
recovery strategy characterised by the deliberate maintenance of distance from normative 
social roles and relationships. They also intersect with cognitive models of negative 
symptoms which contend that apparent deficit presentations are often underpinned by active 
psychological processes41,42. 
 
Limitations 
 
Since the study used qualitative secondary analysis, participants were not specifically asked 
about their experience of negative symptoms. Had an interview schedule specifically 
designed to elicit accounts of negative symptoms been employed, further insights might have 
been gained. However the use of secondary data also conferred advantages, making it 
possible to observe the extent to which negative symptoms were brought up spontaneously 
and the explanatory frameworks used by participants themselves.   
 
The timing of data collection could also be considered a limitation. Participants were 
interviewed for the first time towards the end of their time with EIP or following discharge, 
in some cases several years after their index episode. It is possible this hindered participants’ 
ability to recall their experiences. However, time having passed since the onset of their 
psychosis might also have afforded participants more time to reflect on their experiences.  
 
  
Clinical Implications 
 
The findings indicate the potential value of exploring clients’ personal understandings of their 
negative symptoms and suggest that particular attention should be paid to the possible impact 
of medication side-effects, diminished internal experience, low self-confidence and avoidant 
coping strategies. Clinicians should also consider the possible contribution of internalised 
stigma to negative symptom presentations. That participants often described active 
psychological processes as underpinning the negative symptom-like experiences they 
described supports the potential for tailored psychological interventions to ameliorate 
negative symptoms.   
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Tables 
Table 1. Sample demographic characteristics and mean negative symptom severity scores 
Pseudonyma Study Site Ethnicity Ageb Mean Negative Symptom Scorec 
Baseline 6M  12M 
Daniel 
Max 
Nathan 
Yasmin 
Tom 
Hayley 
John 
Norfolk 
Cheshire 
Birmingham 
Lancashire 
Cambridgeshire 
Cornwall 
Birmingham 
White British 
White British 
White British 
Asian Pakistani 
White British 
White British 
White British 
20 
27 
26 
28 
20 
28 
31 
4.00           4.43          4.00 
4.00           3.43          2.71 
3.43           3.29          2.57          
1.57           3.29          2.57 
1.71           2.29          2.14 
3.00           2.86          2.86 
2.57           3.00          2.57 
Jacob 
Aisha 
Oliver 
Stacey 
Aidan 
Steve 
Birmingham 
Birmingham 
Cornwall 
Cornwall 
Norfolk 
Lancashire 
Black Caribbean 
Asian Pakistani 
White British 
White British 
White British 
White British 
28 
28 
30 
27 
25 
27 
3.43           3.43          1.00 
3.29           2.00          1.43 
3.14           1.29          2.00 
4.29           2.29          1.29 
3.00           3.43          2.14 
2.86           3.71          2.14 
Philip 
Nazir 
Alexander 
Shelly 
Isabella 
Jennifer 
Ben 
Kelly 
Clara 
Jack 
Callum 
Norfolk 
Lancashire 
Devon 
Birmingham 
Cambridgeshire 
Lancashire 
Birmingham 
Norfolk 
Cornwall 
Cambridgeshire 
Cheshire 
White British 
Other Asian 
Other White 
Black Caribbean 
White/Asian 
White British 
White/Caribbean 
White British 
White/African 
White Irish 
White British 
37 
21 
32 
28 
35 
30 
27 
22 
30 
29 
27 
 
1.00          1.29          1.29 
2.29          2.29          1.86 
1.00          2.57          1.00 
1.29          1.57          1.29 
1.57          1.14          1.14 
2.14          1.57          1.00 
2.43          1.57          1.14 
1.43          1.57          1.71 
2.14          1.00          1.00 
1.71          1.00          1.00 
1.14          1.00          1.00 
aPseudonyms are used throughout to protect the anonymity of participants. 
bAge at initial interview. 
cMean negative symptoms score (min 1; max 7) for the seven PANSS items (‘blunted affect’ (N1), ‘emotional 
withdrawal’ (N2), ‘poor rapport’ (N3), ‘passive social withdrawal’ (N4), and ‘lack of spontaneity and flow of 
conversation’ (N6), ‘motor retardation’ (G7) and ‘active social avoidance’ (G16)) found to indicate the negative 
symptoms construct in a factor analysis of PANSS data from the EDEN cohort. 
 
